TW384286B - Novel cyclic urea derivatives and their use in inhibiting cell aggregation and thrombosis - Google Patents
Novel cyclic urea derivatives and their use in inhibiting cell aggregation and thrombosis Download PDFInfo
- Publication number
- TW384286B TW384286B TW083101259A TW83101259A TW384286B TW 384286 B TW384286 B TW 384286B TW 083101259 A TW083101259 A TW 083101259A TW 83101259 A TW83101259 A TW 83101259A TW 384286 B TW384286 B TW 384286B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- tetrahydro
- ethyl
- methyl
- trans
- Prior art date
Links
- 230000002776 aggregation Effects 0.000 title claims abstract description 7
- 238000004220 aggregation Methods 0.000 title claims abstract description 7
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 5
- ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical class OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 title claims description 4
- 208000007536 Thrombosis Diseases 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 137
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 134
- 239000000203 mixture Substances 0.000 claims abstract description 59
- 150000003839 salts Chemical class 0.000 claims abstract description 28
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 18
- 150000007524 organic acids Chemical class 0.000 claims abstract description 6
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 336
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 250
- -1 hexahydropyridyl group Chemical group 0.000 claims description 149
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 147
- 229920001296 polysiloxane Polymers 0.000 claims description 124
- 238000011049 filling Methods 0.000 claims description 108
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 105
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 97
- 229910052757 nitrogen Inorganic materials 0.000 claims description 96
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims description 84
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 81
- 238000002844 melting Methods 0.000 claims description 79
- 230000008018 melting Effects 0.000 claims description 79
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 74
- 230000002079 cooperative effect Effects 0.000 claims description 63
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 62
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 52
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 50
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 49
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 46
- 125000004432 carbon atom Chemical group C* 0.000 claims description 45
- 229910052739 hydrogen Inorganic materials 0.000 claims description 41
- 239000001257 hydrogen Substances 0.000 claims description 40
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 38
- 125000003545 alkoxy group Chemical group 0.000 claims description 36
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 35
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 34
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 34
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 28
- 125000002947 alkylene group Chemical group 0.000 claims description 28
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 24
- 150000003254 radicals Chemical class 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 17
- 125000004429 atom Chemical group 0.000 claims description 16
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 14
- 125000005605 benzo group Chemical group 0.000 claims description 13
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims description 13
- 229910052717 sulfur Inorganic materials 0.000 claims description 12
- 125000005842 heteroatom Chemical group 0.000 claims description 11
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 11
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 claims description 10
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 10
- 150000007857 hydrazones Chemical class 0.000 claims description 9
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 238000000354 decomposition reaction Methods 0.000 claims description 7
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 7
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 7
- 229910052710 silicon Inorganic materials 0.000 claims description 7
- 239000010703 silicon Substances 0.000 claims description 7
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 6
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 235000005985 organic acids Nutrition 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 claims description 3
- 230000010100 anticoagulation Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 238000005034 decoration Methods 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims 3
- 239000010949 copper Substances 0.000 claims 3
- 241000736199 Paeonia Species 0.000 claims 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims 2
- 241000282376 Panthera tigris Species 0.000 claims 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 claims 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims 1
- 230000004520 agglutination Effects 0.000 claims 1
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 230000009747 swallowing Effects 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 11
- 125000003342 alkenyl group Chemical group 0.000 abstract description 9
- 229910052701 rubidium Inorganic materials 0.000 abstract description 6
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical group OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 78
- 229910001868 water Inorganic materials 0.000 description 72
- 230000002441 reversible effect Effects 0.000 description 60
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 59
- 125000003118 aryl group Chemical group 0.000 description 58
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 56
- 239000000243 solution Substances 0.000 description 56
- 238000006243 chemical reaction Methods 0.000 description 51
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 48
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 44
- 239000000460 chlorine Substances 0.000 description 43
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 36
- 229910052786 argon Inorganic materials 0.000 description 36
- 239000002253 acid Substances 0.000 description 32
- 239000002585 base Substances 0.000 description 32
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
- 239000002904 solvent Substances 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 239000000741 silica gel Substances 0.000 description 30
- 229910002027 silica gel Inorganic materials 0.000 description 30
- 230000000875 corresponding effect Effects 0.000 description 29
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 29
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 28
- 239000012267 brine Substances 0.000 description 28
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 26
- 150000001412 amines Chemical class 0.000 description 26
- 230000027455 binding Effects 0.000 description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- 238000006467 substitution reaction Methods 0.000 description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 21
- 235000019441 ethanol Nutrition 0.000 description 21
- 229960000583 acetic acid Drugs 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 19
- 125000004076 pyridyl group Chemical group 0.000 description 19
- 125000001072 heteroaryl group Chemical group 0.000 description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 17
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 17
- 125000003277 amino group Chemical group 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 15
- 150000001721 carbon Chemical group 0.000 description 15
- 238000001819 mass spectrum Methods 0.000 description 15
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 15
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 15
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 14
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
- 125000003282 alkyl amino group Chemical group 0.000 description 14
- 125000004663 dialkyl amino group Chemical group 0.000 description 14
- 235000019253 formic acid Nutrition 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 13
- 229910021529 ammonia Inorganic materials 0.000 description 13
- 125000003710 aryl alkyl group Chemical group 0.000 description 13
- 239000012362 glacial acetic acid Substances 0.000 description 13
- 229910052740 iodine Inorganic materials 0.000 description 13
- 235000015170 shellfish Nutrition 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000003054 catalyst Substances 0.000 description 12
- 229910052801 chlorine Inorganic materials 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 11
- 229910052731 fluorine Inorganic materials 0.000 description 11
- 239000011737 fluorine Substances 0.000 description 11
- 239000007858 starting material Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 10
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 10
- 239000013543 active substance Substances 0.000 description 10
- 239000012298 atmosphere Substances 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 238000005984 hydrogenation reaction Methods 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 9
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 9
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 9
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 210000004907 gland Anatomy 0.000 description 9
- 239000012948 isocyanate Substances 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 125000000714 pyrimidinyl group Chemical group 0.000 description 9
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 8
- 125000000732 arylene group Chemical group 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 238000004587 chromatography analysis Methods 0.000 description 8
- 230000000269 nucleophilic effect Effects 0.000 description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 7
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 235000011054 acetic acid Nutrition 0.000 description 7
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 7
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 7
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 6
- AJZYEHVNCIZJSC-UHFFFAOYSA-N 3-[4-[2-oxo-3-(5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)imidazolidin-1-yl]phenyl]propanoic acid Chemical compound C1=CC(CCC(=O)O)=CC=C1N1C(=O)N(C=2N=C3CNCCC3=CN=2)CC1 AJZYEHVNCIZJSC-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 125000000879 imine group Chemical group 0.000 description 6
- 125000001841 imino group Chemical group [H]N=* 0.000 description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 6
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 5
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 description 5
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 5
- 125000005129 aryl carbonyl group Chemical group 0.000 description 5
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 5
- 150000002513 isocyanates Chemical class 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 229910052702 rhenium Inorganic materials 0.000 description 5
- 235000009518 sodium iodide Nutrition 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- 125000004434 sulfur atom Chemical group 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- FSUKOOSBMJUNFZ-UHSGGMBLSA-N Cl.C1C[C@@H](CCC(=O)O)CC[C@@H]1N1C(=O)N(C=2C=C3CCNCC3=CC=2)CC1 Chemical compound Cl.C1C[C@@H](CCC(=O)O)CC[C@@H]1N1C(=O)N(C=2C=C3CCNCC3=CC=2)CC1 FSUKOOSBMJUNFZ-UHSGGMBLSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 125000005101 aryl methoxy carbonyl group Chemical group 0.000 description 4
- 229940049706 benzodiazepine Drugs 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000005265 dialkylamine group Chemical group 0.000 description 4
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 4
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000005360 mashing Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 239000011975 tartaric acid Substances 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 3
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 3
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical class N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 3
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000001409 amidines Chemical class 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 3
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 3
- 125000004104 aryloxy group Chemical group 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 125000004966 cyanoalkyl group Chemical group 0.000 description 3
- 150000001924 cycloalkanes Chemical class 0.000 description 3
- 125000000000 cycloalkoxy group Chemical group 0.000 description 3
- 125000002993 cycloalkylene group Chemical group 0.000 description 3
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 description 3
- 239000012024 dehydrating agents Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 239000002024 ethyl acetate extract Substances 0.000 description 3
- 238000005242 forging Methods 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 238000010422 painting Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 3
- 229960005235 piperonyl butoxide Drugs 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 229910052712 strontium Inorganic materials 0.000 description 3
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 description 2
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 2
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical class C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
- LILXUZCFFQKRIH-UHFFFAOYSA-N 2,5-dihydro-1,2,5-thiadiazole 1,1-dioxide Chemical compound O=S1(=O)NC=CN1 LILXUZCFFQKRIH-UHFFFAOYSA-N 0.000 description 2
- XGLVDUUYFKXKPL-UHFFFAOYSA-N 2-(2-methoxyethoxy)-n,n-bis[2-(2-methoxyethoxy)ethyl]ethanamine Chemical compound COCCOCCN(CCOCCOC)CCOCCOC XGLVDUUYFKXKPL-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- LILXDMFJXYAKMK-UHFFFAOYSA-N 2-bromo-1,1-diethoxyethane Chemical compound CCOC(CBr)OCC LILXDMFJXYAKMK-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- GAWAYYRQGQZKCR-UHFFFAOYSA-N 2-chloropropionic acid Chemical compound CC(Cl)C(O)=O GAWAYYRQGQZKCR-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- ZUQOBHTUMCEQBG-UHFFFAOYSA-N 4-amino-5-hydroxynaphthalene-1,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC(O)=C2C(N)=CC=C(S(O)(=O)=O)C2=C1 ZUQOBHTUMCEQBG-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LFMFPKKYRXFHHZ-UHFFFAOYSA-N R24 Chemical compound C1=C(Cl)C(C)=CC=C1NC1=NC(N)=C(C=CC=C2)C2=N1 LFMFPKKYRXFHHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000004103 aminoalkyl group Chemical group 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 125000005140 aralkylsulfonyl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- VPKDCDLSJZCGKE-UHFFFAOYSA-N carbodiimide group Chemical group N=C=N VPKDCDLSJZCGKE-UHFFFAOYSA-N 0.000 description 2
- 125000006355 carbonyl methylene group Chemical group [H]C([H])([*:2])C([*:1])=O 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000008619 cell matrix interaction Effects 0.000 description 2
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 2
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical group C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- GQKZBCPTCWJTAS-UHFFFAOYSA-N methoxymethylbenzene Chemical compound COCC1=CC=CC=C1 GQKZBCPTCWJTAS-UHFFFAOYSA-N 0.000 description 2
- KXRBOTJIGGSYTC-UHFFFAOYSA-N methyl 3-(4-isocyanatophenyl)propanoate Chemical compound COC(=O)CCC1=CC=C(N=C=O)C=C1 KXRBOTJIGGSYTC-UHFFFAOYSA-N 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- PXXKQOPKNFECSZ-UHFFFAOYSA-N platinum rhodium Chemical compound [Rh].[Pt] PXXKQOPKNFECSZ-UHFFFAOYSA-N 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 229910021332 silicide Inorganic materials 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 2
- 229910001948 sodium oxide Inorganic materials 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000003459 sulfonic acid esters Chemical class 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- FWMUJAIKEJWSSY-UHFFFAOYSA-N sulfur dichloride Chemical compound ClSCl FWMUJAIKEJWSSY-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 2
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 2
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 description 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
- 125000006557 (C2-C5) alkylene group Chemical group 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- SFGZVCSNIFTVNN-UHFFFAOYSA-N 1,1,1-trifluoro-2-(1,1,1-trifluoropropan-2-yloxy)propane Chemical compound FC(F)(F)C(C)OC(C)C(F)(F)F SFGZVCSNIFTVNN-UHFFFAOYSA-N 0.000 description 1
- HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical compound COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical compound O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- NNQDMQVWOWCVEM-UHFFFAOYSA-N 1-bromoprop-1-ene Chemical compound CC=CBr NNQDMQVWOWCVEM-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZEOVXNVKXIPWMS-UHFFFAOYSA-N 2,2-dichloropropane Chemical compound CC(C)(Cl)Cl ZEOVXNVKXIPWMS-UHFFFAOYSA-N 0.000 description 1
- QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- CSJCEQXZVMIHRX-UHFFFAOYSA-N 2,3-dibenzyl-2,3-dihydroxybutanedioic acid Chemical compound C=1C=CC=CC=1CC(O)(C(O)=O)C(O)(C(=O)O)CC1=CC=CC=C1 CSJCEQXZVMIHRX-UHFFFAOYSA-N 0.000 description 1
- ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- OYHWVPFGVJYAAG-UHFFFAOYSA-N 2-phenylmethoxyoxolane Chemical compound C=1C=CC=CC=1COC1CCCO1 OYHWVPFGVJYAAG-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- YCOOVFDCNXNOAJ-UHFFFAOYSA-N 3-(4-aminophenyl)-3-phenylpropanoic acid Chemical compound C1=CC(N)=CC=C1C(CC(O)=O)C1=CC=CC=C1 YCOOVFDCNXNOAJ-UHFFFAOYSA-N 0.000 description 1
- ALXQDXZBKIZUIC-UHFFFAOYSA-N 3-[4-[3-(2-methyl-3,4-dihydro-1h-isoquinolin-6-yl)-2-oxoimidazolidin-1-yl]phenyl]propanoic acid Chemical compound C=1C=C2CN(C)CCC2=CC=1N(C1=O)CCN1C1=CC=C(CCC(O)=O)C=C1 ALXQDXZBKIZUIC-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- IOBKAWMJICSVBL-UHFFFAOYSA-N 3-ethoxycarbonylpentan-3-ylphosphonic acid Chemical compound CCOC(=O)C(CC)(CC)P(O)(O)=O IOBKAWMJICSVBL-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical compound OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 description 1
- RWMDJQJCEISWRT-UHFFFAOYSA-N 4-(dibenzylamino)cyclohexan-1-ol Chemical compound C1CC(O)CCC1N(CC=1C=CC=CC=1)CC1=CC=CC=C1 RWMDJQJCEISWRT-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- FIIDVVUUWRJXLF-UHFFFAOYSA-N 4-phenylmethoxyaniline Chemical compound C1=CC(N)=CC=C1OCC1=CC=CC=C1 FIIDVVUUWRJXLF-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- SCGORAJGRKNBSY-UHFFFAOYSA-N 9h-fluorene-1-sulfonic acid Chemical group C1C2=CC=CC=C2C2=C1C(S(=O)(=O)O)=CC=C2 SCGORAJGRKNBSY-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- OQLZINXFSUDMHM-UHFFFAOYSA-N Acetamidine Chemical compound CC(N)=N OQLZINXFSUDMHM-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- COVMQSAWBFMQGN-SAABIXHNSA-N C1C[C@@H](CCC(=O)OC)CC[C@@H]1N(CCO)CC1=CC=CC=C1 Chemical compound C1C[C@@H](CCC(=O)OC)CC[C@@H]1N(CCO)CC1=CC=CC=C1 COVMQSAWBFMQGN-SAABIXHNSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000021513 Cinchona Nutrition 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- ULAUKHJWYMEFQE-UHFFFAOYSA-N ClC(CC(=O)OO)CCCCCCCCCCCCCCC Chemical compound ClC(CC(=O)OO)CCCCCCCCCCCCCCC ULAUKHJWYMEFQE-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102100029158 Consortin Human genes 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 102100021899 Cyclin-L2 Human genes 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010014513 Embolism arterial Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000725476 Geranium sibiricum Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 101000771062 Homo sapiens Consortin Proteins 0.000 description 1
- 101000897452 Homo sapiens Cyclin-L2 Proteins 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 208000035752 Live birth Diseases 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- KBPXSFRRRQUXSA-LJGSYFOKSA-N N[C@@H]1CC[C@H](CC1)OCC(=O)O Chemical compound N[C@@H]1CC[C@H](CC1)OCC(=O)O KBPXSFRRRQUXSA-LJGSYFOKSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920001774 Perfluoroether Polymers 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 102000017975 Protein C Human genes 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 101000964052 Rattus norvegicus 5-hydroxytryptamine receptor 5B Proteins 0.000 description 1
- 208000035397 Ring chromosome 7 syndrome Diseases 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- WTGOBOYXMAOFPT-UHFFFAOYSA-N [O-][N+](P(C1=CC=CC=C1)C1=CC=CC=C1)=O Chemical compound [O-][N+](P(C1=CC=CC=C1)C1=CC=CC=C1)=O WTGOBOYXMAOFPT-UHFFFAOYSA-N 0.000 description 1
- HHFLORIUWMQJMT-UHFFFAOYSA-N [PH4+].[PH4+].[O-]P([O-])=O Chemical compound [PH4+].[PH4+].[O-]P([O-])=O HHFLORIUWMQJMT-UHFFFAOYSA-N 0.000 description 1
- HQLRZXQUXVMOQM-UHFFFAOYSA-N [Pt].C(C)(=O)OCC Chemical compound [Pt].C(C)(=O)OCC HQLRZXQUXVMOQM-UHFFFAOYSA-N 0.000 description 1
- UHFKWPGAMUQLKD-UHFFFAOYSA-N acetic acid argon Chemical compound [Ar].CC(=O)O UHFKWPGAMUQLKD-UHFFFAOYSA-N 0.000 description 1
- 150000007960 acetonitrile Chemical class 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 208000037919 acquired disease Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000004689 alkyl amino carbonyl alkyl group Chemical group 0.000 description 1
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000005277 alkyl imino group Chemical group 0.000 description 1
- 125000004647 alkyl sulfenyl group Chemical group 0.000 description 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 1
- 125000006356 alkylene carbonyl group Chemical group 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003420 antiserotonin agent Substances 0.000 description 1
- 239000003698 antivitamin K Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- VEWPBNXVANZNAD-UHFFFAOYSA-N argon sodium Chemical compound [Na].[Ar] VEWPBNXVANZNAD-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000003968 arylidene group Chemical group [H]C(c)=* 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- JHVLLYQQQYIWKX-UHFFFAOYSA-N benzyl 2-bromoacetate Chemical compound BrCC(=O)OCC1=CC=CC=C1 JHVLLYQQQYIWKX-UHFFFAOYSA-N 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- 229910052614 beryl Inorganic materials 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- YHNUDLCUIKMNSN-UHFFFAOYSA-N bis(1,2,4-triazol-1-yl)methanone Chemical compound C1=NC=NN1C(=O)N1C=NC=N1 YHNUDLCUIKMNSN-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 150000001621 bismuth Chemical class 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- UCKORWKZRPKRQE-UHFFFAOYSA-N bromo(triethyl)silane Chemical compound CC[Si](Br)(CC)CC UCKORWKZRPKRQE-UHFFFAOYSA-N 0.000 description 1
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 238000005661 deetherification reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000004639 dihydroindenyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- PKRPQASGRXWUOJ-UHFFFAOYSA-L dipotassium;dichloride Chemical compound [Cl-].[Cl-].[K+].[K+] PKRPQASGRXWUOJ-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- CGBWIRRFOJZDEB-UHFFFAOYSA-N ethyl 3-(4-isocyanatophenyl)-2-methylpropanoate Chemical compound CCOC(=O)C(C)CC1=CC=C(N=C=O)C=C1 CGBWIRRFOJZDEB-UHFFFAOYSA-N 0.000 description 1
- XBSGYVHOINMTIM-UHFFFAOYSA-N ethyl 3-isocyanatopropanoate Chemical compound CCOC(=O)CCN=C=O XBSGYVHOINMTIM-UHFFFAOYSA-N 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-O ethylaminium Chemical compound CC[NH3+] QUSNBJAOOMFDIB-UHFFFAOYSA-O 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000012771 household material Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000009112 irreversible response Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NGFCTYXFMDWFRQ-UHFFFAOYSA-N isoquinolin-6-amine Chemical compound C1=NC=CC2=CC(N)=CC=C21 NGFCTYXFMDWFRQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- MUERZYSPGYLGBT-UHFFFAOYSA-N lithium;molecular hydrogen Chemical compound [Li].[H][H] MUERZYSPGYLGBT-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- GSYSFVSGPABNNL-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-(phenylmethoxycarbonylamino)acetate Chemical group COC(=O)C(P(=O)(OC)OC)NC(=O)OCC1=CC=CC=C1 GSYSFVSGPABNNL-UHFFFAOYSA-N 0.000 description 1
- HDAICMQUQIBGQB-UHFFFAOYSA-N methyl 4-(2-isocyanatoethyl)benzoate Chemical compound COC(=O)C1=CC=C(CCN=C=O)C=C1 HDAICMQUQIBGQB-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- DSWNRHCOGVRDOE-UHFFFAOYSA-N n,n-dimethylmethanimidamide Chemical compound CN(C)C=N DSWNRHCOGVRDOE-UHFFFAOYSA-N 0.000 description 1
- OXKCYPQPSYCJDM-UHFFFAOYSA-N n-(2,2-diethoxyethyl)-4-phenylmethoxyaniline Chemical compound C1=CC(NCC(OCC)OCC)=CC=C1OCC1=CC=CC=C1 OXKCYPQPSYCJDM-UHFFFAOYSA-N 0.000 description 1
- GYJRQXPYBNZQDN-UHFFFAOYSA-N n-(2,2-dimethoxyethyl)-2-methyl-3,4,4a,5,6,7,8,8a-octahydro-1h-isoquinolin-6-amine Chemical compound C1N(C)CCC2CC(NCC(OC)OC)CCC21 GYJRQXPYBNZQDN-UHFFFAOYSA-N 0.000 description 1
- NUKDFOGRUWKTCS-UHFFFAOYSA-N n-(2-aminoethyl)thiohydroxylamine Chemical compound NCCNS NUKDFOGRUWKTCS-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 238000010428 oil painting Methods 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000003259 prostaglandin group Chemical group 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 108091006082 receptor inhibitors Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 108010073863 saruplase Proteins 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- FVBUAEGBCNSCDD-UHFFFAOYSA-N silicide(4-) Chemical compound [Si-4] FVBUAEGBCNSCDD-UHFFFAOYSA-N 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- UYCAUPASBSROMS-AWQJXPNKSA-M sodium;2,2,2-trifluoroacetate Chemical compound [Na+].[O-][13C](=O)[13C](F)(F)F UYCAUPASBSROMS-AWQJXPNKSA-M 0.000 description 1
- UPDATVKGFTVGQJ-UHFFFAOYSA-N sodium;azane Chemical compound N.[Na+] UPDATVKGFTVGQJ-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 150000003463 sulfur Chemical class 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000008027 tertiary esters Chemical class 0.000 description 1
- MCZDHTKJGDCTAE-UHFFFAOYSA-M tetrabutylazanium;acetate Chemical compound CC([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC MCZDHTKJGDCTAE-UHFFFAOYSA-M 0.000 description 1
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- CWLNAJYDRSIKJS-UHFFFAOYSA-N triethoxymethoxyethane Chemical compound CCOC(OCC)(OCC)OCC CWLNAJYDRSIKJS-UHFFFAOYSA-N 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical group C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DYVOLUUJJDFBFC-UHFFFAOYSA-N tripotassium butan-1-olate Chemical compound [K+].[K+].[K+].CCCC[O-].CCCC[O-].CCCC[O-] DYVOLUUJJDFBFC-UHFFFAOYSA-N 0.000 description 1
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940019333 vitamin k antagonists Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
A6 B6 五、發明説明(1 ) 本發明係有關下式之.環狀衍生物A6 B6 V. Description of the invention (1) The present invention relates to the following formula. Cyclic derivatives
XX
N-Rfc γN-Rfc γ
(D {請先閲讀背面之注意事項再琪窝本頁} 經 濟 部 中 央 標 準 局 員 工 消 费 合 作 社 印 製 互變異構物•立 其與具重要藥理 酸或鹸所形成之 轚藥姐合物,有 在以上通式I X表示碳亞胺 芳基或氰基取代 -2,2-二基或 1, Y表示直鏈C2 以Re和Rd取代, 加地1或2個伸甲 或具5至7個碳原 和Rd取代, 或具5至7個碳原 1和Rd取代, 或1,2-伸芳基, 或1,2-伸笨基, 體異構物包括 性質,較佳地 生理上可接受 關其用途及有 中: 基,視情況在 ,或羰基、硫 1-二氰基乙烯 -4伸烷基或伸 且其可附加地 基各可Μ羰基 子之1,2-伸環 其混合物和其鹽類,特別地 聚集抑制;性質之無機或有機 之鹽,有;關含此等化合物之 關其製法。 氮原子上以烷基、芳基、雜 羧基、磺醢基、1-硝基乙烯 -2,2-二基; 烯基,其視情況以Re或Rd或 Μ 1或2個烧基取代和其中附 置換, 烷基,視情況K R。或!^或Κ 子之1,2-伸環烯基,視情況或Μ 其中1或2個次甲基各Μ氮原子置換或其中 -3 本紙張尽度遑用t _,Η家櫺準(CNS)甲4规格(210X297公聲) A6 B6 五、發明説明(2 ) 1或2個-CH = CH-基團各M-CO-NH基團置換或其中1個次甲 基Μ氮原子置換且1個-CH = CH-基團M-CO-NH基團置換,然 而上述雜環基團可附加地以1或2個烷基取代, 或- CO-HH-、-HH-CO-、-CH = N-或- N = CH -基團,視情況以 R<^Rd取代·,(D {Please read the notes on the back first, then Qiwo page} The tautomers are printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. In the above general formula IX represents a carbodiimide aryl or cyano substituted -2,2-diyl or 1, Y represents a straight chain C2 substituted with Re and Rd, plus 1 or 2 dyne or with 5 to 7 carbons Ortho and Rd substitution, or 1 to Rd substitution with 5 to 7 carbon atoms, or 1,2-arylidene, or 1,2-phenylene, isomers including properties, preferably physiologically acceptable Related to its use and the following: base, as the case may be, or carbonyl, sulfur 1-dicyanoethylene-4 alkane or alkene and its additional base can each carbonyl group 1,2-ring ring mixtures and Its salts, especially the inhibition of aggregation; the nature of inorganic or organic salts, there are; related to the preparation of these compounds. The nitrogen atom is alkyl, aryl, heterocarboxyl, sulfonyl, 1-nitro Ethylene-2,2-diyl; Alkenyl, optionally substituted by Re or Rd or M 1 or 2 alkyl groups, and attached thereto, alkyl, optionally KR. Or! ^ Or 1,2-cycloalkenyl group, as appropriate or M where 1 or 2 methine groups are replaced by nitrogen atoms of each M or where -3 paper is used as much as possible, Η 家 棂 准 (CNS) 甲 4 Specifications (210X297) A6 B6 V. Description of the invention (2) 1 or 2 -CH = CH- groups each M-CO-NH group is replaced or 1 methine M nitrogen atom is replaced and 1- CH = CH- group M-CO-NH group substitution, however the above heterocyclic group may additionally be substituted with 1 or 2 alkyl groups, or-CO-HH-, -HH-CO-, -CH = N -Or- N = CH- group, optionally substituted with R < ^ Rd,
Re至Rd基團之第1個表示A-B基團,其中A為下式 {請先閲讀背面之注意事項再填寫本頁) 和 經濟部中央標準局員工消費合作社印製The first group from Re to Rd represents the A-B group, where A is the following formula (Please read the precautions on the back before filling out this page) and printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy
R2R2
Ri4v (CH2)nRi4v (CH2) n
4- -裝 訂; # 本紙張尺度遑甩中國國家揉準(CNS)甲4规格(210X297公釐) 經濟部中央標準局員工消費乂 A6 _^_ 五、發明説明(3 ) 之一 *其中上述基囿之苯并部分可以R25單取代、或以 R2e單或雙取代,或M R2B單取代且附加地以R2e單取代 ,其中R2S和R2e取代基,其可相同或不同,係界定如下, 且附加地在上述苯并部分中1至3個次甲基各可K氮原子置 換,或-CH = CH-基團可M-COH-基團置換,或1個次甲 基可Μ氮原子置換且1個-CH = CH-基囿M-CO-HRi置換,其 中 表示氫原子或烷基, G da G 4各代表一鍵或伸甲基,其可K烷基、芳基或雑芳基 單或雙取代,其中該等取代基可相同或不同, G2表示一鍵或以R7和1取代之伸甲基, G3表示一鍵或Μ 1?3和取代之伸甲基,或若卩2不表示一 鍵時,G3亦可表示羰基,4--Binding; # This paper size is based on China National Standards (CNS) A4 specifications (210X297 mm) Staff Consumption of the Central Standards Bureau of the Ministry of Economic Affairs A6 _ ^ _ One of the invention description (3) * Among the above The benzo moiety of the hydrazone may be mono-substituted by R25, mono- or di-substituted by R2e, or mono-substituted by MR2B and additionally mono-substituted by R2e, wherein the R2S and R2e substituents may be the same or different and are defined as follows, and Additionally 1 to 3 methine groups may each be replaced by a K nitrogen atom in the above benzo moiety, or -CH = CH- group may be replaced by an M-COH- group, or 1 methine group may be replaced by an M nitrogen atom And one -CH = CH- group 囿 M-CO-HRi substitution, which represents a hydrogen atom or an alkyl group, G da G 4 each represents a bond or a methyl group, which may be K alkyl, aryl or fluorene aryl Single or double substitution, where the substituents may be the same or different, G2 represents a bond or a methyl group substituted with R7 and 1, G3 represents a bond or a methyl group and a substituted methyl group, or 卩 2 When it does not represent a bond, G3 can also represent a carbonyl group,
Gs表示氮原子或次甲基,視情況Μ焼基、芳基或雜芳基取 代, R2表示氫原子或烷基、芳基或雜芳基或,若G2*G3中至少 一個不表示一鍵時,R2亦可表示羥基或烷氧基, R 3表示氫原子或烷基、芳基或雜芳基或,若〇2和63中至少 一個不表示一鍵時‘,R3與R2-起亦可表示氧原子, R4和R14各表示氫原子,在環烷基部分上各具3至7個碳原 子之環烷基或環垸基烷基、Ci-8-烷基、C3-e-烯基(其烯 基可不經由乙烯基部分連接至氮原子)、或羥基烷基、烷 氧基烷基、胺基烷基、烷基胺基烷基、二烷基胺基烷基、 氰基烷基、羧基烷基、焼氧基羰基烷基、胺基栽基烷基、 一 5 - 戈尺度遑用t®國家標準(CNS)甲4规格(210X297公釐) ...................................................................................装::…訂.....................綠 {請先閱讀背面之注意事項再填窝本頁) 五、發明説明(4 ) {請先閲讀背面之注意事項再填寫本頁) N-烷基胺基羰基烷基、Ν,Ν-二烷基胺基羰基烷基、芳基垸 基、雜芳基烷基、烷氧基羰基、芳基甲氧基羰基、甲醢基 、乙豳基、三氟乙醯基、烯丙氧基羰基、甲脒基或 RuCO-O-UuCiUy-O-CO基圈,其中 RU表示烷基、Cs-7環烷基或芳基或芳基烷基, R12表未氫原子、烷基、C5-7環烷基或芳基和 R13表示氫原子或烷基, 或114與R3—起表示具2至4個碳原子之直鍵伸烷基或,若 G2F代表一鍵時,R4可表示伸甲基, R5表示氫原子、烷基、芳基或雜芳基或,若Gi不代表一鍵 時,Rs亦可表示羥基或烷氧基或, GL·代表一鍵時,R4與Re—起可表示另一鐽和 Re代表氫原子、烷基、芳基或雜芳基或,若(K代表一鏈且 R 4與R5—起代表另一鍵時,Re可代表氛原子或羥基、甲氧 基、胺基、烷基胺基或二烷基胺基,或若Gi不表示一鏈時 ,Re與Rs—起可表示氧原子, R7表示氫原子或烷基、芳基或雜芳基,Gs represents a nitrogen atom or a methine group, optionally substituted by a methyl group, an aryl group, or a heteroaryl group; R2 represents a hydrogen atom or an alkyl group, an aryl group, or a heteroaryl group; if at least one of G2 * G3 does not represent a bond R2 may also represent a hydroxyl group or an alkoxy group, R3 represents a hydrogen atom or an alkyl group, an aryl group or a heteroaryl group, or if at least one of 〇2 and 63 does not represent a bond, R3 and R2- It can represent an oxygen atom, R4 and R14 each represent a hydrogen atom, and a cycloalkyl or cyclofluorenylalkyl, Ci-8-alkyl, C3-e-ene having 3 to 7 carbon atoms each in a cycloalkyl portion (Its alkenyl group may be attached to the nitrogen atom without via a vinyl moiety), or a hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, cyanoalkyl Group, carboxyalkyl group, alkoxycarbonylalkyl group, amidoalkyl group, 5-gaussian standard t® national standard (CNS) A4 specifications (210X297 mm) ......... ........................................ ............................. Install :: ... Order ... Green {Please read the notes on the back before filling in this page) 5. Description of the invention (4) { (Please read the notes on the back before filling this page) N-alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl, arylfluorenyl, heteroarylalkyl, alkoxycarbonyl , Arylmethoxycarbonyl, formamyl, ethenyl, trifluoroethenyl, allyloxycarbonyl, formamyl or RuCO-O-UuCiUy-O-CO radicals, where RU represents alkyl, Cs-7 cycloalkyl or aryl or arylalkyl, R12 represents a hydrogen atom, alkyl, C5-7 cycloalkyl or aryl, and R13 represents a hydrogen atom or alkyl, or 114 and R3 together represent A straight bond of 2 to 4 carbon atoms is alkylene or, if G2F represents a bond, R4 may represent methylene, R5 represents a hydrogen atom, alkyl, aryl or heteroaryl or if Gi does not represent a bond When Rs can also represent a hydroxyl group or an alkoxy group, or when GL · represents a bond, R4 and Re together can represent another 鐽 and Re represents a hydrogen atom, an alkyl group, an aryl group, or a heteroaryl group, and if (K When R 4 represents a chain and R 4 and R 5 represent another bond, Re may represent an atmospheric atom or a hydroxyl group, a methoxy group, an amino group, an alkylamino group, or a dialkylamino group, or when Gi does not represent a chain. , Re and Rs—can represent oxygen atoms R7 represents a hydrogen atom or an alkyl group, an aryl group or a heteroaryl group,
Ra表示氫原子或烷基、芳基或雜芳基或1^與114一起可表示 直鏈C2-5-伸烷基, R9表示氫原子或烷基、芳基或雜芳基或,若G2不代表一鍵 時》Re亦可表示羥基或烷氧基, 經濟部中央標準局員工消费合作社印製- R1〇表示氫原子或烷基、芳基或雜芳基或R1〇與R4—起可 表示直鏈C2-4-伸烷基, R1S表示氫或氛原子或焼基、芳基、雜芳基、經基、甲氧 —6 — ^紙St尺本遴|€理國家標準(CNS)肀4規格(210X297公釐)"" 經濟部中央標準局貝工消費合作社印製 A6 B6 _ 五、發明説明(5 ) 基、胺基、烷基胺基或二烷基胺基,Rie表示氫原子、在 環烷基部分上各具3至7個碳原子之環烷基或環烷基烷基、 Cx-8-烷基、C3-a-烯基(其烯基可不經由乙烯基團連接至 氮原子)、或羥基烷基、烷氧基烷基、胺基烷基、烷基胺 基烷基、二烷基胺基烷基、氰基烷基、羧基烷基、烷氧基 羰基烷基、胺基羰基烷基、N-烷基胺基羰基烷基、Ν,Ν-二 烷基胺基羰基烷基或芳基烷基· R17表示氫原子或烷基或*若G4表示一鍵時,Rie與1?17 一起可表示另一鐽, R18表示氫原子或烷基或,若“代表一鍵且Rie和R17 — 起代表另一鍵時,Ria表示氟、氯或溴原子或羥基、甲氧 基、胺基、烷基胺基或二烷基胺基和 η代表數字1或2,Μ及 Β表示一鍵、Che-伸烷基、C2_e-伸烯基或伸芳基, 或伸吡啶基、伸啼啶基、伸吡哄基或伸嗒畊基,其中1或 2個-CH = N-基團各可M-CO-NH-基圏置換且氮原子之一可 结合至A基團*而不與氫原子结合,然而上述雜環基圈可 附加地Μ 1或2個烷基取代, 或Β表示伸環烷基,視情況Κ1或2個烷基取代, 或Cs-7-伸環烷基,其視情況Ml或2個烷基取代,且其中 1個〉CH單位以氮原子置換,然而附加地在上述5至7員環 中與氮原子緊鄰之伸甲基可以羰基置換; 1至1^基團之第2個表示下式之基團 t請先閲讀背面之注意事項再填窝本頁} .装 •訂. .繃. 一 7 — 本紙張尽度逍用中國國家¥¥(〇肪)甲4規格(210X297公釐) 經濟部中央標準局員工消费合作社印製 A6 B6_ 五、發明説明(6 ) 其中D表示Ci-e-伸烷基,其中1個伸甲基可以氧或硫原子 或以亞磺醯基、磺醯基或”13基團置換,或其中1個伸乙 基可M-C0-NR2O-或-HR2O-C0-基團置換(其中Rie表示氫 原子或烷基、烷基羰基、烷基磺醢基、芳基羰基或芳基磺 醯基及R2〇表示氬原子或烷基), 或D表示C2-e-伸烯基或伸芳基, 或伸吡啶基、伸嘧啶基、伸吡畊基或伸嗒哄基*其中1或 2個-CH = N-基團各可M-CO-NH-基團置換且氮原子之一可 結合至E基團,而不與氫原子结合,其限制條件為其本身 不代表一鍵或不以雜原子或羰基與D基團鄰接,然而上述 雜環基囿可附加地K 1或2個烷基取代, 或D表示伸二氫茚基、伸萘基、1,2,3,4-伸四氫萘基或伸 苯并環庚基,其中環之一结合至E基囿且另一環與通式I 之環狀基團结合,然而飽和環各可Ml或2個烷基取代且芳 族環各可K氟、氯、溴或碘原子或K烷基、三氟甲基、羥 基、烷氧基、烷基次磺醢基、烷基亞磺醢基、烷基磺醢基 或氰基取代, 或伸環烷基,視情況K1或2個烷基取代, 或伸環烷基*其視情況K 1或2儷烷基取代且其中1 個〉CH單位Μ氮原子置換,然而在上述5至7員環中與氮原 子緊鄰之伸甲基可Μ羰基置換; 或伸六氫吡哄基,其視情況以1或2個烷基取代,且其中與 氮原子緊鄰之伸甲基可Κ羰基置換; 或*若Ε代表環狀亞胺基圃時,D亦可表示具2至6個總碳 (諳先閲讀背面之注意事項再填窝本頁> •裝 .訂. —8 — 本紙ft尺度逋甩+國國家«準(CNS)甲4規格(210X297公釐)~ 經濟部中夹標準局員工消费合作社印製 五、發明説明(7 ) 原子之伸烷基羰基,其中該羰基與E基團之環狀亞胺基團 之氮原子结合, 或,若E不表示一_時,D可代表一鍵, E表不一'鍵, 或“-β-伸烷基,其可κι或2個“-8-烷基、以C2-4-烯 基或C2-4-炔基、K羥基、胺基、芳基或雜芳基、以 Ci-s-烷氧基或Ci-a-烷基胺基、Μ具2至10個總碳原子 之二烷基胺基、或KHNR2i或Ν-烷基- NR2i基團取代,其 中 R21表示在烷基部分各具1至8個碳原子之烷基羰基或 •焼基磺醚基、具2至5個總碳原子之烷氧基羰基、在環 烷基部分各具5至7個碳原子之環烷基羰基或環烷基磺 醢基、或芳基烷基羰基、芳基烷基磺醢基、芳基烷氧 基羰基、芳基羰基或芳基磺醢基, 或C2-e_伸稀基, 或伸芳基* 或伸吡啶基、伸嘧啶基、伸吡哄基或伸嗒畊基·視情況Μ 1或2涸烷基取代, 或C5-7-伸環烷基,其視情況Ml或2個烷基取代,且其中 1個〉CH單位Μ與D基團之碳原子鍵連之氮原子置換, 或C4-7-伸環烷基,視情況Ml或2個Cpe-烷基、Μ C2烯基或C2-4-炔基、Μ羥基、胺基、芳基或雜芳基 、MCi-e-烷氧基或Ci-a-烷基胺基、Κ具2至10個總碳 原子之二烷基胺基、或或{(-烷基-NR21取代(其 (請先閲讀背面之注意事項再填寫本頁} 一 9 一 本紙張尺來4时B 8家料(哪} T4規格(210X297公釐) 經濟部中央標準局貝工消费合作社印製, A6 __B6 ___ 五、發明説明(8 ) 中R21係依如上所界定), 或,若D不表示一鍵時,伸烷基經由W基围鍵連至D基围 ,其中W表示氧或硫原子或亞磺醢基、磺醯基、NR1S、 NR2o-C0-、或-CO-NR2〇-基團,其中Rie和R20係依如上所 界定且伸烷基可附加地以1或2® Ci-e-烷基、M C2-4-烯 基或C2-4-炔基、以羥基、胺基、芳基或雜芳基、K Ci-e-烷氧基或烷基胺基、Μ具2至10個總碳原子 之二烷基胺基、K HNR21或《-烷基-NR21取代•其中附加 取代基之雜原子Μ至少2個碳原子與W基團之雜原子分離 ,及R21係依如上所界定,和 F表示Μ羥基、KCi-e-烷氧基、以芳基烷氧基或K R22〇基團取代之羰基,其中 •. R22表示C4-e-環烷基或在環烷基部分上具3至8個碳 原子之環烷基烷基*其中該環烷基可K烷基、烷氧基 或二烷基胺基、以烷基和Ml至3個甲基取代,且其中 附加地在4至8員環烷基環上之伸甲基可以氧原子或K 烷基亞胺基置換,或R22表示Ce-12-苯并環烷基或芳 基, 或F表示磺酸基、膦酸基、0-烷基膦酸基、二烷基 滕酸基、四唑-5-基或R23C0-0-CHR24-0-C0基團,其中 R23表示Ci-8-烷基或Ci-8-烷氧基、在環烷基部分上 各具5至7原子之環烷基或環烷氧基,或芳基、芳氧基 、芳基烷基或芳基烷氧基和 R24表示氫原子或烷基* -10- 本纸張尺度遑用中國國家棋準(CNS)甲4规格(210X297公釐) ............................-........................................................装......................訂.....................線 (請先閲讀背面之注意事項再填寫本頁) A6 B6 經濟部中央標準局员工消费合作社印製m 五、發明説明(9 ) 及F基團與A-B基團上距F基團最遠之氮原子之最短距離為 至少11鐽; Re至1^基團之第3個表示氫原子、垸基、全氟烷基、 烷氧基、燒基亞磺醯基、烷基次磺醢基、烷基磺醯基、胺 基、烷基胺基、二烷基胺基、芳基、雜芳基或芳基烷基; 和 1^至1^基團之第4個表示氫原子或烷基或芳基; 然而除非另有說明 在Μ上基團定義中所提之各芳基部分為苯基,其可 單取代,K R2e單、雙或三取代或K 單取代且附加地 M R2e單或雙取代*其中取代基可相同或不同和 R2S表示氰基、羧基、胺基羰基、烷基胺基羰基、二 烷基胺基羰基、烷氧基羰基、烷基羰基、烷基次磺醢 基、烷基亞磺醯基、燒基磺醯基、焼基磺醯氧基、全 氟烷基、全氟烷氧基、硝基、胺基、烷基胺基、二烷 基胺基、烷基羰基胺基、苯基烷基羰基胺基、苯基羰 基胺基、烷基磺醢基胺基、苯基烷基磺醯基胺基、苯 基磺醢基胺基、垸基-烷基羰基胺基、烷基-苯 基烷基羰基胺基、Η-烷基-笨基羰基胺基、N-烷基-烷基磺醢基胺基、Ν-烷基-苯基烷基-磺醢基胺基、 Ν-烷基-笨基磺睡基胺基、胺基磺醢基、烷基胺基磺 醸基或二烷基胺基磺醢基,和 * R2e表示烷基、羥基或烷氧基或氟、氛、溴或碘原子 •及若2涸R2e基團與其相鄰碳原子结合時*其亦可代 ..................................................................................裝........................玎I. 線 (請先閲讀背面之注意事項再填寫本頁}; _ 11 一 本紙at尺度遴用中國國家櫺準(CNS)甲4规格(210X297公釐) 經濟部中央標準局員工消费合作社印製 A6 ____^_B6_^_ 五、發明説明(10 ) 表C3-e-伸烷基、1,3-伸丁、二烯-1,4-二基或伸甲二 氧基, 和在上述基團定義中所提之各伸芳基部分為伸苯基,其可 M R25單取代,M R2e單或雙取代或K R2S單取代和附加地 KR2e單取代,其中取代基可相同或不同且依如上所界定 » 和在Μ上基團定義中所提之雜芳基部分為5員雜芳族環, 其含有1個氧、硫或氮原子•或1個氮原子和1個氧、硫 或氮原子,或2個氮原子和1個氧、硫或氮原子,或為6 員雜芳族環,其含有1、2或3個氮原和其中附加地1或2個 -CH = N-基團各可M-C0-NR2o-基囿置換(其中R2〇係依如 上所界定),及附加地上述雜芳族環可Ml或2個烷基或 在碳骨架上K氟、氯、溴或碘原_子或Μ羥基或烷氧基取代 9 和除非另有說明,上述烷基、伸烷基和烷氧基部分各具1 至4個碳原子和在上述伸烷基和伸環烷基部分上之各碳原 子至多與1個雜原子鍵連接 和互變異構物、立體異構物及其鹽類。 然而Μ上通式I之較佳化合物係此等,其中: X表示碳亞胺基,視情況在氮原子上Μ烷基或氰基取代 ,或X表示羰基、硫羰基或磺醢基; Υ代表直鍵C2-3伸烷基,其視情況或Rd、或MRdtl I取代,且其可附加地Ml或2個烷基取代和其中附加地1 個伸甲基可K羰基置換, -12- 本紙張尺度逋用t國國家櫺準(CNS)甲4規格(210X297公釐) {請先閲讀背面之注意事項再填寫本頁) ......................~3·.....................每. 、或Rc和Rd取代 基置換, A6 B6 五、發明説明(11 ) 或直鏈C2-3伸烯基,其視情況Μ巳或Rd 且其中附加地任何存在的.伸甲基可Μ羰 或具5至7個碳原子之1,2-伸環烷基,視情況Μ 1或1^、或 M 1U和Rd取代, 或具5至7個碳原子之1,2-伸環烯基, 或1 , 2-伸芳基, 或1,2-伸苯基,其中1或2個次甲基各Μ氮原子置換,其中 上述雜環基圑可附加地Κ1或2個烷基取代, 或-CO-HH-、-HH-CO-、-CH = N-或 ΚΗ-基團,視情況 Μ Rc或Rd取代, !^至1基團之第1個表示A-B基團,其中A為下式 {請先閱讀背面之注意事項再填"本頁) -裝Ra represents a hydrogen atom or an alkyl group, an aryl group or a heteroaryl group or 1 ^ together with 114 may represent a linear C2-5-alkylene group, R9 represents a hydrogen atom or an alkyl group, an aryl group or a heteroaryl group, or if G2 When it does not represent a bond, Re can also represent hydroxyl or alkoxy, printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs-R10 represents a hydrogen atom or an alkyl group, an aryl group or a heteroaryl group or R10 and R4 can be used together. Represents a straight-chain C2-4-alkylene, R1S represents hydrogen or an amine atom or a fluorenyl group, an aryl group, a heteroaryl group, a mesityl group, and a methoxy group—6 — ^ Paper St rule | China National Standards (CNS)规格 4 specifications (210X297 mm) " " Printed by A6 B6, Shellfish Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs _ V. Description of the invention (5) Base, amine, alkylamine or dialkylamine, Rie Represents a hydrogen atom, a cycloalkyl or cycloalkylalkyl group having 3 to 7 carbon atoms each in a cycloalkyl portion, a Cx-8-alkyl group, a C3-a-alkenyl group (the alkenyl group may not pass through a vinyl group Group is attached to a nitrogen atom), or hydroxyalkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, cyanoalkyl, carboxyalkyl, alkoxy Carbonyl alkyl Aminocarbonylalkyl, N-alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl or arylalkyl. R17 represents a hydrogen atom or an alkyl group or * If G4 represents a single bond, Rie together with 1-17 can represent another hydrazone, R18 represents a hydrogen atom or an alkyl or, if "represents a bond and Rie and R17 together represent another bond, Ria represents a fluorine, chlorine or bromine atom or a hydroxyl, methyl Oxy, amine, alkylamino or dialkylamino and η represent the numbers 1 or 2, M and B represent a single bond, Che-alkylene, C2-e-alkenyl or arylene, or pyridine Group, cylamidyl group, pyridyl group, or dhamyl group, in which 1 or 2 -CH = N- groups can each be replaced by M-CO-NH- groups and one of the nitrogen atoms can be bonded to the A group The group * is not bonded to a hydrogen atom, however, the above heterocyclyl ring may be additionally substituted by 1 or 2 alkyl groups, or B represents a cycloalkyl group, optionally K1 or 2 alkyl groups may be substituted, or Cs-7- Cycloalkyl, which is optionally substituted by M1 or 2 alkyl groups, and one of them> CH unit is replaced by a nitrogen atom, however, in the above 5- to 7-membered ring, a methyl group adjacent to the nitrogen atom may be substituted by a carbonyl group ; 1 to 1 ^ groups 2 groups representing the following formula, please read the precautions on the back before filling in this page}. Binding • Binding.. 7 — This paper is free to use the Chinese country ¥¥ (〇 胖) A4 specifications (210X297 mm) A6 B6 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (6) where D represents Ci-e-alkylene, and one methyl group can be an oxygen or sulfur atom or a sulfene Fluorenyl, sulfonyl or "13" groups, or one of them may be replaced by M-C0-NR2O- or -HR2O-C0- groups (where Rie represents a hydrogen atom or an alkyl group, an alkylcarbonyl group, Alkylsulfonyl, arylcarbonyl or arylsulfonyl and R2O represents an argon atom or an alkyl group), or D represents C2-e-alkenyl or arylene, or pyridyl, pyrimidyl, Pyridyl or tacky group * of which 1 or 2 -CH = N- groups can each be replaced by M-CO-NH- groups and one of the nitrogen atoms can be bonded to the E group without being associated with a hydrogen atom The binding condition is that it does not represent a bond by itself or is not adjacent to the D group with a heteroatom or carbonyl group. However, the above heterocyclic group 囿 may be additionally substituted by K 1 or 2 alkyl groups, or D represents an indenyl group. Span , 1,2,3,4-tetrahydronaphthyl or benzocycloheptyl, in which one of the rings is bonded to the E group and the other ring is bonded to a cyclic group of the general formula I, but the saturated ring each It can be substituted by M1 or 2 alkyl groups, and each of the aromatic rings can be a K fluorine, chlorine, bromine or iodine atom or a K alkyl group, a trifluoromethyl group, a hydroxyl group, an alkoxy group, an alkylsulfinylsulfenyl group, an alkylsulfinyl group Fluorenyl, alkylsulfonyl or cyano substituted, or cycloalkyl, optionally K1 or 2 alkyl substituted, or cycloalkyl ** optionally K 1 or 2 alkyl substituted and 1 of them 〉 CH unit M nitrogen atom replacement, but in the above 5- to 7-membered ring immediately adjacent to the nitrogen atom may be replaced by M carbonyl group; or hexahydropyridyl, which is optionally substituted with 1 or 2 alkyl groups, In addition, the methyl group adjacent to the nitrogen atom may be replaced by a carbonyl group; or * If E represents a cyclic imine group, D may also represent 2 to 6 total carbons (read the precautions on the back before filling the nest Page > • Binding. —8 — This paper ft scale + national «standard (CNS) A4 specifications (210X297 mm) ~ printed by the staff consumer cooperatives of the China Standards Bureau of the Ministry of Economic Affairs 7) Atomic An alkylcarbonyl group in which the carbonyl group is bonded to a nitrogen atom of a cyclic imine group of the E group, or, if E does not represent a _, D may represent a bond, E represents a '' bond, or "-β -Alkylene, which may be κ or 2 "-8-alkyl, as C2-4-alkenyl or C2-4-alkynyl, K hydroxyl, amine, aryl or heteroaryl, as Ci-s -Alkoxy or Ci-a-alkylamino, dialkylamino having 2 to 10 total carbon atoms, or KHNR2i or N-alkyl-NR2i group substitution, in which R21 represents an alkyl moiety Alkylcarbonyl or sulfonylsulfonyl groups with 1 to 8 carbon atoms each, alkoxycarbonyl groups with 2 to 5 total carbon atoms, cycloalkanes with 5 to 7 carbon atoms each in the cycloalkyl portion Carbonyl or cycloalkylsulfonyl, or arylalkylcarbonyl, arylalkylsulfonyl, arylalkoxycarbonyl, arylcarbonyl or arylsulfonyl, or C2-e , Or arylene *, or pyridyl, pyrimidyl, pyrimidyl, or daphthyl · As the case may be 1 or 2 alkyl substitution, or C5-7-cycloalkyl, as the case may be Ml Or 2 alkyl substituted, and 1 of them> a nitrogen atom bonded to a carbon atom of the D group of CH unit M Substitution, or C4-7-cycloalkyl, optionally M1 or 2 Cpe-alkyl, MC2 alkenyl or C2-4-alkynyl, Mhydroxy, amine, aryl or heteroaryl, MCi- e-alkoxy or Ci-a-alkylamino, K dialkylamino with 2 to 10 total carbon atoms, or {(-alkyl-NR21 substituted (which (please read the note on the back first) Please fill in this page again on the matter} A 9 A paper ruler comes at 4 B 8 household materials (Which) T4 size (210X297 mm) Printed by the Bayer Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, A6 __B6 ___ V. Description of the invention (8 R21 is as defined above), or, if D does not represent a bond, the alkylene group is connected to the D group via a W group bond, where W represents an oxygen or sulfur atom or a sulfinyl, sulfonyl group , NR1S, NR2o-C0-, or -CO-NR20- groups, where Rie and R20 are as defined above and the alkylene group may additionally be 1 or 2® Ci-e-alkyl, M C2-4 -Alkenyl or C2-4-alkynyl, hydroxy, amine, aryl or heteroaryl, K Ci-e-alkoxy or alkylamino, M dioxane having 2 to 10 total carbon atoms -Amino, K HNR21 or "-alkyl-NR21 substitutions" in which the heteroatom M of the additional substituent has at least 2 carbon atoms Is separated from the hetero atom of the W group, and R21 is as defined above, and F represents an M hydroxy group, a KCi-e-alkoxy group, a carbonyl group substituted with an arylalkoxy group or a K R22 group, where R22 represents a C4-e-cycloalkyl group or a cycloalkylalkyl group having 3 to 8 carbon atoms in the cycloalkyl portion * wherein the cycloalkyl group may be a Kalkyl group, an alkoxy group, or a dialkylamino group , Substituted with an alkyl group and M1 to 3 methyl groups, and wherein the methyl extension group additionally on a 4- to 8-membered cycloalkyl ring may be substituted with an oxygen atom or a K alkylimino group, or R22 represents Ce-12- Benzocycloalkyl or aryl, or F represents a sulfonic acid group, a phosphonic acid group, a 0-alkylphosphonic acid group, a dialkyltenyl acid group, a tetrazol-5-yl group or R23C0-0-CHR24-0- C0 group, where R23 represents Ci-8-alkyl or Ci-8-alkoxy, cycloalkyl or cycloalkoxy each having 5 to 7 atoms in the cycloalkyl portion, or aryl, aryloxy Group, arylalkyl or arylalkoxy and R24 represents a hydrogen atom or an alkyl group * -10- This paper size is based on China National Standard (CNS) A4 specifications (210X297 mm) ... .......................-.................. ......................................... .......... Order ......... line (please read the notes on the back before filling this page) A6 B6 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards m. Description of Invention (9) and the shortest distance between the F group and the nitrogen atom farthest from the F group on the AB group is at least 11 至少; 3 represents a hydrogen atom, a fluorenyl group, a perfluoroalkyl group, an alkoxy group, a sulfenylsulfinyl group, an alkylsulfinyl group, an alkylsulfonyl group, an amine group, an alkylamine group, and a dialkylamine Group, aryl group, heteroaryl group or arylalkyl group; and the fourth group of 1 ^ to 1 ^ represents a hydrogen atom or an alkyl group or an aryl group; however, unless otherwise stated in the definition of group on M, Each aryl moiety is phenyl, which may be mono-substituted, K R2e mono-, di- or tri-substituted or K mono-substituted and additionally M R2e mono- or di-substituted * where the substituents may be the same or different and R2S represents cyano, carboxyl , Aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, alkylcarbonyl, alkylsulfenylsulfenyl, alkylsulfinylsulfenyl, alkylsulfonylsulfenyl, sulfenylsulfonyl Fluorenyloxy, perfluoroalkyl, perfluoroalkoxy, nitro Amine, alkylamino, dialkylamino, alkylcarbonylamino, phenylalkylcarbonylamino, phenylcarbonylamino, alkylsulfonylamino, phenylalkylsulfonylamine , Phenylsulfonylamino, fluorenyl-alkylcarbonylamino, alkyl-phenylalkylcarbonylamino, fluorenyl-alkyl-benzylcarbonylamino, N-alkyl-alkylsulfonyl Amino, N-alkyl-phenylalkyl-sulfonylamino, N-alkyl-benzylsulfonylamino, aminosulfonyl, alkylaminosulfonyl or dialkyl Aminosulfonyl, and * R2e represents an alkyl, hydroxyl or alkoxy or fluorine, molybdenum, bromine or iodine atom, and if a 2 涸 R2e group is bonded to its adjacent carbon atom * it can also substitute ... ........................................ ............................................................. .... 玎 I. Line (Please read the precautions on the back before filling out this page}; _ 11 A paper at size selected by China National Standards (CNS) A4 specifications (210X297 mm) Central Bureau of Standards, Ministry of Economic Affairs A6 printed by employee consumer cooperatives ____ ^ _ B6 _ ^ _ V. Description of the invention (10) Table C3-e-alkylene, 1,3-butylene, diene-1,4-diyl Or methylenedioxy, and each of the arylidene moieties mentioned in the definition of the above group is phenylene, which may be mono-substituted by M R25, mono- or di-substituted by M R2e, or mono-substituted by K R2S and additionally KR2e-mono Substitution, where the substituents may be the same or different and are as defined above »and the heteroaryl moiety mentioned in the definition of the group on M is a 5-membered heteroaromatic ring containing 1 oxygen, sulfur or nitrogen atom or 1 nitrogen atom and 1 oxygen, sulfur or nitrogen atom, or 2 nitrogen atoms and 1 oxygen, sulfur or nitrogen atom, or 6-membered heteroaromatic ring containing 1, 2 or 3 nitrogen atoms and among them Additionally, 1 or 2 -CH = N- groups may each be replaced by M-C0-NR2o-groups (where R2O is as defined above), and additionally the above heteroaromatic ring may be M1 or 2 alkyl groups Or on the carbon skeleton with K fluorine, chlorine, bromine or iodine or M hydroxyl or alkoxy substituted 9 and unless stated otherwise, the above alkyl, alkylene and alkoxy moieties each have 1 to 4 carbons Atoms and each carbon atom on the above-mentioned alkylene and cycloalkylene moieties are connected to at most one heteroatom bond and tautomers, stereoisomers and salts thereof. However, the preferred compounds of the general formula I above are these, in which: X represents a carbodiimide group, optionally substituted on the nitrogen atom by an M alkyl or cyano group, or X represents a carbonyl, thiocarbonyl or sulfonyl group; Represents a straight bond C2-3 alkylene, which is optionally substituted by Rd or MRdtl I, and which may be additionally substituted by M1 or 2 alkyl groups and wherein an additional methyl group may be substituted by K carbonyl group, -12- This paper uses the national standard (CNS) A4 specification (210X297 mm) {Please read the precautions on the back before filling this page) ...... ...... ~ 3 · .............. Each or Rc and Rd substituent substitution, A6 B6 V. Description of the invention (11) Or a straight-chain C2-3 alkenyl group, optionally M 巳 or Rd and any of them additionally present. Methylmethyl may be carbonyl or 1,2-cycloalkylene having 5 to 7 carbon atoms, depending on Case M 1 or 1 ^, or M 1U and Rd substituted, or 1,2-cycloalkenyl having 5 to 7 carbon atoms, or 1, 2-arylene, or 1,2-phenylene, Wherein 1 or 2 methine groups are replaced by each M nitrogen atom, wherein the heterocyclic group 圑 may be additionally substituted by K1 or 2 alkyl groups, or -CO-HH-, -HH-CO-, -CH = N- orΚΗ-group, if appropriate Μ Rc or Rd substitution, the first one of the! ^ To 1 group represents the A-B group, where A is the following formula (please read the precautions on the back before filling " this page)-install
r2 訂. -綿·· (CH2)nr2 order.-Mian ... (CH2) n
13 經 濟 部 t 央 標 準 員 工 消 費 合 作 社 印 製 本紙埤尽本遄用t國國家標準(CNS)肀4規格(210 χ 297公釐) A6 B6 五、發明説明(12 和13 Printed by t Central Standards Consumer Cooperatives of the Ministry of Economic Affairs This paper is printed to the fullest extent. National Standards (CNS) 4 specifications (210 x 297 mm) A6 B6 V. Description of the invention (12 and
只16—N16-N only
之一,其中上 R^e單或雙取 基*其可相同 部分中1至3個 K -CO-NRi 基 K -CO-NRi 基 述基圑 代,或 或不同 次甲基 圃置換 團置換 R、表示氫原子或烷基 和CU各代表一鍵或 代,其中該等 經 濟 部 t 央 標 準 局 員 工 消 费 合 作 社 印 製 G2表示一鍵或 G 3表示一鍵或 G B表不氮原子 R2表示氫原子 一個不表示一 R3表示氫原子 取代基 M R7和 K Re和 或次甲 或烷基 鍵時, 或烷基 之笨并 M R 2 β ,係界 各可Μ ,或次 ,其中 伸甲基 可相同 R β取代_ R 1 〇取 基,視 、芳基 R2亦可 或芳基 部分可 單取代 定如下 氮原子 甲基可 以ϋ2Β單取代、或Μ ,其中R25和R2e取代 ,和附加地在上述苯并 置換,或-CH = CH基團可 以氮原子和-CH = CH基團 •其可 或不_同 之伸甲 代之伸 情況Μ 或雑芳 表示羥 14 本紙張尺度遑用中•國家揲準(CNS)甲4规格(210X297公釐) 以焼:基或芳基單或雙取 9 基,. 甲基, 烷基或芳基取代, 基或,若02和G3中至少 基或烷氧基, ...................................................................................^........................^.....................縐 {請先閲讀背面之注意事項再填窝本頁) 五、發明説明(13 ) R 4和各表示氫原子,在環烷基部分上各具3至7個碳原 子之環烷基或環烷基烷基、Cx烷基、C3-e-烯基(其烯 基可不經由乙烯基部分鍵接至氮原子)、羥基烷基、烷氧 基烷基、羧基烷基、烷氧基羰基烷基、胺基羰基烷基、 N-烷基胺基羰基烷基、N,N-二烷基胺基羰基烷基、芳基烷 基、烷氧基羰基、芳基甲氧基羰基、甲醢基、乙醯基、三 氟乙醯基、丙烯氧基羰基、甲胖基或 RuCO-O-UwCRid-O-CO-基團,其中 Ria表示Ci-a烷基、C5-7環烷基或芳基或芳基烷基, R12表示氫原子、烷基、Cs-7-環烷基或芳基,和 Rl3表?F氫原子· 或1^4與1{3—起可.表示直鍵C2-4-伸烷基或*若G2不代表一 鍵時,表示伸甲基’ 1U表示氫原子、烷基或芳基或,若Gi不代表一鍵時,羥基 或烷氧基或,若Ga代表一鏈時* R4與RB—起可表示另一鍵 ,和One of the above R ^ e single or double radicals * which may be substituted by 1 to 3 K-CO-NRi groups in the same part, or K-CO-NRi groups may be substituted or replaced by different methine groups R, represents a hydrogen atom or an alkyl group, and CU each represents a bond or a generation, wherein the Ministry of Economic Affairs and the Central Standards Bureau employee consumer cooperative printed G2 represents a bond or G 3 represents a bond or GB represents a nitrogen atom R2 represents hydrogen One atom does not represent one, R3 represents a hydrogen atom when the substituents M R7 and K Re and or a methine or alkyl bond, or an alkyl group is MR 2 β, each of the system boundaries may be M, or times, wherein the methyl group may be The same R β is substituted for _ R 1 0, and the aryl group R2 may also be substituted or the aryl portion may be mono-substituted as follows: the nitrogen atom may be mono-substituted by 2B, or M, wherein R25 and R2e are substituted, and additionally in the above Benzo substitution, or -CH = CH group can be nitrogen atom and -CH = CH group • It may or may not be the same as the case where it is replaced by M or 雑 fang means hydroxyl 14 This paper is not used in the country • Country Standard (CNS) A4 (210X297 mm) Take 9 groups based on 双: group or aryl single or double, methyl Alkyl or aryl substitution, radical or, if at least radical or alkoxy in 02 and G3, ............ ........................................ ..... ^ ........................ ^ ...................... .. Crepe {Please read the notes on the back before filling in this page) 5. Description of the invention (13) R 4 and each represents a hydrogen atom, and each of the cycloalkyl groups has 3 to 7 carbon atoms Or cycloalkylalkyl, Cxalkyl, C3-e-alkenyl (the alkenyl group may be bonded to the nitrogen atom without a vinyl moiety), hydroxyalkyl, alkoxyalkyl, carboxyalkyl, alkoxy Carbonylalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl, arylalkyl, alkoxycarbonyl, arylmethoxycarbonyl, Formamyl, ethylammonium, trifluoroacetamyl, propenyloxycarbonyl, methylcarbyl or RuCO-O-UwCRid-O-CO- groups, where Ria represents Ci-a alkyl, C5-7 cycloalkane Aryl or aryl or arylalkyl, R12 represents a hydrogen atom, alkyl, Cs-7-cycloalkyl or aryl, and Rl3? F hydrogen atom, or 1 ^ 4 and 1 {3—may be a straight bond C2-4-alkylene or * if G2 does not represent a bond, it represents a methyl group; 1U represents a hydrogen atom, an alkyl group or an aromatic group Radical or, if Gi does not represent a bond, hydroxyl or alkoxy or, if Ga represents a chain, * R4 and RB together may represent another bond, and
Re表示氫原子或烷基或芳基或,若Gi表示一鍵且與Rb-起表示另一鍵時,Re可代表氛原子或羥基、甲氧基、胺基 、烷基胺基或二烷基胺基, R·/表示氫原子或烷基或芳基* 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填窝本頁} R8表示氫原子或烷基或芳基或Ra與R4-起可表示直鍵 Ca-s-伸焼基,Re represents a hydrogen atom or an alkyl group or an aryl group, and if Gi represents a bond and Rb- represents another bond, Re may represent an atmosphere atom or a hydroxyl group, a methoxy group, an amine group, an alkylamine group, or a dioxane. Amino group, R · / represents hydrogen atom or alkyl group or aryl group * Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling this page) R8 represents hydrogen atom or alkyl group or aromatic group Radicals or Ra and R4- may represent straight-bonded Ca-s-extendyl radicals,
Re表示氫原子或烷基或芳基或,若〇2不代表一鍵時,Re可 表示羥基或烷氧基, 一 15 — 本紙張尺度逍用t a國家標準(CNS)甲4规格(210X297公釐h A6 B6 經濟部中央標準局員工消费合作社印製 五、發明説明(14 ) R1〇表示氫原子或烷基或芳基,或1U。與R4—起可表示直 鍵C2-4-伸烷基, R15表示氫或氯原子或烷基、芳基、羥基、甲氧基、胺基 、烷基胺基或二烷基胺基 Rie表示氫原子、在環烷基部分上各具3至7個碳原子之環 烷基或環烷基烷基、(^-β-烷基、C3-e-烯基(其烯基可不 經由乙烯基團連接至氮原子)、或羥基烷基、烷氧基皖基 、羧基烷基、烷氧基毅基烷基、胺基羰基烷基、N-烷基胺 基羰基烷基、N,N-二烷基胺基羰基烷基或芳基烷基, R17代表氫原子或烷基或,若G4表示一鍵時,Rle與R17 一起可表不另一鍵*_ R18表示氫原子或烷基或,若G4表示一鐽且Rie與卩17 — 起代表另一鍵時,R18可表示氟、氯或溴原子或羥基、甲 氧基、胺基、烷基胺基或二烷基胺基,和 η代表數字1或2,K及 Β表示一鍵或伸烷基或伸芳基, 或伸吡啶基、伸嘧啶基、伸吡哄基或伸嗒哄基,其中1或 2個-CH = H-基團各可M-CO-NH-基團置換,然而上述雜環 基團可附加地K 1或2個烷基取代* 或視情況K 1或2個烷基取代之C4-7-伸環烷基, 或(:3-7-伸環烯基,其視情況K1或2個烷基取代,且其中 1個〉CH單位Μ氮原子置換,然而附加地,在上述5至7 員環中與氮原子緊鄰之伸甲基可Μ羰基置換; 至Rd基團之第2個表示下式之基團 ..................................................................................裝........................玎.....................縐 (請先閲讀背面之注意事項再填寫本頁) -16- 本紙張尺度遑用中a國家榣準(CNS)甲4规格(210X297公釐) 五、發明説明(15 ) A6 B6 經濟部t央標準局員工消费合作社印製 其中 D表示Ci-e-伸烷基•其中1個伸甲基可K氧或硫原子或K 亞磺醯基、磺醸基或NRle*囿置換,或其中1個伸乙基可 M-CO-NR2(^-NR2〇-CO基團置換(其中Rie表示氫原子或 烷基、烷基羰基、烷基磺醸基、芳基羰基或芳基磺醢基及 R2。表示氫原子或烷基), 或C2-e-伸烯基或伸芳基· 或伸吡啶基、伸嘧啤基、伸吡畊基或伸嗒哄基*其中1或 2個-CH = N-基團各可M-CO-HH-基團置換,然而上述雜環 基團可附加地K 1或2個烷基取代, 或伸二氫節基、伸萘基、1,2,3,4-伸四氫萘基或伸苯并環 庚基,其中環之一與E基團结合且另一環與通式I之環狀 基圏結合,然而飽和環各可K1或2個烷基取代且芳族環各 可以氟、氛、溴或碘原子或Μ烷基、三氟甲基、羥基、烷 氧基、烷基次磺醢基、烷基亞磺醢基、烷基磺醯基或氰基 取代, 或視情況Κ1或2涸烷基取代之C4-7-伸環烷基, 或(:5-7-伸環烷基,其視情況K1或2個烷基取代且其中1 個〉CH單位Μ氮原子置換,然而在上述5至7員環中與氮原 子緊鄰之伸甲基可Κ羰基置換; 或伸六氫吡畊基,其視情況Ml或2個烷基取代,且其中與 氮原子緊鄰之伸甲基可Μ羰基置換; 或,若Ε代表環狀亞胺基團時,D亦可表示具2至6個總碳 (請先閲請背面之注意事項再填窝本頁) .裝 .訂 -17- 本纸張Λ度遑用中國國家標準(CNS)甲4規格(210X297公釐). 五、發明説明(16) (請先閲讀背面之注意事項再填窝本頁) 原子之伸烷基羰基,該羰基與Ε基團之環狀亞胺基團之氮 原子结合, 或,若Ε不表示一鍵時,D亦可代表一鐽, Ε表示一鐽, 或Ci-e-伸烷基,其可Μ 1或2個Ci-e-烷基、以羥基、胺 基或芳基、Μ各具丨至6個碳原子之烷氧基或烷基胺基、以 各具2至8個總破原子之二烷基胺基或MHHR21或卩-烷基 -HR21-基團取代,(其中R21表示在烷基部分上各具1至 6個碳原子之烷基羰基或烷基磺醢基、具2至5個總碳原子 之烷氧基羰基、在環烷基部分上各具5至7個碳原子之環烷 基羰基或環烷基磺醯基、芳基烷基羰基、芳基烷基磺醢基 、芳基烷氧基羰基、芳基羰基或芳基磺醯基), 或C 2 - a _伸烯基, 或伸芳基, 或伸吡啶基、伸嘧啶基、伸吡畊基或伸嗒哄基,視情況K 1或2個烷基取代, 或CB-7-伸環烷基,其視情況K 1或2個烷基取代,且其中 1個〉CH單位以與D基團之碳原子键連之氮原子置換* 或在伸環烷基部分上具4至7個碳原子之伸環烷基,視情況 K1或2個Ci-e-烷基、Μ羥基、胺基或芳基、MCi-e-烷 氧基或Cn-烷基胺基、Μ具2至8個總碳原子之二烷基胺 基或KHNR21或卜烷基-HR21基團取代(其中R21係依如 上所界定), 或,若D不表示一鐽時,E可表示經由基團鍵结至D基 -18 - 本紙張尺度逍用肀困國家標準(CNS)甲4规格(210X297公釐) A6 B6 五、發明説明(17) {請先閲讀背面之注意事項再填窝本頁) 團之伸烷基,其中W表示氧或硫原子、亞磺醯基、磺豳基 、-NRie-、 -NRao-CO-或-C0-NR2o-基圃,其中Rie和 R2〇係依如上所界定且伸烷基可附加地Μ 1或2個Ci-e-烷 基、Μ羥基、胺基或芳基、Μ各具丨至6個碳原子之烷氧基 或烷基胺基、Μ各具2至8個總碳原子之二烷基胺基或Κ HNR21或1<-烷基-NR21-基團取代,其中附加取代基之雜原 子K至少2個碳原子與W基圑之雜原子分雛,及R21係依 如上所界定,和 .装 F表示Μ羥基、K Ci-e-烷氧基、K芳基烷氧基或K R220基團取代之羰基(其中R22表示C4-7-環综基或在環 烷基部分上具3至7個碳原子之環烷基烷基,其中該環烷基 可Μ焼基、烷氧基或二烷基胺基或以烷基和Ml至3個甲基 取代及附加地在5至7員環烷基環上之伸甲基可Μ氧原子或 Μ烷基亞胺基置換*或R22表示-苯并環烷基), 或膦酸基、0-烷基膦酸基、二烷基膦酸基、四唑 -5-基或 R23C0-0-CHR24-0-C0基團,其中 R23表示各具1至8個碳原子之烷基或烷氧基、在環烷 基部分上各具5至7個原子之環烷基或環烷氧基或芳基 、芳氧基、芳基烷基或芳基烷氧基和 R24表示氫原子或烷基, 經濟部中央標準局貝工消费合作社印製- 及F基團與A-B基圈上距F基團最遠之氮原子間之最短距離 為至少11鍵;Re represents a hydrogen atom or an alkyl group or an aryl group. If 〇2 does not represent a bond, Re may represent a hydroxyl group or an alkoxy group. A 15 — This paper is a national standard (CNS) A4 specification (210X297). Printed by A6 B6 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (14) R10 represents a hydrogen atom or an alkyl or aryl group, or 1U. Together with R4, it can represent a straight bond C2-4-ethan R15 represents a hydrogen or chlorine atom or an alkyl group, an aryl group, a hydroxyl group, a methoxy group, an amine group, an alkylamino group, or a dialkylamino group. Rie represents a hydrogen atom, each having 3 to 7 on a cycloalkyl portion. Cycloalkyl or cycloalkylalkyl of one carbon atom, (^ -β-alkyl, C3-e-alkenyl (the alkenyl group may be connected to the nitrogen atom without a vinyl group), or hydroxyalkyl, alkoxy Alkyl, carboxyalkyl, alkoxyalkyl, aminocarbonylalkyl, N-alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl, or arylalkyl, R17 represents a hydrogen atom or an alkyl or, if G4 represents a bond, Rle and R17 together can represent another bond * _ R18 represents a hydrogen atom or an alkyl or, if G4 represents a 鐽 and Rie and 卩 17 together When representing another bond, R18 may represent a fluorine, chlorine or bromine atom or a hydroxyl group, a methoxy group, an amino group, an alkylamino group or a dialkylamino group, and η represents the number 1 or 2, K and B represent a bond Or alkylene or aryl, or pyridyl, pyrimidyl, pyridyl, or daphthyl, where 1 or 2 -CH = H- groups may each be M-CO-NH- groups Substitute, however, the above heterocyclic group may additionally be substituted with K 1 or 2 alkyl groups * or optionally a C 4-7-cycloalkyl group substituted with K 1 or 2 alkyl groups, or (: 3-7-cyclic ring Alkenyl, which is optionally substituted by K1 or 2 alkyl groups, and 1 of them> CH unit M nitrogen atom is replaced, however, in addition, in the above 5 to 7-membered ring, the extended methyl group adjacent to the nitrogen atom may be replaced by M carbonyl group ; The second group to the Rd group represents the following formula ... ............................................... ......... 玎 ........... crape (please read the back first Please note this page before filling in this page) -16- This paper size is in use in a country standard (CNS) A4 specification (210X297 mm) V. Description of invention (15) A6 B6 Employees of the Central Standards Bureau of the Ministry of Economic Affairs Printed by a consumer cooperative where D stands for Ci-e-alkylene • One of the methylene groups can be replaced by a K oxygen or sulfur atom or K sulfinyl, sulfonyl or NRle * 囿, or one of them It can be replaced by M-CO-NR2 (^-NR2O-CO group (where Rie represents a hydrogen atom or an alkyl group, an alkylcarbonyl group, an alkylsulfonyl group, an arylcarbonyl group or an arylsulfonyl group and R2. (Represents a hydrogen atom or an alkyl group), or C2-e-alkenyl or arylene · or pyridyl, pyrimyl, pyridyl, or daphthyl * among which 1 or 2 -CH = N -Each group may be replaced by an M-CO-HH- group, however, the above heterocyclic group may additionally be substituted by K 1 or 2 alkyl groups, or dihydrobenzyl, naphthyl, 1,2,3,4 -Tetrahydronaphthyl or benzocycloheptyl, in which one of the rings is bonded to the E group and the other ring is bonded to the cyclic group 圏 of the general formula I, however the saturated rings may each be substituted by K1 or 2 alkyl groups and The aromatic rings may each be a fluorine, cyano, bromine or iodine atom or an M alkyl group, a trifluoromethyl group, a hydroxyl group, an alkoxy group, an alkylsulfinylfluorenyl group, an alkylsulfinylfluorenyl group, an alkylsulfonylfluorenyl group, or a cyano Or C4-7-cycloalkyl substituted with K1 or 2 alkyl, or (: 5-7-cycloalkyl, optionally K1 or 2 alkyl substituted with 1> CH unit M is replaced by a nitrogen atom, however, in the above 5- to 7-membered ring, a methyl group adjacent to the nitrogen atom may be replaced by a carbonyl group; or a hexahydropyridyl group, which is optionally substituted by M1 or 2 alkyl groups, and wherein A methyl group immediately adjacent to the nitrogen atom may be replaced by an carbonyl group; or, if Ε When representing a cyclic imine group, D can also be said to have 2 to 6 total carbons (please read the precautions on the back before filling this page). Binding. Bookmark-17- This paper is made in China National Standard (CNS) A4 specification (210X297 mm). 5. Description of the invention (16) (Please read the notes on the back before filling this page) Atomyl carbonyl group, the ring of carbonyl group and E group The nitrogen atom of the imine-like imine group is combined, or, if E does not represent a bond, D may also represent a pyrene, E represents a pyrene, or Ci-e-alkylene, which may be 1 or 2 Ci- e-alkyl, hydroxy, amine or aryl, M alkoxy or alkylamine groups each having 6 to 6 carbon atoms, dialkyl amine groups each having 2 to 8 total broken atoms or MHHR21 or fluorene-alkyl-HR21- group substitution, (where R21 represents an alkylcarbonyl or alkylsulfonyl group each having 1 to 6 carbon atoms in the alkyl portion, an alkyl group having 2 to 5 total carbon atoms Alkoxycarbonyl, cycloalkylcarbonyl or cycloalkylsulfonyl, each having 5 to 7 carbon atoms in the cycloalkyl portion, arylalkylcarbonyl, arylalkylsulfonyl, arylalkoxy Carbonyl, arylcarbonyl or arylsulfonyl ), Or C 2-a -alkenyl, or arylene, or pyridyl, pyrimidyl, pyridyl, or daphthyl, optionally substituted with 1 or 2 alkyl groups, or CB- 7-cycloalkyl, which is optionally substituted by K 1 or 2 alkyls, and 1 of them> CH units are replaced with nitrogen atoms bonded to the carbon atom of the D group * or have a cycloalkyl moiety Cycloalkyl groups of 4 to 7 carbon atoms, optionally K1 or 2 Ci-e-alkyl, M hydroxyl, amine or aryl, MCi-e-alkoxy or Cn-alkylamino, M A dialkylamino group or a KHNR21 or a dialkyl-HR21 group with 2 to 8 total carbon atoms (where R21 is as defined above), or if D does not represent a single atom, E may represent a via group Group bond to D-base-18-National paper standard (CNS) A4 specification (210X297 mm) A6 B6 V. Invention description (17) {Please read the precautions on the back before filling the book (Page) an alkyl group of a group, in which W represents an oxygen or sulfur atom, a sulfenyl group, a sulfofluorenyl group, -NRie-, -NRao-CO-, or -C0-NR2o-based group, wherein Rie and R2〇 are based on As defined above and the alkylene group may additionally be M 1 or 2 Ci-e-alkyl M hydroxyl, amine or aryl, M alkoxy or alkylamino groups each having from 6 to 6 carbon atoms, M each dialkylamino groups having 2 to 8 total carbon atoms or K HNR21 or 1 < -Alkyl-NR21- group substitution, in which the heteroatom K of the additional substituent has at least 2 carbon atoms separated from the heteroatom of the W group, and R21 is as defined above, and F represents MH, K Ci-e-alkoxy, Karylalkoxy or K R220 group substituted carbonyl groups (where R22 represents a C4-7-cyclohexyl group or a cycloalkane having 3 to 7 carbon atoms in the cycloalkyl portion Alkyl, in which the cycloalkyl can be substituted with a methyl, alkoxy or dialkylamino group or substituted with an alkyl group and M1 to 3 methyl groups and additionally extending from a 5 to 7 membered cycloalkyl ring A methyl group may be replaced by an M oxygen atom or an M alkylimine group (or R22 represents a benzocycloalkyl group), or a phosphonate group, a 0-alkylphosphonic acid group, a dialkylphosphonic acid group, or a tetrazole-5 -Groups or R23C0-0-CHR24-0-C0 groups, where R23 represents an alkyl or alkoxy group having 1 to 8 carbon atoms each, and a cycloalkane having 5 to 7 atoms each in a cycloalkyl portion Or cycloalkoxy or aryl, aryloxy, arylalkyl or arylalkoxy R24 represents a hydrogen atom or an alkyl group, Ministry of Economic Affairs Bureau of Standards HIGHLAND consumer cooperative printed - and F groups and the shortest distance between the furthest from the group F of the A-B group on the ring nitrogen atom is at least 11 bonds;
Re至Rd基團之第3個表示氫原子、烷氧基(其烷氧基 不能與氮原子结合)、烷基、三氟甲基、芳基、芳基垸基 一 19 — ^纸張尺度遴用中國國家揉準(CNS)甲4規格(210X297公釐) 經濟部中央標準局貝工消費合作社印製 A6 B6__ 五、發明説明(18 ) 、噻吩基、噻唑基、吡啶基、嘧啶基、吡哄基或嗒畊基; 和 1^至Rd基團之第4個表示氫原子或烷基; 然而除非另有說明 在以上基團定義中所提之各芳基部分為苯基•其可M 單取代,Κϋ2β單、雙或三取代或單取代且附加地 以R2e箪或雙取代,其中取代基可相同或不同,和 r25表示氰基、胺基羰基、烷基胺基羰基、二烷基胺 基羰基、烷基羰基、烷基次磺醯基、烷基亞磺醢基、 烷基磺醯基或三氟甲基和 R2e表示烷基、羥基或烷氧基或氟、氯或溴原子,然 而若2個R2e基團與其相鄰碳原子结合時,其亦可代表 C3-e-伸烷基、1,3-伸丁二烯-1,4-二基或伸甲二氧 基, 和在上述基團定義中所提之各伸芳基部分為伸苯基,其可 以R2S單取代,或K 單或雙取代、或K R2S單取代且附 加地以單取代,其中取代基可相同或不同且依如上所 界定· 和除非另有說明,上述烷基、伸烷基和烷氧基部分各可具 1至4涸碳原子和在上述伸烷基和伸環烷基部分上之各碳 原子至多與1個雜原子鏈連; 和互變異構物、立體異構物及其鹽類。 特別佳的係通式I之此等化合物,其中 X表示在氮原子上Μ氰基取代之碳亞胺基,或X表示羰 一 20- 本紙張尺度逍用t國國家樑準(CNS)甲4规格(210X297公 (請先閲讀背面之注意事項再填窝本頁} -裝 訂. A6 B6 五、發明説明(19 ) 基或磺醯基; I γ 表示ch2ch2- 、ch2ch2ciu-、-ch4ch、-CH2CO-或 I i -COCH2-基團,視情況MRC或MRC和Rj取代,或-CO-NH-、-NH-CO-、CH = N-或-N = CH 基園,視情況 MRcSRd 取代; 1至Rd基團之第1個表示A-B基匾,其中A為下式The third group from Re to Rd represents a hydrogen atom, an alkoxy group (its alkoxy group cannot be combined with a nitrogen atom), an alkyl group, a trifluoromethyl group, an aryl group, and an arylfluorenyl group. Selection of China National Standards (CNS) A4 (210X297 mm) Printed by A6 B6 of the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (18), thienyl, thiazolyl, pyridyl, pyrimidinyl, Pyridyl or daphthyl; and the fourth from 1 to Rd represents a hydrogen atom or an alkyl group; however, unless otherwise stated, each aryl moiety mentioned in the definition of a group is phenyl. M mono-substituted, κϋ2β mono-, di- or tri-substituted or mono-substituted and additionally substituted with R 2e 箪 or di-substituted, wherein the substituents may be the same or different, and r25 represents cyano, aminocarbonyl, alkylaminocarbonyl, dioxane Alkylaminocarbonyl, alkylcarbonyl, alkylsulfenyl, alkylsulfinyl, alkylsulfonyl or trifluoromethyl and R2e represents alkyl, hydroxy or alkoxy or fluorine, chlorine or bromine Atom, however, if two R2e groups are bonded to their adjacent carbon atoms, it may also represent C3-e-alkylene, 1,3-butadiene- 1,4-diyl or methylenedioxy, and each of the arylene moieties mentioned in the definition of the above group is a phenyl group, which may be monosubstituted by R2S, or substituted by K mono or di, or K R2S mono Substituted and additionally monosubstituted, where the substituents may be the same or different and are as defined above; and unless stated otherwise, each of the above alkyl, alkylene, and alkoxy moieties may each have 1 to 4 carbon atoms and at Each carbon atom on the above-mentioned alkylene and cycloalkylene moiety is connected to at most one heteroatom chain; and tautomers, stereoisomers and salts thereof. Particularly preferred are compounds of the general formula I, where X represents a cyano-substituted carbimide group on the nitrogen atom, or X represents a carbonyl-20. This paper is based on National Standards (CNS) A 4 specifications (210X297 male (please read the precautions on the back before filling this page)-binding. A6 B6 V. Description of the invention (19) group or sulfofluorene group; I γ means ch2ch2-, ch2ch2ciu-, -ch4ch,- CH2CO- or I i -COCH2- group, optionally substituted by MRC or MRC and Rj, or -CO-NH-, -NH-CO-, CH = N- or -N = CH radical, optionally substituted by MCrSRd; The first of the 1 to Rd groups represents an AB-based plaque, where A is the formula
Ri4x (CH2)nRi4x (CH2) n
H2CH2C
(請先閲讀背面之注意事項再填窝本頁} 和 經濟部中央標準局員工消费合作社印製(Please read the notes on the back before filling in this page)
之一,其中上述基圃之苯并部分可K氟、氯或溴原子或κ 21 本紙張尺度遴用辛國國家標準(CNS)甲4规格(210X297公釐> 五、發明説明(20 ) (請先閲讀背面之注意事項再填寫本頁) 烷基、氰基、三氟甲基、羥基、烷氧基取代,或1至3涸次 甲基各可K氮原子置換,One, among which the benzo part of the above-mentioned base can be K fluorine, chlorine or bromine atom or κ 21 This paper size is selected from the National Standard (CNS) A4 specification (210X297 mm >) 5. Description of the invention (20) (Please read the notes on the back before filling this page) Alkyl, cyano, trifluoromethyl, hydroxyl, alkoxy substitution, or 1 to 3 methine can each be replaced by K nitrogen atom,
Gi表示一鍵或伸甲基*其可K烷基單或雙取代,然而取代 基可相同或不同, G2表示一鍵或Μ 1{7和R8取代之伸甲基, G3表示Μ 1?9和R10取代之伸甲基, “表示一鍵,Gi represents a bond or a methyl group * which may be mono- or di-substituted by K alkyl, however the substituents may be the same or different, G2 represents a bond or a methyl group substituted by M 1 {7 and R8, and G 3 represents M 1-9 And R10 substituted methyl, "" means a bond,
Gs表示氮原子或次甲基,視情況Μ烷基取代, 表示氫原子或烷基, R3表示氫原子或烷基, R4表示氫原子,在環烷基部分上各具3至7個碳原子之環烷 基或環烷基烷基、Ci-e-烷基、C3-e-烯基(其烯基可不經 由乙烯基團與氮原子鍵連)、或羥基烷基、烷氧基烷基、 羧基烷基、烷氧基羰基烷基、胺基羰基烷基、烷基胺基 羰基烷基、Ν,Ν-二烷基胺基羰基烷基、芳基烷基、烷氧基 羰基、芳基甲氧基羰基、甲醢基、乙醢基、三氟乙醯基或 RuCO-O-UnCJUd-O-CO-基圈,(其中Rn表示烷基, R12表示氫原子或院基,及R13表示氬原子), 或R4與R3—起可表示直鐽(:2-3-伸烷基·Gs represents a nitrogen atom or a methine group, as appropriate, M alkyl substituted, represents a hydrogen atom or an alkyl group, R3 represents a hydrogen atom or an alkyl group, R4 represents a hydrogen atom, and each has 3 to 7 carbon atoms in a cycloalkyl portion Cycloalkyl or cycloalkylalkyl, Ci-e-alkyl, C3-e-alkenyl (the alkenyl group may be bonded to the nitrogen atom without a vinyl group), or hydroxyalkyl, alkoxyalkyl , Carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonylalkyl, N, N-dialkylaminocarbonylalkyl, arylalkyl, alkoxycarbonyl, aromatic Methoxycarbonyl, formamidine, ethenyl, trifluoroethenyl, or RuCO-O-UnCJUd-O-CO- radicals, (where Rn represents an alkyl group, R12 represents a hydrogen atom or a radical, and R13 Represents argon atom), or R4 and R3 together can represent straight chirped (: 2-3-alkylene ·
Rs表示氫原子或烷基或,若Gt代表一鍵時,IU與RB—起可 表示另一鍵, 經濟部中央標準局貝工消費合作社印製Rs represents a hydrogen atom or an alkyl or, if Gt represents a bond, IU and RB together can represent another bond, printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
Re表示氫原子或烷基或,若Gi表示一鍵且與R5—起代表 另一鍵時* Re可表示胺基, R7表示氫原子或烷基, -22- 本纸張尺度逋用t國國家揉準(CHS) T 4规格(210X 297公釐) A6 B6 五、發明説明(21 )Re represents a hydrogen atom or an alkyl or, if Gi represents a bond and R5 represents another bond * Re can represent an amine group, R7 represents a hydrogen atom or an alkyl group, -22- This paper uses t National Standard (CHS) T 4 Specification (210X 297 mm) A6 B6 V. Description of Invention (21)
Rs表示氫原子或烷碁,或Re與R4一起可表示直鍵C3-4-伸 烷基, R9表示氫原子或烷基, R1〇表示氩原子或烷基或R1〇與h一起可表示直鍵C3-4-伸烷基·Rs represents a hydrogen atom or an alkane, or Re together with R4 may represent a straight bond C3-4-alkylene, R9 represents a hydrogen atom or an alkyl group, R10 represents an argon atom or an alkyl group, or R10 together with h may represent a straight bond Bond C3-4-alkylene ·
Rm表示氫原子或烷基, R15表示氫原子或烷基,Rm represents a hydrogen atom or an alkyl group, R15 represents a hydrogen atom or an alkyl group,
Rie表示氫原子或烷基, R17表示氫原子或烷基或一起可表示另一鐽* Rie表示氫原子或烷基或,若lUe和R17 —起表示另一鍵 時,R18可表示氛原子或胺基, η代表數字1或2,及 Β表示一鏈, 或伸烷基, 或伸芳基, 或伸吡啶基、、伸嘧啶基、伸吡畊基或伸嗒畊基,視情況 以1或2個烷基取代, 或視情況Κ Κ1或2涸烷基取代之伸環己基, 或伸六氫吡畊基,其視情況以1或2個烷基取代,且其中 與氮原子緊鄰之伸甲基可Μ羰基置換;Rie represents a hydrogen atom or an alkyl group, R17 represents a hydrogen atom or an alkyl group or together may represent another 鐽 * Rie represents a hydrogen atom or an alkyl group or, if 1Ue and R17 together represent another bond, R18 may represent an atmospheric atom or Amine group, η represents the number 1 or 2, and B represents a chain, or alkylene, or aryl, or pyridyl, pyrimidyl, pyridyl, or daphthyl, with 1 as appropriate Or 2 alkyl substituted, or cyclohexyl substituted with KK 1 or 2 alkyl, or hexahydropyridyl, optionally substituted with 1 or 2 alkyl, and which is immediately adjacent to the nitrogen atom Methylene can be replaced by M carbonyl;
ReMRd基團之第2個表示下式之基團 經濟部中央標準局员工消费合作社印製 {請先閲讀背面之注意事項再填窝本頁) 装 F - E - D - 其中 D表示伸烷基, —23 — 本紙張尺度逍用中國8家標準(CNS)甲4規格(210X297公爱) 經濟部中央標準局員工消费合作社印製 A6 _B6__ 五、發明説明(22) 或伸芳基, 或伸吡啶基、伸嘧啶基、伸吡畊基或伸咯畊基·視情況K 1或2涸烷基取代, 或伸二氫茚基、伸萘基、1,2,3,4-伸四氫萘基或伸苯并環 庚基,其中環之一與E基團结合且另一環與通式I之環狀 基團结合, 或視情況K1或2涸烷基取代之C4-7-伸環烷基, 或C 5-7-伸環烷基,其視情況Μ 1或2個烷基取代,且其中 1儷〉CH單位Μ氮原子置換,然而附加地在上述5至7員環 中與氮原子緊鄰之伸甲基可Μ羰基置換; 或 > 若Ε表示環狀亞胺基團時,D可表示伸烷基羰基,其 中該羰基與Ε基團之環狀亞胺基匾之氮原子结合, 或若Ε不表示一鍵時,D亦可代表一鍵, Ε:表示一鍵, 或伸烷基,其可以C^-e-烷基或Μ胺基、芳基、烷基胺基 、二烷基胺基、HNR21或1烷基- NR21-基團取代,(其中 R21表示在烷基部分上各具1至6個碳原子之烷基羰基或烷 基磺醯基、具2至5個總碳原子之烷氧基羰基、在環烷基部 分上各具5至7個碳原子之環烷基羰基或環烷基磺醢基、或 芳基烷基羰基、芳基烷基磺醯基、芳基烷氧基羰基、芳基 羰基或芳基磺醢基), 或C2-4•伸烯基’ 或伸芳基, 或伸吡啶基、伸嘧啶基、伸吡畊基或伸嗒畊基,視情況枞 -24- 本纸張尺度逍用中國國家樣準(CNS)甲4规格(210X297公釐)^~ ....................................................................................裝...................…訂...................._ (請先閲讀背面之注意事項_再填窝本頁} B6 五、發明説明(23 ) 1或2個烷基取代* 或(:5-7-伸環烷基,其視情況Ml或2個烷基取代,且其中 1個>CH單位以與D基團之碳原子鍵連之氮原子置換* 視情況Μ 1或2個烷基取代之C4-7-伸環烷基, 或*若D不表示一鍵時,E亦可表示經由W基團與D基團 鍵结之伸烷基,其中W表示氧或硫原子或亞磺醢基、磺醢 基、-NR2o-C0-或-CO-NR2〇-基團*其中R2〇表示氫原子 或烷基和伸烷基可附加地-烷基、或Μ胺基、芳基 、烷基胺基、二烷基胺基、HNR21或Ν-烷基-NR21-基團取 代*其中附加取代基之雜原子K至少2個碳原子與W基團 之雜原子分離,及R21係依如上所界定,和 F表示Μ羥基、烷氧基、芳基烷氧基或R220基围取代之羰 基(其中表示C5-7-環烷基或在環烷基部分上具5至 7個碳原子之環烷基烷基), 或R23C0-0-CHR24-0-C0-、膦酸基或0-烷基膦酸基,其中 R23表示烷基、烷氧基、在環烷基部分上各具5至7 個碳原子之環烷基或環烷氧基和 R24表示氧原子或烷基, 及F基團與A-B基團上距F基團最遠之氮原子間之最短距離 為至少11鍵; 經 濟 部 中 央 標 準 局 員 工 消 费 合 作 社 印 製 {請先閲讀背面之注意事項再填寫本頁)The second of the ReMRd group is printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page). F-E-D-where D is the alkylene group. — 23 — This paper is scaled to 8 Chinese Standards (CNS) A4 specifications (210X297 public love) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A6 _B6__ V. Description of the invention (22) or Shenfangji Pyridyl, pyrimidyl, pyridyl, or pyridyl. • K 1 or 2 alkyl substituted as appropriate, or dihydroindenyl, naphthyl, 1,2,3,4-tetrahydronaphthalene Or benzocycloheptyl, in which one of the rings is bonded to the E group and the other ring is bonded to a cyclic group of the general formula I, or optionally a C1-7-cycloalkylene substituted with a K1 or 2 alkyl group Group, or C 5-7-cycloalkyl, which is optionally substituted by 1 or 2 alkyl groups, and wherein 1CH> CH unit M nitrogen atom is replaced, but additionally with nitrogen in the above 5 to 7-membered ring A methyl group adjacent to the atom may be replaced by an carbonyl group; or > If Ε represents a cyclic imine group, D may represent an alkylene carbonyl group, wherein the carbonyl group and the cyclic imine group of the Ε group Nitrogen atom, or if Ε does not represent a bond, D may also represent a bond, Ε: represents a bond, or alkylene, which may be C ^ -e-alkyl or M amine, aryl, alkane Amino, dialkylamino, HNR21 or 1 alkyl-NR21- groups, (where R21 represents an alkylcarbonyl or alkylsulfonyl group each having 1 to 6 carbon atoms in the alkyl portion, Alkoxycarbonyl groups having 2 to 5 total carbon atoms, cycloalkylcarbonyl groups or cycloalkylsulfonyl groups having 5 to 7 carbon atoms each in a cycloalkyl portion, or arylalkylcarbonyl groups, aryl groups Alkylsulfonyl, arylalkoxycarbonyl, arylcarbonyl or arylsulfonyl), or C2-4 • alkenyl 'or arylene, or pyridyl, pyrimidyl, pyridyl Base or extended base, depending on the situation -24- This paper size is free to use China National Standard (CNS) A4 specifications (210X297 mm) ^ ~ .............. ........................................ ..................................... Order ... ............_ (Please read the notes on the back _ then fill in this page) B6 V. Description of the invention (23) 1 or 2 alkyl substitutions * or ( : 5-7-cycloalkyl, which is optionally substituted by M1 or 2 alkyl groups, and 1 of which> CH unit is replaced with a nitrogen atom bonded to a carbon atom of the D group * as appropriate M 1 or 2 Alkyl substituted C4-7-cycloalkyl, or * If D does not represent a bond, E can also represent an alkylene bonded via a W group to a D group, where W represents an oxygen or sulfur atom Or a sulfinyl, sulfonyl, -NR2o-C0- or -CO-NR2 0- group * where R2O represents a hydrogen atom or an alkyl group and an alkylene group may additionally be an alkyl group, or an amine group, an aromatic group Group, alkylamino group, dialkylamino group, HNR21 or N-alkyl-NR21- group substitution * wherein the heteroatom K of the additional substituent has at least 2 carbon atoms separated from the heteroatom of the W group, and R21 Are as defined above, and F represents a hydroxy group substituted with an hydroxy group, an alkoxy group, an arylalkoxy group, or an R220 group (wherein C5-7-cycloalkyl or 5 to 7 in the cycloalkyl portion is represented) Carbon atom cycloalkylalkyl), or R23C0-0-CHR24-0-C0-, phosphonic acid group or 0-alkylphosphonic acid group, in which R23 represents an alkyl group, an alkoxy group, on a cycloalkyl moiety Cycloalkyl or cycloalkoxy and R24 with 5 to 7 carbon atoms each The shortest distance between the oxygen atom or alkyl group, and the F group and the nitrogen atom farthest from the F group on the AB group is at least 11 bonds; printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs {Please read the note on the back first (Fill in this page again)
Re至Rd基團之第3個表示氫原子、烷氧基(其中烷氧基 可不與氮原子结合)或烷基、三氟甲基或芳棊;和 Ra至1^基團之第4個表示氫原子或烷基, 然而除非他處指示之 2 5 本纸張尺度逋用中國國家標準(CNS)甲4规格(210X297公釐) 經濟部中央標準局貝工消費合作社印製 A6 B6_ '五、發明説明(24 ) 在Μ上基圏定義中所提之各芳基部分為苯基,其可M R25 單取代,單、雙或三取代,或M R2B單取代且附加 地以R2e單或雙取代,其中取代基可相同或不同*和 R2B表示氰基、胺基羰基、烷基胺基羰基、二烷基胺 基羰基、烷基羰基、烷基次磺醯基、烷基亞磺醢基、 烷基磺釀基或三氟甲基和 R2e表示烷基、羥基或烷氧基或氟、氯或溴原子,然 而若2涸R2e基團與其相鄰碳原子结合時,其亦可代表 直鍵C3-4-伸烷基、1,3-伸丁二烯-1,4-二基或亞甲 二氧基, 和在上述基團定義中所提之各伸芳基部分為伸笨基,其可 以1?25單取代,單或雙取代,或MR2S單取代且附加 地MR2e單取代,其中取代基可相同或不同且依如上所界 定,. 和除非另有說明,上述烷基、伸烷基和烷氧基部分各可具 1至4個碳原子和在上述伸烷基和伸環烷基部分上之各碳 原子至多與1個雜原子鏈連; 和互變異構物、立體異構物及其鹽類。 特別佳的通式I之化合物係此等,其中: X表示羰基或磺醢基; Y 表示 CH2CH2、CH2CH2CH2 、CH = CH 、CH2CO 或 COCH2 基團,視情況Ml或2個甲基取代,或視情況K Re取代之 CO-NH、CH = N或 N = CH 基團; 1^至Rc基團之第1個表示A-B基團,其中A表示下式 -26- 本紙張尺度遑甩中國國家標準(CNS)甲4规格(210X297公釐) ...........................................................-K.....................裝......................訂....................㉟ (請先閲讀背面之注意事項再填窝本頁) A6 B6_ 五、發明説明(25 )The third group from Re to Rd represents a hydrogen atom, an alkoxy group (where the alkoxy group may not be bound to a nitrogen atom) or an alkyl group, a trifluoromethyl group, or an arylene group; and the fourth group from Ra to 1 ^ group Represents a hydrogen atom or an alkyl group, but unless otherwise instructed, this paper size uses the Chinese National Standard (CNS) A4 size (210X297 mm). Printed by A6 B6_5 of the Central Laboratories of the Ministry of Economic Affairs. 2. Description of the invention (24) Each of the aryl moieties mentioned in the definition of sulfonium on M is a phenyl group, which may be mono-substituted, mono-, di- or tri-substituted by M R25, or mono-substituted by M 2B and additionally mono- or R 2 e Double substitution, where the substituents may be the same or different * and R2B represents cyano, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylcarbonyl, alkylsulfenylfluorene, alkylsulfinylfluorene Group, alkylsulfonyl group or trifluoromethyl group and R2e represents an alkyl group, a hydroxyl group or an alkoxy group or a fluorine, chlorine or bromine atom, however, if a 2 涸 R2e group is bonded to its adjacent carbon atom, it may also represent Straight bond C3-4-alkylene, 1,3-butadiene-1,4-diyl or methylenedioxy, and each of the The base moiety is a dibenzyl group, which may be mono-, mono- or di-substituted, or MR2S mono-substituted and additionally MR2e mono-substituted, wherein the substituents may be the same or different and are as defined above, and unless otherwise specified Each of the alkyl, alkylene and alkoxy moieties may have 1 to 4 carbon atoms and each carbon atom on the alkylene and cycloalkyl moieties is linked to at most 1 heteroatom chain; and intervariant Structures, stereoisomers and their salts. Particularly preferred compounds of the general formula I are these, where: X represents a carbonyl or sulfonyl group; Y represents a CH2CH2, CH2CH2CH2, CH = CH, CH2CO or COCH2 group, optionally M1 or 2 methyl substitutions, or Case K Re-substituted CO-NH, CH = N or N = CH groups; the first one from 1 ^ to Rc represents the AB group, where A represents the following formula -26- This paper is based on Chinese national standards (CNS) A4 specifications (210X297 mm) .............. ....- K .................... ...... Order ............ ㉟ (Please read the notes on the back before filling in the book (Page) A6 B6_ V. Description of the invention (25)
r2r2
:(...........................................................................裝 ......................tr...................._ {請先閲讀背面之注意事項再填寫本頁} 經濟部中央標準局員工消費合作社印製 之一,其中在上述基囿之苯并部分中1:至2個次甲基各可μ 氮原子置換,: (................................................ ................................................. tr ............._ {Please read the notes on the back before filling out this page} One of the printed products of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 1: to 2 methine groups in the benzo part of the above-mentioned fluorene may each be replaced by μ nitrogen atoms,
Gi表示一鍵或伸甲基, G 2表示一鍵, -27- 本紙張尺皮逍甩中Η國家揉準(@S)甲4规格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(26 ) G3表示伸甲基, G 4表7F —鍵, 05表示氮原子或次甲基, R 2表示氫原子, R 3表氮原子, R4表示氫原子,環丙基或環丙基甲基、Ci-e-烷基或烯 丙基、羥基焼基、羧基烷基、烷氧基羰基烷基或苄基, RB表示氫原子,Gi means one key or extension of methyl, G 2 means one key, -27- The paper ruler is free to take off the national standard (@S) A4 size (210X297 mm) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation of A6 B6 V. Explanation of the invention (26) G3 represents methylene, G 4 represents 7F—bond, 05 represents nitrogen atom or methine, R 2 represents hydrogen atom, R 3 represents nitrogen atom, R 4 represents hydrogen atom, ring Propyl or cyclopropylmethyl, Ci-e-alkyl or allyl, hydroxymethyl, carboxyalkyl, alkoxycarbonylalkyl or benzyl, RB represents a hydrogen atom,
Re表示氫原子, R14表示氫原子或烷基* R1B表示氫原子或烷基,Re represents a hydrogen atom, R14 represents a hydrogen atom or an alkyl group * R1B represents a hydrogen atom or an alkyl group,
Rie表示氫原子或烷基, R17表示氫原子或Rie與1^7 —起可表示另一鍵, R13表示氫原子或•若Rle和“7 —起表示另一鍵時二 R18可表示胺基, η代表數字1或2,及 Β表示一鍵或伸苯基, 1至1基團之第2涸表示下式之基團 F _ Ε _ D _ 其中 D表示伸烷基, 或伸苯基, 或伸環己基, 或伸六氫吡畊基,其中該環氮原子與Ε基圃之視情況取代 —2 8 — .本紙張尺度逋用中.國困家搮準.(CNS)甲4规格(210X297公釐) ....................................................................................裝........................玎....................^ {請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製· A6 _._,_B6_ . 五、發明説明(27 ) 直鏈伸烷基鐽連, 或一鍵, E表示直鏈伸烷基,其可Μ烷基或苯基取代, 或C2-4伸稀基, 或伸苯基, 或,若D不表示一鍵時,Ε可表示經由氧原子與D基團鍵 連之直鏈0-伸烷基,和 F表示Κ羥基或烷氧基取代之羰基, 及F基團與Α-Β基團上距F基團最遠之氮原子間之最短距離 為至少11鍵,和Rie represents a hydrogen atom or an alkyl group, R17 represents a hydrogen atom or Rie and 1 ^ 7 together can represent another bond, R13 represents a hydrogen atom or • If Rle and "7 together represent another bond, R18 can represent an amine group , Η represents the number 1 or 2, and B represents a bond or a phenylene group, and the second 1 of the 1 to 1 group represents a group of the formula F_Ε_D_ where D represents an alkylene group, or a phenylene group , Or cyclohexyl, or hexahydropyridyl, in which the ring nitrogen atom and the E base are replaced as appropriate — 2 8 —. This paper is in use. National Standards (CNS) A 4 Specifications (210X297 mm) ............ ......................................................... ............... 玎 .................... ^ (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs · A6 _._, _B6_. V. Description of the Invention (27) Linear alkylene chain coupling, or a bond, E means linear alkylene group, which can be M alkyl group Or phenyl substituted, or C2-4 diphenyl, or phenyl, or if D does not represent a bond, E may represent a bond to the D group via an oxygen atom Straight-chain 0-alkylene, and F represents a K-hydroxy or alkoxy-substituted carbonyl group, and the shortest distance between the F group and the nitrogen atom farthest from the F group on the A-B group is at least 11 bonds ,with
Re至IU基團之第3個表示氫原子、烷 烷氧基 可不與氮原子结合)或烷·基或苯基; 然而除非他處指定之,上述烷基、伸烷基和烷氧基部分各 可具1至4個碳原子和在上述伸烷基和伸環烷基部分上之 各碳原子至多與1個雜原子鏈連; 和互變異構物、立體異構物及其鹽類。 特別最佳的通式I化合物係此等,其中 X表示羰基; Y 表示 CH2CH2、CH2CH2CH2 、CH = CH 、CH2CO 或 COCH2 基圃, 或視情況M甲基取代之N=CH基围; 1基團表示A-B基團,其中 Λ表示下式 -29- 本紙張尺度逍用中國國家標準(CNS)甲4規格(210X297公釐) {請先閲讀背面之注意事項再填寫本頁) •裝 訂. A6 B6 五、發明説明(28)The third from the Re to the IU group represents a hydrogen atom, an alkalkoxy group may not be bonded to a nitrogen atom) or an alkyl group or a phenyl group; however, unless specified elsewhere, the above alkyl, alkylene, and alkoxy moieties Each may have 1 to 4 carbon atoms and each carbon atom on the above-mentioned alkylene and cycloalkylene moiety is linked to at most 1 heteroatom chain; and tautomers, stereoisomers and salts thereof. Particularly preferred compounds of the general formula I are these, where X represents a carbonyl group; Y represents a CH2CH2, CH2CH2CH2, CH = CH, CH2CO or COCH2 base, or optionally a M-substituted N = CH group; 1 group The AB group, where Λ is the following formula: 29- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210X297 mm) {Please read the precautions on the back before filling this page) • Binding. A6 B6 V. Description of Invention (28)
r2r2
裝.....................:-玎....................,線 (請先閲讀背面之注意事項再填窝本頁} 經濟部中央標準局員工消費合作社印製 之一,其中在上述基團之苯并部分中1或2個次甲基各可μ 氮原子置換,Install .....................:-玎 ............, line (please first Read the note on the back and fill in this page again.} One of the products printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, where 1 or 2 methine groups in the benzo portion of the above group can each be replaced by μ nitrogen atoms
Ga表示一鍵或伸甲基, -30- 本纸張尺度逋用中國國家揉準(CNS)甲4规格(210X297公釐) 烷基、或烯丙基或苄基 A6 B6 五、發明説明(29 ) 〇2表示一鐽* G3表示伸甲基 G 4表示一鍵,Ga means one bond or methyl group. -30- This paper size is based on Chinese National Standard (CNS) A4 (210X297 mm) alkyl, or allyl or benzyl A6 B6. 5. Description of the invention ( 29) 〇2 means 鐽 * G3 means methyl, G 4 means one bond,
Gs表示次甲基 R2表示氫原子 R 3表7F复原子 表示氫原子 表示氫原子 Re表示氫原子 R14表示氫原子或甲基,Gs represents a methine group, R2 represents a hydrogen atom, and R 3 represents a hydrogen atom.
RlS表示氫原子,R1S represents a hydrogen atom,
Rle與與R17—起表示一鍵, R18表示氫原子或胺基,和 η代表數字1 , Β表示一鍵; 基團表示下式之基團 F - E - D - 其中 D表示CH2CH2基圑, 或1,4-伸苯基,或 或1,4-伸環己基, E表示視情況Μ甲基取代之CH2CH2基團、CH = CH 、1,4-伸 苯基或0-CH2-基團,其中0-CH2-基團之氧原子與D基團鍵 連, 31 本紙張尺度遑用中.國國家搮準(CNS)甲4規格(.210X297公釐) ........................................................... 裝.......................^.................... (請先閲讀背面之注意事項再填窝本頁} 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 製 經濟部中央標準局員工消費合作社印製. A6 B6 五、發明説明(30 ) 和 F表示Μ羥基或Ci-4-烷氧基取代之羰基, 和F基團與A-B-基團上距F基團最遠之氮原子間之最短距 醢為至少11鍵; 和互變異構物、立體異構物及其鹽類。 Μ下所提的係特別最佳化合物之實例: (a) 1-[4-[2-(甲氧基羰基)乙基]苯基]-3-(1,2,3,4-四氫 異喹啉-6-基)-四氫咪唑-2-醑, (b) 卜[4-(2-羧基乙基)笨基]-3-(1,2,3,4-四氫異喹啉 -6-基)-四氫咪唑-2-酮, (c) 卜[4-(2-羧基乙基)苯基]-3-(2-甲基-1,2,3,4-四氫 異喹啉-6 -基)-四氫咪唑-2 -酮, (d) 1- [4-[2-(異丁氧羰基)乙基]苯基]-3- (1,2,3,4-四氫 異喹啉-6-基)-四氫眯唑-2-酮, (e) 1-[4-(2-羧基乙基)苯基]-3-(2,3,4,5-四氫-1H-3-苯 并一氮七團-7-基)-四氫眯唑-2-酮, (f) 1- [4-[2-(甲氧基羰基)乙基]苯基]-3-(2,3,4,5-四氬 -1H-3 -苯并一氮〜七團'-7 -基)-四氮蹄哩-2-嗣, U) 1- [4-[2-(異丙氧基羰基)乙基]笨基]-3-(2,3,4,5-四 氳-1H-3-苯并一氮七園-7-基)-四氫咪唑-2-酮, (h) 卜[4-(2-羧基乙基)笨基]-3-(3-甲基-2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮, (i) 4-[4-[2-(羧基乙基)苯基]-5-甲基-2-(2,3,4,5-四氫 -1H-3-苯并一氮七画-7 -基)-4Η-1,2,4 -三唑-3-酮, -32- 本紙張尺度逋用中國國家棋準(CNS)甲4規格(210X297公釐) {請先閲讀背面之注意事項再填寫本頁) -裝 .訂; B6 五、發明説明(31 ) {請先閲讀背面之注意事項再填寫本頁) (j) 1-[反-4-(2-羧基乙基)環己基]-3-(2,3,4,5-四氫 -1H-3-苯并一氮七園-7-基)-四氫咪唑-2-酮, (k) 1-[4-[2-(甲氧基羰基)乙基]苯基]-3-(3-甲基- 2.3.4.5- 四氫-1H-3-苯并一氮七圖-7-基)-四氫咪唑 -2 -酮, (l) 1-[4-[2_(乙氧基羰基)乙基]苯基]-3-(3-甲基- 2.3.4.5- 四氫-1H-3-苯并一氮七團-7-基)-四氫咪唑 -2-嗣, (m) 1-[4-[2-(異丙氧基羰基)乙基]苯基]-3-(3-甲基- 2.3.4.5- 四氫-11^-3-苯并一氮七園-7-基)-四氫咪哩 -2 -酮, (η) 1-[反-4-(2-羧基乙基)環己基]-3-(3-甲基- 2.3.4.5- 四氫-1H-3-笨并一氮七圃-7-基)-四氫咪唑 -2 -嗣, (ο) 1-[反-4-[2-(異丙氧基羰基)乙基]環己基]-3-(3-甲 基-2,3,4,5-四氫-111-3-苯并一氮七画-7-基)-四氫眯 哇-2 -嗣, (p) 1-[反-4-[2-(乙氧基羰基)乙基]環己基]-3-(3-甲基 -2,3,4,5-四氫-111-3-苯并一氮七團-7-基)-四氫咪唑 -2 -嗣, 經濟部中央標準局員工消費合作社印製 U) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(3-甲基 -2,3,4,5-四氫-111-3-苯并一氮七_-7-基)-四氫咪唑 -2 -萌, (r) 1-[反-4-[(羧基甲基)氧]環己基]-3-(3-甲基- -33- 冬紙張尺度逍用t國國家標準(CNS)甲4規格(210X297公釐) B6 五、發明説明(32 ) 1 2,3,4,5-四氫-1H-3-苯并一氮七画-7-基)-四氫咪唑 -2 -酮, | (s) 3 -[反-4- (2-羧基乙基)環己基]-1-(3-甲基-2,3,4,5 -四氫-1H-3-苯并一氮七團-7-基卜尿囊素和 (t) 1-[反-4-(2-羧基乙基)環己基]-3-(3-乙基-2,3,4,5 -四氫-1H-3-苯并一氮七麵-7-基)-四氫眯唑-2-酮, 和互變異構物及其鹽類。 根據本發明通式I之新化合物可K *例如•下列方法製 備·· a) 為了製備通式I之化合物,其中F表示羧基: 下式化合物 (請先閲讀背面之注意事項再填窝本頁)Rle and R17 represent a bond, R18 represents a hydrogen atom or an amine group, and η represents the number 1, and B represents a bond; the group represents a group of the formula F-E-D-where D represents a CH2CH2 group, Or 1,4-phenylene, or 1,4-cyclohexyl, E represents optionally a methyl substituted CH2CH2 group, CH = CH, 1,4-phenylene or 0-CH2- Among them, the oxygen atom of the 0-CH2- group is bonded to the D group, and 31 paper sizes are in use. National Standard (CNS) A4 specification (.210X297 mm) ........ ........................................ .......................... (Please read first Note on the back of the page to refill this page} Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. The shortest distance between the alkoxy-substituted carbonyl group and the F group and the nitrogen atom farthest from the F group on the AB group is at least 11 bonds; Examples of particularly preferred compounds mentioned under M : (A) 1- [4- [2- (methoxycarbonyl) ethyl] phenyl] -3- (1,2,3,4-tetrahydroisoquinolin-6-yl) -tetrahydroimidazole -2- 醑, (b) [4- (2-carboxyethyl) benzyl] -3- (1,2,3,4-tetrahydroisoquinolin-6-yl) -tetrahydroimidazole-2 -Ketone, (c) [4- (2-carboxyethyl) phenyl] -3- (2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl) -tetrahydro Imidazole-2 -one, (d) 1- [4- [2- (isobutoxycarbonyl) ethyl] phenyl] -3- (1,2,3,4-tetrahydroisoquinolin-6-yl ) -Tetrahydrooxazol-2-one, (e) 1- [4- (2-carboxyethyl) phenyl] -3- (2,3,4,5-tetrahydro-1H-3-benzo Heptaazine-7-yl) -tetrahydrooxazol-2-one, (f) 1- [4- [2- (methoxycarbonyl) ethyl] phenyl] -3- (2,3, 4,5-tetra argin-1H-3 -benzo-nitrogen ~ seven group'-7-yl) -tetrazolium-2-fluorene, U) 1- [4- [2- (isopropoxycarbonyl ) Ethyl] benzyl] -3- (2,3,4,5-tetrafluorene-1H-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one, (h) Bu [4- (2-carboxyethyl) benzyl] -3- (3-methyl-2,3,4,5-tetrahydro-1H-3-benzodiazine-7-yl) -tetra Hydroimidazol-2-one, (i) 4- [4- [2- (carboxyethyl) phenyl] -5-methyl-2- (2,3,4,5-tetrahydro-1H-3- Benzotriazine-7-yl) -4fluorene-1 2,4 -triazol-3-one, -32- This paper size uses the Chinese National Standard (CNS) A4 specification (210X297 mm) {Please read the precautions on the back before filling this page)-Pack. Order; B6 V. Description of the invention (31) {Please read the notes on the back before filling this page) (j) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3 , 4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one, (k) 1- [4- [2- (methoxycarbonyl) ethyl Phenyl] phenyl] -3- (3-methyl-2.3.4.5-tetrahydro-1H-3-benzodiazepta-7-yl) -tetrahydroimidazole-2 -one, (l) 1- [4- [2_ (ethoxycarbonyl) ethyl] phenyl] -3- (3-methyl- 2.3.4.5- tetrahydro-1H-3-benzomonoazine-7-yl) -tetra Hydroimidazole-2-fluorene, (m) 1- [4- [2- (isopropoxycarbonyl) ethyl] phenyl] -3- (3-methyl- 2.3.4.5- tetrahydro-11 ^- 3-Benzoazine-7-yl) -tetrahydroimid-2-one, (η) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl -2.3.4.5- tetrahydro-1H-3-benzylazine-7-yl) -tetrahydroimidazole-2 -fluorene, (ο) 1- [trans-4- [2- (isopropyloxy Carbonyl) ethyl] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-111-3-benzotriazine-7- ) -Tetrahydropyridine-2 -pyrene, (p) 1- [trans-4- [2- (ethoxycarbonyl) ethyl] cyclohexyl] -3- (3-methyl-2,3,4 , 5-tetrahydro-111-3-benzodiazepam-7-yl) -tetrahydroimidazole-2 -fluorene, printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, U) 1- [反 -4- [ 2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-111-3-benzo-azahepta-7-yl)- Tetrahydroimidazole-2-Moe, (r) 1- [trans-4-[(carboxymethyl) oxy] cyclohexyl] -3- (3-methyl- -33- winter paper standard (CNS) A4 specifications (210X297 mm) B6 V. Description of the invention (32) 1 2,3,4,5-tetrahydro-1H-3-benzo-nitroazine-7-yl) -tetrahydroimidazole -2 -ketone, | (s) 3-[trans-4- (2-carboxyethyl) cyclohexyl] -1- (3-methyl-2,3,4,5 -tetrahydro-1H-3- Benzoazine-7-kib allantoin and (t) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-ethyl-2,3,4, 5-tetrahydro-1H-3-benzo-nitroazahepta-7-yl) -tetrahydrooxazol-2-one, and tautomers and their salts. The new compounds of general formula I according to the present invention can be K * For example, the following methods are prepared: a) In order to prepare compounds of general formula I, where F represents a carboxyl group: compounds of the following formula (please read the precautions on the back before filling this page) )
XX
y 經濟部中央標準局貝工消费合作社印製 (其中 丨y Printed by Shellfish Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs (of which 丨
II
II
Re、Rb、X和Y係依如上所界定,其_制條件為至基 圑之一表示F'-E-D基團,其中E和D係&如上所界定,且 F*代表可Μ水解、K酸處理、熱解或龠解轉化成羧基之基 團) 轉化成通式I之化合物,其中F表示羧基。 例如,羧基之官能衍生物如未取代或取代的酿胺、酯、 一 34 — 本纸張尺度遑用中Β國家揉準(CNS)甲4破格(210X2W公釐)> 五、發明説明(33 ) A6 B6 濟 部 t 央 標 準 局 貝 合 作 社 印 製 硫酯、三 Μ水解轉 Μ酸處理 酯,可Μ 水解作 三氟乙酸 化納或氫 、水/乙 水/二氧 和反應液 在上述 亞胺基如 胺基。再 任何存在 乙醢氧基 若F’在 團亦可Μ 劑之硫酸 若F ’在 三丁基亦 璘酸或聚 、苯、甲 -10 1C 和 ,或加熱 甲基矽 化成羧 或熱解 氫解轉 用適當 或其混 氧化鉀 醇、水 六團內 沸騰溫 之反應 三氟 者,在 的醇性 0 式II之 亞硝酸 存在下 式II之 可Κ酸 磷酸處 苯、乙 120t: 地視情 烷酯、原酯、亞胺 基*具三级酵之酯 轉化成羧基,及具 化成羧基。 地在酸如鹽酸、硫 合液之存在下,或 之存在下,於合適 /異丙醇、甲酵、 ,在-lot 和 12〇υ 度間之溫度下進行 條件下,任何存在 乙醯基亞胺基可轉 Μ有機酸如三氯乙 羥基可同時轉化成 酯、脒或酸酐、或腈可 ,例如第三丁基酯,可 芳烷醇之酯 > 例如苄基 酸、磷酸、三氯乙酸或 在碱如氫氧化鋰、氫氧 的溶劑如水、水/甲酵 乙醇、水/四氫呋喃或 間之溫度,例如在室溫 〇 的N-醯基胺基或N-醢基 化成相對應之胺基或亞 酸或三氟乙酸處理期間 相對應之醯氧基如三氟 化合物中代表氰基或胺基羰基時,該等基 鹽如亞硝酸納在酸如可適當地同時作為溶 ,在0至50 t:間之溫度下,轉化成羧基。 化合物中代表例如第三丁氧基羰基時,第 如三氟乙酸、甲酸、對甲苯磺酸、硫酸、 理,視情況在憤性溶劑如二氯甲烷、氣仿 醚、四氫呋哺或二氧六画内,較佳地在 間之溫度,例如〇至6〇υ間之溫度下裂解 況在惰性溶劑如二氯甲烷、氛仿、苯、甲 35 本纸張尺度遑用中國國家標準(CNS)甲4规格(210X297公釐} (請先閱讀背面之注意事項再填窝本頁) .裝 •訂.. Α6 Β6 五、發明説明(34 ) 苯、四氫呋喃或二氧六園内,且較佳地在觸媒量之酸如對 甲苯磺酸、硫酸、磷酸或聚磷酸之存在下,較佳地在所用 溶劑之沸騰溫度,例如40 t:至100 υ間#溫度下裂解。在 上述之反應條件下,任何存在之Ν-第三j丁氧基羰基胺基或 I N-第三丁氧基羰基亞胺基可轉化成相對I應之胺基或亞胺基 若F ’在式 可在氫化觸 酵、乙醇/ 醯胺内,較 5巴之氫壓 同時被堪原 基,且N-苄 苄氧基羰 b) 為了製 一鍵 ,表 甲氧基、胺 或二烷基胺 將下式之化 11之化合物中代表例如苄氧基羰基"時,苄基亦 媒如Pd/C之存在下,於合適之溶劑如甲酵、乙 水、冰醋酸、乙酸乙酯、二氧六画或二甲基甲 佳地在0至50Ό間之溫度,例如室溫下,在1至 下氫離裂解。在氫解期間,其他的基围亦可在 ,例如硝基可堪原成胺基或苄氧基可堪原成羥 基胺基、N-苄基亞胺基、N-:苄氧基羰基胺基或 基亞胺基可轉化成相對懕之胺基或亞胺基。 備通式I之化合物,其中Rle與R17—起代表另 示一鍵且R1S或R18基團中至:少一個表示羥基、 基、在烷基部分上具1至4個;碳原子之烷基胺基 基: 合物 t請先閲讀背面之注意事項再填窝本買} -裝 經濟部中央標準局員工消费合作社印製Re, Rb, X, and Y are as defined above, and their conditions are that one of the radicals represents the F'-ED group, where E and D are as defined above, and F * represents hydrolyzable, K acid-treated, pyrolyzed or decomposed groups converted to carboxyl groups) into compounds of general formula I, where F represents a carboxyl group. For example, functional derivatives of carboxyl groups such as unsubstituted or substituted fermented amines and esters, a 34 — this paper size is used in China B country standard (CNS) A4 grid (210X2W mm)> 5. Description of the invention ( 33) A6, B6, Ministry of Economic Affairs, Central Bureau of Standards, Benxi Cooperative Co., Ltd., printed thioesters, 3M hydrolyzed transesterified acid esters, which can be hydrolyzed to sodium trifluoroacetate or hydrogen, water / ethyl water / dioxygen, and the reaction solution in the above An imino group such as an amine group. If any ethoxyl is present, if F 'is in the group, it can be sulfuric acid. If F' is in tributylisobutyric acid or poly, benzene, methyl-10 1C, or by heating methyl silicide to carboxyl or pyrolysis hydrogen Decompose the reaction of trifluoro with appropriate or mixed potassium oxide alcohol and boiling temperature in the six-group of water in the presence of nitric acid of formula II in the presence of nitric acid of formula II. Benzene and ethyl 120t: Esteryl esters, orthoesters, imide groups * tertiary esters are converted to carboxyl groups and converted to carboxyl groups. In the presence of an acid such as hydrochloric acid or sulfur solution, or in the presence of an appropriate isopropyl alcohol, formazan, at a temperature between -lot and 120 ° C, any acetamidine is present Imino group can be converted to organic acids such as trichloroethyl hydroxyl can be simultaneously converted into esters, hydrazones or anhydrides, or nitriles, such as the third butyl ester, aralkyl alcohol esters> such as benzyl acid, phosphoric acid, tris Chloroacetic acid or a solvent such as water, water / formaldehyde, water / tetrahydrofuran, or an intermediate in a base such as lithium hydroxide, hydroxide, for example, N-fluorenylamino or N-fluorenyl at room temperature When the corresponding amine or acetic acid or trifluoroacetic acid is treated during the treatment of the corresponding alkoxy group such as cyano or amine carbonyl group in the trifluoro compound, such base salts such as sodium nitrite can be suitably dissolved simultaneously in the acid, Converted to carboxyl at temperatures between 0 and 50 t: When the compound represents, for example, a third butoxycarbonyl group, such as trifluoroacetic acid, formic acid, p-toluenesulfonic acid, sulfuric acid, and aryl, as appropriate, in an angry solvent such as dichloromethane, gas-form ether, tetrahydrofuran or dichloromethane. Within the oxygen six paintings, it is preferred to lyse at a temperature of between 0 and 60 ° in an inert solvent such as dichloromethane, chloroform, benzene, and chloroform. This paper uses Chinese national standards ( CNS) A4 specifications (210X297mm) (please read the precautions on the back before filling in this page). Binding and binding: Α6 Β6 V. Description of the invention (34) Benzene, tetrahydrofuran or dioxin, and more than Preferably in the presence of a catalytic amount of acid such as p-toluenesulfonic acid, sulfuric acid, phosphoric acid or polyphosphoric acid, it is preferably cracked at the boiling temperature of the solvent used, for example, between 40 t: to 100 ° C. In the above-mentioned Under the reaction conditions, any N-tertiary butoxycarbonylamino group or N-tertiary butoxycarbonylimino group present can be converted into the corresponding amine or imino group if F 'in the formula can In hydrogenated catalysis, ethanol / amidine, the hydrogen pressure is more than 5 bar at the same time, and N-benzyloxycarbonyl b) In order to make a bond, epimethoxy, amine or dialkylamine will be represented in the compound of formula 11 below, for example, benzyloxycarbonyl " benzyl is also suitable in the presence of Pd / C, as appropriate Solvents such as formic acid, ethyl water, glacial acetic acid, ethyl acetate, dioxane, or dimethylformate are preferably at a temperature between 0 and 50 ° C, for example, at room temperature, at 1 to 2 under hydrogen cleavage. During the hydrogenolysis, other radicals can also be present, such as nitrocokanogen to amine or benzyloxycokan to hydroxyamine, N-benzylimine, N-: benzyloxycarbonylamine The radical or imino group can be converted into the relative amidine or imino group. Compounds of general formula I, in which Rle and R17 together represent another bond and in R1S or R18 groups, at least: at least one represents a hydroxyl group, a group, and has 1 to 4 alkyl groups; an alkyl group of carbon atoms Amino group: Please read the precautions on the back before filling out the book}-Installed by the Central Consumers Bureau of the Ministry of Economic Affairs and printed by the Consumer Cooperative
RaNRaN
N-Rb m (其中 36 :本紙張尽度遑用中Η國家揉準(CNS)甲4規格(210X297公*) 五、發明説明(35 )N-Rb m (of which 36: this paper is used to the fullest extent possible in the Central and China National Standards (CNS) A4 specification (210X297) *) 5. Description of the invention (35)
Ra、Rb、)(和Υ係依如上所界定,其限制:條件為L至L基團 : 之一表示A-B基靨,其中 | B係依如上所界定且 ' A表示下式之基團 Z2Ra, Rb,) (and Υ are as defined above, with restrictions: conditions are L to L groups: one represents the A-B group 其中, where | B is as defined above and 'A represents a group of the formula
NN
(請先閲讀背面之注意事項再填窝本頁) 其中苯并部分和Gs係依如上所界定* 乙1和22,其可相同或不同*各表示親核性脫離基如齒 原子,例如氯或溴原子,但Ζα基画亦可具如上所 給定之意義或叾2基團可具Rie如上所給定之意義) 與下式之化合物反應 (IV) 經 濟 部 中 央 標 準 Μ 員 X 消 費 合 作 社 印 製 其中R27表示羥基、甲氧基、胺基、甲醢基胺基、乙醸基 胺基、在烷基部分上具1至4個碳原子之烷基胺基或二烷基 胺基。 反應便利地於溶劑如水、丙嗣、乙醇> 四氫呋喃、二氧 37 本纸張尺度遑甩tB國家櫺卒(CNS) f 4規格(210x297公釐) 經濟部中央標準局員工消費合作社印製 五、發明説明(36 ) 六醒、二甲基甲醢胺或二甲基亞碾内,但視情況在遇量作 為溶翔I之通式IV化合物内,且視情況在碱如氫氧化納、氫 氧化鉀、碳酸鉀、醢胺納或氫化故之存在下,在0至250t: 間之溫度,但較佳地在50至225 t:間之丨溫度下進行。 I c) 為了製備通式I之化合物,其中11〇|0與—起表示另 m 丨4表示一鐽且Rle表示氛或溴原:子: 將下式之.化合物(Please read the notes on the back before filling in this page.) The benzo part and Gs are as defined above * B 1 and 22, which may be the same or different * Each represents a nucleophilic leaving group such as a tooth atom, such as chlorine Or bromine atom, but the Zα-based painting can also have the meaning given above or the 叾 2 group can have the meaning given above by Rie) React with compounds of the formula (IV) Central Standards of the Ministry of Economic Affairs M Member X Consumer Cooperative Wherein R27 represents a hydroxyl group, a methoxy group, an amino group, a methylamino group, an ethylamino group, an alkylamino group or a dialkylamino group having 1 to 4 carbon atoms in the alkyl portion. The reaction is conveniently performed in solvents such as water, propyl alcohol, ethanol > tetrahydrofuran, dioxane 37 paper size tB national standard (CNS) f 4 specifications (210x297 mm) printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 2. Description of the invention (36) Liu Xing, dimethylformamide or dimethylimine, but in the case of the compound of the general formula IV as dissolved I, if appropriate, and in a base such as sodium hydroxide, In the presence of potassium hydroxide, potassium carbonate, ammonium sodium or hydrogenation, it is carried out at a temperature between 0 and 250 t :, but preferably at a temperature between 50 and 225 t :. I c) In order to prepare a compound of the general formula I, in which 11 0 and 0 represent another m 丨 4 represents a 鐽 and Rle represents a methane or bromide: a compound of the following formula.
(V) (其中 I 、Rb、X和Y係依如上所界定,其限制條件為1^至Rd基團 之一代示A-B基團,其中 ί Β係依如上所界定且 Α表示下式之基團 〇、(V) (where I, Rb, X, and Y are as defined above, and the restriction is that one of 1 ^ to Rd represents the AB group, where ί is as defined above and A represents the base of the formula Mission 0,
其中苯并部分和g5係依如上所界定且 38 {請先閲讀背面之注意事項再填窝本頁} B6 五、發明説明(37 ) R15’表示氫原子或代表上述R1S之烷基或芳基),與 酸鹵化物反應。 反應从酸鹵化物如氧氛化磷或氧溴化磷,視情況在溶劑 如苯、二氛苯、硝基苯或四氛化碳之存在下,且視情況在 相對應氫鹵酸之鹽如氛化納或溴化納之存在下,在升高的 溫度•例在50至250 t:間之溫度,但較佳地在反應液之沸 騰溫度下進行。 d) 為了製備通式I之化合物,其中X表示氰基取代之碳 亞胺基或羰基或磺醸基且Y表示視情況W R。或或Μ !^和 Rd取代之直鐽C2-4-伸烷基: 將下式之化合物環化 X' (請先閲讀背面之注意事項再填窝本頁)The benzo part and g5 are as defined above and 38 {Please read the notes on the back before filling this page} B6 V. Description of the invention (37) R15 'represents a hydrogen atom or an alkyl or aryl group representing the aforementioned R1S ), React with acid halide. The reaction starts from an acid halide such as oxophosphorus or oxybromide, optionally in the presence of a solvent such as benzene, dioxobenzene, nitrobenzene, or tetraoxocarbon, and optionally the corresponding salt of a hydrohalide In the presence of sodium cyanide or sodium bromide, the temperature is raised between 50 and 250 t: but preferably at the boiling temperature of the reaction solution. d) For the preparation of compounds of the general formula I, wherein X represents a cyano-substituted carbonimino or carbonyl or sulfonyl group and Y represents W R as appropriate. Or a straight C2-4-alkylene substituted with M or ^ and Rd: cyclize a compound of the formula X '(Please read the precautions on the back before filling this page)
RR
N I N —R. I U. b (VI) 經 濟 部 中 央 標 準 局 貝 X 消 费 合 作 社 其中 1?»和Rb係依如上所界定, Xf表示氰基取代的碳亞胺基或羰基或磺醮基* “或!^基團之一表示氫原子和(^或!^基團之另一表示視情 況M Rc或Rd、或M 1U和Rd取代之直鍵C2-4-伸烷基, 至附加地末端结合的親核性脫離基如鹵原子、羥基或磺酸 酯,例如氯、溴或碘原子或羥基、甲基磺醸氧基或對甲苯 磺醢氧基。 反應較佳地於溶劑如二氛甲烷、乙腈、四氫呋喃、甲苯 、二甲基甲醢胺或二甲基亞碾內,視情況在碱如氫化納、 39 ,本纸度適用中a國家揉準(CNS)甲4規格(210X297公金1 經濟部中央標準局員工消費合作社印製 五、發明説明(38 ) 碳酸鉀、第三丁氧化鉀或N -乙基二異丙基胺之存在下,或 視情況在脫水劑如三苯基膦/偶氮二甲酸二乙酯之存在下 ,在-20至100 υ間之溫度,較佳地在0至60 1C間之溫度下 進行。 e) 為了製備通式I之化合物,其中X表示羰基且Y表示 上述伸烷基或伸烯基之一: 將下式之化合物 Rze - HH ~ T 與下式之異氰酸酯反應 (VII) (VIII) (其中 R2e或R2e基圃之一具Re如上所給定之意義且Rze或R2e基 團之另一具Rb如上所給定之意義和 T表示下式之基團 -(CH2)»-HC(0R3〇)2 視情況在次烷基部分上以或Rd或.Re和Rd取代,其中 m表示數字1、2或3和 尺30表Cl-4_烧基) -40- 本紙張尺度逋用t國.國家標準(CNS)甲4规格(210X297公釐) {請先閲讀背面之注意事項再填窝本頁) 五、發明説明(39 視情況 反應 200 t: 然而, 在通 情況所 氟乙酸 酵、乙 騰溫度 視情 存在下 情況加 室溫至 至5巴 f) 為 ,G3代 IU各代 原子或 氫化下 進行其後之 視情況於惰 間之溫度, 反應亦可在 式V 11之化 得為中間物 、對甲苯磺 酵、四氫呋 間之溫度下 況之其後氫 ,於溶師如 人如鹽酸之 5 0 1C間之溫 間之氫壓下 了製備通式 表伸甲基, 表氫原子, C 1 - 4 _院基 式之化合物 氫化作 性溶劑 較佳地 無溶劑 合物與 之開鍵 酸或鹽 喃或二 其後轉 化作用 甲醇、 酸,在 度下, 進行。 (I)之 視情況 且1?3和 用0 如二氧六画 在20至160 下進行。 通式VIII之 腺*若需要 酸之存在下 氛甲院内.’ 化成所要之 較佳地Μ氬 乙酵、乙酸 0至loot:間 且在1至7巴 A6 B6 或:甲苯内*在20至 t:間之溫度下進行。 異氰酸酯之反應中視 時,在酸如乙酸、三 ,視情況在溶劑如甲 在0 t:至反應液之沸 產物。 在觸媒如Pd/C或鉑之 乙酯或冰醋酸内,視 之溫度,但較佳地在 之氫壓*但較佳地3 化合物,其中G2各代表一鍵 M C1 - 4 -焼 Re,其可栢 基取代, 同或不同 、R4和 各代表氫 (請先閲讀背面之注意事項再填窝本頁) •裝 經濟部中夬標準局貝工消費合作社印製 I :截NIN —R. I U. b (VI) Central Standards Bureau of the Ministry of Economic Affairs X Consumer Cooperatives where 1? »And Rb are as defined above, Xf represents a cyano-substituted carbodiimide or carbonyl or sulfonyl group *" Or one of the ^ groups represents a hydrogen atom and the other of the ^ or! ^ Groups represents, as the case may be, M Rc or Rd, or a straight bond C2-4-alkylene substituted with M 1U and Rd, to the end of the additional Associated nucleophilic leaving group such as a halogen atom, a hydroxyl group or a sulfonic acid ester, such as a chlorine, bromine or iodine atom or a hydroxyl group, a methylsulfonyloxy group or a p-toluenesulfonyloxy group. The reaction is preferably in a solvent such as dioxo Methane, acetonitrile, tetrahydrofuran, toluene, dimethylformamide or dimethyl methylene chloride, as appropriate, in bases such as sodium hydride, 39, this paper is applicable in China National Standard (CNS) A4 specifications (210X297) 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (38) In the presence of potassium carbonate, third potassium butoxide, or N-ethyldiisopropylamine, or a dehydrating agent such as triphenyl, as the case may be. In the presence of phosphine / diethyl azodicarboxylate, a temperature between -20 and 100 υ, preferably between 0 and 60 1C E) In order to prepare a compound of general formula I, where X represents a carbonyl group and Y represents one of the above-mentioned alkylene or alkylene groups: a compound of the formula Rze-HH ~ T is reacted with an isocyanate of the formula (VII) (VIII) (wherein one of the R2e or R2e bases has the meaning given above as Re and the other Rb of the Rze or R2e group has the meaning given above and T represents a group of the formula-(CH2) »-HC (0R3〇) 2 optionally substituted with or Rd or .Re and Rd on the alkylidene moiety, where m represents the number 1, 2 or 3 and 30 feet (Table Cl-4_), -40- the size of this paper 逋National standard (CNS) A4 specification (210X297 mm) {Please read the precautions on the back before filling in this page) V. Description of the invention (39 Response 200 t as the case may be: The temperature of acetic acid fermentation and ethanization is increased to room temperature to 5 bar in the presence of f). For the G3 generation IU atom or hydrogenation, the subsequent temperature is inert, depending on the situation. The reaction can also be performed in formula V 11 It is converted into intermediates, p-toluene sulfonate, and tetrahydrofuran, and then hydrogen, and the temperature is between 50 ° C and 100 ° C. The hydrogen pressure under the temperature is used to prepare the general formula epimethyl, table hydrogen atom, C 1-4 _ compound of the formula hydrogenation as a solvent, preferably without a solvate and an open-bonded acid or sulfan or di Subsequent conversions are carried out at methanol and acid at a temperature of (1) as appropriate and 1 to 3 and 0 to 2 dioxane at 20 to 160. Glands of general formula VIII * in the presence of acid if the presence of acid is needed. 'Formation of the desired argon acetic acid, acetic acid 0 to loot: between 1 and 7 bar A6 B6 or: toluene * within 20 to t: It is performed at a temperature in between. The reaction of isocyanate may be carried out in the presence of an acid such as acetic acid, tris, and optionally a solvent such as formazan at 0 t: to the boiling product of the reaction solution. In catalysts such as Pd / C or platinum ethyl acetate or glacial acetic acid, depending on the temperature, but preferably under hydrogen pressure * but preferably 3 compounds, where G2 each represents a bond M C1-4-焼 Re , It can be replaced by beryl, same or different, R4 and each representative hydrogen (please read the notes on the back before filling in this page)
Ra-NRa-N
N-RbN-Rb
(DO 41 本纸張尺度遑用中國國家揉準(CNS) 规格(210X297公釐) A6 B6 五、發明説明(40 ) 其中 1U、Rb、X和Y係依如上所界定*其限制條件為R-至Rd基團 之一表示A-B基團,其中 B係依如上所界定和 : I A表示下式之基團 丨(DO 41 This paper size is in accordance with China National Standards (CNS) specifications (210X297mm) A6 B6 V. Description of the invention (40) Among which 1U, Rb, X and Y are defined as above * The restriction is R -One of the Rd groups represents the AB group, where B is as defined above and: IA represents a group of the formula 丨
經濟部中央標準局貝工消費合作社印製 其中 苯并部分係依如上所界定, I GB •表示視情況M Ci-4-烷基取代之次甲基, R1B"和Rie ’,其可相同或不同,各:代表氫原子或 氬化作用較佳地於合適之溶劑如甲醇、甲酵/水、乙酸 、乙酸乙酯、乙醇、乙醚、四氫呋喃、二氧六圈或二甲基 甲醢胺内,K氫在氫化觸媒如Raney鎳、鉑、二氧化鉑、 铑或Pd/C之存在下,視情況加入如鹽酸之酸,在0至loot: 間之溫度,較佳地在20至80¾間之溫度下進行。任何在通 式IX之化合物中存在之視情況取代之伸烯基因而可轉化成 ................................................................................装.......................訂.....................緯 (請先閲+讀背面之注意事項再填窝本頁) 一 42- 本紙張尺度遑用t Η Η家揉準(CNS)甲4规格(210X297公釐)' B6 五、發明説明(41 ) 視情況取代伸烷基。 I ' g) 為了製備通式I之化合物,其中F表示羰基,以 Ci-e-烷氧基、以芳基烷氧基(在烷氧ί基部分上具1至4 個碳原子且其中芳基部分係依如上所界定)、或MR22〇基 圄取代: 將下式之化合物Printed by the Shell Standard Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, where the benzo part is as defined above, I GB Different, each: represents a hydrogen atom or argonization preferably in a suitable solvent such as methanol, formic acid / water, acetic acid, ethyl acetate, ethanol, ether, tetrahydrofuran, dioxane or dimethylformamide , K hydrogen in the presence of hydrogenation catalysts such as Raney nickel, platinum, platinum dioxide, rhodium or Pd / C, and optionally add an acid such as hydrochloric acid, at a temperature between 0 and loot :, preferably 20 to 80 ¾ Intertemporal temperature. Any optionally substituted exene gene present in a compound of general formula IX can be converted into ... ........................................ .............. Order ........ Weft (Please Read first + read the precautions on the back and then fill in this page.) 42- This paper size is t 遑 揉 揉 揉 揉 (CNS) A4 size (210X297 mm) 'B6 V. Description of the invention (41) Depending on the situation Substituted alkylene. I'g) For the preparation of compounds of the general formula I, in which F represents a carbonyl group, Ci-e-alkoxy, arylalkoxy (having 1 to 4 carbon atoms in the alkoxy moiety and wherein aryl The moieties are as defined above), or the MR22 radical is substituted: a compound of the formula
(X) 經濟部中央橾準局貝工消費合作社印製 (其中 Re、Rb、X和Y係依如上所界定,其限制條件為1^至Rd基團 之一表示F”-E-D基團,其中 E和D係依如上所界定且 F"表示羧基或烷氧基羰基) 與下式之醇反應 HO - R31 ; (XI) 其中 民31具1?22如上所給定之意義#表示Cn-烷基或芳基烷基 ,其中芳基部分係依如上所界定,且烷:基部分可具1至4個 43 ,,丰紙》尽度遑用中國a家揉準(CNS)甲4规格(21〇Χ297公釐) ..................................................................................裝........................玎....................., {請先閲讀背面之注意事項再填窝本頁) 經濟部中央標準局貝工消费合作社印製 A6 —__B6__ 五、發明説明(42 ) ,•^. 碳原子。 羧基化合物之反應視情況於溶劑或溶劑混合液如二氛甲 烷、二甲基甲醢胺、苯、甲苯、氛苯、四氫呋喃、苯/四 氫呋喃或二氧六臑内*或特別有利地於通式XI之相對應醇 内,視情況在如鹽酸之酸之存在下或在脫水劑之存在下, 例如在氯甲酸異丁酯、原碳酸四乙酯、原乙酸三甲酯、 2,2-二甲氧基丙烷、四甲氧基矽烷、亞磺醢氯、三甲基氛 矽烷、硫酸、甲基磺酸、對甲苯磺酸、三氛化瞵、五氧化 瞵、Η,Ν'-二環己基羰二亞胺、Ν,ΙΓ-二環己基羰二亞胺 /1-羥基苯并三唑、Ν,Ν’-二環己基羰二亞胺/ Ν-羰基琥 珀醢亞胺、N,fT-羰基二咪唑或三苯基膦/四氛化碳之存 在下,且視情況加入碱如吡啶、4-二甲基胺基吡啶或三乙 基胺,便利地在〇至150C間之溫度,較佳地在〇至l〇〇C間 之溫度下進行。 相對應烷氧基羰基化合物與通式XI之醇之反應較佳地在 作為溶劑之相對應醇内,視情況在再一個溶劑如二氛甲烷 或乙醚之存在下,較佳地在如鹽酸之酸之存在下*在〇至 1501:間之溫度,較佳地在50至100T間之溫度下進行。 h) 為了製備通式I之化合物,其中R4、R14或Rie基團 之一代表在上述R4、R14或Rie基團定義中之視情況取代烷 基、烯基、環烷基、環烷基烷基或芳烷基之一: 將下式之化合物 —44 — --.',深夂本紙,張尺度逋用中國國家揉準(CNS)甲4規格(210X297公釐) ....................................................................................裝.......................訂-..............办 (請先閲讀背面之注意事項再填寫本頁) 五、發明説明(43 )(X) Printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards and Quarantine of the Ministry of Economic Affairs (where Re, Rb, X, and Y are as defined above, and the restriction is that one of the 1 to Rd groups represents the F "-ED group, Where E and D are as defined above and F " represents a carboxyl group or an alkoxycarbonyl group) is reacted with an alcohol of the formula HO-R31; (XI) in which 31 has the meaning given above as 1? 22 as indicated above # represents Cn-alkane Or arylalkyl, in which the aryl part is as defined above, and the alkane: base part can have 1 to 4, 43, Feng Zhi "to the fullest extent possible, using China National Standard (CNS) A4 specifications ( 21〇 × 297mm) ............... ............................................................ ............. 玎 ............., (Please read the precautions on the back before filling this page) Printed by A6 —__ B6__ from the Central Bureau of Standards of the Ministry of Economic Affairs —__ B6__ V. Description of the Invention (42), • ^. Carbon atom. The reaction of carboxyl compounds depends on the solvent or solvent mixture, such as methane and dimethyl formamidine, as appropriate. Amine, benzene, toluene, benzene, tetrahydrofuran, benzene / tetrahydrofuran or dioxane * or particularly advantageous In the corresponding alcohol of the general formula XI, optionally in the presence of an acid such as hydrochloric acid or in the presence of a dehydrating agent, such as isobutyl chloroformate, tetraethyl orthocarbonate, trimethyl orthoacetate, 2 , 2-dimethoxypropane, tetramethoxysilane, sulfenyl chloride, trimethyl aluminosilane, sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, triammonium hydrazone, osmium pentoxide, osmium, N '-Dicyclohexylcarbonyldiimide, Ν, ΙΓ-Dicyclohexylcarbonyldiimide / 1-hydroxybenzotriazole, N, N'-Dicyclohexylcarbonyldiimide / N-carbonylsuccinimide , N, fT-carbonyldiimidazole or triphenylphosphine / tetraaminated carbon, and optionally a base such as pyridine, 4-dimethylaminopyridine or triethylamine, conveniently at 0 to 150C The temperature is preferably between 0 and 100 ° C. The reaction between the corresponding alkoxycarbonyl compound and the alcohol of the general formula XI is preferably in the corresponding alcohol as a solvent, as the case may be In the presence of a further solvent such as methane or ether, preferably in the presence of an acid such as hydrochloric acid * at a temperature between 0 and 1501 :, preferably at a temperature between 50 and 100T. H) For the preparation of compounds of the general formula I, in which one of the R4, R14 or Rie groups represents an optionally substituted alkyl, alkenyl, cycloalkyl, naphthenic group in the above definition of R4, R14 or Rie groups One of alkyl group or aralkyl group: The compound of the following formula —44 —-. ', Deep into the paper, the scale of the paper uses the Chinese National Standard (CNS) A4 specification (210X297 mm) ... ........................................ ............................................................. .... Order -.............. (please read the precautions on the back before filling out this page) 5. Description of the invention (43)
A6 B6 (其中 ; I Re、Rb、X和Y係依如上所界定,其限制!條件為R·至Rd基腫 I 之一表示A-B基團,其中 A和B係依如上所界定,其限制條件為IU、和Rle各表示 氬原子) 與下式之化合物反應 Z3 - R32 (XIII) {請先閲讀背面之注意事項再填窝本頁} .裝 經濟部中央標準局員工消费合作社印製/1 其中 R32表示ί^-β-烷基、環烷基或環烷基琮基,其中環垸基部 分可具3至7俚碳原子且烷基部分可具1至4個碳原子、 C3-e-烯基或芳基烷基、羥基烷基、焼氧基烷基、氰基烷 基、羧基烷基、烷氧基羰基烷基、胺基羰基烷基、N-烷基 ! 胺基羰基烷基或N,N-二烷基胺基羰基,其中芳基部分和烷 基部係依如上所界定*且Z3表示親核脫離基如鹵原子,例 如氯、溴或碘原子或磺酸酯,例如甲基磺醢氧基或對甲苯 磺醣氧基,或23與R32基團相鄰氫原子一起表示氧原子。 與其中Z3表示親核脫離基之式XIII化合物之烷化作用便 45 本紙張尺度遑用中覼國家揉準(CNS)甲4规格(210 X 297公釐} A6 B6 五、發明説明(44 ) 利地於溶劑如二氛.甲烷、四氫呋喃、二氧六困、二甲基亞 礪或二甲基甲醚胺内,視情況在碱如碳i酸納、碳酸鉀或氪 氧化納溶液之存在下或在三级有機碱如N-乙基二異丙基胺 或N-甲基嗎啉,其可同時作為溶劑,之.i存在下,在-30至 150 間之溫度,但較佳地在20至120 υ間之溫度下進行A6 B6 (where; I Re, Rb, X, and Y are as defined above and their limitations! The condition is that one of the R · to Rd radicals represents the AB group, where A and B are as defined above and their limitations The conditions are that IU and Rle each represent an argon atom.) Reaction with a compound of the formula Z3-R32 (XIII) {Please read the precautions on the back before filling this page}. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs / 1 wherein R32 represents ί-β-alkyl, cycloalkyl or cycloalkylfluorenyl, wherein the cyclofluorenyl moiety may have 3 to 7 carbon atoms and the alkyl moiety may have 1 to 4 carbon atoms, C3- e-alkenyl or arylalkyl, hydroxyalkyl, alkoxyalkyl, cyanoalkyl, carboxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, N-alkyl! Aminocarbonyl Alkyl or N, N-dialkylaminocarbonyl, wherein the aryl and alkyl moieties are as defined above * and Z3 represents a nucleophilic leaving group such as a halogen atom, such as a chlorine, bromine or iodine atom or a sulfonate, For example, methylsulfonyloxy or p-toluenesulfonyloxy, or 23 together with the adjacent hydrogen atom of the R32 group represents an oxygen atom. With the alkylation of the compound of the formula XIII in which Z3 represents a nucleophilic cleavage group, the paper size is in Chinese paper standard (CNS) A4 specification (210 X 297 mm) A6 B6 5. Description of the invention (44) Favorable in solvents such as dioxane, methane, tetrahydrofuran, dioxane, dimethylarene or dimethyl methyl etheramine, optionally in the presence of a base such as sodium carbonate, potassium carbonate or sodium oxide solution Or in a tertiary organic base such as N-ethyldiisopropylamine or N-methylmorpholine, which can be used as a solvent at the same time, in the presence of .i, at a temperature between -30 and 150, but preferably At temperatures between 20 and 120 υ
I Ο 與通式XIII之羰基化合物之遨原性烷化作用在氫化金屬 複合物如氫硼化納、氫晒化鋰或氰基氫硼化納之存在下, 便利地在6-7之t>H且在室溫下,或在氫化觸媒之存在下, 例如Μ氫在Pd/C之存在下•在卜5巴之氫壓下進行。然而 ,甲酯化作用較佳地在甲酸作為堪原劑之存在下,在升高 的溫度,例如在60至120 υ間之溫度下進行。 i) 為了製備通式I之化合物,其中X代表羰亞胺•其以 氰基在氮原子上取代,或X代表羰基或磺醢基, 將下式之化合物 ...........................................................................................................訂.....................綠. (請先閲讀背面之注意事項再填窝本頁)Ionizing alkylation with carbonyl compounds of general formula XIII in the presence of hydrogenated metal compounds such as sodium borohydride, lithium hydrogen hydride or sodium cyanoborohydride, conveniently at t >6-7; H and at room temperature, or in the presence of a hydrogenation catalyst, such as M hydrogen in the presence of Pd / C • under hydrogen pressure of 5 bar. However, the methylation is preferably carried out in the presence of formic acid as a kanogen at elevated temperatures, such as between 60 and 120 υ. i) In order to prepare a compound of general formula I, where X represents a carbimide, which is substituted on a nitrogen atom with a cyano group, or X represents a carbonyl or a sulfonyl group, a compound of the formula: ........................................ ................................... ..... Green. (Please read the notes on the back before filling in this page)
γ 經濟部中夬標準局員工消费合作社印製 與下式之化合物反應 Ζλ - R34 (XV) _ 46 —t a a t4*«·(210x297^) A6 B6 經濟部中央標準局員工消費合作社印製 | 五、發明説明(45 ) (其中 Y係依如上所界定, X”表示K氰基在氮原子上取代之碳亞胺基,或X”表示羰基 或磺醸基, R33或1134基_之一具Re如上所給定之意義,且R33或R34基 團之另一具Rb如上所給定之意義, 且Z 4表示親核脫離基如鹵原子、羥基或磺酸_,例如氟、 氛、溴或碘原子或甲基磺醯氧基或對甲苯磺醢氧基)。 反應較佳地於溶劑如二氛甲烷、乙膊、四氫呋喃、甲苯 、吡啶、二甲基甲醣胺、二甲基亞5S或N-甲基吡咯啶嗣内 ,視情況在1或多個碱如氫化轱、碳酸鉀、第三丁氧化鉀 、N-乙基二異丙基胺、三-[2-(2-甲氧基乙氧基)乙基]胺 或Ν,Ν,ΙΓ,ίΓ -四甲基伸乙基二胺之存在下,和視情況在如 三苯基膦/偶氮二甲酸二乙酯之脫水劑之存在下*和視情 況在銅粉或1或多個銅鹽如碘化亞網作為反應加速劑之存 在下,在-20和250¾間之溫度,但若Ζ4與脂族碳原子结合 時,較佳地在0至60Ό間之溫度,若Ζ*與芳族碳原子结合 時,或在60至180 t:間之溫度下進行,然而在此情形下, Z4僅能代表鹵原子。 J) 為了製備通式I之化合物,其中IU或R14表示烷氧基 羰基、芳基甲氧基羰基、甲醢基、乙醢基、三氟乙酿基、 丙烯氧基羰基或RuCO-O-UwCRid-O-CO基围,其中Ru 至R13和芳基部分係依如上所界定且焼氧基部分可具1至4 _ 47- 本紙張尺度逋用中國國家樣準(CNS)甲4规格(210X297公釐)^' .....................................................................................裝........................玎..................... {請先閲讀背面之注意事項再填窝本頁) A6 B6 五、發明説明(46 ) 儸碳原子: 將下式之化合物γ Printed by the Consumer Cooperative of the China Standards Bureau of the Ministry of Economic Affairs and the compound of the following formula λ-R34 (XV) _ 46 —taa t4 * «· (210x297 ^) A6 B6 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs | Five (45) (wherein Y is as defined above, X "represents a carbodiimide group substituted by a nitrogen atom of K cyano, or X" represents a carbonyl group or a sulfonyl group, and one of R33 or 1134 Re has the meaning given above, and another Rb of the R33 or R34 group has the meaning given above, and Z 4 represents a nucleophilic leaving group such as a halogen atom, a hydroxyl group or a sulfonic acid, such as fluorine, atmosphere, bromine or iodine. Atom or methylsulfonyloxy or p-toluenesulfonyloxy). The reaction is preferably in a solvent such as dichloromethane, ethyl acetate, tetrahydrofuran, toluene, pyridine, dimethylmethosamine, dimethyl 5S or N-methylpyrrolidine, optionally in one or more bases. Such as hydrazone, potassium carbonate, potassium third butoxide, N-ethyldiisopropylamine, tri- [2- (2-methoxyethoxy) ethyl] amine or Ν, Ν, ΙΓ, ίΓ -In the presence of tetramethylethylene diamine, and optionally in the presence of a dehydrating agent such as triphenylphosphine / diethyl azodicarboxylate * and optionally in copper powder or 1 or more copper salts For example, in the presence of the iodide subnet as a reaction accelerator, at a temperature between -20 and 250¾, but if Zn4 is bonded to an aliphatic carbon atom, it is preferably at a temperature between 0 and 60 ° C. If Z * and aromatic When carbon atoms are bonded, or at a temperature between 60 and 180 t: However, in this case, Z4 can only represent a halogen atom. J) For the preparation of compounds of the general formula I, in which IU or R14 represents an alkoxycarbonyl, arylmethoxycarbonyl, formamyl, ethenyl, trifluoroethyl, propyleneoxycarbonyl or RuCO-O- UwCRid-O-CO group, in which Ru to R13 and aryl part are defined as above and the ethoxy part can have 1 to 4 _ 47- This paper uses China National Standard (CNS) A4 specification ( 210X297 mm) ^ '............................ ............................................... ...... 玎 ........................ {Please read the notes on the back before filling in the book Page) A6 B6 V. Description of the invention (46) 㑩 Carbon atom: the compound of the following formula
Ra-NRa-N
N_Rb 經 濟 部 t 央 標 準 局 貝 X 消 费 合 作 社 印 製 (其中 Re、Rb、X和Y係依如上所界定,其限制條件為_ 示氫原子) 與下式之化合物反應 Zb - R 35 (XVII) 其中 R3B代表具2至5儸總碳原子之烷氧基羰基、其中芳基部分 係依如上所界定之芳基甲氧基羰基、或甲醯基、乙醚基、 丙烯氧基羰基、RuCO-O-U^CRid-tHCO或三氟乙醸基, 其中Ru至R13係依如上所界定,及 ZB表示親核脫離基如鹵原子或芳氧基、芳硫基、烷氧基、 烷氧基羰氧基、芳烷氧基羰氧基或N-眯唑基•例如氣或溴 原子或4-硝基笨氧基。 釀化作用便利地於溶劑如四氫呋哺、二氛甲烷、氛仿、 48 备本纸張Λ度逍用t國國家爭乎iC|NS),.4规格(2^Χ297公金)v ___________________________________________'............................................................... *可+..................! (請先閱讀背面之注意事項再填寫本頁) Α6 Β6 五、發明説明(47 ) 二甲基甲醯胺、水或其溶劑之混合液内,視情況在碱如碳 酸納、碳酸鉀或氫氧化納溶液之存在下1,或在三级有機碱 如三乙基胺、Ν-乙基二異丙基胺、Ν-甲基嗎啉或吡啶,其 可同時作為溶劑,之存在下,在-30至1丨〇〇t:間之溫度*但 較佳地在-10至60¾間之溫度下進行。丨 k)為了製備通式I之化合物,其中F表示截基*其以 烷氧基、Μ芳烷氧基(其中芳基部分係依如上所界 定且烷氧基部分可具1至4個碳原子)、或M 或 R23C0-0CHR240基團取代,其中R22至《24係依如上所界定 * 將下式之化合物 (請先閲讀背面之注意事項再填窝本頁) .装N_Rb Printed by the Ministry of Economic Affairs t Central Standards Bureau X Consumer Cooperatives (where Re, Rb, X, and Y are as defined above, and their restrictions are _ shown as hydrogen atoms) react with a compound of the formula Zb-R 35 (XVII) Wherein R3B represents an alkoxycarbonyl group having a total carbon atom of 2 to 5 㑩, wherein the aryl part is an arylmethoxycarbonyl group as defined above, or a methyl group, an ether group, an acryloxycarbonyl group, RuCO-OU ^ CRid-tHCO or trifluoroacetamyl, where Ru to R13 are as defined above, and ZB represents a nucleophilic leaving group such as a halogen atom or aryloxy, arylthio, alkoxy, alkoxycarbonyloxy , Aralkoxycarbonyloxy, or N-oxazolyl • such as a gas or bromine atom or 4-nitrobenzyloxy. The fermentation effect is conveniently in solvents such as tetrahydrofuran, dichloromethane, dichloromethane, 48 papers, Λ degree free use, country t country, iC | NS), .4 specifications (2 ^ × 297 public gold) v ___________________________________________ '....................................... .............. * May + ........! (Please read the notes on the back before filling in this page) Α6 Β6 5. Description of the invention (47) In a mixed solution of dimethylformamide, water or its solvent, as appropriate, in the presence of a base such as sodium carbonate, potassium carbonate or sodium hydroxide solution 1, or a tertiary organic base Such as triethylamine, N-ethyldiisopropylamine, N-methylmorpholine or pyridine, which can be used as a solvent at the same time, in the temperature range of -30 to 10,000 t: It is preferably carried out at a temperature between -10 and 60¾.丨 k) In order to prepare a compound of general formula I, where F represents a truncated group * which is alkoxy, M aralkoxy (where the aryl moiety is as defined above and the alkoxy moiety may have 1 to 4 carbons Atom), or M or R23C0-0CHR240 group substitution, in which R22 to "24 is as defined above * will be the compound of the following formula (please read the precautions on the back before filling the page)
R*-NR * -N
N-Rb 訂 之 經 濟 部 中 央 標 準 Μ 貝 X 消 费 合 作 社 (其中 ·、Rb、X和Y係依如上所界定,其限制條件為R«•至Rd基圃 表示F ' ’ '-E-D基囿,其中 E和D係依如上所界定且 :The central standard of the Ministry of Economic Affairs of the Ministry of Economic Affairs, M Be X Consumer Cooperatives (where ·, Rb, X, and Y are as defined above, and their restrictions are R «• to Rd. The base represents F '' '-ED basis, Where E and D are as defined above and:
II
I F 表示羧基) | 與下式之化合物反應 49 本紙張尺度逋用中國國家揉準(CNS) f 4规格(210X297公釐) A6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(48 ) Ze - R3e (XIX) 其中 R3e代表Ca-e-烷基、芳基烷基(其中芳基部分係依如上所 界定且烷基部分可具1至4個碳原子)、或R22-或 R23C0-0-CHR24-基圏(其中R22至R24係依如上所界定)* 和 I I ζβ表示親核脫離基如鹵原子或磺酸酯,i例如氛或溴原或甲 基磺醢氧基或對甲苯磺醢氧基。 反應較佳地於溶劑如二氣甲烷、四氫呋喃、二氧六画、 二甲基亞碾或二甲基甲醚胺内,視情況在如碘化納或碘化 鉀之反應加速劑之存在下且較佳地在碱如碳酸納、碳酸鉀 或氬氧化納溶液之存在下或在三级有機·碱如N-乙基二異丙 基胺或N-甲基嗎啉,其可同時作為溶劑,之存在下,或視 情況在碳酸銀或氧化銀之存在下,在-30至100 "Ό間之溫度 ,但較佳地在-10至80笱間之溫度下進行。 1) 為了製備通式I之化合物,其中X :表示羰基且Υ表示 直鍵C2-4-伸烷基,其情況以匕或。、或MR。和Rd取代* 且其中在末端位置上之伸甲基以羰基置換: 將下式之化合物環化 R*—^N-Rb (XX)’ ΰ4 (請先閲讀背面之注意事項再填窝本頁} .裝 -訂 .,·· —5 0 — 丰纸張尺度遑用+國國家揉準(CNS)T 4规格(210X297公釐) 五、發明説明(49 A6 B6 經. 濟 部 中 央 標 準 局 員 工 消 费 合 作 社 印 製 (其中 和R»係 X”表示羰 U3或114基 C 2 - 4 -伸 其中末端 離基如鹵 如氯或溴 ),視情 反應較 、二甲基 酸鉀、第 情況在脫 基二咪唑 至 160TC 若根據 其可Μ觸 觸媒氫 溶劑如甲 鹽酸之酸 之溫度下 在上述 、膦酸基 胺基或甲 依如上所界定* 基, 圏之一代表氫原子且113或114基 烷基,其視情況Μ 1^或Rd、或 伸甲基以Z7-CO基囿置換,其 原子或羥基、烷氧基、芳氧基 原子或羥基、甲氧基、乙氧基 況在反應液中形成。 佳地於溶劑如二氛甲烷、乙腈 甲醢胺或二甲基亞颯,視情況 三丁氧化鉀或H -乙基二異丙基 水劑如三苯基膦/偁氮二甲酸 之存在下,在-20至200t:間之 間之溫度下進行。 本發明所得之通式I化合物具 媒氫化轉化成通式I之相對應 化作用較佳地Μ氩在如Pd/C之 醇、乙醇、乙酸乙酯或冰醋酸 ,在0至100¾間之溫度,但較 ,和在1至7巴*較佳地3至5巴 之反應中*任何存在的反應性 、甲咪基、0-烷基膦酸基、胺 咪基在反應期間可藉反應後再 團之另一代表直鏈 K Rc或Rd取代,且 中Z7代表親核性脫 或芳基烷氧基,例 、笨氧基或苄氧基 、四氫呋喃、甲苯 在碱如氫化納、碳 胺之存在下,或視 二乙酯或N , N '-羰 溫度,較佳地在0 不飽和C-C鍵時, 飽和化合物。 觸媒之存在下,於 内,視情況加入如 佳地在20至60t:間 之氫壓下進行。 基團如羥基、羧基 基、烷基胺基、亞 裂解之傳统保護基 {請先閲讀背面之注意事項再填寫本頁) -裝 51- 本纸張尺度逍用中國國家標準(CNS)甲4规格(210X297公釐) 經濟部中央標準局员工消费合作社印製 五、發明説明(50 ) 予K保護。._ . 例如,羥基之保護基可為三甲基矽烷基、乙醢基、苄酿 基、第三丁基、三苯基甲基、苄基或四氫哌喃基,羧基之 保護基可為三甲基矽烷基、甲基、乙基、第三丁基、苄基 或四氫哌哺基* 膦酸基之保護基可為烷基如甲基、乙基、異丙基或正丁基 、苯基或苄基, 視情況烷基取代之甲咪基之保護基可為苄氧基羰基和 胺基、烷基胺基或亞胺基之保護基可為甲醣基、乙醢基、 三氟乙醢基、乙氧基羰基、第三丁氧基羰基、苄氧基羰基 、苄基、甲氧基苄基或2,4-二甲氧基苄基,以及甲基亦可 能來保護亞胺基和ft醸基亦可考盧K保護胺基。 保護基視情況之其後裂解*例如,可水解地於水性溶劑 ,例如於水、異丙醇/水、乙酸/水、四氫呋喃/水或二 氧六匾/水内,在酸如三氟乙酸、鹽酸或硫酸之存在下或 在碱金羼碱如氫氧化納或氫氧化鉀之存在下,或以醚裂解 ,例如在碘三甲基砂烷之存在下,在〇至120t:間之溫度* 較佳地在10至100 t:間之溫度下進行。 然而,窄基、甲氧基苄基或苄氧基羰基可氫解地裂解, 例如使用氫在觸媒如Pd/C之存在下,於溶劑如甲酵、乙醇 、乙酸乙酯或冰醋酸内,視情況加入如鹽酸之酸,在〇至 100 Ό間之溫度•但較佳地在20至60t:間之溫度下*在1 至7巴,較佳地3至5巴之氬壓下。然而,2,4-二甲氧基苄 基較佳地於三氟乙酸内,在甲氧基苯之存在下裂解。 (請先閲讀背面之注意事項再填窝本頁) 一 5 2 — 本紙張尺度遑用中國Η家揉承(CNS)〒4規格(210X297公^~ 五、發明説明(51) A6 B6 經 濟 部 中 央 標 準 局 貝 X. 消 费 合 作 社 印 製 第三丁基或第三丁氧基 酸處理、或κ碘三乙基矽 二氛甲烷、二氧六園、甲 三氟乙醚基較佳地Μ如 或甲酵之溶劑内,在50至 氧化納溶液處理*視情況 在0至50t:間之溫度下裂 甲基自甲基亞胺基之裂 氛甲酸1-氯乙酯之存在下 胺基)-萘之存在下,於如 或二氧六圈之溶劑内,在 20¾至反應液沸騰溫度間 之醇,在201:至該醇沸騰 呔醢基較佳地在肼或一 存在下,於溶劑如甲醇、 六圈内,在20至50t:間之 僅1個烷基自0,0二 化鉀,於溶劑如丙酮、乙 內,在40至150 t間之溫 溫度下進行。 2個烷基自二烷 乙基矽烷、溴三乙基矽烷 如二氯甲烷、氯仿或乙腈 之溫度,但較佳地在20至 羰基較佳 烷處理裂 酵或乙醚 鹽酸之酸 120 Ό 間 在如四氫 解。 解較佳地 *較佳地 二氯甲烷 0 至 150Ό 之溫度下 溫度間之 级胺如甲 乙酵、異 溫度下裂 烷基膦酸 基甲基酮 度,但較 基膦酸棊 或氯三乙 内,在0 6 Ot:間之 地Κ酸如三氟乙酸或鹽 解•視情況使用溶繭如 〇 處理,視情況在如乙酸 之溫度下裂解*或Μ氫 呋喃或甲醇之溶劑内, 在1-氯烷基 在喊如1, 8 -、1,2-二氯 間之溫度, 進行,且其 溫度下處理 胺、乙胺或 丙醇、甲苯 解0 基之裂解較 、乙腈或二 佳地在60至 氛甲酸酯如 雙-(二甲基 乙烷、甲苯 較佳地在 後Μ如甲醇 〇 正丁基胺之 /水或二氧 佳地使用碘 甲基甲醯胺 1 ο ο π間之 之裂解,例如,Μ碘三 基矽烷/碘化納在溶劑 至反應液之沸騰溫度間 溫度下進行。 .................................................................................裝........................玎....................., {請先閲讀背面之注意事項再填寫本頁} 53 本紙張尺度遑用中國國家搮準(CNS)肀4规格(210x297公釐) 經濟部中央標準局員工消费合作社印製· A6 B6 五、發明説明(52 ) 再者•所得通式I之化合物可依如上所述地解析成其鏡 像異構物和/或非鏡像異構物。因此,例如順/反混合物 可解析成其順或反式異構物,及具至少1個光學活性碳原 子之化合物可解析成鏡像異構物。 因此,所得的順/反混合物可K層析法解析出其順和反 式異構物及消旋形式之通式I化合物可K熟知之方法(見 Allinger H. L.和 Eli.el E. L.於"Topics in Stereochemistry",第6 卷 » Wiley Interscience, 1971)分離成其光學鏡像異構物,和具至少2個不對稱碳 原子之通式I化合物可基其物理化學之差異使甩已知方法 ,例如Μ層析法和/或分结晶作用,分離成其非鏡像異構 物,其若且消旋形式時,其後可依如上所述地分離成鏡像 異構物。 鏡像異構物之分雔Μ於對掌相之管柱分離或Μ自光學活 性溶劑之再结晶,或Κ與光學活性物質反應較有效,特別 地酸或其活化衍生物或醇,其與消旋化合物形成鹽或衍生 物如酯或趣胺,再分離如此所得非鏡像異構鹽混合物或衍 生物,例如基於其不同的溶解度,然而游雜的鏡像異構物 可自純非鏡像異構鹽Κ合適的試劑作用釋出。特別常用的 光學活性酸包括,例如D-和L-形式之酒石酸和二苄醯基酒 石輯、二鄰茄基酒石酸、蘋果酸、苯乙醇酸、樟腦磺酸、 麩胺酸、天冬胺酸或金雞納酸。光學活性醇之實例包括 (+ )或薄荷腦和醯胺中之光學活性醢基之實例包括 (+ )或(-)-芰氧基羰基。 —5 4 — 本紙張尺度逋用t s a家揉準(CNS)甲4规格(210x297公釐) ...........................................................................................^.......................ΤΓ.....................$ (請先閲讀背面之注意事項再填窝本頁) 經濟部中央標準局員工消费合作社印製 A6 _ B6_ 五、發明説明(53 ) — 再者,所得式I之化合物可轉化成其鹽類*特別地作為 路藥用途與無機或有機酸轉化成其生理上可接受之鹽。合 適的酸之實例包括鹽酸、氫溴酸、硫酸、磷酸、延胡索酸 、琥珀酸、乳酸、檸檬酸、酒石酸或順丁烯二酸。 此外,如此所得之式I之新化合物,若其具羧基、磺酸 基、膦酸基、0-烷基膦酸基或四唑-5-基時,若需要時, 其後可與無櫬或有機酸轉化成其加成鹽,更特別地作為K 藥用途,轉化成其生理上可接受之鹽。合適的碱之實例包 括氫氧化納、氫氧化鉀、精胺酸、環己基胺、乙醇胺、二 乙酵胺和三乙醇胺。 作為起始物之化合物在一些情形下係自文獻中已知或可 以自文獻中已知之方法製備(見實施例)。 因此*例如,相對應三唑化合物之製備描述於"The Organic Chemistry of Heterocyclic Compounds'*,第 3.7卷,C. Temple Jr., John Wiley & Sons, 1981,之第 13、14 和 19章 ° 相對應環狀脲化合物之製備係描述於Houben-Weyl, "Methoden.der Organischen Chenie",第 E4卷Η· Hagemann, Georg Thieme.Verlag, 1983,之第 368 頁起。 同時,在同一卷内,描述可能需求為起始化合物之相對應 開鍵腺化合物製備之實例方法於355頁起。 因此,例如相對應環狀腺衍生物以環化相對應取代的腺 (其依序Μ將相對應胺與相對應異氰酸酯反應製備)*或 Κ將相對應取代的二胺與如二氛化羰之碳酸衍生物反應製 —5 5 _ 本纸張尺度逍用中國國家揉準(CNS) ▼ 4規格{210Χ297公釐) .....................................-...............................................裝........................可..............……综 (請先閲讀背面乏注意事項再填窝本頁) 經濟部中央標準局貝工消费合作社印製 A6 B6 五、發明説明(54) 備,或相對應二氫三唑酮衍生物以環化相對應半卡肼製備 ,其依序κ將相對應異氰酸酯與相對應醯肼反應製備。 在如此所得環狀腺衍生物中,若需要時,羰基其後可使 已知方法轉化成相對應硫羰基或碳亞胺基。 在生成的環狀起始物或在需求Μ製備此等之起始物中, 任何存在之酯基可Κ水解轉化成羧基或任何存在之羧基可 轉化成酯基。 如前述地,通式I之新環狀衍生物和其加成鹽•特別地 其與無櫬或有機酸或醎之生理上可接受之加成鹽具重要特 性。因此,通式I之化合物具重要藥理特性,且除了具抑 制炎性和骨降解效果外,特別地具抗凝血、抗聚集和腫瘤 或轉移抑制效果。 藉實例方式通式I之化合物經探討其生物效果如下: 1. 拙制3Η-ΒΤΒΗ 52结合牵人艄Ifa爪f 血漿中人體血小板之懸浮液與3H-BIBU 52〔二 (3$,53)-5-[(4’-甲咪基-4-聯苯基)氧甲基]-3-[(羧基)甲 基]-2-吡咯啶酮[3-3 Η-4-聯苯基]]一間培養,其置換自文 獻(見德國專利申請案Ρ 42 14 245.8 ,由相同申請人於 1992年4月30日申請,內參考碼:案號5/1093-FL >已知 之配位子12SI-血纖維蛋白元和不同濃度之测試物質。游 離和结合的配位子Μ離心分離且以閃嫌計数定最地測定。 自所得測定值決定由测試物質所導致之SH_BIBlj 52结合之 抑制。 為了進行此試驗,供體血液自反肘靜脈抽出且以檸樺酸 —5 6 — 本紙張尺度遑甩中國國家揉Ϋ(⑶S)甲4規格(210X297公釐) {請先閲讀背面之注意事項再填寫本頁) .裝.. .3J+. A6 B6 五、發明説明(55 ) 三納(最終濃度13毫萁耳濃度)抗凝聚。血液在170 x g 下離心10分鐘且移出上清血小板濃度血漿(PRP)。剌餘的 血液再一次澈烈離心Μ回收血漿。P R P K自體血漿1 : 10稀 釋。750微升與50微升生理食鹽水、100微生測試物質溶 液、50微升14C-蔗糖(3700 Bq)和50微升3H-BIBU 52 (最 終濃度5毫微奠耳濃度)在室溫下培養20分鐘。為了測定 非特定结合*使用5微升BIBU 52 (最終濃度30微萁耳濃度 )而非测試物質。樣品在10000 X s下離心20秒且吸出上 清液。其100微升經測定以決定游雛配位子。沉澱片溶於 500微升0.2當量濃度NaOH,450微升與2毫升閃爍劑和 25微升5當量濃度HC1混合且測定。剌餘在片中之殘留血 漿自14C-含虽決定,且结合配位子自3H-測定值決定。經 減去非特定结合後,沉澱片活性對测試物質濃度作圖且決 定50!«结合抑制之濃度。 2. 抗凝rfii法柹 方法 血小板聚集使用Bor η·和Cross法(J. Physiol. 170:397 (1964))於自健康志願者所抽出之血小板湄厚血 漿中洒定。為了抑制聚集,血液將3.14¾檸樺酸納Μ 1:10之體積比例混合。 膠番白諉翥聚輋 血小板懸浮液在光學密度上降低棋式在加入聚集引發物 質後光度分析地測定且記錄。聚集速率自密度曲線之傾斜 角決定。曲線上最大光穿透之點用來計算光學密度。所用 -57- 本紙張尺度遑用中a a家標準(CNS)甲4规格(210X 297公釐) t請先閲讀背面之注意事項再填窝本頁} .裝 .訂. 經濟部中央標準局員工消費合作社印製 A6 __B6___ 五、發明説明(56) 膠蛋白量僅可能地小,但足夠K產生不可逆反應曲線。所 使用的標準膠蛋白商品產自慕尼黑(Munich)之 Hormonche丨ie〇 在加入膠蛋白之前*血漿與棚試物質在37 t:下培養10分 鐘。 自所得的测定值,圖形地決定ECB〇,即在光學密度上Μ 聚集抑制而言之50¾改變。 随後之表含所得之结果: (請先閲讀背面之注意事項再填窝本頁} 經濟部中央標準局貝工消費合作社印製 物質(實施 例編號) 3H-BIBU 52-结合 試驗 IC5〇[nM] 血小板聚集之抑 制 ECB。[nM] 1 190 >10000 2(1) 5400 >10000 2 (2) 24 40 6 110 40 8(1) 36 150 9 85 190 9(1) 760 gg〇 19 59 230 19(1) 120 350 19 (3) 81 430 .裝 _ 5 8 — 本紙張尺度逍用t國國家榣準(CNS)甲4规格(210X297公爱) A6 B6 五、發明説明(57 ) (請先閲讀背面之注意事項再填寫本頁) 再者,實施例7和19之化合物,例如,在口眼施藥1毫 克/公斤後*分別在Rhesus猴體内抑制膠蛋白誘導血小板 聚集多於5和多於8小時。 根據本發明之化合物是可容忍的*因為經靜脈注射30毫 克/公斤之實施例(8)1和19之化合物至3隻小鼠後· 3隻 測試動物並無死亡。 依其在细胞畑胞間和细胞基質間交互作用之抑制作用* 通式I之新環狀腺衍生物和其生理上可接受之加成鹽適合 地Μ對抗或防止其中發生較小或較大之细胞聚集體之疾病 或其中细胞基質間交互作用扮演部分角色之疾病,例如以 治療或防止靜脈和動脈栓塞、腦血管疾病、肺插塞、心栓 塞、動脈硬化、骨疏鬆症和腫瘤之轉移及治療由细胞間或 细胞與固體结構間交互作用之逍傳造成或後天之障礙。其 亦適合於與孅維蛋白分解劑或血管插入法如撤亮血管胚细 胞在血栓溶解上之並行治療或在休克、乾癖、糖尿病和炎 症治療上之並行治療。 為了治療或防止上述之疾病,施用劑量在0.1微克至 30毫克/公斤體重之間,較佳地1微克至15毫克/公斤體 重之間,而施用至每日4劑量。為此目的,根據本發明所 產生之式I化合物,視情況與其他活性物質如前列凝素细 胞受體括抗劑和前列凝素合成抑制劑或其組合、5-羥基色 胺拮抗劑、α—受體拮抗劑、烷基硝酸酯如甘油三硝酸酯 、磷酸二酯海抑制劑、前列環素和其類似物、纖維蛋白分 解劑如tPA 、原尿激酶、尿激酶、鏈激酶或抗凝聚劑如肝 —5 9 — 本紙張尺纽时8 Η家料(哪)T4絲(210X297公釐) A6 B6IF represents a carboxyl group) | Reacts with a compound of the following formula. 49 This paper size uses the Chinese National Standard (CNS) f 4 specifications (210X297 mm) A6 B6 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. ) Ze-R3e (XIX) where R3e represents Ca-e-alkyl, arylalkyl (where the aryl moiety is as defined above and the alkyl moiety may have 1 to 4 carbon atoms), or R22- or R23C0 -0-CHR24-based hydrazone (where R22 to R24 are as defined above) * and II ζβ represents a nucleophilic leaving group such as a halogen atom or a sulfonic acid ester, i. Tosylsulfonyloxy. The reaction is preferably in a solvent such as digasmethane, tetrahydrofuran, dioxane, dimethylmethylene or dimethyl methyl ether amine, optionally in the presence of a reaction accelerator such as sodium iodide or potassium iodide, and more preferably Preferably in the presence of a base such as sodium carbonate, potassium carbonate or sodium argon solution or in a tertiary organic · base such as N-ethyldiisopropylamine or N-methylmorpholine, which can be used simultaneously as a solvent, It is carried out in the presence, or optionally in the presence of silver carbonate or silver oxide, at a temperature between -30 and 100 ° C, but preferably at a temperature between -10 and 80 ° C. 1) In order to prepare a compound of general formula I, where X: represents a carbonyl group and Υ represents a straight bond C2-4-alkylene, in which case d or d is used. , Or MR. And Rd are substituted with * and the methyl group at the terminal position is replaced with a carbonyl group: The compound of the formula R * — ^ N-Rb (XX) 'ΰ4 (Please read the precautions on the back before filling this page }. Binding-booking ,, ... — 5 0 — Rich paper size + national standard (CNS) T 4 (210X297 mm) 5. Description of the invention (49 A6 B6 Economics. Central Bureau of Standards, Ministry of Economic Affairs Printed by the employee's consumer cooperative (where R and X are "X" means carbonyl U3 or 114-based C 2-4 -ends with terminal radicals such as halogen such as chlorine or bromine). At the temperature of dealkylated diimidazole to 160TC, according to the temperature of its catalytic hydrogen solvent, such as the acid of methyl hydrochloric acid, the above-mentioned, phosphonoamino group or methyl group as defined above * group, one of 圏 represents a hydrogen atom and 113 Or 114-based alkyl, whose M 1 ^ or Rd or methyl group is replaced with Z7-CO-based fluorene, its atom or hydroxyl group, alkoxy group, aryloxy atom or hydroxyl group, methoxy group, ethoxy group In the reaction solution, it is preferably formed in a solvent such as dioxan methane, acetonitrile formamidine or dimethylsulfinium, optionally potassium tributoxide or The H-ethyl diisopropyl water agent such as triphenylphosphine / fluorenazine is carried out at a temperature between -20 and 200 t: The compound of the general formula I obtained by the present invention has a hydrogenated conversion. The corresponding reaction of formula I is preferably M argon, such as Pd / C alcohol, ethanol, ethyl acetate or glacial acetic acid, at a temperature between 0 and 100 ¾, but more, and between 1 and 7 bar *. In the reaction of 3 to 5 bar, any reactivity, methylimidyl group, 0-alkylphosphonic acid group, and aminoimidyl group may be used during the reaction to represent another straight-chain K Rc or Rd. Substituted, and Z7 represents a nucleophilic de- or arylalkoxy group, for example, benzeneoxy or benzyloxy, tetrahydrofuran, toluene in the presence of a base such as sodium hydride, carboamine, or diethyl or N, N′-carbonyl temperature, preferably at 0 unsaturated CC bond, saturated compounds. In the presence of the catalyst, internally, if appropriate, added Rujia at 20 to 60t: hydrogen pressure between. The group such as Traditional protective groups for hydroxyl, carboxyl, alkylamino, and cleavage (Please read the precautions on the back before filling this page)-装 51- China National Standard (CNS) A4 specification (210X297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. The invention description (50) is protected by K. _. For example, the protective group of the hydroxyl group may be trimethylsilane Group, ethenyl group, benzyl group, third butyl group, triphenylmethyl group, benzyl group or tetrahydropiperanyl group, and the protecting group of carboxyl group may be trimethylsilyl group, methyl group, ethyl group, third group The protective group of butyl, benzyl or tetrahydropiperidinyl group * can be an alkyl group such as methyl, ethyl, isopropyl or n-butyl, phenyl or benzyl, optionally substituted by alkyl The protecting group of the imidyl group may be benzyloxycarbonyl and the protecting group of the amine, alkylamino or imino group may be methylosyl, ethylfluorenyl, trifluoroethylfluorenyl, ethoxycarbonyl, and tert-butyl Oxycarbonyl, benzyloxycarbonyl, benzyl, methoxybenzyl, or 2,4-dimethoxybenzyl, and methyl groups may also be used to protect imine and ft-methyl groups. Kao K-protected amines are also possible. base. The base is optionally cleaved thereafter * For example, hydrolyzable in an aqueous solvent such as water, isopropanol / water, acetic acid / water, tetrahydrofuran / water or dioxane / water, in an acid such as trifluoroacetic acid , In the presence of hydrochloric acid or sulfuric acid or in the presence of alkali scopolamine, such as sodium hydroxide or potassium hydroxide, or with ether cleavage, such as in the presence of iodotrimethylsarane, at a temperature between 0 and 120 t: * It is preferably performed at a temperature between 10 and 100 t :. However, narrower, methoxybenzyl, or benzyloxycarbonyl groups can be cleaved by hydrogenolysis, for example using hydrogen in the presence of a catalyst such as Pd / C in a solvent such as formic acid, ethanol, ethyl acetate, or glacial acetic acid. If appropriate, add an acid such as hydrochloric acid, at a temperature between 0 and 100 Torr • but preferably at a temperature between 20 and 60 t: between 1 and 7 bar, preferably under an argon pressure of 3 to 5 bar. However, 2,4-dimethoxybenzyl is preferably cleaved in trifluoroacetic acid in the presence of methoxybenzene. (Please read the precautions on the back before filling in this page.) I 5 2 — This paper size is in Chinese paper (CNS) 〒 4 specifications (210X297 cm ^ ~ 5. Description of the invention (51) A6 B6 Ministry of Economic Affairs Central Bureau of Standards X. Consumer cooperatives print third-butyl or third-butoxy acid treatment, or κ-iodotriethylsilyl dimethane, dioxane, methyltrifluoroethyl ether, preferably M such as or In the solvent of formazan, treat with 50 to sodium oxide solution * Depending on the situation, the amine group is cleaved from methyl-methylimine group in the presence of 1-chloroethyl formic acid at a temperature between 0 and 50 t:- In the presence of naphthalene, in a solvent such as or dioxane, an alcohol between 20¾ to the boiling temperature of the reaction solution, at 201: to the boiling of the alcohol, the fluorenyl group is preferably in the presence of hydrazine or a solvent such as Methanol, six cycles, between 20 and 50 t: only one alkyl group from 0,0 potassium dichloride, in a solvent such as acetone, ethyl, at a temperature between 40 and 150 t. The temperature of 2 alkyl radicals is from dialkylethylsilane, bromotriethylsilane such as dichloromethane, chloroform or acetonitrile, but preferably between 20 and 120 ° C. Such as tetrahydrolysis. The solution is preferably * preferably a diamine with a temperature between 0 and 150 ° C in dichloromethane, such as methyl ethyl fermentation, and a degree of cleavage of alkylphosphonic acid methyl ketone at different temperatures, but is higher than that of phosphonium phosphonate or chlorotriethyl. Within 0 6 Ot: between the K-acid such as trifluoroacetic acid or salt hydrolysis • optionally use a cocoon such as 0 treatment, and optionally cleave at a temperature such as acetic acid * or in a solvent of hydrogen furan or methanol, in 1-Chloroalkyl is carried out at a temperature such as 1, 8-, 1,2-dichloro, and the cleavage of amine, ethylamine or propanol, and the tolyl group at the same temperature is better than that of acetonitrile or dijia. Iodine methylformamide 1 is preferably used at 60 to about formic acid esters such as bis- (dimethylethane, toluene, preferably at the end, such as methanol, n-butylamine / water, or dioxane. The cleavage between π, for example, M iodotriyl silane / sodium iodide is carried out at a temperature between the solvent and the boiling temperature of the reaction solution ... ........................................ ........... install ..................... ........, {Please read the notes on the back before filling out this page} 53 Dimensions: China National Standards (CNS) 4 specifications (210x297 mm) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs · A6 B6 V. Description of the invention (52) Furthermore • The compound of general formula I obtained can be as above It can be resolved into its isomers and / or non-image isomers. Therefore, for example, a cis / trans mixture can be resolved into its cis or trans isomer, and a compound having at least one optically active carbon atom can be resolved. Resolution to mirror isomers. Therefore, the obtained cis / trans mixture can be resolved by K chromatography to obtain its cis and trans isomers and the racemic form of the compound of the general formula I can be well-known methods (see Allinger HL and Eli .el EL was isolated from "Topics in Stereochemistry", Volume 6 »Wiley Interscience, 1971) into its optically mirrored isomers, and the compounds of general formula I with at least 2 asymmetric carbon atoms may differ in their physical chemistry A known method, such as M chromatography and / or fractional crystallization, is used to separate the non-mirromeric isomers, which, if in racemic form, can be separated into the mirror isomers as described above. Mirror isomers Phase column separation or recrystallization from optically active solvents, or K reacts more effectively with optically active substances, especially acids or their activated derivatives or alcohols, which form salts or derivatives with racemic compounds such as esters or fungi. The amine is then separated and the non-mirromeric salt mixture or derivative thus obtained is, for example, based on its different solubility, however, free-running mirror image isomers can be released from pure non-mirroimage isomers by suitable reagents. Particularly commonly used optically active acids include, for example, tartaric acid and dibenzyl tartaric acid in the D- and L-forms, di-o-solanyl tartaric acid, malic acid, phenylglycolic acid, camphorsulfonic acid, glutamic acid, asparagine Tart or cinchona acid. Examples of optically active alcohols include (+) or examples of optically active fluorenyl groups in menthol and amidine include (+) or (-)-fluorenyloxycarbonyl. —5 4 — This paper size is tsa home standard (CNS) A4 size (210x297 mm) ............... ........................................ ............... ^ ............................ ΤΓ ............. ........... $ (Please read the notes on the back before filling in this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A6 _ B6_ V. Description of the Invention (53) — Furthermore, The resulting compounds of formula I can be converted into their salts *, especially for road medicine use and inorganic or organic acids into their physiologically acceptable salts. Examples of suitable acids include hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid or maleic acid. In addition, the new compound of formula I thus obtained, if it has a carboxyl group, a sulfonic acid group, a phosphonic acid group, a 0-alkylphosphonic acid group, or a tetrazol-5-yl group, can be subsequently reacted with Or organic acids are converted into their addition salts, more particularly as K-medicine uses, into their physiologically acceptable salts. Examples of suitable bases include sodium hydroxide, potassium hydroxide, arginine, cyclohexylamine, ethanolamine, diethylenamine, and triethanolamine. The compounds as starting materials are in some cases known from the literature or can be prepared by methods known from the literature (see Examples). So * For example, the preparation of corresponding triazole compounds is described in " The Organic Chemistry of Heterocyclic Compounds' *, Volume 3.7, C. Temple Jr., John Wiley & Sons, 1981, Chapters 13, 14, and 19 ° The preparation of corresponding cyclic urea compounds is described in Houben-Weyl, " Methoden.der Organischen Chenie ", Volume E4 Η Hagemann, Georg Thieme. Verlag, 1983, p. 368. Also, in the same volume, an example method describing the preparation of a corresponding open bond gland compound that may require a starting compound starts on page 355. Therefore, for example, the corresponding cyclic gland derivative is cyclized to the corresponding substituted gland (which is sequentially prepared by reacting the corresponding amine with the corresponding isocyanate) * or K is to replace the corresponding substituted diamine with, for example, a dioxocarbonyl Carbonic acid derivative reaction system—5 5 _ This paper is scaled to the Chinese National Standard (CNS) ▼ 4 specifications (210 × 297 mm) ......... ........-............................ ... installation ......... may ... ............ Comprehensive (please read the notes on the back before filling in this page) Printed by A6 B6, Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (54), or corresponding dihydrogen Triazolone derivatives are prepared by cyclizing the corresponding hemicarbazide, which is sequentially prepared by reacting the corresponding isocyanate with the corresponding hydrazine. In the cyclic gland derivative thus obtained, if necessary, a carbonyl group can thereafter be converted into a corresponding thiocarbonyl or carbimide group by a known method. In the resulting cyclic starting material or in the preparation of such starting materials on demand, any ester group present can be hydrolyzed to convert to a carboxyl group or any existing carboxyl group can be converted to an ester group. As mentioned before, the novel cyclic derivatives of the general formula I and their addition salts • particularly their physiologically acceptable addition salts with no hydrazone or organic acid or hydrazone have important characteristics. Therefore, the compounds of the general formula I have important pharmacological properties and, in addition to their anti-inflammatory and bone-degrading effects, they particularly have anti-coagulant, anti-aggregation and tumor or metastatic inhibitory effects. By way of example, the biological effect of the compound of general formula I has been discussed as follows: 1. Manufactured 3Η-ΒΤΒΗ 52 combined with suspension of human Ifa claw f. Human platelet suspension in plasma and 3H-BIBU 52 [two (3 $, 53) -5-[(4'-methylimidyl-4-biphenyl) oxymethyl] -3-[(carboxy) methyl] -2-pyrrolidone [3-3 hydrazone-4-biphenyl] ] A culture, its replacement from the literature (see German patent application P 42 14 245.8, filed by the same applicant on April 30, 1992, internal reference code: case number 5 / 1093-FL > known coordination 12SI-fibrinogen and different concentrations of test substance. Free and bound ligand M is centrifuged and determined by flash count. The SH_BIBlj 52 binding caused by the test substance is determined from the obtained measurement value. In order to perform this test, the donor blood was drawn from the reverse elbow vein and citric acid—56 was used. This paper is scaled to the size of China National Knead (CDS) A 4 (210X297 mm) {Please read the back first Please note this page before filling in). Packing .. 3J +. A6 B6 V. Description of the invention (55) Three nanometers (final concentration of 13 millirales) anti-coagulation. The blood was centrifuged at 170 x g for 10 minutes and the supernatant platelet concentration plasma (PRP) was removed. The remaining blood was centrifuged again to recover the plasma. P R P K autologous plasma was diluted 1:10. 750 μl with 50 μl saline, 100 μl test substance solution, 50 μl 14C-sucrose (3700 Bq) and 50 μl 3H-BIBU 52 (final concentration 5 nanomolar) at room temperature Incubate for 20 minutes. For the determination of non-specific binding * 5 μl of BIBU 52 (final concentration 30 μM) was used instead of the test substance. The samples were centrifuged at 10,000 X s for 20 seconds and the supernatant was aspirated. Its 100 microliters were determined to determine the motif of the moult. The pellet was dissolved in 500 microliters of 0.2 equivalent NaOH, 450 microliters were mixed with 2 ml of scintillator and 25 microliters of 5 equivalent HC1 and measured. The residual plasma in Yuyu in the film was determined from 14C-containing, and the binding ligand was determined from 3H-measured value. After subtracting non-specific binding, the pellet activity is plotted against the test substance concentration and the 50! «Binding inhibition concentration is determined. 2. Anticoagulant rfii method 柹 Method Platelet aggregation was determined by Bor η · Cross method (J. Physiol. 170: 397 (1964)) in platelet-derived thick blood plasma extracted from healthy volunteers. In order to inhibit aggregation, the blood was mixed with a volume ratio of 3.14 ¾ sodium citrate 1:10. Decrease in optical density of platelet suspensions of G. sibiricum L. polysaccharides was measured and recorded photometrically after the addition of aggregation-initiating substances. The aggregation rate is determined by the inclination angle of the density curve. The point of maximum light penetration on the curve is used to calculate the optical density. -57- Used in this paper standard AA standard (CNS) A4 size (210X 297 mm) t Please read the precautions on the back before filling in this page}. Binding. Binding. Staff of the Central Bureau of Standards, Ministry of Economic Affairs Printed by the consumer cooperative A6 __B6___ 5. Description of the invention (56) The amount of gelatin is only as small as possible, but it is enough to produce an irreversible response curve. The standard gelatin product used was from Hormonche in Munich. Before the gelatin was added * the plasma and the test substance were incubated at 37 t for 10 minutes. From the obtained measured values, ECB0 is determined graphically, that is, a change in M aggregation inhibition in terms of optical density by 50 °. The following table contains the results obtained: (Please read the notes on the back before filling in this page} Substances printed by Shellfish Consumer Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs (Example No.) 3H-BIBU 52-Binding Test IC5〇 [ nM] ECB inhibition of platelet aggregation. [nM] 1 190 > 10000 2 (1) 5400 > 10000 2 (2) 24 40 6 110 40 8 (1) 36 150 9 85 190 9 (1) 760 gg〇19 59 230 19 (1) 120 350 19 (3) 81 430. Packing_ 5 8 — This paper size is not applicable to the national standard (CNS) A4 specification (210X297 public love) A6 B6 V. Description of the invention (57) (Please read the precautions on the reverse side before filling out this page) Furthermore, the compounds of Examples 7 and 19, for example, were administered orally and ocularly at 1 mg / kg * to inhibit gelatin-induced platelet aggregation in Rhesus monkeys, respectively. At 5 and more than 8 hours. The compound according to the present invention is tolerable * because after intravenous injection of 30 mg / kg of the compound of Examples (8) 1 and 19 to 3 mice · 3 test animals did not have Death. Depending on its inhibitory effect on cell-cell and cell-matrix interactions * New cyclic gland derivatives of general formula I and their growth The above-acceptable addition salts are suitable for combating or preventing diseases in which smaller or larger cell aggregates occur or diseases in which cell-matrix interactions play a part, such as to treat or prevent venous and arterial embolism, the brain Vascular disease, pulmonary embolism, cardiac embolism, arteriosclerosis, osteoporosis, and tumor metastasis and treatment are caused by free passage between cells or the interaction between cells and solid structures, or acquired disorders. It is also suitable for the treatment of vitamin Decomposers or vascular insertion methods such as concurrent treatment of vascular germ cells for thrombolysis or concurrent treatment for shock, dry addiction, diabetes and inflammation. To treat or prevent the above diseases, the dosage is 0.1 microgram to 30 Between mg / kg of body weight, preferably between 1 microgram and 15 mg / kg of body weight, and is administered to 4 daily doses. For this purpose, the compounds of formula I produced according to the invention, as appropriate, with other active substances such as Prostaglandin cell receptor inhibitors and prostaglandin synthesis inhibitors or combinations thereof, 5-hydroxytryptamine antagonists, alpha-receptor antagonists, alkyl nitrates Esters such as glycerol trinitrate, phosphodiester sea inhibitors, prostacyclin and its analogs, fibrinolytic agents such as tPA, prourokinase, urokinase, streptokinase or anticoagulants such as liver — 5 9 — this paper When the ruler is 8 Η Home materials (where) T4 wire (210X297 mm) A6 B6
五、發明説明(58 ) 素、硫酸皮虜素 素、凝血海或其 或多種惰性傳統 、蔗糖、微晶纖 酸、酒石酸、水 /聚乙二醇、丙 質如硬腊或其合 (galenic)製劑 、溶液、噴霧液 随後之實施例 g油{例T 、活化蛋白質C 、維生素K拮抗劑、水姪 他活化凝结因子之抑制劑之結合,可與1 載體和/或稀釋劑,例如玉米澱粉、乳糖 維素、硬脂酸鎂、聚乙烯吡咯啶_、檸樣 、水/乙醇、水/甘油、水/山梨酵、水 二酵、硬脂醇、羧基甲基嫌維素或脂性物 適之混合物·一同併入至傳统蓋倫 如普通和塗佈片錠、醪囊、粉末、懸浮液 或栓劑。 在於說明本發明: {諳先閲讀背面之注意事項再填寫本頁) -裝 經 濟 部 中 央 標 準 局 貝 1 -(虽晻瞅-H-氬化物-fi-某甲氬某雔某某 1 -笼某1 -四Μ眯邮-2-靦 2.6克1-(異喹啉-6-基)-3-[4-[2-(甲氧基羰基)乙基 ]-苯基]-四氫眯唑-2-酮Μ加熱溶於175毫升二氛甲烷中 。混合液在冰浴中冷卻且與1.46克3-氯過氧笨甲酸(90¾ 強度)混合。在0 t攪拌24小時後,混合液Μ二氯甲烷稀 釋且Μ碳酸氫納和硫代硫酸納溶液萃取2次,然後Κ水萃 取。有機層經分雛、脫水和蒸發。 產量:2.4克(理論值之88¾) 值:0.15 (矽膠;二氛甲烷/甲醇/乙酸乙酯=20:1 :1) 啻淪例T T N-(2-锊某乙某)-H’-(異蝰啉-fi-某)-H-「4-「2- f田氩甚锻 60 本紙張尺度適用t國B家揉準(CNS)甲4规格(210X 297公釐) .訂_V. Description of the invention (58) Glucotin, pitroxin sulfate, clotting sea or one or more of its inert traditions, sucrose, microcrystalline fibric acid, tartaric acid, water / polyethylene glycol, acryl such as hard wax or its combination (galenic ) Formulations, solutions, and sprays of Example g oil {Example T, Activated protein C, Vitamin K antagonist, Inhibitor of hydration activating coagulation factor, can be combined with 1 carrier and / or diluent, such as Corn starch, lactose vitamins, magnesium stearate, polyvinylpyrrolidine, citrate-like, water / ethanol, water / glycerin, water / sorbitan, dihydratase, stearyl alcohol, carboxymethyl retinoin or fatty A suitable blend · Incorporates into traditional galens such as regular and coated tablets, capsules, powders, suspensions or suppositories. It is to explain the present invention: (谙 Please read the notes on the back before filling in this page)-Install the Central Standards Bureau of the Ministry of Economic Affairs 1-(Although dark 瞅 -H-argon-fi-some methyl argon some 雔 some 1 -cage 2.6 grams of 1- (isoquinolin-6-yl) -3- [4- [2- (methoxycarbonyl) ethyl] -phenyl] -tetrahydropyrene The oxazol-2-one M was heated and dissolved in 175 ml of dichloromethane. The mixture was cooled in an ice bath and mixed with 1.46 g of 3-chloroperoxy stearic acid (90¾ strength). After stirring at 0 t for 24 hours, the mixture was stirred. Diluted with M dichloromethane and extracted twice with M sodium bicarbonate and sodium thiosulfate solution, followed by K water extraction. The organic layer was separated, dehydrated and evaporated. Yield: 2.4 g (88¾ of theory) Value: 0.15 (silicone) ; Dichloromethane / methanol / ethyl acetate = 20: 1: 1) 例 Examples TT N- (2- 锊, 乙, 某) -H '-(Isophospholine-fi- 某) -H- 「4- "2-f Tian argon even forging 60 This paper size is applicable to country B family standard (CNS) A4 specifications (210X 297 mm). Order_
I 經濟部t央標準局貝工消费合作社印製 A6 B6 五、發明説明(59 ) 某)乙某1荣某1 -脲 於7.2克咪唑和10.1克Ν,Ν’-羰基二咪唑於1〇〇毫升二 甲基醣胺中•在0至l〇t!下逐滴加入9.0克6-胺基異喹啉 於70毫升二甲基甲醢胺。在室溫播拌2小時後*逐滴加入 15.3克H-(2-羥基乙基卜4-[2-(甲氧基羰基)乙基]-笨胺 且混合液在室溫撗拌2-1/2日。混合液K 750毫升乙酸乙 酯稀釋且Μ水和飽和鹽水萃取二次。有櫬層經分雛、脫水 和蒸發。殘渣Μ靥析法於矽膠管柱中使用乙酸乙酯/二氛 甲烷/甲薄=70 :30 : 10纯化。 產虽:4.8克(理論值之19HO ,I Printed by A6 B6, Shellfish Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs 5. Description of Invention (59) A) B, 1, Rong, 1-urea in 7.2 g of imidazole and 10.1 g of N, N'-carbonyldiimidazole in 1 In 0 ml of dimethyl sugar amine • Add 9.0 g of 6-aminoisoquinoline to 70 ml of dimethylformamide at 0 to 10 t! Dropwise. After stirring for 2 hours at room temperature * 15.3 g of H- (2-hydroxyethyl 4- [2- (methoxycarbonyl) ethyl] -benzylamine was added dropwise and the mixture was stirred at room temperature for 2- 1/2 day. The mixture was diluted with 750 ml of ethyl acetate and extracted twice with M water and saturated brine. The layer was separated, dehydrated, and evaporated. The residue was decanted in a silica gel column using ethyl acetate / Di atmospheric methane / methylbenzene = 70:30:10 purification. Yield: 4.8 grams (19HO of theoretical value,
Ri·值:0.48 (矽膠;二氯甲烷/甲醇/乙酸乙酯=20:1 :1) 以下化合物自類似於實施例II製備: (1) 1-(2,2-二乙氧基乙基)-1<,-(異喹啉-6-基)-1<-[4-[2-(甲氧基羰基)乙基]苯基]-腺Ri · value: 0.48 (silicone; dichloromethane / methanol / ethyl acetate = 20: 1: 1) The following compounds were prepared from analogous to Example II: (1) 1- (2,2-diethoxyethyl ) -1 <,-(isoquinolin-6-yl) -1 <-[4- [2- (methoxycarbonyl) ethyl] phenyl] -gland
Rf值;0.50 (矽膠;二氛甲烷/甲醇=20:1) (2) N-(3-乙基-2,3,4,5-四氫-111-3-苯并一氮七画-7-基 )4’-(2,2-二乙氧基乙基)-^('-[反-4-[2-(甲氧基羰基) 乙基]-環己基]-腺 熔點:101-104 υRf value; 0.50 (silicone; dichloromethane / methanol = 20: 1) (2) N- (3-ethyl-2,3,4,5-tetrahydro-111-3-benzo-nitrozine seven- 7-yl) 4 '-(2,2-diethoxyethyl)-^ ('-[trans-4- [2- (methoxycarbonyl) ethyl] -cyclohexyl] -gland melting point: 101 -104 υ
Rf值:0.63 (矽膠;二氣甲烷/甲醇/濃水性氨= 90:10:2) (3) 11-(7-乙基-6,7,8,9-四氫-511-吡哄并-[2,3-〇1]—氮七 圔-2-基)-N’-(2,2-二乙氧基乙基)-M'-[反-4- [2-(甲氧 — 61 — 威:_...本紙.張尺度遑用中國Η家揉準(CNS)甲4规格(210X297公釐) ..............................................................ii...................裝.......................ΤΓ....................., (請先閲讀背面之注意事項再填窝本頁} A6 B6 經濟部中央標準局員Η消費合作社印製 五、發明説明(60 ) 基羰基)乙基]-環己基]-腺與1,1’-與1,1’-羰基-二 -(1,2,4-三啤)進行 熔點:100-102 t: 值:0.41 (矽膠;二氛甲烷/甲醇= 9:1) 理論值:C 62.40 Η 8.73 Ν 13.48 實測值: 62.19 8.79 13.62 (4)^1-(7-苄基-6,7,8,9-四氫-511-嘧畊并-[4,5-0]—氮七 固-2-基)-1<’-(2,2-二乙氧基乙基)-^’-[反-4-[2-(甲氧 基羰基)-乙基]-環己基]-腺 熔與1,1’-羰基-二- (1,2,4-三唑)進行 值:0.23 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 奮淪例T T T 料-(3-笛~丁氬某锻某-?..3.4.5-四氩-114-:?-荣#一氣十晒 -7-某)-M-(2-揮某乙某)-N’-U-「2-(申氬某羰某)乙某1-笼某1 -腩 克3-(第三丁氧基羰基)-7-[(2-羥基乙基)胺基] -2,3,4,5-四氫-111-3-苯并一氮七園和3.7克4-[2-(甲氧 基羰基)乙基]-笨基-異氰酸酯(自相對應胺Μ與二氯化羰 反應製備)於35毫升二氧六圃中在室溫攪拌3.5小時。反 應液經蒸發,殘渣Μ第三丁基甲基醚搗碎且抽氣過溏。產 物Κ第三丁基甲基醚清洗和乾燥。 產量:6.3克(理論值之76¾) 熔點:11 5 -117 C, Rf :0.30 (矽膠;環己烷/乙酸乙酯=1:1) (請先閲讀背面之注意事項再填窝本頁) -裝 訂. -62- 本紙張ϋ运用t國國家揉準(CNS)甲4規格(210X297公釐)"―~ 五、發明説明(61 ) Μ下化合物自類似於實施例111製備: (1) 卜乙醯基-4-[4-[2-(甲氧基羰基)乙基)苯基]-半卡肼 (乙醣基肼與4-[2-(甲氧基羰基)-乙基]-苯基異氰酸 醋0 熔點:159-165ΧRf value: 0.63 (silicone; methane / methanol / concentrated aqueous ammonia = 90: 10: 2) (3) 11- (7-ethyl-6,7,8,9-tetrahydro-511-pyridine -[2,3-〇1] -azaheptazone-2-yl) -N '-(2,2-diethoxyethyl) -M'-[trans-4- [2- (methoxy- 61 — Prestige: _... this paper. Zhang Zhiyuan uses the Chinese National Standard (CNS) A4 size (210X297 mm) ... .......................... ii ....... ..................... TΓ ............. ........, (Please read the notes on the back before filling in this page} A6 B6 Member of the Central Standards Bureau of the Ministry of Economic Affairs ΗPrinted by Consumer Cooperatives V. Description of the Invention (60 carbonylcarbonyl) ethyl] -ring Hexyl] -gland with 1,1'- and 1,1'-carbonyl-di- (1,2,4-triple beer) Melting point: 100-102 t: Value: 0.41 (silicone; dichloromethane / methanol = 9: 1) Theoretical value: C 62.40 Η 8.73 Ν 13.48 Found value: 62.19 8.79 13.62 (4) ^ 1- (7-benzyl-6,7,8,9-tetrahydro-511-pyrimido- [4 , 5-0] -azahepta-2-yl) -1 < '-(2,2-diethoxyethyl)-^'-[trans-4- [2- (methoxycarbonyl)- Ethyl] -cyclohexyl] -glandular fused with 1,1'-carbonyl-di- (1,2,4-triazole) Value: 0.23 (reverse-phase silicone; methanol / 5¾ saline solution = 6: 4) Fenton's example TTT material-(3- flute ~ butyl argon forging a certain-? .. 3.4.5-tetra argon -114-:?-荣 # 一气 十 照 -7-a) -M- (2-a certain a second) -N'-U- "2- (Shen arg a certain carbonyl a) A a certain 1-cage a 1- 腩 克 3- ( Third butoxycarbonyl) -7-[(2-hydroxyethyl) amino] -2,3,4,5-tetrahydro-111-3-benzodiazepine and 3.7 g of 4- [2 -(Methoxycarbonyl) ethyl] -benzyl-isocyanate (prepared from the reaction of the corresponding amine M with carbonyl dichloride) was stirred in 35 ml of dioxane at room temperature for 3.5 hours. The reaction solution was evaporated and the residue was M tertiary butyl methyl ether is mashed and evacuated. The product K tertiary butyl methyl ether is washed and dried. Yield: 6.3 g (76¾ of theory) Melting point: 11 5 -117 C, Rf: 0.30 (silicone; ring Hexane / ethyl acetate = 1: 1) (Please read the precautions on the back before filling in this page)-Binding. -62- This paper ϋ uses national standard (CNS) A4 size (210X297 mm) ) " V. Explanation of the invention (61) The compound was prepared from Example 111 similar to: (1) Buethenyl-4- [4- [2- (methoxycarbonyl) ethyl) phenyl ] -Half Card Hydrazine (ethylglycosylhydrazine and 4- [2- (methoxycarbonyl) -ethyl] -phenyl isocyanate vinegar 0 Melting point: 159-165χ
Rr值:0.37 (矽膠;二氛甲烷/甲醇= 9:1) (2) N-(2-羥基乙基)-N-[反-4-[2-(甲氧基羰基)乙基)-環乙基]-^-(3-三氟乙醢基-2,3,4,5-四氫-111-3-苯并一 氮七園-7-基)-腺 熔點:15 0 - 15 2/0,Rr value: 0.37 (silicone; methane / methanol = 9: 1) (2) N- (2-hydroxyethyl) -N- [trans-4- [2- (methoxycarbonyl) ethyl)- Cycloethyl]-^-(3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzotriazine-7-yl) -gland Melting point: 15 0-15 2/0,
Rf: 0.31 (矽膠;環己垸/乙酸乙酯= 1:1) (3) N-(2,2-二乙氧基乙基)-N-(3-三氟乙醯基-2,3,4,5-四氫-lH-3-笨并一氮七園-7-基)-^Γ-[反-4-[2-(甲氧基 羰基)-乙基]-環乙基]-腺 所用之[反-4-[2-(甲氧基羰基)乙基]環乙基]-異氰酸 酯自相對應胺氯化氫K與二氯化羰反應製備。所用之 7-[ (2,2-二乙氧基乙基)胺基]-3-三氟乙醯基-2,3,4,5-四 氫-1H-3-苯并一氮七園〔Rf : 0.76 (矽膠;環己烷/乙酸 乙酯=3:2)〕M7 -胺基-3 -三氟乙醯基-2,3,4,5-四氫-1[1 -3-苯并一氮七團與溴乙醛二乙基縮醛在N-乙基二異丙基 胺之存在下反應製備。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填窝本頁)Rf: 0.31 (silicone; cyclohexane / ethyl acetate = 1: 1) (3) N- (2,2-diethoxyethyl) -N- (3-trifluoroethylfluorenyl-2,3 , 4,5-tetrahydro-lH-3-benzylazine-7-yl)-^ Γ- [trans-4- [2- (methoxycarbonyl) -ethyl] -cycloethyl] -[Trans-4- [2- (methoxycarbonyl) ethyl] cycloethyl] -isocyanate used in glands is prepared by reacting the corresponding amine hydrogen chloride K with carbonyl dichloride. 7-[(2,2-diethoxyethyl) amino] -3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1H-3-benzomonoazine [Rf: 0.76 (silicone; cyclohexane / ethyl acetate = 3: 2)] M7 -amino-3 -trifluoroacetamido-2,3,4,5-tetrahydro-1 [1 -3- Benzoazine groups are prepared by reacting bromoacetaldehyde diethyl acetal in the presence of N-ethyldiisopropylamine. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page)
Rf: 0.26 (矽膠;環己烷/乙酸乙酯= 3:2) (4) N-[反-[[(甲氧基羰基)甲基]氧]環乙基]-K’-(2,2-二 乙氧基乙基)-11'-(3-三氟乙醯基-2,3,4,5-四氫-1{1-3-苯 -63- 本紙張Λ度逋用t國國家標準(CNS)甲4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(62 ) 并一氮七園-7-基)-腺 所用之[反-4-[[(甲氧基羰基)甲基]氧]環乙基]-異氰酸 酯自相對應胺氯化氫Μ與二氛化羰反應製備。Rf: 0.26 (silicone; cyclohexane / ethyl acetate = 3: 2) (4) N- [trans-[[((methoxycarbonyl) methyl] oxy] cycloethyl] -K '-(2, 2-diethoxyethyl) -11 '-(3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1 {1-3-benzene-63- National Standard (CNS) A4 Specification (210X297mm) Printed by A6 B6, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (62) Zirconium Seven Park-7-based)-used by the gland [anti- 4-[[(methoxycarbonyl) methyl] oxy] cycloethyl] -isocyanate is prepared by reacting the corresponding amine hydrogen chloride M with a dicarbonylated carbonyl.
Rr : 0。20 (矽膠;環己烷/乙酸乙酯=1 :1) (5) N-(2-羥基乙基)-N-[4-[反-2-(甲氧基羰基)-次乙基 ]苯基]-Ν·-(3-三氟乙釀基-2,3,4,5-四氫-111-3-苯并一氮 七團-7-基)-腺 所用之(3-三氟乙醯基-2,3,4,5-四氫-1Η-3-苯并一氮 七園-7-基)-異氰酸酯自相對應胺以與二氣化羰反應製備 Ο 熔點:自118t:Rr: 0.20 (silicone; cyclohexane / ethyl acetate = 1: 1) (5) N- (2-hydroxyethyl) -N- [4- [trans-2- (methoxycarbonyl)- Ethyl] phenyl] -N ·-(3-trifluoroethynyl-2,3,4,5-tetrahydro-111-3-benzo-nitroazine-7-yl) -gland (3-Trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1fluorene-1benzo-3-azine-7-yl) -isocyanate is prepared from the corresponding amine by reaction with carbonyl dicarbonyl Melting point: from 118t:
Rf: 0,18 (矽膠;環己烷/乙酸乙酯= 1:1) (6) 1[4-(2-(乙氧基羰基)-1-丙基]苯基]-^-(2,2-二乙 氧基乙基)-Ν’ -(3-三氟乙醸基-2,3,4,5 -四氫-1H-3-笨并 一氮七画-7-基)-腺 所用之[4-[2-(乙氧基羰基)-卜丙基]苯基]-異氰酸酯 Μ相對應胺與二氯化羰反應製備。 :0.35(矽膠;環己烷/乙酸乙酯= 2:1) (7) [反-4-[2-(甲氧基羰基)乙基]環己基]-N’-[(苄氧 基羰基)甲基]-Ν’- (3 -三氟乙醢基-2,3,4,5-四氫-1H-3 -苯 并一氮七團-7-基)-脲 所用之7-[[(苄氧基羰基)甲基]胺基]-3-三氟乙醯基 -2,3,4,5-四氫-111-3-苯并一氮七團〔1^值:0.24(矽膠 ;環己烷/乙酸乙酯= 4:1)〕Μ7-胺基-3-三氟乙醯基 一 64_ 本紙張尺度逍用t國國家揉準(CNS)甲4規格(210X297公釐) .....................................................................-...............裝.......................訂....................., (請先閲讀背面之注意事項再填窝本頁} 經濟部中央標準局員工消费合作社印製 A6 B6 五、發明説明(63) -2,3,4,5-四氫-1H-3-苯并一氮七園與溴乙酸苄酯在N-乙 基二異丙基胺之存在下反應製備。 : 0.51 (矽膠;環己烷/乙酸乙酯=1 : 1) (8) N-(3-羥基丙基)-N-[反-4-[2-(甲氧基羰基)乙基]環 己基]-^'-(3-三氟乙醢基-2,3,4,5-四氫-111-3-笨并一氮 七園-7-基)-腺 熔點:129-130¾ (9) 1-乙醢基-4-[反-4-[2-(甲氧基羰基)乙基]-環己基 ]-半卡肼 熔點:176-179 ¾ 值:0.24 (矽膠;二氣甲烷/甲醇= 95:5) (10) 1-甲醯基-4-[反-4-[2-(甲氧基羰基)乙基]-環己基 ]-半卡肼 熔點:169-1711: (11) Ν-[4-[2-(乙氧基羰基)-1-苯基-乙基]苯基]-N’-(2,2-二乙氧基乙基)-N’- (3-三氟乙醢基-2,3,4,5-四氫 -1H-3-苯并一氮七園-7-基)-腺 所用之[4-[2-(乙氧基羰基)-卜苯基-乙基]苯基]-異氰 酸酯自相對應胺Μ與二氯化羰反應製備。 粗產物直接用於製備實施例5 (6)之化合物。 (12) 卜甲醢基-4-(3-三氣乙醯基-2,3,4,5-四氫-1}1-3-苯 并一氮七画-7-基)-半卡肼Rf: 0,18 (silicone; cyclohexane / ethyl acetate = 1: 1) (6) 1 [4- (2- (ethoxycarbonyl) -1-propyl] phenyl]-^-(2 , 2-diethoxyethyl) -N '-(3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1H-3-benzylazine-7-yl)- The corresponding [4- [2- (ethoxycarbonyl) -propyl] phenyl] -isocyanate M used by the gland is prepared by reacting the corresponding amine with carbonyl dichloride.: 0.35 (silicone; cyclohexane / ethyl acetate = 2: 1) (7) [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -N '-[(benzyloxycarbonyl) methyl] -N'- (3-trifluoroacetamidine -2,3,4,5-tetrahydro-1H-3 -benzo-nitroazine-7-yl) -urea 7-[[(benzyloxycarbonyl) methyl] amino] -3 -Trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzomonoazine seven groups [1 ^ value: 0.24 (silicone; cyclohexane / ethyl acetate = 4: 1)] Μ7-amino-3-trifluoroacetamido-64_ This paper is standard for the national standard (CNS) A4 (210X297 mm) ............... ........................................ ....-......... Equipment ............ Order ... ......, (Please read the notes on the back before filling in this page) Printed by A6 B6, Consumer Cooperatives of the Associate Bureau. 5. Description of the Invention (63) -2,3,4,5-tetrahydro-1H-3-benzodiazepine and benzyl bromoacetate in N-ethyldiiso Prepared by reaction in the presence of propylamine.: 0.51 (silicone; cyclohexane / ethyl acetate = 1: 1) (8) N- (3-hydroxypropyl) -N- [trans-4- [2- ( (Methoxycarbonyl) ethyl] cyclohexyl]-^ '-(3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzylazine-7-yl) -Gland melting point: 129-130¾ (9) 1-Ethylfluorenyl-4- [trans-4- [2- (methoxycarbonyl) ethyl] -cyclohexyl] -hemicarbazine Melting point: 176-179 ¾ Value : 0.24 (silicone; digas methane / methanol = 95: 5) (10) 1-methylfluorenyl-4- [trans-4- [2- (methoxycarbonyl) ethyl] -cyclohexyl] -half card Hydrazine Melting point: 169-1711: (11) N- [4- [2- (ethoxycarbonyl) -1-phenyl-ethyl] phenyl] -N '-(2,2-diethoxyethyl ) -N'- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1H-3-benzo-azaazine-7-yl) -gland [4- [2 -(Ethoxycarbonyl) -phenylphenyl-ethyl] phenyl] -isocyanate is prepared by reacting the corresponding amine M with carbonyl dichloride. The crude product was used directly to prepare the compound of Example 5 (6). (12) Carboxamyl-4- (3-trifluoroethenyl-2,3,4,5-tetrahydro-1) 1-3-benzo-nitroazine-7-yl) -half card Hydrazine
Rf值:0.41 (矽膠;二氯甲烷/甲醇= 9:1)Rf value: 0.41 (silicone; dichloromethane / methanol = 9: 1)
奩淪例T V 一 6 5 — 本鉍張尺度逋用中國國家標準(CNS)T4規格(210X297公釐) ...............................................................:i....................裝.......................ΤΓ.....................^ (請先閲讀背面之注意事項再琪窝本頁) B6 五、發明説明(64 ) 3 -(笛三丁氣某羰甚)-7-「(2-經某乙某)胺某1 - 2.3.4· 5-四 想一 1 H-3-笼# 一 Μ七園 7.2克7-胺基-3-(第三丁氧基羰基)-2,3,4,5-四氫一 lH-3-笨并一氮七画(自7-硝基一2,3,4,5-四氫一lH-3-苯并一氮七匾與焦碳酸二第三丁酯反應和其後在Pcl/C之存 在下氫化製備)於130毫升甲醇與1.53毫升冰醋酸和1.8 克乙二酵醛(雙體)攪拌混合。然後加入1.9克氛基氫硼 化納且混合液在室溫攪拌1小時。反應液經蒸發且殘渣於 乙酸乙酯和水間區分。有機曆經分雛、K水清洗2次、脫 水和蒸發。殘渣Μ廇析法於矽膠管柱經環己烷/乙酸乙酯 (4 : 6 )纯化。 產量:5.4克(理論值之64¾), 熔點:86-89 1:Example TV-1 65 — This bismuth sheet scale uses the Chinese National Standard (CNS) T4 specification (210X297 mm) ............. ........................................: i ........ ..................... TΓ ............. ........ ^ (Please read the notes on the back first, then Qiwo on this page) B6 V. Description of the invention (64) 3-(Di Sanchi gas carbonyl even) -7-"(2- 经A certain a) amine 1-2.3.4 · 5-tetrathine 1 1 H-3-cage # 7.2 g 7-amino-3- (third butoxycarbonyl) -2,3, 4,5-tetrahydro-lH-3-benzyl-nitrogen seven paintings (from 7-nitro-2,3,4,5-tetrahydro-lH-3-benzo-nitrozine seven plaques and dicarbonate Tributyl ester reaction and subsequent hydrogenation in the presence of Pcl / C) Prepared in 130 ml of methanol with 1.53 ml of glacial acetic acid and 1.8 g of glyoxal (dimer). Then add 1.9 g of sodium hydroborate And the mixture was stirred at room temperature for 1 hour. The reaction solution was evaporated and the residue was separated between ethyl acetate and water. The organic solution was washed twice, washed with K water twice, dehydrated and evaporated. The residue was decanted on a silica gel column. Purified with cyclohexane / ethyl acetate (4: 6). Amount: 5.4 g (64¾ theoretical value), mp: 86-891:
Rf值:0.39 (矽膠;環己烷/乙酸乙酸=4:6) 以下化合物自類似於實施例IV製備: (1)反-4-[(2-羥基乙基)胺基]-桂皮酸甲酯 熔點:117-118¾Rf value: 0.39 (silicone; cyclohexane / acetic acid acetate = 4: 6) The following compounds were prepared from analogous to Example IV: (1) trans-4-[(2-hydroxyethyl) amino] -cinnamate Ester melting point: 117-118¾
Rf值:0.25 (矽膠;環己烷/乙酸乙酯=1:1)Rf value: 0.25 (silicone; cyclohexane / ethyl acetate = 1: 1)
SJii_MJL L4aRS^_6RS. 8aRS) - 6- Γ C2.2-— g 氬某乙某 ϊ 昉某 1-2 -田 * -1.2.3.4.4a. S.fi.7Ua- + M 届晻瞅 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填窝本頁) 在 9,0 克(4aRS,8aRS)-2-甲基-6-氧-l,2,3,4,4a,5,6, 7,8,8a-十氫異噠啉和6.8克胺基乙醛二甲基縮醛於9 0毫 升乙腈之溶液中,加入31毫升3當量濃度鹽酸且混合液在 66 本紙張尺度遑用中困國家棋準(CNS) T4规格(210x297公釐) 五、發明説明(65 ) 室溫播拌30分鐘。然後其於冰浴中冷卻和分批加入4.4克 氰基氫硼化納。在室溫攪拌30分鐘和靜置過夜後,混合液 經蒸發、以冰水稀釋和調整pH至10-11 。混合液以乙酸乙 酯萃取3次。姐合的乙酸乙酯萃取液Μ飽和鹽水液清洗2 次、脫水和蒸發。殘渣Μ層析法於氧化鋁管柱(碱性)中 純化。 產量:7.35克(理論值之53¾)SJii_MJL L4aRS ^ _6RS. 8aRS)-6- Γ C2.2-— g arg y y y y y y y 1-2-Tian * -1.2.3.4.4a. S.fi.7Ua- + M Session of the Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards (please read the precautions on the back before filling this page) at 9,0 g (4aRS, 8aRS) -2-methyl-6-oxyl-l, 2,3,4, 4a, 5,6,7,8,8a-decahydroisopyridine and 6.8 g of aminoacetaldehyde dimethyl acetal in 90 ml of acetonitrile, 31 ml of 3 equivalent hydrochloric acid was added and the mixture was at 66 This paper uses the standard Chinese National Standards for Difficulties (CNS) T4 (210x297 mm). 5. Description of the invention (65) Stir at room temperature for 30 minutes. It was then cooled in an ice bath and 4.4 g of sodium cyanoborohydride was added in portions. After stirring at room temperature for 30 minutes and standing overnight, the mixture was evaporated, diluted with ice water and adjusted to a pH of 10-11. The mixture was extracted three times with ethyl acetate. The ethyl acetate extract M saturated saline solution was washed twice, dehydrated and evaporated. The residue M was purified on an alumina column (basic). Yield: 7.35 grams (53¾ of theory)
Rr值:0.25 (氧化鋁,乙酸乙酷) (1) (4aRS,6RS,8aRS)-6-[(2,2-二甲氧基乙基)胺基]-2- 甲基-l,2,3,4,4a,5,6,7,8,8a-十氫異喹啉M實施例V之 副產物分離出來。Rr value: 0.25 (alumina, ethyl acetate) (1) (4aRS, 6RS, 8aRS) -6-[(2,2-dimethoxyethyl) amino] -2-methyl-1,2 , 3,4,4a, 5,6,7,8,8a-decahydroisoquinoline M by-product of Example V was isolated.
Rf值:0.56 (氧化鋁,乙酸乙酯)Rf value: 0.56 (alumina, ethyl acetate)
管淪例V T 7-碰-3-=.氩7,酿某-2.3.4.5-四氳一1卩-3-笼#一氳十圈 經濟部中央標準局貞工消费合作社印製 (請先閲讀背面之注意事項再填窝本頁) 2.6克7-胺基-3-三氟乙醢基-2,3,4,5-四氬一1[1-3-笨 并一氮七園與50毫升103!鹽酸簡短地攪拌加熱,然後冷至 0 t!和在0 t:和進一步冷卻下逐滴加入695毫克亞硝酸納 於14奄升水。在0 t:下逐滴加入1.7克碘化鉀和1.3克换 於10奄升之溶液和混合液在室溫搛拌遇夜。然後傾倒上層 液且所得之殘渣溶於二氯甲烷。有櫬曆以重亞硫酸納溶液 和水濟洗、分雛、脫水.、過濾和蒸發。粗產物以層析法於 矽膠管柱中經環己烷/乙酸乙酯(4:1)純化。 產量:2.4克(理論值之65¾), 熔點:80-82t: -67 - 本纸張尺度遑用中B國家樣準(CNS)甲4规格(210X297公釐) 經濟部中央標準局貝工消費合作社印製 A6 _ B6 五、發明説明(66 )Example of VT 7-Touch-3- =. Argon 7, 2.3-4.5-Four 氲 1 1 卩 -3- Cage # 1 氲 10 Circles Read the notes on the back and fill in this page) 2.6 g of 7-amino-3-trifluoroacetamido-2,3,4,5-tetra-argon-1 [1-3-benzyl-nitrozine Fifty milliliters of 103! Hydrochloric acid was heated with brief stirring, then cooled to 0 t! And 695 mg of sodium nitrite was added dropwise under 0 t: and further cooling to 14 l of water. At 0 t: 1.7 g of potassium iodide and 1.3 g of a solution and a mixture of 10 g of the solution were added dropwise and stirred overnight at room temperature. The upper layer was then poured and the resulting residue was dissolved in dichloromethane. It has a calendar with sodium bisulfite solution and water for washing, brooding, dehydration, filtration and evaporation. The crude product was purified by chromatography on a silica gel column with cyclohexane / ethyl acetate (4: 1). Yield: 2.4 grams (65¾ of theoretical value), Melting point: 80-82t: -67-This paper size uses China B National Standard (CNS) A4 specifications (210X297 mm). Cooperative printed A6 _ B6 V. Description of invention (66)
I值:0.61 (矽膠;環己烷/乙酸乙酯= 4:1) g淪例V丨T 7 -胺某Ί =儒7,蘊某-2.H5 -四氫一1H-3-笼#一葡十I value: 0.61 (silicone; cyclohexane / ethyl acetate = 4: 1) g Example V 丨 T 7 -Amine = Confucian 7, Yunmou-2.H5 -Tetrahydro-1H-3-cage # One Portuguese ten
I 3克7-硝基-3-三氟乙醸基-2,3,4,5-四氫一1Η-3-苯并 一氮七睡於200毫升乙酸乙酯中Κ3克10»! Pd/C在室溫下 及50 pSi氫歷下氫化1小時。觸媒以抽氣過濾除去和遇液 經蒸發。殘渣與第三丁基甲基醚加熱且然後冷卻°沉锻經 抽氣遇濾、Μ第三丁基甲基醚清洗和乾燥。 產量:12.2克(理論值之79¾), 熔點:102-104¾I 3 g of 7-nitro-3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-l-fluorene-benzo-nitrazine in 200 ml of ethyl acetate κ3 g 10 »! Pd / C was hydrogenated at room temperature under 50 pSi hydrogenation for 1 hour. The catalyst is removed by suction filtration and the liquid is evaporated. The residue is heated with tertiary butyl methyl ether and then cooled and then filtered through suction, washed with tertiary butyl methyl ether and dried. Yield: 12.2 g (79¾ of theory), Melting point: 102-104¾
Rf值:0.31 (矽膠;環己烷/乙酸乙酯= 2:1) K下化合物自類似於實施例VII製備: (1) 7-胺基-3-第三丁氧基羰基-2,3,4,5-四氫一 1H_3_苯 并一氮七團 作為起始物之3-第三丁氧基羰基-7-硝基-2,3, 4,5-&氫 -111-3-笨并一氮七園以7-硝基-2,3,4,5-四氫一111_3-苯 并一氮七画-氫氛化物與焦碳酸二第三丁酯在H & $胃 液之存在下反應製備。Rf value: 0.31 (silicone; cyclohexane / ethyl acetate = 2: 1) The compound under K was prepared similarly to Example VII: (1) 7-amino-3-tert-butoxycarbonyl-2,3 , 3,3-butoxycarbonyl-7-nitro-2,3,4,5- & hydro-111-3 -Benzomonoazine with 7-nitro-2,3,4,5-tetrahydro-111_3-benzodiazepine-Paper-hydrogenated compound with di-tert-butyl pyrocarbonate Prepared by reaction in the presence.
Rr值:0.40 (矽膠;環己烷/乙酸乙酯=7:3) (2) 7-肢基-3-乙基-2,3,4,5-四氫一1H-3-笨并一氮七團 M Raney鎳在甲酵中進行。 值:0.50 (矽膠:甲苯/二氧六画/甲醇/港®水. =20:50:20:3) —δ 8 — 本紙張尺度逋用t國Β家椹準(CNS) f 4規格(210X2974^ ............................................................ 裝訂..................綱 <請先閲讀背面之注意事項再填窝本頁} ‘ 經濟部中央標準局貝工消費合作社印製 A6 B6 五、發明説明(67 ) (3) 3-(4-胺基苯基)-3-苯基丙酸乙酿氫氛化物 在乙酵中在乙醇性鹽酸之存在下進行。起始物3-(4-硝 基苯基)-3-苯基丙烯酸乙酯〔值:0.36 (矽膠;環己烷 /二氯甲烷= 1:1)〕Μ 4-硝基二苯基嗣與三乙基膦酸基乙 酸反應製備。 值:0.40 (逆相矽膠;甲酵/5¾鹽水液= 6:4)Rr value: 0.40 (silicone; cyclohexane / ethyl acetate = 7: 3) (2) 7-limyl-3-ethyl-2,3,4,5-tetrahydro-1H-3-benzyl Nitrogen group M Raney nickel is carried out in formazan. Value: 0.50 (Silicone: Toluene / Dioxane / Methanol / Port® Water. = 20: 50: 20: 3) —δ 8 — This paper uses the national standard (CNS) f 4 specifications ( 210X2974 ^ ...................................... ............ Binding ........ Outline < Please read the notes on the back before filling in this page} '' Ministry of Economy Printed by A6 B6, Shellfish Consumer Cooperative of the Central Bureau of Standards 5. Description of the invention (67) (3) 3- (4-Aminophenyl) -3-phenylpropionic acid ethyl alcohol hydrogenated in ethyl acetate It is carried out in the presence of hydrochloric acid. Starting material 3- (4-nitrophenyl) -3-phenylethyl acrylate [value: 0.36 (silicone; cyclohexane / dichloromethane = 1: 1)] M 4- Prepared by reaction of nitrodiphenylphosphonium with triethylphosphonoacetic acid. Value: 0.40 (reverse phase silicone; formazan / 5¾ saline solution = 6: 4)
奮掄俐VT T T 7 -硝某-3 = Μ 7·猫某-m 5 -四Μ - 1 Η Ί荣并一 Μ十 H_ 於23.3克3-三氟乙醸基-2,3,4,5-四氫一1H-3-苯并一氮 七画〔Rf值:0.76 (矽膠;環己烷/乙酸乙酯= 1:1),其 M 2,3,4,5-四氫一 1H-3-苯并一氮七團與三氣乙酸酐在 N-乙基二異丙基胺之存在下反應製備〕於60毫升濃硫酸中 ,在0至8 TC下,於1.5小時内逐滴加入9.7克硝酸鉀和 50毫升濃硫酸之混合液。混合液加熱至室溫,倒入至1升 之冰中*且K乙酸乙酯萃取。姐合的乙酸乙酯萃取液Μ水 和以飽和鹽水液清洗、脫水和蒸發。殘渣與第三丁基甲基 醚加熱。其然後冷卻且產物以抽氣過濾和Μ第三丁基甲基 醚清洗。 產量:16.2克(理論值之59¾), 熔點:116-119 ΌFen Lili VT TT 7-nitrate-3 = Μ7 · cat certain -m 5 -tetra-M-1 5-tetrahydro-1H-3-benzo-nitrogen seven [Rf value: 0.76 (silicone; cyclohexane / ethyl acetate = 1: 1), its M 2,3,4,5-tetrahydro-1H -3-Benzanitazine and trigas acetic anhydride prepared in the presence of N-ethyldiisopropylamine] in 60 ml of concentrated sulfuric acid, 0 to 8 TC, dropwise within 1.5 hours Add a mixture of 9.7 g of potassium nitrate and 50 ml of concentrated sulfuric acid. The mixture was warmed to room temperature, poured into 1 liter of ice * and extracted with ethyl acetate. Ethyl acetate extract M water and washed with saturated saline solution, dehydrated and evaporated. The residue was heated with tertiary butyl methyl ether. It was then cooled and the product was filtered with suction and washed with M tert-butyl methyl ether. Yield: 16.2 g (59¾ of theory), Melting point: 116-119 Ό
Rr值:0.57 (矽膠;環己烷/乙酸乙酯= 2:1) K下化合物自類似於實施例VIII製備: (1) 7-硝基-2,3,4,5-四氫一 1H-3-苯并一氮七麵-氫氛化 -69- 本紙張尺度遑用中國國家揉準(CNS)甲4规格(210X297公釐) .....................................................................................裝.......................可.....................韓 {請先閲讀背面之注意事項.再填窝本頁} 經濟部中央標準局員工消費合作社印製 A6 ____B6_ 五、發明説明(68 ) 物 Μ硫酸/硝酸鉀進行且K氫氛化物分離出來 熔點:235-238 t:(分解) 理論值:C 52.52 Η 5.74 Ν 12.25 Cl 15.50 實驗值: 52.44 5.80 12.07 15.36Rr value: 0.57 (silicone; cyclohexane / ethyl acetate = 2: 1) The compound under K was prepared similarly to Example VIII: (1) 7-nitro-2,3,4,5-tetrahydro-1H -3-Benzo-nitrogen heptahedral-hydrogen atmosphere-69- This paper size is in accordance with China National Standard (CNS) A4 (210X297 mm) .............. ........................................ ........... installation ............ may ... ....... Korean {Please read the notes on the back. Then fill in this page} Printed by A6 __B6_ of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 68) The reaction was performed with sulphuric acid / potassium nitrate and K hydrogen was separated. Melting point: 235-238 t: (decomposition) Theoretical value: C 52.52 Η 5.74 N 12.25 Cl 15.50 Experimental value: 52.44 5.80 12.07 15.36
窗掄俐T X 4-「4-「2-(申氬華镛某)7,某1笼某1-5-田某-/^-1.2.4-二 贫一-邮- 3 _ 爾 8·1克1-Z>醸基-4-[4-[2-(甲氧基羰基)乙基]-苯基]-半卡肼與60毫升1當量湄度氫氧化納溶液於蒸汽浴加熱 1.5小時。混合液然後冷卻、過滤且濾液以檸檬酸輕微地 酸化。其經過濾且濾液與濃鹽酸姐合。沉澱經過濾、Μ水 清洗和脫水。中間物在甲酵中與一些甲醇性鹽酸攒拌遇夜 。反應液經蒸發和殘渣Κ第三丁基甲基醚搗碎、抽氣過» 和乾燥。 產量:4.98克(理論值之65¾), 值·· 0.40 (矽膠;甲笨/二氧六園/乙醇/冰醋酸 =90:10:10:6) 理論值: C 59.76 Η 5.79 Η 16.08 實驗值: 59.54 5.86 16.05 Κ上化合物自類似於實施例IX製備: (1) 4-[反-4-[2-(甲氧基羰基)乙基]環己基]-5-甲基-4Η -1,2,4-二氫三唑-3-_ 熔點:179-181¾ -70 — 本纸張尺度逋用中困國家標準(CNS) T.4规格(210x297公釐) <請先閲讀背面之注意事項再填窝本頁) .裝 •訂. 經濟部中央標準局員工消费合作社印製 A6 B6__ 五、發明説明(69 ) (2) 4-[反-4-[2-(甲氧基羰基)乙基]環己基]-4H-1,2,4-二氫三唑-3-酮 熔點:142-144*0 (3) 4-(3-第三丁氧基羰基-2,3,4,5-四氫一111-3-苯并一 氮七睡-7 -基)-4Η-1,2,4 -二氫三唑-3-酮 起始物:實施例III (12)之化合物 中間物與焦碳酸二第三丁酷而非甲酵性鹽酸反應。 熔點:185-186¾Jing Li TX 4- "4-" 2- (Shen Xihua Huamou) 7, some 1 cage some 1-5- Tianmian-/ ^-1.2.4- two poor one-post-3 _ Seoul 8.1 1-Z > fluorenyl-4- [4- [2- (methoxycarbonyl) ethyl] -phenyl] -hemicarbazide and 60 ml of a 1-equivalent makoto sodium hydroxide solution were heated in a steam bath for 1.5 hours. The mixture was then cooled, filtered, and the filtrate was slightly acidified with citric acid. It was filtered and the filtrate was combined with concentrated hydrochloric acid. The precipitate was filtered, washed with water, and dehydrated. The intermediate was mixed with some methanolic hydrochloric acid in formic fermentation. Night. The reaction solution was evaporated and the residue was mashed with tertiary butyl methyl ether, evacuated »and dried. Yield: 4.98 g (65¾ of theory), value: 0.40 (silicone; methylbenzyl ether / dioxane / Ethanol / glacial acetic acid = 90: 10: 10: 6) Theoretical value: C 59.76 Η 5.79 Η 16.08 Experimental value: 59.54 5.86 16.05 The compound on K is prepared similarly to Example IX: (1) 4- [Trans-4- [ 2- (methoxycarbonyl) ethyl] cyclohexyl] -5-methyl-4Η -1,2,4-dihydrotriazole-3-_ Melting point: 179-181¾ -70 — For paper size National Standards for Difficulties (CNS) T.4 (210x297 mm) < Please read the notes on the back first Fill in this page). Binding and binding. Printed by A6 B6__ of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (69) (2) 4- [trans-4- [2- (methoxycarbonyl) ethyl ] Cyclohexyl] -4H-1,2,4-dihydrotriazol-3-one Melting point: 142-144 * 0 (3) 4- (3-Third-butoxycarbonyl-2,3,4,5 -Tetrahydro-111-3-benzomonoazine-7-yl) -4fluorene-1,2,4-dihydrotriazol-3-one starting compound: the compound intermediate of Example III (12) Reacts with di- and di-butyric pyrocarbonate instead of formic acid. Melting point: 185-186¾
Rf值:0.25 (矽膠;環己烷/乙酸乙酯= 2:3)Rf value: 0.25 (silicone; cyclohexane / ethyl acetate = 2: 3)
實施例X K-「反(田氬某糖某)乙某1掼R某1-7,醅肪 5. 0克N-苄基-N-[反-4-[2-(甲氧基羰基)乙基]環己基 ]-乙醇胺於150奄升甲醇中M1.0克10!K Pd/C在50t:下及 50 pS i氳壓下氫化1-3/4小時。混合液連過濾和蒸發。 產量:3.3克(理論值之9250 值:0.20 (矽膠;二氯甲烷/甲醇/濃氨水 =9:1:0.4) K下化合物自類似於實施例X製備: (1)(反-4-胺基環己基)氧乙酸第三丁酯 起始物[反-(4-二苄基胺基)環己基]-氧乙酸第三丁酯〔 值:0.51;(矽膠;環己烷/乙酸乙酯= 4:1)] Μ反 -4-(二苄基胺基)-環己醇與溴乙酸第三丁酯於甲苯/50* 氳氧化納溶液中在碕酸氫四丁基銨之存在下反應製備。 1值:0.56 (逆相矽膠;甲醇/ 5¾鹽水液=6:4)。 -71- 本紙張尺度逍用中國Η家標準(CNS)甲4规格(210X297公釐) ' {請先閲讀背面之注意事項再填窝本頁) .裝: •訂. -絲. 經濟部中央標準局員工消費合作社印製 A6 B6__ 五、發明説明(7C)) (2> H-(3-羥基丙基)-N-[反-4-[2-(甲氧基羰基)-乙基]環 己基]-胺Example X K- "trans (field argon sugar) ethyl 1 1R R 1-7, 5.0 g N-benzyl-N- [trans-4- [2- (methoxycarbonyl ) Ethyl] cyclohexyl] -ethanolamine in 150 liters of methanol M1.0 g of 10! K Pd / C hydrogenated at 50 t and 50 pS i pressure for 1-3/4 hours. The mixture was filtered and evaporated Yield: 3.3 g (9250 of theoretical value: 0.20 (silica gel; dichloromethane / methanol / concentrated ammonia = 9: 1: 0.4) The compound under K was prepared similarly to Example X: (1) (trans-4- Aminocyclohexyl) tert-butyloxyacetate [trans- (4-dibenzylamino) cyclohexyl] -tert-butyloxyacetate [value: 0.51; (silicone; cyclohexane / ethyl acetate) Ester = 4: 1)] M trans-4- (dibenzylamino) -cyclohexanol and tert-butyl bromoacetate in toluene / 50 * trioxide solution in the presence of tetrabutylammonium hydrogen acetate Prepared by the following reaction: 1 value: 0.56 (reverse phase silica gel; methanol / 5¾ saline solution = 6: 4). -71- This paper size is in accordance with China National Standard (CNS) A4 specification (210X297 mm) '{Please Read the notes on the back before filling in this page). Packing: • Order.-Silk. Printed by A6 B6__, the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Explanation (7C)) (2> H- (3-hydroxypropyl) -N- [trans-4- [2- (methoxycarbonyl) -ethyl] cyclohexyl] -amine
Rf值:0.10 (矽膠;二氯甲烷/甲醇= 9:1) (3)[[反-4-[2-(甲氧基羰基)乙基]-環己基]-胺基]-乙酸 甲酯氫氛化物 熔點:166-168TC: 在甲醇性鹽酸之存在下氫化。Rf value: 0.10 (silicone; dichloromethane / methanol = 9: 1) (3) [[trans-4- [2- (methoxycarbonyl) ethyl] -cyclohexyl] -amino] -methyl acetate Hydrogenated substance melting point: 166-168TC: Hydrogenated in the presence of methanolic hydrochloric acid.
Rf值:0.69 (矽膠;二氣甲烷/甲醇/濃氨水= 95:5:1) 窗倫例X T N-爷某 -N-「反 -4-「2-f甲氬某羝某某1-措R某1-7,醅Rf value: 0.69 (silicone; methane / methanol / concentrated ammonia water = 95: 5: 1) Example of window XT Measure R 1-7, 醅
iL 6.2克N-[反-4-[2-(甲氧基羰基)乙基]環己基]-苄基胺 -氫氛化物、12.8克N -乙基二異丙基胺和5.0克2 -溴乙醇 在100 攪拌22小時,然後冷卻。混合液於乙酸乙酯和水 間區分,水層以乙酸乙酯萃取和姐合的乙酸乙酯層Μ飽和 鹽水液清洗。乙酸乙酯層經蒸發且殘渣Κ層析法於矽膠管 柱中使用二氛甲烷/甲醇(9:1)純化。 產量:5.1克(理論值之80¾),iL 6.2 g of N- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -benzylamine-hydrogenated compound, 12.8 g of N-ethyldiisopropylamine and 5.0 g of 2- Bromoethanol was stirred at 100 for 22 hours and then cooled. The mixture was separated between ethyl acetate and water, and the aqueous layer was extracted with ethyl acetate and washed with the saturated ethyl acetate layer and saturated brine. The ethyl acetate layer was evaporated and the residue was chromatographed on a silica gel column using dichloromethane / methanol (9: 1). Yield: 5.1 g (80¾ of theory),
Rf值:0.67 (矽膠;二氛甲皖/甲醇= 9:1) 以下化合物自類似實施例XI製備: (1) H-(3-羥基丙基)-N-[反-4-[2-(甲氧基羰基)-乙基]環 己基]-苄基胺 值:0.70 (矽膠;二氯甲烷/甲醇=9:1) (2) N-苄基-[[反-4-[(2-甲氧基羰基)-乙基]環己基]胺基 -72- 本紙張尺度遑用中國國家搮準(CNS)甲4规格.(210_X297公釐) ...................................................................................裝......................ΤΓ..............綿 (請先閱讀背面之注意事項再填寫本頁) A6 B6 經濟部中央標準局貝工消費合作社印製.V ^ 五、發明説明(71 ) ]-乙酸甲酯 值:0.86 (矽膠;環己烷/乙酸乙酯=3:7) (3) 3-乙基-7-硝基-2,3,4, 5-四氫一1H-3-苯并一氮七園 R*·值:0.32 (矽膠;二氛甲烷/甲醇= 95:5) 啻倫俐X T T H -「反-甚鹅甚1乙基1環己某1-笮基胺-氫氣化SL 8.0克3-(反-4 -胺基環己基)丙酸甲酯-氫氛化物、4.3 克苯甲醛和5.0毫升三乙基胺於150毫升甲酵Μ 1.0克 Ramey鎳在50Ό下於50 psi氬壓下氫化4小時。冷卻後’ 混合液經抽氣過滹和濾液經蒸發。殘渣於乙酸乙酯和水間 區分,水層Μ氫氧化納溶液調整pH至8-9且KZ«酸乙酯萃 取。組合的乙酸乙醋層K飽和鹽水液清洗、脫水和蒸發。 殘渣在乙醚中懸浮且與甲醇性鹽酸混合。沉澱經抽氣過瀘 、以乙醚清洗和乾煉。 產量:7.4克(理論值之66¾), 熔點:170- 172¾ 理論值: C 65.47 Η 8.40 Ν 4.49 Cl 11.37 實驗值: 65.38 8.44 4.46 1 1.40 g倫剜X T T T f反-4-胺某損R某)氬π酴审酯-氣氣化物 氛化氫氣體打入59.4克(反-4-胺基環己基)氧乙酸第三 丁基於500毫升甲醇之溶液1小時,在冰浴中冷卻,和然 後混合液在室溫攪拌過夜。其蒸發至乾涸,殘渣以丙釅搗 (請先閲讀背面之注意事項再填寫本頁) -装 • .«J. .絲. -73- 本紙張尺度逍用申困國家揉準(CNS)甲4规格(210X297公釐} 經 部 中 央 標 準 局 貝 工 消 费 合 作 社 A6 B6 五、發明説明(72) 碎和固體經抽氣遇濉及乾嫌。 產量:34.3克(理論值之59»!)· 熔酤:157-160”Rf value: 0.67 (silicone; dioxane / methanol = 9: 1) The following compounds were prepared from similar Example XI: (1) H- (3-hydroxypropyl) -N- [trans-4- [2- (Methoxycarbonyl) -ethyl] cyclohexyl] -benzylamine value: 0.70 (silicone; dichloromethane / methanol = 9: 1) (2) N-benzyl-[[trans-4-[(2 -Methoxycarbonyl) -ethyl] cyclohexyl] amino-72- This paper uses Chinese National Standard (CNS) A4 specifications (210_X297 mm) ........... ........................................ ................................... TΓ .... .......... Mian (please read the notes on the back before filling this page) A6 B6 Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. V ^ V. Description of the Invention (71)]-Acetic acid Methyl ester value: 0.86 (silicone; cyclohexane / ethyl acetate = 3: 7) (3) 3-ethyl-7-nitro-2,3,4,5-tetrahydro-1H-3-benzo Nitrogen Seven Parks R * Value: 0.32 (silicone; Dichloromethane / methanol = 95: 5) 啻 伦利 XTTH-"Trans-Vitamin 1 Ethyl 1 Cyclohexyl 1-fluorenylamine-hydrogenated SL 8.0 g of methyl 3- (trans-4-aminocyclohexyl) propionate-hydrogenated, 4.3 g of benzaldehyde and 5.0 ml of triethylamine 150 ml formazan 1.0 g Ramey nickel hydrogenated at 50 psi for 4 hours under 50 psi argon pressure. After cooling, the mixture was aspirated and the filtrate was evaporated. The residue was separated between ethyl acetate and water. The aqueous layer was M The sodium hydroxide solution was adjusted to pH 8-9 and KZ «ethyl acetate extraction. The combined ethyl acetate layer was washed, dehydrated and evaporated with K saturated brine. The residue was suspended in ether and mixed with methanolic hydrochloric acid. The precipitate was evacuated It was washed with ether, washed and dried. Yield: 7.4 g (66¾ of theoretical value), melting point: 170-172¾, theoretical value: C 65.47 Η 8.40 Ν 4.49 Cl 11.37 experimental value: 65.38 8.44 4.46 1 1.40 g 剜 XTTT f Trans-4-amine damages R) argon π-hexyl ester-gas vaporized hydrogenated gas into 59.4 g (trans-4-aminocyclohexyl) oxyacetic acid third butyl solution based on 500 ml of methanol for 1 hour , Cooling in an ice bath, and then stirring the mixture at room temperature overnight. It evaporates to dryness, and the residue is mashed with propane (please read the precautions on the back before filling this page) -Packing.. «J. .Silk. -73- The standard of this paper is to apply for National Standards (CNS) A4 (210X297 mm) Central Bureau of Standards HIGHLAND consumer cooperatives A6 B6 five described (72) and the solid was crushed invention Sui and dry suction case too. Yield: 34.3 grams (59 »of theoretical value) · Melt: 157-160”
窗淪锎XTV -三氩7,龅某-2.H5-四g — 1H-3-笼# 一匍十圜 -7 -某-3.4 -二値-2H..H2.R-臃二睞-1.1-二氩伤物 a ) N-(2 -規 Ζι 某)j 福乙酿某氣一 1 H-3-笼# 一氤屮圓-7-甚V-碴醏二BB胳 於7.6克7-胺基-3-三氟乙醸基-2,3,4,5-四氫一 1H-3-苯并一氮t園和7.7毫升H-乙基二異丙基胺於70毫升二氛 甲烷之混合液中,在-5 ΐ:下逐滴加入4.8克[(2-氛乙基) 胺基]磺醢氛於30毫升二氛甲烷。混合液在0 t:下攪拌1 小時且在室溫攪拌過夜。反應液K二氛甲烷稀釋和Μ水、 1當量濃度鹽酸和再Μ水清洗。有機層經脱水、蒸發和殘 渣Κ層析法於矽膠管柱中使用環己烷/乙酸乙酯(1:1)纯 化。 產量:7.8克(理論值之72¾), 熔點:128-130¾ 值:0.64 (矽膠;環己烷/乙酸乙酯= 1:1) b) 2-(3-三廑乙醸某-2.:^.4.5-四《 — 1^-笼#一氤·!-圃-7-某)-3.4-二瘇-UH-1.2.5-瞭二皡-1.1- H M. 7.8克實施例XlVa之化合物溶於20毫升二甲基甲醸胺和 與2.5克第三丁氧化鉀混合。在室溫攪拌3小時後,其加 74 本紙張尺度遑用中困國家櫺準(CNS)甲4规格(210X297公釐) ............................................................i .ii ……:…裝! -:!…-訂 (請先閲讀背面之注意事項再填窝本頁) 經濟部中央標準局員工消費合作社印製 A6 _ B6 _ 五、發明説明(73 ) 入至300奄升15¾檸檬酸水溶液和以乙酸乙酯萃取3次。 姐合的有櫬曆經脫水和蒸發及殘渣以層析法於矽膠管柱中 使用環己烷/乙酸乙酯(1:1)純化。 產量:_ 2.1克(理論值之30¾), 熔點:165-167Ϊ:Window 锎 XTV -Three Argon 7, 龅 -2.H5-Fg — 1H-3- Cage # 一 匍 十 圜 -7---3.4-二 値 -2H..H2.R- 臃 二 睐- 1.1- Di argon wound a) N- (2-gauge) j Fuyi brewed a certain gas 1 H-3-cage # 1 氤 屮 round-7-V- 碴 醏 二 BB tickled 7.6 grams 7 -Amino-3-trifluoroacetamido-2,3,4,5-tetrahydro-1H-3-benzodiazepine and 7.7 ml of H-ethyldiisopropylamine in 70 ml of dioxane In a mixture of methane, 4.8 g of [(2-aminoethyl) amino] sulfonium in 30 ml of dichloromethane was added dropwise at -5 torr. The mixture was stirred for 1 hour at 0 t: and overnight at room temperature. The reaction solution was diluted with dichloromethane and washed with M water, 1 equivalent strength hydrochloric acid and then with M water. The organic layer was purified by dehydration, evaporation, and residue K chromatography on a silica gel column using cyclohexane / ethyl acetate (1: 1). Yield: 7.8 g (72¾ of theory), Melting point: 128-130¾ Value: 0.64 (silicone; cyclohexane / ethyl acetate = 1: 1) b) 2- (3-tris (2,3-tetramethylacetin) -2 .: ^ .4.5- 四 《— 1 ^-笼 # 一 氤 ·! --- 7- 某) -3.4- 二 瘇 -UH-1.2.5- 了 二 皡 -1.1- H M. 7.8 grams of Example XlVa The compound was dissolved in 20 ml of dimethylformamide and mixed with 2.5 g of potassium third butoxide. After stirring at room temperature for 3 hours, it added 74 paper sizes (CNS) A4 specification (210X297 mm) ... ................ i .ii ……: ... !! -:! ...- Order (please read the notes on the back before filling in this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A6 _ B6 _ V. Description of the invention (73) Enter 300 liters of 15¾ citric acid aqueous solution And extracted 3 times with ethyl acetate. Youhe Youyi was dehydrated and evaporated, and the residue was purified by chromatography on a silica gel column using cyclohexane / ethyl acetate (1: 1). Yield: _ 2.1 g (30¾ of theory), Melting point: 165-167Ϊ:
Rr值:0.30 (矽膠;環己烷/乙酸乙酯=1 :1)Rr value: 0.30 (silicone; cyclohexane / ethyl acetate = 1: 1)
當淪俐X V (3-田甚-2..?.4.只-四竄一1{^3-笼#一值+*圃-7-某)-«18Dang Lili X V (3-Tian Shi-2 ..?. 4. Only-Four Channels and One 1 {^ 3- Cage # 一 值 + * Pu-7-some)-«18
I 於7,1克7-碘-3-甲基-2,3,4,5-四氫一 1H-3-苯并一氮 七團〔Rf值:0.85 (矽膠;甲苯/二氧六團/甲醇/濃水 性氨=20 : 50 :20:5);自實施例VI之化合物以與氫氧化納 溶液/甲酵反應和其後與甲醛液/甲酸反應製備〕於50毫 升乙醚中,在-70至-75t:下加入17.7毫升1.6莫耳濃度正 丁基鋰溶於己烷。在-7 0 t:攫拌30分後•加入5.7毫升硼 酸三異丙酯於30毫升乙醚至反應液中。其後混合液在-75 t:下播拌1小時*然後溫至-50 t:。加入70毫升水和在室 溫播拌1小峙後,水層經分離。水層Μ冰醋酸調整pH至 8-8.5 。沉锻經過濾、K少量冷水清洗和在60t:下乾燥。 產量:3.7克(理論值之73¾), 熔點:153-155 t:(自 148 1C 燒结) 值:0.80 (逆相矽膠,甲醇/ 5¾鹽水液=6:4)I in 7,1 g of 7-iodo-3-methyl-2,3,4,5-tetrahydro-1H-3-benzo-nitrogen seven groups [Rf value: 0.85 (silicone; toluene / dioxane / Methanol / concentrated aqueous ammonia = 20: 50: 20: 5); prepared from the compound of Example VI by reaction with sodium hydroxide solution / formaldehyde and then with formaldehyde solution / formic acid] in 50 ml of ether, in -70 to -75t: Dissolve 17.7 ml of 1.6 mol n-butyl lithium in hexane. After -7 0 t: stir for 30 minutes • Add 5.7 ml of triisopropyl borate in 30 ml of ether to the reaction solution. Thereafter, the mixed solution was seeded at -75 t: for 1 hour * and then warmed to -50 t :. After adding 70 ml of water and stirring at room temperature for 1 hour, the aqueous layer was separated. The aqueous layer was adjusted to pH 8-8.5 by glacial acetic acid. Sinking is filtered, washed with a small amount of cold water and dried at 60t. Yield: 3.7 g (73¾ of theory), Melting point: 153-155 t: (from 148 1C sintering) Value: 0.80 (reverse phase silicone, methanol / 5¾ brine = 6: 4)
當油{例XVT —7 5 — 本纸張尺度逋用中國國家櫺準(CNS) T 4规格(210 X 297公釐)— {請先閲讀背面之注意事項再填窝本頁} -装 訂. 經濟部中央標準局員工消費合作社印製 A6 _B6_ 五、發明説明(74 ) 1-「2-(乙氬某糠某)乙某U-U-f三蘊田某礒醢氬某1笼某 1-四g眯_-2-酾 a) M-(2.二7,璧:某7,某)-4-笮氬某笼醣 自4-苄氧基苯胺和溴乙醛二乙基縮醛在N-乙基二異丙基 胺之存在下製備。When the oil {Example XVT —7 5 — This paper size uses the Chinese National Standard (CNS) T 4 specifications (210 X 297 mm) — {Please read the precautions on the back before filling the nest page}-binding Printed by A6 _B6_ of the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (74)眯 _-2- 酾 a) M- (2.2,7, 璧: some 7, some) -4- 笮 argon a cage sugar from 4-benzyloxyaniline and bromoacetaldehyde diethyl acetal in N- Prepared in the presence of ethyl diisopropylamine.
Rf值:0.42 (矽膠;環己烷/乙酸乙酯= 85:15) b) M-U-笮氬某笼某)-H-(2.2 -二乙氫某乙某)-Ν’-Γ2-( 乃氬某钺某某1-腩 自Ν-(2,2-二乙氧基乙基)-4-苄氧基苯胺和[2-(乙氧基 羰基)乙基]-異氰酸酯。 值:0.45(矽膠;環己烷/乙酸乙酯= 1:1) c) 1-(4-笮氬某笼某)-3-「2-(7,氬某羝某)乙某卜別-二 瓴瞇邮-_ 自N-(4-苄氧基笨基)-N-(2,2-二乙氧基乙基)-N’-[2-( 乙氧基羰基)乙基]-脲和三氟乙酸於二氯甲烷中製備。 熔點:66-68t: 1值:0.41 (矽膠;環己烷/乙酸乙酯=1 :1) d) 1-(4-筠某笼某)-3-7·,氬某羰某)乙某1 四葡眯_ -2 - _ 自1-(4-苄氧基苯基)-3-[2-(乙氧基羰基)乙基]-3H-二 氫眯唑-2-嗣於乙醇中在40°C且50 psi氫壓下在Pd/C之存 在下Μ氫化製備。 1值:0.20 (矽膠;二氛甲烷/甲酵= 100:2) e) 1-「2-(乙氬基镅某)乙某1-3- U-(三氩申某碏酼氬某 一 7 6 _ 本紙張尺度逋用t國國家棋準(CNS)甲.4規格(210X297公釐) ..............................................................:…裝:…:……:……訂 ……:…線 (請先閲讀背面之注意事項再填寫本頁) _____B6___ 五、發明説明(75 ) )-苯基卜四氩眯睞- 自1-(4-羥基苯基>-3-[2-(乙氧基羰基)乙基]-二氫眯唑 -2-酮和三氟甲基磺酸酐於吡啶中在〇 t:下製備。 熔點:δ卜83” 值:0.66 (矽膠;二氛甲烷/甲醇=1〇〇:1) 理論值:C 43.90 Η 4.18 N 6.83 Cl 7.81 實驗值: 43.92 4.20 6.98 7.91 g細剜1 1 - (1-胺基黄喹瞅-fi-甚)-3-「4-(2-掰某21某)-笼某1 -四氣 咪唑-2-釅 x 1 7k x 1 . 2酿醏 300毫克3-[4-(2-羧基乙基)苯基]-1-(1-氯異喹啉-6-基)-四氫咪唑-2-酮、895毫克乙海[胺和524奄克碳酸鉀在 研缽中辙底混合,和然後在氮氣及攫拌下加熱至200t: 3小 時。冷卻後*混合液與20毫升水姐合和使用1當量濃度鹽 酸調整pH至8-9 。沉殺經抽氣過濾且Κ水清洗數次。乾燥 後,沉澱懸浮於50毫升二氯甲烷/甲酵(4:1)且在超音波 浴下暴蕗於超音波30分鐘。沉澱經抽氣遇濾和Μ二氛甲烷 /甲醇在超音波浴中重覆處理2次。濾紙殘渣在30毫升甲 醇和10毫升冰醋酸之混合液中緩慢加热下攪拌。不溶性物 質經濾掉和母液蒸發至乾涸。殘渣再一次與甲苯混合且蒸 發。然後其在60 t:下真空乾燥。 經濟部中央標準局員工消费合作社印製 {請先閲讀背面之注意事項再填窝本頁) 產量:70毫克(理論值之20»〇, 熔點:> 250T:, 值:0,78 (逆相矽膠;甲醇/5¾鹽水液= 8:4) -77- 本紙張尺度遑用中困國家揉準(CNS)甲4規格(210x297公釐) 經濟部中央標準局員工消費合作社印製. A6 B6 五、發明説明(76 ) 理論值: C 60.25 Η 5.79 Ν 12.01 實驗值: 60.20 5.43 1 1.54 質譜圖:fT = 376 g淪例2 3-U-(2 -撖某乙某)¾甚1-1-Π -毎[里睹瞅-fi -某四g眯 _ -2-蒯 1克1-(1-氛異喹啉-6-基)-3-[4-(2-甲氧基羰基)-乙基 ]笨基]-四氫咪唑-2-酮、100毫升二氧六園、80毫升水和 8.5毫升1當量濃度氫氧化納溶液在室溫攪拌3小時。加 入9毫升1當量濃度鹽酸,混合液經蒸發且沉澱經抽氣過濾 。產物K水清洗且在50C下乾燥。 產量:0.78克(理論值之80¾), 熔點:236-240 1:(分解)Rf value: 0.42 (silicone; cyclohexane / ethyl acetate = 85:15) b) MU- argon in a certain cage) -H- (2.2 -diethyl hydrogen in some ethyl) -N'-Γ2- ( Ar 钺 钺 1- 腩 from N- (2,2-diethoxyethyl) -4-benzyloxyaniline and [2- (ethoxycarbonyl) ethyl] -isocyanate. Value: 0.45 ( Silicone; Cyclohexane / Ethyl acetate = 1: 1) c) 1- (4- 笮 Argon in a cage) -3- 「2- (7, Argin in a certain cage) Beibubu-Secondary Post -_ From N- (4-Benzyloxybenzyl) -N- (2,2-diethoxyethyl) -N '-[2- (ethoxycarbonyl) ethyl] -urea and trifluoro Acetic acid is prepared in dichloromethane. Melting point: 66-68t: 1 value: 0.41 (silicone; cyclohexane / ethyl acetate = 1: 1) d) 1- (4- 筠 a certain cage) -3-7 · , Argon, carbonyl), ethyl, 1 tetraglucamidine _ -2-_ from 1- (4-benzyloxyphenyl) -3- [2- (ethoxycarbonyl) ethyl] -3H-dihydrofluorene Izo-2-amidine is prepared by hydrogenation in ethanol at 40 ° C and 50 psi hydrogen pressure in the presence of Pd / C. 1 value: 0.20 (silicone; dichloromethane / formaldehyde = 100: 2) e) 1 -"2- (Ethyl argonyl), Ethyl 1-3- U- (Three argon, argon, argon, a certain 7 6 _ _ This paper uses national standard (CNS) A.4 specifications ( 210X (297 mm) .............................. ......: ... fitting: ...: ...: ... order ...: ... line (please read the precautions on the back before filling this page) _____B6___ V. Invention Description (75))-Phenyl tetrazolium favor-Since 1- (4-hydroxyphenyl > -3- [2- (ethoxycarbonyl) ethyl] -dihydrooxazol-2-one and Trifluoromethanesulfonic anhydride was prepared in pyridine at 0 t: melting point: δ 83 = value: 0.66 (silicone; dichloromethane / methanol = 100: 1) Theoretical value: C 43.90 Η 4.18 N 6.83 Cl 7.81 Experimental value: 43.92 4.20 6.98 7.91 g of fine fluorene 1 1-(1-aminoxanthoquinone-fi-even) -3- "4- (2-fluorene 21-one) -cage 1-tetrakimidazole- 2- 酽 x 1 7k x 1.2 醏 300 mg 3- [4- (2-carboxyethyl) phenyl] -1- (1-chloroisoquinolin-6-yl) -tetrahydroimidazole-2 -Ketone, 895 mg of diethylamine [amine and 524 g of potassium carbonate are mixed in a mortar, and then heated to 200 t under nitrogen and nitrogen: 3 hours. After cooling, the mixture is combined with 20 ml of water Use 1 equivalent of hydrochloric acid to adjust the pH to 8-9. The sinker was filtered by suction and washed several times with K water. After drying, the pellet was suspended in 50 ml of dichloromethane / formaldehyde (4: 1) and exposed to ultrasound for 30 minutes in an ultrasound bath. The precipitate was subjected to suction filtration and M diazemethane / methanol repeated treatment twice in an ultrasonic bath. The filter paper residue was stirred in a mixture of 30 ml of methanol and 10 ml of glacial acetic acid under slow heating. The insoluble material was filtered off and the mother liquor was evaporated to dryness. The residue was mixed with toluene again and evaporated. It was then dried under vacuum at 60 t. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs {Please read the notes on the back before filling in this page) Yield: 70 mg (theoretical value of 20 »〇, melting point: > 250T :, value: 0,78 (reverse Phase Silicone; Methanol / 5¾Brine = 8: 4) -77- This paper size is printed in the middle of a difficult country (CNS) A4 size (210x297 mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. A6 B6 V. Description of the invention (76) Theoretical value: C 60.25 Η 5.79 Ν 12.01 Experimental value: 60.20 5.43 1 1.54 Mass spectrum: fT = 376 g Example 2 3-U- (2-撖 某一 某) ¾ even 1-1 -Π-毎 [里 见 瞅 -fi -some four g 眯 _-2- 蒯 1g 1- (1-azaisoquinolin-6-yl) -3- [4- (2-methoxycarbonyl) -Ethyl] benzyl] -tetrahydroimidazol-2-one, 100 ml of dioxane, 80 ml of water and 8.5 ml of 1 equivalent sodium hydroxide solution was stirred at room temperature for 3 hours. 9 ml of 1 equivalent hydrochloric acid was added The mixture was evaporated and the precipitate was filtered by suction. The product was washed with water and dried at 50C. Yield: 0.78 g (80¾ of theory), melting point: 236-240 1: (decomposition)
Rf值:0.36 (矽膠;二氛甲烷/乙醇/乙酸乙酯 =20:1:1) Μ下化合物自類似於實施例2製備: (1) 1-[4-(2-羧基乙基)笨基]-3-(異蝰啉-6-基)-3Η-二氫 咪唑-2-酮 熔點:305-310¾, 1^值:0.49 (矽膠;二氛甲烷/甲醇= 9:1) 理論值: C 70.18 Η 4.77 Ν 11.69 實驗值: 69.95 4.93 1 1.64 (2) 1-[4-(2-狻基乙基)笨基]-3-(1,2,3,4-四氫異喹啉 -6-基)-四氫咪唑-2-酮 -78 — 本紙張尺度遑用中國國家搮準(CNS)甲4規格(210X 297公釐) ' {請先閲讀背面之注意事項再填寫本頁} -裝 -ΤΓ. 經濟部中央標準局員工消費合作社印製 _B6__ 五、發明説明(77 ) Rr值:0.44 (逆相矽膠;甲酵/ 5¾鹽水液= 6:4) 理論值: C 67.54 Η 6.21 Η 11.25 寊驗值: 67.58 6.42 11.23 (3) 卜[4-(2-狻基乙基)笨基]-3-(2,3,4,5-四氫-1Η-3-笨 并一氮七画-7-基)-3H-二氫咪唑-2-酮 (4) 2-[反-4-(2-甲氧基羰基)乙基]-5-(2,3,4,5-四氳 -1H-3-笨并一氮七圆-7-基)-3,4-二氫-2H,5H-1,2,5-噻二 唑-1, 1 -二氧化物 於甲醇/氫氧化納溶液中進行; 起始物:實施例18之化合物。 1^值:0.36 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (5) 3-[4-(2-羧基乙基)苯基]-1-(2,3,4, 5-四氫-1H-3-苯 并一氮七圃-7-基)-四氫咪唑-2,4-二酮 (6) 1-[4-[2-羧基-2-(正丁基磺醯基胺基)-乙基]笨基 ]-3-(2,3,4,5-四氫-1[1-3-苯并一氮七圜-7-基)-四氫咪唑 -2-酮 (7) 1-[4-[2-羧基- 2-(正戊基幾基胺基)-乙基]苯基]-3-(2,3,4,5-四氫-lH-3-苯并一氮七國-7-基)-四氫咪唑-2-酮 (8) 卜[4-(2-羧基乙基)苯基]-3-(5,6,7,8-四氫吡啶并 [3,4-d]嘧啶-2-基)-四氫咪唑-2-酮 (9) 1-[4-[(羧基甲基)磺釀基]苯基]-3-(2,3,4,5-四氫 -1H-3-苯并一氮七園-7-基)-四氫眯唑-2-酮 (10) 1- [(4-羧基-卜六氫吡啶基)羰基甲基]-3-(2,3,4,5- (請先閲讀背面之注意事項再填窝本頁) -79 — 本纸張Λ度適用令困國家標準(CNS)肀4規格(210x297公釐) 經濟部中央標準局員工消费合作社印製 A6 B6 五、發明説明(78 ) 四氫-1H-3-苯并一氮七團-7-基)-四氫咪唑-2-釅 (11) 1-[2-[(2-羧基乙基)胺基羰基]乙基]-3-(2,3,4,5-四 氫-1H-3-苯并一氮七國-7-基)-四氫眯唑-2-酮 (12) 1-[4-(2-羧基乙基)笨基]-3-(2,3,4,5-四氫-111-2-苯 并一氮七園-7-基)-四氫咪唑-2-酮 (13) 1-[4-(2-羧基乙基)苯基]-3-(1,1-二甲基-1,2,3,4-四氫-異喹啉-6-基)-四氫眯唑-2-釅 奮掄例3 1-(1-埴留晻Bft-fi-某)-·?-Γ4-Γ2-(甲氬某糖某某1-笼某 1 -四氩眯_ -2-酾 22克1-(異喹啉-Ν-氧化物-6-基)-3-[4-[2-(甲氧基羰基 )-乙基]苯基]-四氫眯唑-2-酮和25毫升氧氯化磷經迴流2 小時。然後氧氛化磷蒸餾掉且殘渣與冰混合。混合液之 pH使用飽和碳酸氫納溶液調整至8-9 。其Μ二氯甲烷萃取 數次,有機曆經脫水和蒸發且殘渣Κ曆析法於矽膠管柱中 使用二氛甲烷/甲醇(20 : 1)純化。 產量:1.0克(理論值之43¾),Rf value: 0.36 (silicone; dichloromethane / ethanol / ethyl acetate = 20: 1: 1) The compound was prepared from analogous to Example 2: (1) 1- [4- (2-carboxyethyl) benzene [Methyl] -3- (isofluorin-6-yl) -3) -dihydroimidazol-2-one Melting point: 305.310¾, 1 ^ value: 0.49 (silicone; dichloromethane / methanol = 9: 1) Theoretical value : C 70.18 Η 4.77 Ν 11.69 Experimental value: 69.95 4.93 1 1.64 (2) 1- [4- (2-fluorenylethyl) benzyl] -3- (1,2,3,4-tetrahydroisoquinoline -6-based) -tetrahydroimidazol-2-one-78 — This paper uses China National Standard (CNS) A4 specification (210X 297 mm) '{Please read the precautions on the back before filling this page } -Pack-TΓ. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs _B6__ V. Description of the invention (77) Rr value: 0.44 (reverse phase silicone; formazan / 5¾ saline solution = 6: 4) Theoretical value: C 67.54 Η 6.21 Η 11.25 寊 Test value: 67.58 6.42 11.23 (3) Bu [4- (2-fluorenylethyl) benzyl] -3- (2,3,4,5-tetrahydro-1Η-3-benzyl Triazine-7-yl) -3H-dihydroimidazol-2-one (4) 2- [trans-4- (2-methoxycarbonyl) ethyl] -5- (2,3,4, 5-tetrapyrene-1H-3-benzylazine-7-yl) -3,4-dihydro-2H, 5H-1 , 2,5-thiadiazole-1, 1 -dioxide was performed in a methanol / sodium hydroxide solution; starting material: the compound of Example 18. 1 ^ value: 0.36 (reverse phase silicone; methanol / 5¾ brine = 6: 4) (5) 3- [4- (2-carboxyethyl) phenyl] -1- (2,3,4, 5- Tetrahydro-1H-3-benzomonoazine-7-yl) -tetrahydroimidazole-2,4-dione (6) 1- [4- [2-carboxy-2- (n-butylsulfonylsulfonium Aminoamino) -ethyl] benzyl] -3- (2,3,4,5-tetrahydro-1 [1-3-benzomonoazine-7-yl) -tetrahydroimidazole-2- Ketone (7) 1- [4- [2-Carboxy-2- (n-pentyl-chitylamino) -ethyl] phenyl] -3- (2,3,4,5-tetrahydro-lH-3 -Benzobenzoazine-7-yl) -tetrahydroimidazol-2-one (8) [4- (2-carboxyethyl) phenyl] -3- (5,6,7,8-tetrakis Hydropyrido [3,4-d] pyrimidin-2-yl) -tetrahydroimidazol-2-one (9) 1- [4-[(carboxymethyl) sulfonyl] phenyl] -3- (2 , 3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydrooxazol-2-one (10) 1- [(4-carboxy-buhexahydropyridyl ) Carbonylmethyl] -3- (2,3,4,5- (Please read the notes on the back before filling in this page) -79 — This paper Λ degree is applicable to the national standard (CNS) 肀 4 specifications (210x297 mm) A6 B6 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (78) Tetrahydro-1H-3-benzo-nitrogen seven groups-7-yl) -tetrahydroimidazole-2- 酽(1 1) 1- [2-[(2-Carboxyethyl) aminocarbonyl] ethyl] -3- (2,3,4,5-tetrahydro-1H-3-benzo-nitrogen seven countries-7- ) -Tetrahydrooxazol-2-one (12) 1- [4- (2-carboxyethyl) benzyl] -3- (2,3,4,5-tetrahydro-111-2-benzo Hepta-7-yl) -tetrahydroimidazol-2-one (13) 1- [4- (2-carboxyethyl) phenyl] -3- (1,1-dimethyl-1,2 , 3,4-tetrahydro-isoquinoline-6-yl) -tetrahydrooxazole-2-fluorene Example 3 1- (1-retention dark Bft-fi-some)-·? -Γ4-Γ2 -(Methyl argon, a sugar, a certain, a, a cage, a 1-tetra argon, a 2-tetrahydropyrene, 2-gram, 22 grams of 1- (isoquinoline-N-oxide-6-yl) -3- [4- [2- ( Methoxycarbonyl) -ethyl] phenyl] -tetrahydrooxazol-2-one and 25 ml of phosphorus oxychloride were refluxed for 2 hours. Then the oxygenated phosphorus was distilled off and the residue was mixed with ice. PH of the mixed solution Use saturated sodium bicarbonate solution to adjust to 8-9. Its M dichloromethane extraction several times, the organic was dehydrated and evaporated and the residue K-dialysis method was purified in a silica gel column using dichloromethane / methanol (20: 1) . Yield: 1.0 g (43¾ of theory),
Rf值:0.66 (矽膠;二氛甲烷/甲醇= 20:1) 窗淪例4 1- (留睦瞅-fi-某珥氬某羝某某1-笼某1-四 氩眯_ 酾 於3.0克N-(2-羥基乙基)-1Γ-(異喹啉-6-基)-H-[4-[ 2- (甲氧基羰基)-乙基]苯基]-脲和2.0克三笨基膦於105 毫升乙腈中,在42至52¾下加入1. 31毫升偶氮二甲酸二乙 -80- 本紙張尺度適用t a國家揉準(CNS)甲4規格(210X297公釐y~~ ............................................................... 裝……………訂…………, (請先閱讀背面之注意事項再填窝本頁) 煩1|:· 經濟部中央標準局員工消費合作社印製Rf value: 0.66 (silicone; methane / methanol = 20: 1) Example 4 of the window 1- (Liu Mu 瞅 -fi- 珥 珥 羝 羝 某 1-cage 1- 1-tetra argon _ 酾 3.0 3.0 G of N- (2-hydroxyethyl) -1Γ- (isoquinolin-6-yl) -H- [4- [2- (methoxycarbonyl) -ethyl] phenyl] -urea and 2.0 g of tris Benthylphosphine is added to 105 ml of acetonitrile, and 1.31 ml of diethyl azodicarboxylate-80 is added at 42 to 52¾- This paper is applicable to the national standard (CNS) A4 specification (210X297 mm y ~~). ........................................ ............ Outfit ……………… Order …………, (Please read the precautions on the back before filling in this page) Annoyance 1 |: · Staff Consumption of Central Standards Bureau, Ministry of Economic Affairs Printed by a cooperative
詣於36毫升乙猜。在45 t擾拌2小時後,混合液冷卻至 -5 C和攪拌再2小時。沉澱經抽氣過濾且Μ輅冷之乙腈清 洗' 產量:2 · 6克.(理論值i 3 Ο X;), 熔點:2 1 3 - 2 1 5 » I埴:0 . β〇 ί'矽膠;二氮甲烷/甲醇=20 ·· 1 : 1) 以下化合物自類似於實施例4製潢: ‘:】>1-('.3-茕三丁氧基羰基-2,3,4,5-西氫一1«-3-苯并一 氡七闻-7-基)-3-[4-ί2-ί甲氧基辕基)乙基]笼基:-四氫_ 跑-2 - _ : 1 6 Β - 1 6 7 * I ί言:0 . 7 7 (讷Ρ ;二氛甲烷./乙酸乙詣=9 : i ) |,2> ί-[反-[4 -[2-(甲氧基羰基)乙基]環己基]-3-(3-三氟 乙_基-2,3,4,5-四氫一1«-3-笼并一氮±:圜-7-基)-四氫 骑唣_ 2 -嗣 瑢 IA:250-255tM.分解), h值:0.45 (矽穋;環己烷/乙酸乙龉= 1:1) (3)卜[4-[反- 2- (审氧基羰基)乙烯基]苯基]-3-ί3-三氟 乙_巷-2,3,4,5-四氫一11"!-3-苯并一氮七圜-7-基)-四氫 a来唑-2 - _ 锫點:21β-22〇υ, R 信·· 0 . 3 δ (矽鏐;環己烷/乙酸乙酯=1 ·. 1) 『4)1-[反-4-[2-(串氧基羰基)乙基1環己基]-3-(3-三氧 乙藤基-2.3,4.5-四氫一14-3-笼并一氮七圜-7-基)- (請先聞讀背面之注意事項再填寫本頁) i衣.Scoop in 36 ml of ethoxylate. After stirring at 45 t for 2 hours, the mixture was cooled to -5 C and stirred for another 2 hours. The precipitate was filtered by suction and washed with cold acetonitrile. Yield: 2 · 6 g. (Theoretical value i 3 〇 X;), melting point: 2 1 3-2 1 5 »I 埴: 0. Β〇ί'silicone ; Diazomethane / methanol = 20 ·· 1: 1) The following compounds are similar to the decoration of Example 4: ':] > 1-('. 3- 茕 tributoxycarbonyl-2,3,4, 5-Cyclohydro-1 «-3-benzo-pyridine-7-yl) -3- [4-ί2-ίmethoxyfluorenyl) ethyl] cyl: -tetrahydro_ ran-2- _ : 1 6 Β-1 6 7 * I ί Speech: 0. 7 7 (Nep; dichloromethane. / Ethyl acetate = 9: i) |, 2 > ί- [反-[4-[2- (Methoxycarbonyl) ethyl] cyclohexyl] -3- (3-trifluoroethyl-yl-2,3,4,5-tetrahydro-1 «-3-capped-nitrogen ±: 圜 -7- Base) -tetrahydrocycline 2 2-嗣 瑢 IA: 250-255tM. Decomposition), h value: 0.45 (silicon hydrazone; cyclohexane / ethyl acetate = 1: 1) (3) Bu [4- [反-2- (trioxycarbonyl) vinyl] phenyl] -3-ί3-trifluoroethyl_lane-2,3,4,5-tetrahydro-11 "!-3-benzo-nitroazine- 7-yl) -tetrahydroalyzol-2-_ 锫 point: 21β-22〇υ, R letter ·· 0.3 δ (silicon; cyclohexane / ethyl acetate = 1 ·. 1) 『4 ) 1- [trans-4- [2- (Cyclooxycarbonyl) ethyl 1cyclohexyl ] -3- (3-trioxethenyl-2.3,4.5-tetrahydro-14-3-cage and one nitrogen heptam-7-yl)-(Please read the precautions on the back before filling this page) i clothing.
,1T 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) A6 B6 經 濟 部 中 標 準 局 員 工 消 費 合 作 社 印 製 五、發明説明(80 ) 3,4,5,6-四氫-1{1-嘧啶-2-_ 熔點:125-127¾, Rr值:0.54(矽膠;環己烷/乙酸乙酯= 1:2) g淪俐5 1-(留喹瞅-6-某)-3-U-r?.-(g氬某镅某某卜笼某1-3Η -二想眯_ -2 -醞 7.3克Ν-(2,2-二乙氧基乙基)-Ν'-(異喹啉-6-基)4-[4-[2-1甲氧基羰基)乙基]苯基]-脲於3 5毫升三氟乙酸中 在室溫播拌2小時。然後混合液部分蒸發且加入冰水。其 Μ氫氧化納溶液在攪拌和冷卻下調成碱性,沉澱經抽氣過 濾且Μ少許甲醇清洗。然後產物自甲醇中再結晶。 產量:4.45克(理論值之76¾), 熔點:15 8 -1611:, 值:0.29 (矽膠;二氛甲烷/甲醇= 95:5) 理論值: C 70.76 Η 5.13 Ν 11.25 實驗值: 70.52 5.08 1 1.35 Κ下化合物自類Μ於實施例5製備: (1) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(3-三氟 —.,· , r·--.,. 一- I 乙醯基-2,3,4,5-四氫—111-3-苯并一氮七圈-7-基)-3[1-二 氫蹄唑-2-酮 Μ乾熱至160-170 1C進行。 熔點:121-124¾ 1值:0.35 (矽膠;環己烷/乙酸乙酯=1 :1) (2) 1-[反-4-[[(甲氧基羰基)甲基]氧]-環己基]-3-(3-三 82 本紙張尺度遑用t國國家樣準(CNS).甲4规格(210X297公釐) {請先閲讀背面之注意事項再填寫本頁) -装 訂. 4:Π 01259_庠利申請案 ώ文說闼書修E頁(' 8 6年3月Y Β7 發明説明(別) Η £ί 7f 氧乙藤基-2 VtrirS—-"W—氫'一1H-3 -苯并一氮七圜-7-基)-3H -二氫咪啤-2 - _ 熔點:1 4 8 - 1 4 9 t R f值:0 · 2 S ( 5夕膠;乙酸乙酯/環己烷=2 : 1) (3) 乙氧基羰基)-1-丙基]笼基]-3-(3-三氟乙 藏基-2 , 3 , 4 , 5 -四氫-1 Η - 3 -苯并一氮七圜-7 -基)-3 Η -二氫 H呆胜-2 - _ h草:0.32 (矽穋;環己烷/乙酸乙|_ = 2:1> t4) 1-[反-4-[2-(申氧基辕基)乙基.]環己基]-3-(3-乙基 -2 . 3 , 4 . F‘ -四氫—1 Η - 3 -笼并一氮七圜-7 -基)-3 Η -二氫_唑 堉 30 (逆相矽Ρ ;甲醇/ 5%鹽水亵=6:4) 反-4 甲氧基羰基)乙基]環己基]-3-(7-乙基 (請先閱讀背面之注意事項再填寫本頁) 氫暁 m S5; τρ; 亡丄 Sc? 黄酴 (6 ) 氡乙 R 值 (7 ) -6.7 _,8,9 -四氫-5H-吡 P# 并[2,3-d]— 氮七阈-2-基)-3H -二 啤-2-爾 :1 3 5 - 1 3 6 T: 值: C 6 4,¢, 1 Η 7.78 Ν 16.38 堉: 64 . 8 2 7.84 16.27 卜[4-[2-(乙氧基羰基)-卜苯基-乙基]笼基]-3-(3-三 萌卷-2,3,4,5-四氫一1!^-3-苯并一氮七_-7-基)-34 S碌啤-2 - _ :0 . 2 4 ( δ々p ;環己烷/乙酸乙酯=7 : 3) 卜[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(7-苄基 ,8 , 9 -四氫-5 Η -嘧啶并[4,5 - d]—氮七圜-2 -基]-3 Η -二 -8 3 一 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 五、發明説明(82) 經濟部中央標準局員工消费合作社印製 氫咪唑-2-酮 熔點:131-134¾ 值·· 0.38(矽膠;二氛甲烷/甲醇=20:1) g倫俐ft (1) 1-U-「2-(甲筮某雜某、乙某1¾某四Μ -S喹瞅-fi-某四Μ眯_ 緬-88除酯 2.0克1-(異喳啉-6-基)-3-[4-[2-(甲氧基羰基)乙基 ]-笨基]-3H-二氫咪唑-2-酮於50奄升冰醋酸中M0.5克氧 化鉑在室溫及50 psi氫壓下氫化40分鐘。觸媒經過濾,濾 液經蒸發且殘渣自甲酵中再結晶。 產量' :ί . 7克(理論值之72*), 熔點:170-173 °C (分解) 理論值: C 65.59 Η 6.65 Η 9.56 實驗值: 65.90 6.78 9.69 L值:0.30 (矽膠;甲苯/二氧六画/甲醇/濃氨水 =20:50:20:5) 質譜圖:Μ + = 379 (2) 1-[反-4-(2-狻基乙基)環己基]-3-(3-甲基-2,3,4,5 ,53,6,7,8,9,93-十氫-111-3-苯并一氮七園-7-基)-四氫咪 I 唑-2-酮 X 1.35 HC1 X 1.9 H2〇 使用二氧六睡/水和鉑-铑觸媒。 使用實施例19之化合物為起始物。 質譜圖:M* = 405 理論值: C 56.49 Η 9,10 Ν 8.5 Cl 9.79 一 8 4 一 略θ V本紙張尺度逋用中國國家揉準(CNS)甲4规格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) __ B6__ 五、發明説明(83 ) 實驗值: 56.63 8.81 8.60 9.92 (3) 1-[反-4-(2-羧基乙基)環己基]-3-(2,3,4,5,5a,6,7 ,8,9,93-十氫-111-3-苯并一氮七画-7-基)-四氫咪唑-2-酮 X 1.05 HC1 X 0.9 Hz〇 . 使用二氧六画/水和鉑一铑觸媒。使用實施例14(1)之 化合物為起始物。 質譜圖·· M* = 391 理論值: C 59.43 Η 9.03 Η 9.45 Cl 8.05 實驗值: 59.49 8.83 9.35 8.30 以下化合物自類似於實施例6製備: (1) 1-[反-4-[2 -(甲氧基羰基)乙基]環己基]-3 - (1,2,3, 4-四氫-異喹啉-6-基)-四氫眯唑-2-酮-醋酸酯 (2) 1-[反-4-(2-羧基乙基)環己基]-3-(3-甲基-2,3,4,5 ,53,6,7,8,9,93-十氫-1!1-3-苯并一氮七画-7-基)-四氫咪 唑-2-釅-氫氯化物 實施例19之化合物作為起始物。 啻掄剜7 1-U-「2-(届丁氬某锶某)7,某1茏某1-3-(1 U.4-四贫鹿 喹瞄-6-基)-四氣咪邮-2-釅-M氣化物 X 1水 經濟部中央標準局員工消費合作社印製 {請先閲讀背面之注意事項再填寫本頁} 氛化氫以攪拌通入150毫克卜[4- (2-羧基乙基)笨基]_ 3-(1,2,3,4-四氫-異喹啉-6-基)-四氫咪唑-2-嗣於4.6毫 升異丁醇之懸浮液中30分鐘。混合液在室溫攪拌過夜,加 入丙_且沉溅經抽氣過漶。產物懸浮於丙酮,抽氣過濾、 Μ丙酮和乙醚清洗且乾燥。 —85 — 本紙張/Ut遑用.中· ·家揲毕CCNS)子4规格(210x297命愛 A6 B6 經濟部t央標準局員工消費合作社印製 五、發明説明(84) 產量:140奄克(理論值之77¾), 理論值:C 65.56 Η 7.04 Η 9.18 Cl 7.74 實驗值: 65.38 7.03 9.47 7.92 Rr值:0.19 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 質譜圖:M*= 421 Μ下化合物自類似於實施例7製備: (1) 1-[4-[2-(異丙氧基羰基)乙基]苯基]-3-(2,3,4,5-四 氫-1Η-3-苯并一氮七画-7-基)-四氫咪睡-2-酮-氫氛化物 理論值:C 63.0 8 Η 7.20 Κ 8.83 Cl 7.45 實驗值: 6 2.79 7.14 8.83 7.80 Rr值:〇·21(逆相矽膠;甲醇/ 5JK鹽水液= 6:4) 質譜圖:Μ + = 421 (2) 1-[4-[2-(環己氧基羰基)乙基]苯基]-3-(2,3,4,5-四 氫-1Η-3-苯并一氮七園-7-基)-四氫咪唑-2-酮-氬氯化物 (3) 1-U-[2-(甲氧基羰基)乙基]苯基]-3-(3-甲基-2,3, 4.5- 四氫-111-3-苯并一氮七園-7-基)-四氫咪唑-2-酮-氫 氛化物X 0.75 Η20 熔點:248-250¾, 理論值:C 63.01 Η 6.94 Η 9.19 Cl 7.75 實驗值: 63.09 6.98 9.22 7.88 值:0·25 (逆相矽膠;甲醇/ 5ί!鹽水液=6 : 4) (4) 1-[4-[2-(乙氧基羰基〉乙基]苯基]-3 - (3-甲基-2,3, 4.5- 四氫-111-3-苯并一氮七圈-7-基)-四氫蹄哩-2-嗣-氫 氯化物 一 86- 本紙張尺度逋用中國國家搮準.(CNS)甲4规格(210X297公釐) 裝.......................tr.....................線 (.請也閲讀背面之注意事項再填窝本頁) 經濟部中央標準尾員工消費合作社印製+ A6 ____B6_ 五、發明説明(85 ) " 值:0.22 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (5) 1-[4-[2-(異丙氧基羰基)乙基]笨基]-3-(3-甲基-2, 3,4,5-四氫-111-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氛化物 值;0.19 (逆相矽膠;甲醇/ 5«鹽水液= 6:4) (6) 1-[反-4-[2-(異丙氧基羰基)乙基]-環己基]-3-(3-甲 基-2,3,4,5-四氫-111-3-苯并一氮七画-7-基)-四氫咪唑 -2-酮-氫氛化物 使用亞硫醯氛和氯化氫氣。 熔點:> 250Ό, 值:0.17 (逆相矽膠;甲醇/ 5:«鹽水液= 6:4) 理論值: C 65.32 Η 8.43 Ν 8.79 Cl 7.42 實驗值: 65.10 8.41 8.91 7.66 (7) 1-[反-4-[2-(乙氧基羰基)乙基]環己基]-3-(3-甲基 -2,3,4,5-四氫-111-3-苯并一氮七園-7-基)-四氫咪唑-2-酮-氫氛化物 使用亞硫醢氯和氯化氫氣。 熔點:> 250Ό, 值·· 0.24 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 理論值: C 64.71 Η 8.25 Ν 9.09 Cl 7.64 實驗值: 64.09 8.22 9.08 7.72 (8) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(3-甲基 -2,3,4,5-四氫-111-3-苯并一氮七團-7-基)-四氫咪唑-2-酮-氫氛化物 ..............................................................................琴.......................ΤΓ....................._ (請先閲讀背面之注意事項再填寫本頁} —8 7 — 本紙張尺度逍用t國.國家標準(CNS)甲4规格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(86 ) 使用亞減鹺氟和氯化氫氣。 熔點:> 250X:, 1值:0.29 (逆相矽嗲;甲醇/ 5¾鹽水液= 6:4) 理論值: C 64.05 Η 8.04 Ν 9.34 Cl 7.88 實驗值: 64.10 7.97 9.52 8.11 (9) 1-[反-4-[2-(異丙氧基羰基)乙基]-環己基]-3-(2,3 ,4,5-四氫-111-3-笨并一氮七圃-7-基)-四氫畔唑-2-酮-氫 氛化物 使用亞硫醢氛和氛化氫氣。 值:0.20 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (10) 1-[反-4-[2-(乙氧基羰基)乙基]環己基]-3-(2,3,4, 5-四氫-1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氛 化物 使用亞硫醯氯和氛化氫氣。 1^值:0.23 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 理論值: C 64.05 Η 8.06 Ν 9.34 Cl 7.88 實驗值: 63.77 8.23 9.07 7.91 (11) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3 -(2,3,4, 5-四氫-1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氯 化物 ' 使用亞硫醸氯和氯化氫氣。 值:0.26 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 理論值: C 63.36 Η 7.86 Ν 9.64 Cl 8.13 實驗值: 63.34 7.88 9.73 8.1 1 -88 — 本紙張尺度遑用中a國家棋準(CNS)甲4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝 訂 經濟部中央標準局員工消f合作社印製 A6 B6 五、發明説明(87 ) 9 m m r 1-「4-1~2-(掰某7,某)笼某1-3-(?.-申某-1.2.3.4-四氪里喹 瞅-fi-某)-四银脒_ -2-豳 y fl . ?·氷 350毫克'1-[4-[2-(甲氧基羰基)乙基]苯基]-3-(1,2,3 ,4-四氫異睡琳-6-基)-四氫咪唑-2-酮-醋酸鹽、0.7毫升 水、0.15毫升甲酸和0.7毫升37%水性甲醛溶液在65t: 攫拌1小時。加入甲苯且混合液經蒸發。其與甲苯混合再 蒸發一次。殘渣與2毫升四氫呋喃、1毫升水和0.8毫升 4當量濃度氫氧化納溶液在室溫攫拌2-1/2日。加入220 奄克氛化銨於1毫升水且混合液攪拌2小時。反應液部分 蒸發、Μ冰冷卻且固體產物經抽氣過濾。固體Μ水、丙酮 和乙醚清洗且然後乾燥。 產量:220毫升(理論值之72¾), 熔點:245-248 ¾ 理論值: C 68.98 Η 6.68 Ν 10.97 實驗值: 68.91 6.69 10.92, 1T This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) A6 B6 Printed by the Consumers' Cooperatives of the Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (80) 3,4,5,6-Tetrahydro- 1 {1-pyrimidine-2-_ Melting point: 125-127¾, Rr value: 0.54 (silicone; cyclohexane / ethyl acetate = 1: 2) g 5 5 1- (Leucine-6-some)- 3-Ur? .- (g arg 镅 镅 某 卜 某 Η 二-2 眯 眯--2-7.3 g of N- (2,2-diethoxyethyl) -N '-(iso Quinoline-6-yl) 4- [4- [2-1methoxycarbonyl) ethyl] phenyl] -urea was seeded in 35 ml of trifluoroacetic acid at room temperature for 2 hours. The mixture was then partially evaporated and ice water was added. Its M sodium hydroxide solution was made alkaline with stirring and cooling. The precipitate was filtered by suction and washed with a little methanol. The product was then recrystallized from methanol. Yield: 4.45 g (76¾ of theory), Melting point: 15 8 -1611 :, Value: 0.29 (silicone; dichloromethane / methanol = 95: 5) Theoretical value: C 70.76 Η 5.13 Ν 11.25 Experimental value: 70.52 5.08 1 The compound at 1.35 was prepared from Example M in Example 5: (1) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-trifluoro —., · , R ·-., .- 1-I ethylamido-2,3,4,5-tetrahydro-111-3-benzo-nitrogen seven-cycle-7-yl) -3 [1-dihydrooxazole The 2-ketone M was dry-heated to 160-170 1C. Melting point: 121-124¾ 1 value: 0.35 (silicone; cyclohexane / ethyl acetate = 1: 1) (2) 1- [trans-4-[[(methoxycarbonyl) methyl] oxy] -cyclohexyl ] -3- (3- 三 82 This paper uses the national standard of China (CNS). A4 specifications (210X297 mm) {Please read the precautions on the back before filling this page)-Binding. 4: Π 01259_The application of the patent application says that the book is revised, page E ('March 1986 Y Β7 Description of invention (other) Η £ ί 7f Oxytotenyl-2 VtrirS —- " W-Hydrogen'-1H -3 -Benzazine-7-yl) -3H -Dihydromeptyl-2-_ Melting point: 1 4 8-1 4 9 t R f value: 0 · 2 S (pentane gum; ethyl acetate Ester / Cyclohexane = 2: 1) (3) ethoxycarbonyl) -1-propyl] cyl] -3- (3-trifluoroethylazinyl-2, 3, 4, 5 -tetrahydro- 1 fluorene-3 -benzodiazepine-7 -yl) -3 fluorene -dihydroH sedum-2-_ h grass: 0.32 (silicon hydrazone; cyclohexane / ethyl acetate | _ = 2: 1 > t4) 1- [trans-4- [2- (Senoxyfluorenyl) ethyl.] cyclohexyl] -3- (3-ethyl-2. 3, 4. F '-tetrahydro-1 Η- 3 -Canomonoazine-7-yl) -3 hydrazone-dihydro-oxazole 30 (reverse phase silicon P; methanol / 5% saline = 6: 4) trans-4 methoxycarbonyl) ethyl Huanji ] -3- (7-ethyl (please read the precautions on the back before filling this page) Hydrogen 暁 m S5; τρ; Sc? Huang 酴 (6) 氡 B R value (7) -6.7 _, 8 , 9 -tetrahydro-5H-pyridine P # benzo [2,3-d] —nitrosepta-2-yl) -3H-di beer-2-Er: 1 3 5-1 3 6 T: value: C 6 4, ¢, 1 Η 7.78 Ν 16.38 堉: 64. 8 2 7.84 16.27 [4- [2- (ethoxycarbonyl) -buphenyl-ethyl] cyl] -3- (3-trimene Vol.-2,3,4,5-Tetrahydro-1! ^-3-benzo-azepta-7-yl) -34 Slube-2-_: 0. 2 4 (δ々p; ring Hexane / ethyl acetate = 7: 3) [Trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (7-benzyl, 8, 9-tetrahydro-5 Η -Pyrimido [4,5-d] —Aza-Hepta-2 -Base] -3 Η -2-8 3 A paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 5. Description of the invention ( 82) Printed Hydroimidazol-2-one by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Melting point: 131-134¾ Value · 0.38 (silicone; Dichloromethane / methanol = 20: 1) g Lun ft (1) 1-U -"2- (formamyl, oxazine, B, 1,2, tetramethyl-S-quinoline-fi-tetramethyl-methyl-88-ester) 2.0 g 1- (isopyridin-6-yl) -3- [4- [2- (methoxy Carbonyl) ethyl] - Ben-yl] -3H- dihydro-imidazol-2-one in 50 liters of glacial acetic acid M0.5 Um g platinum oxide was hydrogenated at 50 PSI hydrogen pressure and room temperature for 40 minutes. The catalyst was filtered, the filtrate was evaporated and the residue was recrystallized from formazan. Yield ': ί. 7 g (72 * of theory), melting point: 170-173 ° C (decomposition) Theoretical value: C 65.59 Η 6.65 Η 9.56 Experimental value: 65.90 6.78 9.69 L value: 0.30 (silicone; toluene / di Oxygen / methanol / concentrated ammonia = 20: 50: 20: 5) Mass spectrum: M + = 379 (2) 1- [trans-4- (2-fluorenylethyl) cyclohexyl] -3- (3 -Methyl-2,3,4,5,53,6,7,8,9,93-decahydro-111-3-benzodiazepine-7-yl) -tetrahydroimidazole-2 -Ketone X 1.35 HC1 X 1.9 H2 0 using dioxane / water and platinum-rhodium catalyst. The compound of Example 19 was used as a starting material. Mass spectrum: M * = 405 Theoretical value: C 56.49 Η 9,10 Ν 8.5 Cl 9.79-8 4-a little θ V This paper size is in accordance with China National Standard (CNS) A4 (210X297 mm) (please first Read the notes on the back and fill in this page) __ B6__ V. Description of the invention (83) Experimental value: 56.63 8.81 8.60 9.92 (3) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- ( 2,3,4,5,5a, 6,7,8,9,93-decahydro-111-3-benzotriazine-7-yl) -tetrahydroimidazol-2-one X 1.05 HC1 X 0.9 Hz. Dioxane / water and platinum-rhodium catalyst were used. The compound of Example 14 (1) was used as a starting material. Mass spectrum · · M * = 391 Theoretical value: C 59.43 Η 9.03 Η 9.45 Cl 8.05 Experimental value: 59.49 8.83 9.35 8.30 The following compounds were prepared from similar to Example 6: (1) 1- [Trans-4- [2-( Methoxycarbonyl) ethyl] cyclohexyl] -3-(1,2,3,4-tetrahydro-isoquinolin-6-yl) -tetrahydrooxazol-2-one-acetate (2) 1 -[Trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl-2,3,4,5,53,6,7,8,9,93-decahydro-1! 1-3-Benzodiazepine-7-yl) -tetrahydroimidazole-2-fluorene-hydrochloride The compound of Example 19 was used as a starting material.啻 抡 剜 7 1-U- 「2- (Both strontium, strontium, strontium) 7, some 1 茏, 1-1-3- (1 U.4-tetrapoor decaquine-6-yl) -Siqi -2- 酽 -M gaseous substance X 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Water Economy {Please read the precautions on the back before filling out this page} Stirring hydrogen with 150 mg [4- (2- Carboxyethyl) benzyl] _ 3- (1,2,3,4-tetrahydro-isoquinolin-6-yl) -tetrahydroimidazole-2-fluorene in a suspension of 4.6 ml of isobutanol for 30 minutes The mixture was stirred at room temperature overnight. Propylene was added and the mixture was evacuated. The product was suspended in acetone, filtered by suction, washed with acetone and ether and dried. —85 — This paper / Ut · Furniture CCNS) 4 specifications (210x297 life love A6 B6 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (84) Output: 140 : g (77¾ of theoretical value), Theoretical value: C 65.56 Η 7.04 Η 9.18 Cl 7.74 Experimental value: 65.38 7.03 9.47 7.92 Rr value: 0.19 (reverse phase silicone; methanol / 5¾ saline solution = 6: 4) Mass spectrum: M * = 421 M The compound was prepared similarly to Example 7: (1) 1- [4- [2- (isopropoxycarbonyl) ethyl] phenyl] -3- (2, 3,4,5-tetrahydro-1Η-3-benzodiazepam-7-yl) -tetrahydromeptan-2-one-hydrogenated theory Theoretical value: C 63.0 8 Η 7.20 Κ 8.83 Cl 7.45 Experiment Value: 6 2.79 7.14 8.83 7.80 Rr value: 〇21 (reverse phase silica gel; methanol / 5JK saline solution = 6: 4) Mass spectrum: M + = 421 (2) 1- [4- [2- (cyclohexyloxy) Carbonyl) ethyl] phenyl] -3- (2,3,4,5-tetrahydro-1fluorene-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one-argon Compound (3) 1-U- [2- (methoxycarbonyl) ethyl] phenyl] -3- (3-methyl-2,3, 4.5-tetrahydro-111-3-benzotriazine (Central-7-yl) -tetrahydroimidazol-2-one-hydrogenated compound X 0.75 Η20 Melting point: 248-250¾, Theoretical value: C 63.01 Η 6.94 Η 9.19 Cl 7.75 Experimental value: 63.09 6.98 9.22 7.88 Value: 0 · 25 (Reverse phase silicone; methanol / 5ί! Saline solution = 6: 4) (4) 1- [4- [2- (ethoxycarbonyl> ethyl] phenyl] -3-(3-methyl-2, 3, 4.5- tetrahydro-111-3-benzo-nitrogen seven-ring-7-yl) -tetrahydro-2-methyl-2-hydrazine-hydrochloride-86- This paper is based on the national standard of China. (CNS ) A 4 size (210X297mm) installed ... ..... line (. Please also read the notes on the back again (This page)) Printed by the Central Standard Tail Employee Consumer Cooperative of the Ministry of Economic Affairs + A6 ____B6_ V. Description of the invention (85) " Value: 0.22 (reverse phase silicone; methanol / 5¾ saline = 6: 4) (5) 1- [ 4- [2- (isopropoxycarbonyl) ethyl] benzyl] -3- (3-methyl-2, 3,4,5-tetrahydro-111-3-benzo-nitroazine-7 -Based) -tetrahydroimidazol-2-one-hydrogenation value; 0.19 (reverse phase silicone; methanol / 5 «brine = 6: 4) (6) 1- [trans-4- [2- (isopropyl Oxycarbonyl) ethyl] -cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-111-3-benzotriazine-7-yl) -tetrahydroimidazole The -2-keto-hydrogen atmosphere uses sulfite atmosphere and hydrogen chloride. Melting point: > 250Ό, Value: 0.17 (reverse-phase silicone; methanol / 5: «brine solution = 6: 4) Theoretical value: C 65.32 Η 8.43 Ν 8.79 Cl 7.42 Experimental value: 65.10 8.41 8.91 7.66 (7) 1- [ Trans-4- [2- (ethoxycarbonyl) ethyl] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-111-3-benzodiazepine- 7-yl) -tetrahydroimidazol-2-one-hydrogenated sulphur chloride and hydrogen chloride. Melting point: > 250Ό, value · 0.24 (reverse-phase silica gel; methanol / 5¾ brine = 6: 4) theoretical value: C 64.71 Η 8.25 Ν 9.09 Cl 7.64 experimental value: 64.09 8.22 9.08 7.72 (8) 1- [Reverse -4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-111-3-benzomonoazine seven group-7 -Yl) -tetrahydroimidazol-2-one-hydrogen odorant ............ ..................................... ....... ΤΓ ..........._ (Please read the notes on the back before filling This page} — 8 7 — The paper size is free to use country t. National Standard (CNS) A4 specification (210X297 mm) Printed by A6 B6 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (86) Use of subtraction鹾 Fluorine and hydrogen chloride. Melting point: > 250X :, 1 value: 0.29 (reverse phase silica gel; methanol / 5¾ saline solution = 6: 4) Theoretical value: C 64.05 Η 8.04 Ν 9.34 Cl 7.88 Experimental value: 64.10 7.97 9.52 8.11 (9) 1- [trans-4- [2- (isopropoxycarbonyl) ethyl] -cyclohexyl] -3- (2,3,4,5-tetrahydro-111-3-benzyl Nitrogen-7-yl) -tetrahydropanazol-2-one-hydrogenated Sulfur atmosphere and hydrogenated hydrogen. Value: 0.20 (reverse phase silicone; methanol / 5¾ brine = 6: 4) (10) 1- [trans-4- [2- (ethoxycarbonyl) ethyl] cyclohexyl ] -3- (2,3,4,5-tetrahydro-1H-3-benzotriazine-7-yl) -tetrahydroimidazol-2-one-hydrogenation using thionyl chloride 1 ^ value: 0.23 (reverse phase silica gel; methanol / 5¾ brine = 6: 4) theoretical value: C 64.05 Η 8.06 Ν 9.34 Cl 7.88 experimental value: 63.77 8.23 9.07 7.91 (11) 1- [Trans-4 -[2- (methoxycarbonyl) ethyl] cyclohexyl] -3-(2,3,4,5-tetrahydro-1H-3-benzotriazine-7-yl) -tetrahydroimidazole -2-Ketone-hydrochloride 'uses thionyl chloride and hydrogen chloride. Value: 0.26 (reverse phase silicone; methanol / 5¾ brine = 6: 4) Theoretical value: C 63.36 Η 7.86 Ν 9.64 Cl 8.13 Experimental value: 63.34 7.88 9.73 8.1 1 -88 — Chinese paper standard (CNS) A4 specification (210X297 mm) used in this paper size (Please read the precautions on the back before filling this page)-Staff of Central Bureau of Standards, Ministry of Economic Affairs Printed by Consumer Cooperative A6 B6 V. Description of Invention (87) 9 mmr 1- "4-1 ~ 2- (掰 some 7, some) Cage 1-3-(? .- 申 某 -1.2.3.4- 四Bali瞅 -fi- 某) -tetrasilver 脒 _-2- 豳 y fl.? · Ice 350 mg '1- [4- [2- (methoxycarbonyl) ethyl] phenyl] -3- (1, 2,3,4-tetrahydroisopyrine-6-yl) -tetrahydroimidazol-2-one-acetate, 0.7 ml of water, 0.15 ml of formic acid and 0.7 ml of 37% aqueous formaldehyde solution at 65t: stir for 1 hour . Toluene was added and the mixture was evaporated. It was mixed with toluene and evaporated again. The residue was stirred at room temperature for 2 1/2 days with 2 ml of tetrahydrofuran, 1 ml of water and 0.8 ml of a 4 equivalent strength sodium hydroxide solution. Add 220 μg of aerated ammonium in 1 ml of water and stir the mixture for 2 hours. The reaction solution was partially evaporated, cooled with ice and the solid product was filtered by suction. The solid M was washed with water, acetone and ether and then dried. Yield: 220 ml (72¾ of theoretical value), Melting point: 245-248 ¾ Theoretical value: C 68.98 Η 6.68 Ν 10.97 Experimental value: 68.91 6.69 10.92
Rr值:0.41 (逆相矽膠;甲醇/5¾鹽水液= 6:4) 質譜圖:M* = 379 以下化合物自類似於實施例8製備: (1)1-[ 4-(2-羧基乙基)苯基]-3-(3-甲棊-2 ,3,4,5-四氫 -1H-3-苯并一氮七圈-7-基)-四氫咪唑-2-酮-氫氯化物 X 1.5 水 最後之酯裂係與冰醋酸/鹽酸而非與氫氧化納溶液進行 — 89 — 本紙張大度遑用令國.國家揉準(CNS)甲4規^I210X297公釐) ....................................... .........................裝......................可..............♦ (請先閲讀背面之注意事項再填窝本頁) B6 五、發明説明(·88 ) 理論值·· C 60.45 Η 6.84 Ν 9.20 Cl 7.76 實驗值: 60.45 6.86 9.18 8.09 I值:0.31 (矽膠;二氯甲烷/甲酵/濃氨水 =4:1:0.2) 質譜圖:M*=39 3Rr value: 0.41 (reverse phase silica gel; methanol / 5¾ saline solution = 6: 4) Mass spectrum: M * = 379 The following compounds were prepared from analogous to Example 8: (1) 1- [4- (2-carboxyethyl) ) Phenyl] -3- (3-formamidine-2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one-hydrochloride The final ester cleavage of Compound X 1.5 water was performed with glacial acetic acid / hydrochloric acid instead of sodium hydroxide solution. — 89 — This paper is widely used in the country. National Standards (CNS) A 4 Regulations (I210X297 mm) .. ................................................. ............ installation ............ may ...... ♦ (Please read the precautions on the back before filling in this page) B6 V. Description of the invention (· 88) Theoretical value C 60.45 Η 6.84 Ν 9.20 Cl 7.76 Experimental value: 60.45 6.86 9.18 8.09 I value: 0.31 (silicone; Dichloromethane / formaldehyde / concentrated ammonia = 4: 1: 0.2) Mass spectrum: M * = 39 3
宣施锎Q U4 - (2-淨華乙基)苯基1-3-(2.夂4.5-四瘇-11^-笼#一 氛· 土两-7 -基四铕啤_-;>-黼 800毫克1-[4-[2-(甲氧基羰基)乙基]苯基]_3_(2,3, 4,5-四氫-1卜3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫 氛化物與10毫升半濃鹽酸和1〇毫升冰醋酸播拌。2小時後 ’加入再5毫升半濃鹽酸和5毫升冰醋酸和混合液在室溫 播拌過夜。反應液蒸發後,殘渣懸浮於10毫升水中。“值 Κ2當量濃度氫氧化納達成6 ,固體經抽氣過濾,以冰水 清洗,然後乾燥。 產量:560毫克(理論值之79!«), 值:0.40 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 質譜圖:M*=379 Μ下化合物自類似於實施例9製備: 經濟部中央標準局員工消費合作社印製 {請先閲讀背面之注意事項再填寫本頁) (1) 1-[4-(2-羧基乙基)苯基]-3-(4aRS,6l?S,8aRS)-l,2 ,3,4,43,5,6,7,8,8 3-十氫異_啉-6-基)-四氫咪唑-2-酮 -氫氯化物 Μ氫氛化物分離出來 值:0.41 (逆相矽膠;甲醇/5¾鹽水液= 6:4) —9 0 一 本紙張尺度遴用t國國家棋準(CNS)甲4规格(210X297公釐) 經 濟 部 中 央 標 準 局 員 工 消 費 合 作 社 印 製 A6 B6 五、發明説明(89 ) 質譜臞·· M + = 371 (2) l-[4-(2-羧基乙基)苯基]-3-(3-乙基-2,3,4,5-四氫 -1H-3-苯并一氮七圓-7-基)-四氫咪唑-2-嗣-氫氛化物 值:0.36 (逆相矽膠;甲酵/ 5¾鹽水液= 6:4) 質譜圖:ίΤ = 407 (3) 1-[4-(2-羧基乙基)苯基]-3-(3-異丙基-2,3,4,5-四 氫-1H-3-苯并一氮七醒-7-基)-四氫眯唑-2-麵-氫氛化物 (4) 1-(2-羧基乙基)-3-[4-(異陸啉-6-基)苯基]-四氫眯 嗖-2-酮-氫氯化物 (5) 卜[4-(2-羧基乙基)苯基]-3-(4,4-二甲基-1,2 ,3,4-四氬異喹啉-6-基)-四氫咪唑-2-酮-氫氛化物 (6) 1-[4-(2_ 羧基乙基)苯基]-3-(3-丁基-2,3,4,5-四氫 -1H-3-苯并一氮七匾-7-基)-四氫眯唑-2-_ -氫氯化物 值:0.33 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 質譜圖:= 4 3 5 (7) 1-[4-(2-羧基乙基)苯基]-3-(卜胺基-3,4-二氫-異喹 啉-6-基)-四氫咪唑-2-酮-氫氯化物 (8) 卜[4-(2-羧基乙基)苯基]-3-(2-甲基-3,4-二氫喹唑 啉-7-基)-四氫咪唑-2-酮-氫氛化物 (9) 1-[4-(2-羧基乙基)苯基]-3-(4,4-二甲基-3,4-二氫 U查唑啉-7-基)-四氫咪唑-2-酮-氫氯化物 (10) 3-[反-4-(2-羧基乙基)環己基]-1-(2,3,4,5-四氫 -1H-3-笨并一氮七圈-7-基]-尿囊素-氫氯化物 熔點:〉250Ό 91 本紙張尺度壤用_國國家揉準(CNS)甲4規格(210X297公釐) ...裝......................訂.....................絲 (請先閱讀背面之注意事項再填寫本頁} 五 笔33101250¾專利审請察Xuanshi 锎 Q U4-(2-Jinhua Ethyl) phenyl 1-3- (2. 夂 4.5-tetra- 瘇 -11 ^ -cage # 一 氛 · 土 两 -7- 基 四 铕 beer _-; >-黼 800 mg 1- [4- [2- (methoxycarbonyl) ethyl] phenyl] _3_ (2,3, 4,5-tetrahydro-1b 3-benzo-nitroazine 7-7 -Yl) -tetrahydroimidazol-2-one-hydrogenated scented with 10 ml of semi-concentrated hydrochloric acid and 10 ml of glacial acetic acid. After 2 hours' add another 5 ml of semi-concentrated hydrochloric acid and 5 ml of glacial acetic acid and mix the Stir overnight at room temperature. After evaporation of the reaction solution, the residue was suspended in 10 ml of water. "The value K2 equivalent concentration of sodium hydroxide reached 6, the solid was filtered by suction, washed with ice water, and then dried. Yield: 560 mg (theoretical value) 79! «), Value: 0.40 (reversed-phase silica gel; methanol / 5¾ saline solution = 6: 4) Mass spectrum: M * = 379 M The compound was prepared similarly to Example 9: The Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Printed {Please read the notes on the back before filling in this page) (1) 1- [4- (2-carboxyethyl) phenyl] -3- (4aRS, 6l? S, 8aRS) -1,2, 3,4,43,5,6,7,8,8 3-Decylhydroisoline-6-yl) -tetrahydroimidazol-2-one-hydrochloride M Hydrogenated ions: 0.41 ( Reverse-phase silicone; methanol / 5¾ saline solution = 6: 4) —9 0 A paper size is selected from National Standards (CNS) A4 specifications (210X297 mm) Printed by A6, Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs B6 V. Description of the invention (89) Mass spectrum 臞 ·· M + = 371 (2) l- [4- (2-carboxyethyl) phenyl] -3- (3-ethyl-2,3,4,5 -Tetrahydro-1H-3-benzo-nitrogen heptad-7-yl) -tetrahydroimidazole-2-hydrazone-hydrogenated compound value: 0.36 (reverse phase silicone; formazan / 5¾ saline solution = 6: 4) Mass spectrum: ίΤ = 407 (3) 1- [4- (2-carboxyethyl) phenyl] -3- (3-isopropyl-2,3,4,5-tetrahydro-1H-3-benzene Heptazine-7-yl) -tetrahydrooxazole-2-hexyl-hydrogenated compound (4) 1- (2-carboxyethyl) -3- [4- (isoterolin-6-yl) Phenyl] -tetrahydrofluoran-2-one-hydrochloride (5) [[4- (2-carboxyethyl) phenyl] -3- (4,4-dimethyl-1,2,3 , 4-Tetraargon isoquinolin-6-yl) -tetrahydroimidazol-2-one-hydrogenated compound (6) 1- [4- (2_ carboxyethyl) phenyl] -3- (3-butyl -2,3,4,5-tetrahydro-1H-3-benzo-nitrozine-7-yl) -tetrahydrooxazole-2-_ -hydrochloride value: 0.33 (reverse phase silicone; methanol / 5¾saline solution = 6: 4) Mass spectrum: = 4 3 5 (7) 1- [4 -(2-carboxyethyl) phenyl] -3- (triamino-3,4-dihydro-isoquinolin-6-yl) -tetrahydroimidazol-2-one-hydrochloride (8) [4- (2-carboxyethyl) phenyl] -3- (2-methyl-3,4-dihydroquinazolin-7-yl) -tetrahydroimidazol-2-one-hydrogenated compound (9 ) 1- [4- (2-carboxyethyl) phenyl] -3- (4,4-dimethyl-3,4-dihydroUchazolin-7-yl) -tetrahydroimidazole-2- Ketone-hydrochloride (10) 3- [trans-4- (2-carboxyethyl) cyclohexyl] -1- (2,3,4,5-tetrahydro-1H-3-benzyl-nitrogen seven cycles -7-Base] -Allantoin-Hydrochloride Melting point:> 250Ό 91 This paper is used for soil size _ country national standard (CNS) A4 specification (210X297 mm) ... pack ... ............... Order ............ Silk (Please read the notes on the back before filling in this page } Wubi 33101250¾ Patent Examination
ώ文說萌書殇正頁(8β年3月Y Β7 、發明説明(?G) 年 η η 補充 a=t 甲醇/ 水詨= :σττΒ~· ΤΊ^~ I ; 6:4) 值: C 6 0 .6 1 H f ..94 H 9,64 Cl 8.13 值: 6 0 .45 C .90 9 . i31. 8.28 Π1)1-[反-4-(2 -羧基乙基)環己基]-3-(7 -乙基- 6,7,8,9 -四氫-5 Η -吡哄并[2, 3-d] —氨七圜-2-基)-四氫嗥唑-2-蘭 X 2 H C i X 0.y Ha Ο ^ ΙΑ : 283-286Τ: t-;頁:().4 6 (逆相砂賴;甲醇/ 5怎鹽水液=β : 4 ) 珲諳堉: C 52.36 Η 7.35 Ν 13.88 C 1 14.05 貢翳值: 52.70 7.44 1 3.8 6 14.01 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社>印製 (12) 1 - [反-4 -ί 2 -羧基 乙 基)環 己 基 ]-3- (3 -乙基- 2 ,3,4, -四'f s.- 1 Η - 3 - S并一氮 _L- 圜-7- 基 )- 3H-: 二 f Ϊ眯唑-2 氡化 m χ 0 . 5 Η a 0 R t-值 • 0.38 逆 相矽膠. ;甲醇 / 5¾ _水 液 = 6:4) 理論 值 : C 63 .08 Η \ \ 1 Η 9 • 19 G i 7.76 實驗 值 : 6 3 .2 6 7.69 9 .28 7.64 Π 3) 1 - [反-4 -(2 -羧基 乙 基)環 己 基 ]-3- (2 ,3,4 , 5 - 四氫 -1 Η - 3- 笼并一 氨 七圜- 7- 基]-尿囊素-氫 氯 化物 R r if 0.16 ( p ;二氡甲烷 / 甲 醇/ 濃 氨水 = 8 0:20 :2) 珲論 值 : C ao .61 Η 6.94 Ν 9 .64 C i 8.13 6 0 .34 6.94 9 .58 8.27 ! 1 ί ) 1 - L 反-4 - (2 -羧基 乙 基)環 己 基 1-3- (.2 ,3,4,5- 四氫 -1H- 3- 茏并一 氮 七圓- γ __ 基)-3 ,4 ,5 ,6-四氫-1H-瘤 啶-2- -9 2 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A6 B6__ 五、發明説明(91 ) X 1.65 HC1 X 0.7 H2〇 熔點:230-235Ϊ: 值:0.40 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4)The first page of the book says Mengshu Y (Year March 8 β Β7, the description of the invention (? G) year η η supplement a = t methanol / water 詨 =: σττΒ ~ · ΤΊ ^ ~ I; 6: 4) Value: C 6 0 .6 1 H f ..94 H 9,64 Cl 8.13 Value: 6 0 .45 C .90 9. I31. 8.28 Π1) 1- [trans-4- (2-carboxyethyl) cyclohexyl]- 3- (7-ethyl-6,7,8,9-tetrahydro-5 hydrazone-pyridine [2, 3-d] -aminoheptazone-2-yl) -tetrahydrooxazole-2-lane X 2 HC i X 0.y Ha 〇 ^ ΙΑ: 283-286T: t-; pages: (). 4 6 (reverse phase sand; methanol / 5 sodium chloride solution = β: 4) 珲 谙 堉: C 52.36 Η 7.35 Ν 13.88 C 1 14.05 Tribute value: 52.70 7.44 1 3.8 6 14.01 (Please read the notes on the back before filling out this page) Staff Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs > Printed (12) 1-[Anti- 4 -ί 2 -carboxyethyl) cyclohexyl] -3- (3 -ethyl- 2, 3,4, -tetra'f s.- 1 Η-3 -S and one nitrogen_L- 圜 -7- Base)-3H-: bis f oxazole-2 halide m χ 0. 5 Η a 0 R t-value • 0.38 reverse phase silicone.; Methanol / 5¾ _ water = 6: 4) Theoretical value: C 63 .08 Η \ \ 1 Η 9 • 19 G i 7.76 Experimental value: 6 3 .2 6 7 .69 9 .28 7.64 Π 3) 1-[trans-4-(2 -carboxyethyl) cyclohexyl] -3- (2,3,4,5 -tetrahydro-1 Η-3- caged ammonia Heptafluorene- 7-yl] -allantoin-hydrochloride R r if 0.16 (p; dimethylmethane / methanol / concentrated ammonia = 8 0:20 : 2) 珲 value: C ao .61 Η 6.94 Ν 9 .64 C i 8.13 6 0 .34 6.94 9 .58 8.27! 1 ί) 1-L trans-4-(2-carboxyethyl) cyclohexyl 1-3- (.2,3,4,5-tetrahydro -1H- 3-pyridine-nitrogen-seven-circle-γ __ group) -3,4,5,6-tetrahydro-1H-tumidine-2- -9 2 This paper is applicable to Chinese National Standard (CNS) Α4 Specifications (210X297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A6 B6__ V. Description of the invention (91) X 1.65 HC1 X 0.7 H2 0 Melting point: 230-235Ϊ: Value: 0.40 (reverse phase silicone; methanol / 5¾ brine Liquid = 6: 4)
(15) 1-(2-羧基乙基)-3-[4-(3-甲基-2, 3,4,5-四氫-1H-3 -苯并一氮七園-7-基)苯基]-四氫咪唑-2-酮-氫氯化物 熔點:> 2501C(15) 1- (2-carboxyethyl) -3- [4- (3-methyl-2, 3,4,5-tetrahydro-1H-3 -benzo-nitroazine-7-yl) Phenyl] -tetrahydroimidazol-2-one-hydrochloride Melting point: > 2501C
Rr值:0.20 (逆相矽膠;甲醇/5»;鹽水液= 6:4) (16) 1-[反-4-(2-羧基乙基)環己基]-3-(6,7,8,9-四氫 -5H-嘧啶并[4,5-d] —氮七園-2-基)-四氫眯唑-2-酮-氫氯 化物Rr value: 0.20 (reverse phase silicone; methanol / 5 »; saline solution = 6: 4) (16) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (6,7,8 , 9-tetrahydro-5H-pyrimido [4,5-d] -azahepta-2-yl) -tetrahydrooxazol-2-one-hydrochloride
Rr值:0.53 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (17) 1-[反-4-(2-羧基乙基)環己基]-3-(6,7,8,9-四氫 -5H-吡畊并[2,3-d] —氮七園-2-基)-四氫脒唑-2-銅-氫氛 化物 (18) 1-[反-4-(2-羧基甲基)環己基]-3-(6,7 ,8,9-四氫 -5H-吡啶并[2,3-d] —氮七園-2-基)-四氫眯唑-2-酮-氫氯 化物 (19) 1-[反-4-(2-羧基乙基)環己基]-3-(1,2,3,4-四氫-異 喹啉-6 -基)-四氫咪唑-2-酮-氫氯化物 (20) 1-[反-4-(2-羧基乙基)環己基]-3-(2,3-二甲基-3,4 -二氫喹唑啉-7-基)-四氫咪唑-2-酮-氫氯化物 (21) 1-[反- 4-(2-羧基乙基)環己基]-3-(3-乙基-2,3,4,5 -四氫-1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氯化 物《 一 93- 本紙張尺度遑用中國國家標準(CNS)甲ϊϋ(210x297公釐) 裝—…::訂… i……緯 (請先閲讀背面之注意事項再填窝本頁} 五、發明説明(92 ) 熔點:> 270¾Rr value: 0.53 (reverse phase silicone; methanol / 5¾ brine = 6: 4) (17) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (6,7,8,9 -Tetrahydro-5H-pyropyrano [2,3-d] -azahepta-2-yl) -tetrahydrooxazole-2-copper-hydrogenated compound (18) 1- [trans-4- (2 -Carboxymethyl) cyclohexyl] -3- (6,7,8,9-tetrahydro-5H-pyrido [2,3-d] -azahepta-2-yl) -tetrahydrooxazole-2 -Keto-hydrochloride (19) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (1,2,3,4-tetrahydro-isoquinolin-6-yl)- Tetrahydroimidazol-2-one-hydrochloride (20) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3-dimethyl-3,4-dihydroquine Oxazoline-7-yl) -tetrahydroimidazol-2-one-hydrochloride (21) 1- [trans- 4- (2-carboxyethyl) cyclohexyl] -3- (3-ethyl-2, 3,4,5 -tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one-hydrochloride 《一 93- This paper uses Chinese national standard (CNS ) Formazan (210x297mm) Pack—… :: Order… i …… Weft (please read the precautions on the back before filling in this page) V. Description of the invention (92) Melting point:> 270¾
Rr值:0.35 (逆相矽膠;甲酵/ 5»:鹽水液= 6:4) (22) 1-[反-4-(2-羧基乙基)環己基]-3-(3-丙基-2,3,4,5 -四氫-1H-3-苯并一氮七團-7-基四氫咪唑-2-醑X 1.07 HC1 X 1 H20 熔點;> 250¾ 值:0.32 (逆相矽膠;甲醇/ 5%鹽水液=6:4) 理論值:C 61.96 Η 8.33 Ν 8.67 Cl 7.83 實驗值: 62.10 8.14 8.77 7.94 (23) 1-[反- 4-(2-羧基乙基)環己基]-3-(3-丙稀基_2,3,4 ,5 -四氫-1H-3-苯并一氮七画-7 -基)_四氫咪睡_2_酮x 1.1 HC1 X 1.5 H2〇 熔點:> 250它Rr value: 0.35 (reverse phase silicone; formazan / 5 »: saline solution = 6: 4) (22) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-propyl -2,3,4,5 -tetrahydro-1H-3-benzomonoazine-7-yltetrahydroimidazole-2-fluorene X 1.07 HC1 X 1 H20 melting point; > 250¾ value: 0.32 (reverse phase Silicone; Methanol / 5% saline solution = 6: 4) Theoretical value: C 61.96 Η 8.33 Ν 8.67 Cl 7.83 Experimental value: 62.10 8.14 8.77 7.94 (23) 1- [trans- 4- (2-carboxyethyl) cyclohexyl ] -3- (3-propionyl_2,3,4,5 -tetrahydro-1H-3-benzodiazepto-7-yl) _tetrahydroamido_2_one x 1.1 HC1 X 1.5 H2〇 melting point: > 250 it
Rf值:0.30 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 理論值: C 60.94 Η 8.00 H 8.53 Cl 7.91 實驗值: 61.32 7.63 8.47 7.82 (24) 1-[反-4-(2-狻基乙基)環己基]-3-(3-異丁基-2,3,4 ,5-四氫-1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氛 化物 經 濟 部 中 央 標 準 h 員 工 消 費 合 作 社 印 製 (請先閲讀背面之注意事項再填窝本頁)Rf value: 0.30 (reverse phase silicone; methanol / 5¾ brine = 6: 4) Theoretical value: C 60.94 Η 8.00 H 8.53 Cl 7.91 Experimental value: 61.32 7.63 8.47 7.82 (24) 1- [Trans-4- (2- Fluorenylethyl) cyclohexyl] -3- (3-isobutyl-2,3,4,5-tetrahydro-1H-3-benzotriazine-7-yl) -tetrahydroimidazole-2 -Ketone-Hydrogenated Aromatics Central Standard of Ministry of Economic Affairs, printed by employee consumer cooperatives (please read the precautions on the back before filling this page)
(2 5)1-[反-4-(2-羧基乙基)環己基]-3-[3(2-羥基乙基)-2,3,4,5-四氫-111-3-苯并一氮七團-7-基)-四氫咪唑-2-酮 -氫氯化物 熔點:2 5 7 - 2 6 0 1C 值:0· 46 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 94 本紙張尺度遑用中國國家揉準(CNS)甲4规格(210x297公釐) 經濟部中央標準局貝工消費合作社印製 A6 B6 五、發明説明(93) (26) 1-[反-4-(2-羧基乙基)環己基]-3-[3-(羧基甲基)- 2.3.4.5- 四氫-111-3-苯并一氮七困-7-基)-四氫咪唑-2-酮 -氫氛化物 熔點:> 28010 值:0.39 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) (27) 1-[反-4-(2-羧基乙基)環己基]-3-[3-苄基-2,3,4,5 -四氫-1H-3-苯并一氮七_-7-基)-四氫咪唑-2-酮-氫氛化 物 熔點:> 2 5 0 t:(2 5) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3 (2-hydroxyethyl) -2,3,4,5-tetrahydro-111-3-benzene Benzene-7-yl) -tetrahydroimidazol-2-one-hydrochloride Melting point: 2 5 7-2 6 0 1C Value: 0.46 (reverse phase silicone; methanol / 5¾ brine = 6: 4) 94 This paper size is in Chinese National Standard (CNS) A4 size (210x297 mm) Printed by A6 B6, Shellfish Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs 5. Description of the invention (93) (26) 1- [anti -4- (2-carboxyethyl) cyclohexyl] -3- [3- (carboxymethyl)-2.3.4.5- tetrahydro-111-3-benzo-nitroazine-7-yl) -tetrahydro Imidazol-2-one-hydrogenated substance Melting point: > 28010 Value: 0.39 (reverse phase silicone; methanol / 5¾ saline = 6: 4) (27) 1- [trans-4- (2-carboxyethyl) ring Hexyl] -3- [3-benzyl-2,3,4,5-tetrahydro-1H-3-benzo-azaazine-7-yl) -tetrahydroimidazol-2-one-hydrogen flammable compound : ≫ 2 5 0 t:
Rr值:0.21 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (28) 1-[反-4-(2-羧基乙基)環己基]-3-[3-(環丙基甲基) -2,3,4,5-四氫-1H-3-苯并一氮七團-7-基]-四氫咪唑-2-酮•氫氛化物 熔點:> 2 8 0 t: 值:0.31 (逆相矽膠;甲醇/5¾鹽水液= 6:4) (29) 1-[反-4-(2-羧基乙基)環己基]-3-[3-(環丙基-2,3, 4.5- 四氫-1^1-3-苯并一氮七團-7-基)-四氫咪唑-2-_-氫 氯化物 (30) 1-[反-4-(2-羧基乙基)環己基]-3-[3-(環己基甲基) -2,3,4,5-四氫-1H-3-苯并一氮七園-7-基]-四氫咪唑- 2-酮-氫氯化物 (31) 1-[反-4-(2-羧基乙基)環己基]-3-(3-環己基-2, 3, 4.5- 四氫-111-3-苯并一氮七團-7-基)-四氫咪唑-2-嗣-氫 氛化物 —9 5 — 本紙張元变逋用卡國國家揉準(CNS)甲4規格(210χ2^^ϋ ^.......................ΤΓ................... (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 A6 B6 五、發明説明(94 ) 窨掄Μ 10 Ι^Γ4-「2-(甲氣基糖某)乙基1茏基l-3-^2.3.4.S-TO智-Ί|| -3-¾并一氮七鬮-7-某)-四氲眯睞-2-騙- Μ匍彳h物 2.3克1-(3-第三丁氧基羰基-2,3,4,5-四氫-1H-3-苯并 一氮七園-7-基)-3-[4-[2-(甲氧基鑛基)-乙基]苯基卜四 氫咪唑-2-酮於30毫升甲醇性鹽酸中在室溫攪拌2小時。 反應經蒸發,殘渣與冰水攪拌、抽氣遇濾、以少量甲酵和 第三丁基甲基醚清洗和然後乾燥。 產量:1.8克(理論值之90»), 理論值: C 64.25 Η 6.56 Η 9.77 Cl 8.25 實驗值: 64.08 6.60 9.92 8.51 Rf值:0.26 (逆相矽膠;甲醇/5¾鹽水液= 6:4) 質譜 _ : M+ = 393 窗淪例1 1 1-「(4aRS.6RS.8aRS)-1 .2.3.4.4a.fi.fi.7.8.Sa- + 銳里睦 畊-6 -基)-3-U-「2-(申氬某羰某某Ί笼某Ί -四值睐独 -2 -豳-氩氣仆物 於216毫克1-[4-[2-(甲氧基羰基)乙基]苯基]-3-[ (43尺5,6尺5,831^)-2-甲基-1,2,3,4,43,5,6,7,8,83-十氫 異喹啉-6-基]-四氫眯唑-2-嗣和18 5毫克1,8-雙-(二甲基 胺基)-萘於5毫升1,2-二氯乙烷,加入0.09毫升氛甲酸 -1-氯乙酯,混合液在室溫播拌20分鐘,然後迴流2.5小 時。反應液經蒸發,殘渣與10毫升甲醇姐合和迴流3小時 。反應液Μ甲醇性鹽酸酸化、蒸發和Μ層析法於矽膠管柱 (請先閲讀背面之注意事項再填窝本頁) -裝· -訂. -96 - 本紙張Λ度逋用中困國家揉準(CNS)肀4規格(210X297公釐) 經濟部t央標準局員工消費合作社印製 A6 B6 五、發明説明(95 ) 中使用二氣甲烷/甲酵(92: 8)純化。 產量:200奄克(理論值之873!), 值:0.35 (逆相矽膠;甲醇/5¾鹽水液=6:4) 富啪例1 2 1-「4-Γ2-(甲氬某羰某)乙某 1笼某 l-3-「(/taRS.fiRS.8aRS) -2-甲某-1.2.3.4.43.5.6.7.8.83-+«里陲瞅-(^-某1-四 g眯_ -?-翮 950毫克1-[4-[2-(甲氧基羰基)乙基]苯基]-3-[ (4aRS ,61^,831^)-2-甲基-1,2,3,4,43,5,6,7,8,83-十氫異喹啉 -6-基]-3H-二氫咪唑-2-酮於50毫升之乙酸乙酯中在 Pd/C之存在下,在50 psi氫壓及室溫下氫化5小時,和然 後在50它下5小時。觸媒經瀘掉和濾液經蒸發。殘渣與第 三丁基甲基醚短暫加熱,然後攪拌冷卻。固體抽氣過滹, Κ第三丁基甲基醚和乾燦。 產量:300毫克(理論值之3U), 熔點:1 55-1 57 1Rr value: 0.21 (reverse phase silicone; methanol / 5¾ brine = 6: 4) (28) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (cyclopropylmethyl) Radical) -2,3,4,5-tetrahydro-1H-3-benzo-nitrogen heptad-7-yl] -tetrahydroimidazol-2-one • Hydrogenated compound Melting point: > 2 8 0 t: Value: 0.31 (reverse phase silicone; methanol / 5¾ saline = 6: 4) (29) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- [3- (cyclopropyl-2 , 3, 4.5-tetrahydro-1 ^ 1-3-benzodiazepine-7-yl) -tetrahydroimidazole-2 -_- hydrochloride (30) 1- [trans-4- (2- Carboxyethyl) cyclohexyl] -3- [3- (cyclohexylmethyl) -2,3,4,5-tetrahydro-1H-3-benzo-azaazine-7-yl] -tetrahydroimidazole -2-keto-hydrochloride (31) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-cyclohexyl-2, 3, 4.5- tetrahydro-111-3- Benzoazine group-7-yl) -tetrahydroimidazol-2-fluorene-hydrogenated compound — 9 5 — This paper element is used in the national standard (CNS) A4 (210χ2 ^^ ϋ ^ ....................... ΤΓ ................... (Please read the note on the back first Please fill in this page for further information) Printed by A6 B6, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of Invention (94) 窨 抡 Μ 10 Ι ^ Γ4- 2- (methylamino glycosyl) ethyl 1 fluorenyl l-3- ^ 2.3.4.S-TO 智-||| -3-¾ and one nitrogen heptamidine-7-some)-four favor -2-Cheat-Mhh compound 2.3 g 1- (3-Third-butoxycarbonyl-2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -3- [4- [2- (Methoxyl) -ethyl] phenylb-tetrahydroimidazol-2-one was stirred in 30 ml of methanolic hydrochloric acid at room temperature for 2 hours. After the reaction was evaporated, the residue and Stir in ice water, filter with suction, wash with a small amount of formic acid and tert-butyl methyl ether, and then dry. Yield: 1.8 g (90 ° of theory), Theoretical value: C 64.25 Η 6.56 Η 9.77 Cl 8.25 Experimental value: 64.08 6.60 9.92 8.51 Rf value: 0.26 (reverse phase silica gel; methanol / 5¾ saline solution = 6: 4) Mass spectrum_: M + = 393 Example of window 1 1 1-"(4aRS.6RS.8aRS) -1.2.3.4.4 a.fi.fi.7.8.Sa- + Ruili Mugeng-6 -ji) -3-U- "2- (Shen arg, carbonyl, carb, cymbal, cymbal, cymbal, cymbal, cymbal)-Four-value favored duo -2 -Plutonium-argon Servants in 216 mg 1- [4- [2- (methoxycarbonyl) ethyl] phenyl] -3- [(43 feet 5,6 feet 5,831 ^)-2-methyl-1,2, 3,4,43,5,6,7,8,83-decahydroisoquinolin-6-yl] -tetrahydrooxazole-2-fluorene and 185 mg 1,8-bis- (dimethylamine ) -Naphthalene 5 ml of 1,2-dichloroethane, was added 0.09 ml 1-chloro-ethyl carboxylate atmosphere, the mixture stirred at room temperature for 20 broadcast minutes, then refluxed for 2.5 hours. After the reaction solution was evaporated, the residue was combined with 10 ml of methanol and refluxed for 3 hours. The reaction solution was acidified with methanolic hydrochloric acid, evaporated, and chromatographed on a silica gel column (please read the precautions on the back before filling in this page) -pack · -order. -96-This paper is used in countries with difficulty Standard (CNS) 肀 4 (210X297 mm) Printed by A6 B6, Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs. 5. Description of the invention (95) Purified using digas methane / formaldehyde (92: 8). Yield: 200 g (theoretical value of 873!), Value: 0.35 (reversed-phase silicone; methanol / 5¾ saline solution = 6: 4) rich example 1 2 1- "4-Γ2- (methyl argon carbonyl) B, 1 cage, 1-3-"(/ taRS.fiRS.8aRS) -2-A, -1.2.3.4.43.5.6.7.8.83-+« Li 陲 瞅-(^-某 1-1-4g 眯 _ -?-翮 950 mg 1- [4- [2- (methoxycarbonyl) ethyl] phenyl] -3- [(4aRS, 61 ^, 831 ^)-2-methyl-1,2,3 , 4,43,5,6,7,8,83-decahydroisoquinolin-6-yl] -3H-dihydroimidazol-2-one in 50 ml of ethyl acetate in the presence of Pd / C , Hydrogenated at 50 psi hydrogen pressure and room temperature for 5 hours, and then at 50 hours for 5 hours. The catalyst was decanted and the filtrate was evaporated. The residue was briefly heated with tert-butyl methyl ether, and then stirred to cool. The solid was evacuated Over 滹, K tertiary butyl methyl ether and dry can. Yield: 300 mg (3U of theory), melting point: 1 55-1 57 1
Rr值:0.29 (逆相矽膠·,甲醇/5¾鹽水液= 6:4) Μ下化合物自類似於實施例12製備: (1) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(3-三氟 乙醢基- 2,3,4,5-四氫-1H-3-苯并一氮七圈-7-基)-四氫脒 唑-2-酮 熔點:165-168Ό 1^值:0.44 (矽膠;環己烷/乙酸乙酯=1 :1) (2) 1-反-4-[[(甲氧基羰基)甲基]氧]環己基]-3-(3-三氟 -97 — 本紙張尺度遑用t國國家樣準(CNS)甲4規格(210X297公釐) ........................................................................裝.......................ΤΓ............ 線 (請先閲讀背面之注意事項再填窝本頁) 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(96 ) 乙醣基-2,3.4,5-四氫-111-3-苯并一氮七園-7-基)-四氫畔 唑-2-醑 熔點:146-147¾ 值:0.26 (矽膠;乙酸乙酯/環己烷= 3:1) (3) 1-[4-[2-(乙氧基羰基)-1-丙基]苯基]-3-(3-三氟乙 醸基-2,3,4,5-四氫-111-3-苯并一氮七圈-7-基)-3}1-四氫 咪唑-2-_ 值:0.32 (矽膠;環己烷/乙酸乙酯= 2:1) (4) 1-[2-[4-(甲氧基羰基)笨基]乙基]-3-(3-三氟乙醯基 -2,3,4,5-四氫-111-3-苯并一氮七園-7-基)-四氫咪唑-2-嗣 熔點:143-144t: 值:0.46 (矽膠;環己烷/乙酸乙酯= 1:1) (5) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(3-乙基 -2,3,4,5-四氫-111-3-苯并一氮七園-7-基)-四氫咪唑-2-酮-氫氛化物 熔點:自230 t:(分解)Rr value: 0.29 (reverse phase silica gel, methanol / 5¾ brine = 6: 4) The compound was prepared from analogous to Example 12 at (1) 1- [trans-4- [2- (methoxycarbonyl) Ethyl] cyclohexyl] -3- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1H-3-benzotriazine-7-yl) -tetrahydrooxazole- 2-ketone melting point: 165-168Ό 1 ^ value: 0.44 (silicone; cyclohexane / ethyl acetate = 1: 1) (2) 1-trans-4-[[(methoxycarbonyl) methyl] oxy] Cyclohexyl] -3- (3-trifluoro-97 — This paper uses the national standard (CNS) A4 specification (210X297 mm) of this country ............... ........................................ ................ TΓ ............ Cable (Please read the back first Note for re-filling this page) A6 B6 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economy (Central-7-yl) -tetrahydropanazole-2-fluorene Melting point: 146-147¾ Value: 0.26 (silicone; ethyl acetate / cyclohexane = 3: 1) Ethoxycarbonyl) -1-propyl] phenyl] -3- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzotriazine-7- Radical) -3} 1-tetrahydroimid Azole-2-_ value: 0.32 (silicone; cyclohexane / ethyl acetate = 2: 1) (4) 1- [2- [4- (methoxycarbonyl) benzyl] ethyl] -3- ( 3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzodiazepine-7-yl) -tetrahydroimidazole-2-fluorene Melting point: 143-144t: Value: 0.46 (silicone; cyclohexane / ethyl acetate = 1: 1) (5) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (3-ethyl- 2,3,4,5-tetrahydro-111-3-benzodiazepth-7-yl) -tetrahydroimidazol-2-one-hydrogenated compound Melting point: From 230 t: (decomposition)
Rf值:0. 22 (逆相矽膠;甲醇/ 5¾鹽水液=6 :4) (6) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(7-乙基 -6,7,8,9-四氫- 5H-吡畊并[2, 3-d] —氮七圖-2-基)-四氫 .蹄唑-2-酮 熔點:136-1381 值:0.33 (矽膠;二氯甲烷/甲醇= 9:1) (7) 1-[4-[2-(乙氧基羰基)-1-苯基-乙基]苯基]-3-(3-三 -98- 本紙張尺度遑用中國國家=»準(CNS)甲4¾格(_210 X 297公釐) ....................................................................................裝·.......................可.....................緯 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局®:工消費合作社印製 A6 B6 五、發明説明(97 ) 氟乙醢基-2,3,4,5-四氫-1H-苯并一氮七醺-7-基)-四氳咪 唑-2-酮 值:0.22 (矽除;環己烷/乙酸乙酯= 7:3) g确例1 3 1-「/1-「2-(申氩基毅某)乙基 1 苯某 U-rUaRS.fiRS.hRS) 个田甚-1丄3.4.43.5.6.7.8.83-+篕里晻瞅-6-甚1-;^ -二 Μ 眯唑-2-_ 於 6·9 克(43 115,61^,831^)-6-[(2,2-二甲氧基乙基)-胺 基]-2-甲基-1,2,3, 4,4a, 5,6,7,8, 8a-十氫異蝰啉於30毫 升二氧六困中,加入6.4克4-[2-(甲氧基羰基)乙基]-苯基 異氰酸酯且混合液在室溫攪拌2小時。反應液經蒸發、K 100毫升甲酵溶取、與甲醇性鹽酸混合且迴流20分鐘。反 應液經蒸發和殘渣與200毫升水攪拌。沉澱K抽氣過濾移 出且濾液Μ乙酸乙酯萃取。有機層丟棄。水層Μ碳酸鉀溶 液調成碱性和Μ乙酸乙酯萃取數次。姐合的乙酸乙酯萃取 液Κ飽和鹽水清洗1次、脫水和蒸發。粗產物Κ層析法於 氧化鋁管柱(碱性)中使用乙酸乙酯純化,接著Κ第三丁 基甲基醚搗碎。 產量:1.03克(理論值之9¾), 1^值:0.55 (矽膠;甲苯/二氧六画/甲醇/濃氨水= 20:50:20:5) Μ下伙洽物自類似於實施例13製備: (1)卜[4-[2-(甲氧基羰基)乙基]笨基]-3-[(4aRS,6RS, 8aRS)-2-甲基-1,2,3,4,4a ,5,6,7,8,8a-十氫異晻啉-6-基 -99 - 本纸張尺度遴用中國國家標準(CNS)甲4规格{210 X 297公釐) (請先閲讀背面之注意事項再填窝本頁) .裝 .訂. 經濟部中央標準局員工消#合作社印製 A6 B6 五、發明説明(98 ) ]-3H-二氫咪唑-2-嗣X 0.3水 熔點:140-145T: 理論值: C 68.56 Η 7.91 Η 10.43 實驗值: 68.49 7.97 10.51 (2) 1- [2- [4-(甲氧基羰基)苯基]Ζ基]-3- (3-三氟乙醯基 -2,3,4,5-四氫-111-3-苯并一氮七圃-7-基)-311-二氫眯唑 -2- m 胺和異氰酸酯於二氧六園中先在室溫和然後在蒸汽浴中 攪拌。省去與甲酵性鹽酸之處理。所用之[2-[4-(甲氧基 羰基)苯基]乙基]-異氰酸酯K對應胺-氫氧化物與二氛化 羰反應製備。Rf value: 0.22 (reverse phase silica gel; methanol / 5¾ brine = 6: 4) (6) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- ( 7-ethyl-6,7,8,9-tetrahydro-5H-pyracino [2, 3-d] -azahepta-2-yl) -tetrahydro.Ivorazol-2-one Melting point: 136 -1381 Value: 0.33 (silicone; dichloromethane / methanol = 9: 1) (7) 1- [4- [2- (ethoxycarbonyl) -1-phenyl-ethyl] phenyl] -3- (3- 三 -98- This paper size uses Chinese country = »quasi (CNS) A 4¾ grid (_210 X 297 mm) ... ........................................ .............. installed ............ may ... ........... (Please read the notes on the back before filling this page) Central Standards Bureau of the Ministry of Economic Affairs®: Printed by the Industrial and Consumer Cooperatives A6 B6 V. Description of the invention (97) Fluorethenyl -2,3,4,5-tetrahydro-1H-benzodiazepine-7-yl) -tetrahydroimidazol-2-one value: 0.22 (silicide; cyclohexane / ethyl acetate = 7: 3) Exact example 1 3 1-"/ 1-" 2- (Shenyiyiyi) ethyl 1 Benzene U-rUaRS.fiRS.hRS) Getian -1 甚 3.4.43.5.6.7.8.83- + 篕Liyan 瞅 -6- 甚 1-; ^ -two Μ oxazole-2-_ at 6.9 g (43 115, 61 ^, 831 ^ ) -6-[(2,2-dimethoxyethyl) -amino] -2-methyl-1,2,3, 4,4a, 5,6,7,8, 8a-decahydroiso In 30 ml of dioxane, 6.4 g of 4- [2- (methoxycarbonyl) ethyl] -phenyl isocyanate was added and the mixture was stirred at room temperature for 2 hours. The reaction solution was evaporated and K 100 ml The formic acid was dissolved, mixed with methanolic hydrochloric acid and refluxed for 20 minutes. The reaction solution was evaporated and the residue was stirred with 200 ml of water. The precipitate K was removed by suction filtration and the filtrate was extracted with ethyl acetate. The organic layer was discarded. The aqueous layer was potassium carbonate The solution was made alkaline and extracted several times with ethyl acetate. The combined ethyl acetate extract K was washed once with saturated brine, dehydrated and evaporated. The crude product K chromatography was used in an alumina column (basic). Ethyl acetate was purified, followed by mashing with K tertiary butyl methyl ether. Yield: 1.03 g (9¾ of theory), 1 ^ value: 0.55 (silicone; toluene / dioxane / methanol / concentrated ammonia = 20:50: 20: 5) The following compounds were prepared from similar to Example 13: (1) [4- [2- (methoxycarbonyl) ethyl] benzyl] -3-[(4aRS, 6RS, 8aRS) -2-methyl-1,2,3,4,4a, 5,6,7,8,8a-decahydroisodarolin-6-yl-99-paper Du Lin uses China National Standard (CNS) A4 specifications (210 X 297 mm) (Please read the precautions on the back before filling in this page). Binding. Binding. Staff of the Central Standards Bureau of the Ministry of Economic Affairs # Cooperative Society Printing A6 B6 V. Description of the invention (98)]-3H-dihydroimidazole-2- 嗣 X 0.3 Water melting point: 140-145T: Theoretical value: C 68.56 Η 7.91 Η 10.43 Experimental value: 68.49 7.97 10.51 (2) 1- [2 -[4- (methoxycarbonyl) phenyl] Zyl] -3- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzomonoazine- 7-yl) -311-dihydrooxazole-2-m amine and isocyanate were stirred in dioxane at room temperature and then in a steam bath. Omit the treatment with formic acid. The [2- [4- (methoxycarbonyl) phenyl] ethyl] -isocyanate K used was prepared by reacting the corresponding amine-hydroxide with dicarbonylated carbonyl.
熔點:165-167TCMelting point: 165-167TC
值:0.31 (矽膠;環己烷/乙酸乙_ = 1:1) g W Μ 1 AValue: 0.31 (silicone; cyclohexane / ethyl acetate_ = 1: 1) g W Μ 1 A
在- 撖某乙某)¾ 某 某- 2- (2.3.4.Fi-Eg-1H — - g ^ -fh ϋ»ΐ -7k筘物 410毫克4-[4-[2-(甲氧基羰基)乙基]苯基]-5-甲基-2 -(3-三氟乙醢基-2,3,4,5-四氫-111-3-苯并一氮七圖-7-基)-4H-1,2,4-三唑-3-酮與10毫升冰醋酸和10毫升半濃鹽 酸在901C攫拌7小時。冷卻後,混合液經蒸發*殘渣與水 攪拌、抽氣過滅和以水和丙酮清洗。 產量:240毫克(理論值之57ί〇, 熔點:> 250¾ -100- 本紙張尺度遑用中國困家標準(CHS)甲4规格(210X297公釐)~_ (請先閲讀背面之注意事項再填.窝本頁) .裝 訂. 經濟部中央標準局員工消費合作社印製 A6 B6_' 五、發明説明(99 )In-撖 乙 某 ¾ ¾ 某-2 (2.3.4.Fi-Eg-1H —-g ^ -fh ϋ »ϋ -7k 筘 物 410mg 4- [4- [2- (methoxy Carbonyl) ethyl] phenyl] -5-methyl-2-(3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-111-3-benzodiazepta-7-yl ) -4H-1,2,4-triazol-3-one with 10 ml of glacial acetic acid and 10 ml of semi-concentrated hydrochloric acid and stir at 901C for 7 hours. After cooling, the mixture is evaporated. The residue is stirred with water and evacuated. It was washed with water and acetone. Yield: 240 mg (57 ο of theoretical value, melting point: > 250¾ -100- This paper size is in accordance with Chinese Standard (CHS) A 4 (210X297 mm) ~ _ ( Please read the notes on the back before filling in. (This page). Binding. Printed by A6 B6_ 'of the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of Invention (99)
Rf值:0.43 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 理論值: C 59.12 Η 6.09 Ν 12.53 Cl 7.93 實驗值: 58.96 6.13 12.31 7.74 Μ下化合物自類似於實施例14製備: (1) 1-[反-4-(2-羧基乙基)環己基]-3-(2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氯化物 熔點:> 250ΌRf value: 0.43 (reverse phase silica gel; methanol / 5¾ saline solution = 6: 4) Theoretical value: C 59.12 Η 6.09 Ν 12.53 Cl 7.93 Experimental value: 58.96 6.13 12.31 7.74 The compound was prepared similarly to Example 14: (1 ) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3,4,5-tetrahydro-1H-3-benzodiazine-7-yl) -tetra Hydroimidazol-2-one-hydrochloride Melting point: > 250Ό
Rf值:0.46 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 理論值: C 62.62 Η 7.64 Ν 9.98 Cl 8.40 實驗值: 62.24 7.67 10.01 8.86 (2) 1-[反-4-(2-羧基乙基)環己基]-3-(1,2,3,4,5,6-六 氫-3-苯并一氮八園-8-基)-四氫咪唑-2-酮-氫氛化物 (3) 2-[4-(2-羧基乙基)苯基]-4-(2,3,4,5-四氫-lH-3-苯并一氮七團-7-基)-4H-l,2,4-三唑-3-嗣-氫氛化物 (4) 4-[4-(2-羧基乙基)苯基]-5-苯基-2-(2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)-4Η-1,2,4-三唑-3-酮-氫氯化 物 (5) 4-[4-(2_ 羧基乙基)苯基]-2-(2,3,4,5-四氫-lH-3-苯并一氮七園-7-基)-5-三氟甲基-4H-l,2,4-三唑-3-_-氫氯化物 (6) 卜[4-(2-羧基乙基)苯基]-3-(2,3,4,5-四氫-1H-3-苯 并一氮七團-7-基)-3,4,5 ,6“四氫-1H-嘧啶-2-酮-氫氛化 物 (7) 4-[4-(2-羧基乙基)苯基]-5-乙基-2-(2,3,4,5-四氫 -101 - 本紙張尺度遑用中國國家標準(CNS)甲4规格(210X 297公釐) {請先閱讀背面之注意事項再填寫本頁) .裝 訂. 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(100) -1H-3-苯并一氮七園-7-基)-4H-1.2,4-三唑-3-醑-氫氛化 物 (8) 5-[4-(2-羧基乙基)苯基]-4-甲基-2-(2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)-4Η-1,2,4-三唑-3-醑-氫氛化 物 (9) 4-[4-(2-羧基乙基)苯基]-3-甲基-1-(1,2,3,4-四氫 異喹啉-6-基)-四氫咪唑-2-酮-氫氛化物 (10) 2-[反-4-(2-羧基乙基)環己基]-4-(2,3,4,5-四氫 -111-3-苯并一氮七画-7-基)-211,411-1,2,4-三唑-3,5-二酮 -氫氛化物 (11) 1-[3-(2-羧基乙基)苯基]-3-(2,3,4,5-四氫-111-3-苯 并一氮七團-7-基)-四氫咪唑-2-酮-氫氯化物 (12) 1-[4-(狻基甲基)笨基]-3-(2,3,4,5-四氫-1(1-3-苯并 一氮七園-7-基)-四氫咪唑-2-酮-氫氯化物 (13) 2-[反- 4-(2-羧基乙基)環己基]-5-(2,3,4,5-四氫-1H-3-苯并一氮七圓-7-基)-3,4-二氫- 2H,5H-噻二唑-1,1 -二氧化物 值:0.50 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (14) 卜[4-(2-羧基-1-辛基)苯基]-3-(2,3,4,5-四氫-1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氯化物 (15) 2-[反-4-(2-羧基乙基)環己基]-4-(2.,3,4,5-四氫-1H-3-苯并一氮七園-7-基)-1-甲基-211,411-1,2,4-三唑-3,5-二酮-氫氯化物 (16) 1-[4-(3-羧基丙基)苯基]-3-(2,3,4,5-四氫-111-3-苯 -102- 本紙張尺度遑用中國國家揉準(CNS)甲4規格(210x297公釐) (請先閲讀背面之注意事項再填寫本頁) -裝 訂. 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(101) 并一氮t園-7-基)-四氩咪哇-2-酮-氩氛化物 (17) 1-(5-羧基丙基)-3-(2,3,4,5-四氫-1H-3-苯并一氮七 園-7-基)-四氫眯唑-2-酮-氫氯化物 (18) 1-[4-(2-羧基乙基)-2-氟笨基]-3-(2,3,4,5-四氫-1H-3-笨并一氮七画-7-基)-四氫咪唑-2-嗣-氫氣化物 (19) 1-[4-(2-羧基乙基)-3-甲基-苯基]-3-(2,3,4,5-四氫 -1H-3-苯并一氮七團-7-基)-四氫眯唑-2-酮-氫氯化物 (20) 1-[反-4-[(羧基甲基)氧]環己基]-3-(2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)-四氫眯唑-2-嗣-氫氛化物 熔點:316-317它(分解)Rf value: 0.46 (reverse phase silicone; methanol / 5¾ brine = 6: 4) Theoretical value: C 62.62 Η 7.64 Ν 9.98 Cl 8.40 Experimental value: 62.24 7.67 10.01 8.86 (2) 1- [Trans-4- (2- Carboxyethyl) cyclohexyl] -3- (1,2,3,4,5,6-hexahydro-3-benzodiazepine-8-yl) -tetrahydroimidazol-2-one-hydrogen atmosphere Compound (3) 2- [4- (2-carboxyethyl) phenyl] -4- (2,3,4,5-tetrahydro-lH-3-benzomonoazine-7-yl)- 4H-l, 2,4-triazole-3-hydrazone-hydrogenated compound (4) 4- [4- (2-carboxyethyl) phenyl] -5-phenyl-2- (2,3,4 , 5-tetrahydro-1H-3-benzotriazine-7-yl) -4fluorene-1,2,4-triazol-3-one-hydrochloride (5) 4- [4- (2_ Carboxyethyl) phenyl] -2- (2,3,4,5-tetrahydro-lH-3-benzodiazepine-7-yl) -5-trifluoromethyl-4H-1,2 , 4-triazole-3 -_- hydrochloride (6) [[4- (2-carboxyethyl) phenyl] -3- (2,3,4,5-tetrahydro-1H-3-benzene Pentazine-7-yl) -3,4,5,6 "tetrahydro-1H-pyrimidin-2-one-hydrogenated compound (7) 4- [4- (2-carboxyethyl) phenyl ] -5-ethyl-2- (2,3,4,5-tetrahydro-101-This paper uses Chinese National Standard (CNS) A4 specifications (210X 297 mm). {Please read the note on the back first Matters need to fill in this page). Binding. Economy Printed by A6 B6, Consumer Cooperatives of the Central Bureau of Standards. 5. Description of the invention (100) -1H-3-benzo-nitrogen-seven-garden-7-yl) -4H-1.2,4-triazole-3-hydrazone-hydrogenated compound (8) 5- [4- (2-carboxyethyl) phenyl] -4-methyl-2- (2,3,4,5-tetrahydro-1H-3-benzo-nitroazine-7 -Yl) -4Η-1,2,4-triazole-3- 醑 -hydrogenated compound (9) 4- [4- (2-carboxyethyl) phenyl] -3-methyl-1- (1 , 2,3,4-tetrahydroisoquinolin-6-yl) -tetrahydroimidazol-2-one-hydrogenated compound (10) 2- [trans-4- (2-carboxyethyl) cyclohexyl]- 4- (2,3,4,5-tetrahydro-111-3-benzotriazine-7-yl) -211,411-1,2,4-triazole-3,5-dione-hydrogen atmosphere Compound (11) 1- [3- (2-carboxyethyl) phenyl] -3- (2,3,4,5-tetrahydro-111-3-benzotriazine-7-yl)- Tetrahydroimidazol-2-one-hydrochloride (12) 1- [4- (fluorenylmethyl) benzyl] -3- (2,3,4,5-tetrahydro-1 (1-3-benzene Benzazine-7-yl) -tetrahydroimidazol-2-one-hydrochloride (13) 2- [trans- 4- (2-carboxyethyl) cyclohexyl] -5- (2,3, 4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -3,4-dihydro-2H, 5H-thiadiazole-1,1 -dioxide value: 0.50 (reverse Phase silicone; methanol / 5¾ brine = 6: 4) (14) bu [4- (2-carboxy-1-octyl Phenyl] -3- (2,3,4,5-tetrahydro-1H-3-benzotriazine-7-yl) -tetrahydroimidazol-2-one-hydrochloride (15) 2- [Trans-4- (2-carboxyethyl) cyclohexyl] -4- (2., 3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -1-form -211,411-1,2,4-triazole-3,5-dione-hydrochloride (16) 1- [4- (3-carboxypropyl) phenyl] -3- (2,3 , 4,5-Tetrahydro-111-3-benzene-102- This paper size is in accordance with China National Standard (CNS) A4 (210x297 mm) (Please read the precautions on the back before filling this page)- Binding. A6 B6 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the Invention (101) Benzodinitrogen-7-based) -Tetramimine-2-one-Argonate (17) 1- ( 5-carboxypropyl) -3- (2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydrooxazol-2-one-hydrochloride ( 18) 1- [4- (2-carboxyethyl) -2-fluorobenzyl] -3- (2,3,4,5-tetrahydro-1H-3-benzylazine-7-yl ) -Tetrahydroimidazole-2-fluorene-hydrogen (19) 1- [4- (2-carboxyethyl) -3-methyl-phenyl] -3- (2,3,4,5-tetrahydro -1H-3-benzomonoazine-7-yl) -tetrahydrooxazol-2-one-hydrochloride (20) 1- [trans-4-[(carboxymethyl) oxy] cyclohexyl] -3- ( 2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydrooxazole-2-fluorene-hydrogenated compound Melting point: 316-317 it (decomposed)
Rf值:0.6 6(逆相矽膠;甲醇/ 5S;鹽水液= 6:4) 理論值:C 59.50 Η 7.13 Η 9.91 Cl 8.36 實驗值: 59.26 7.13 9.94 8.44 (21) 卜[4-(反-2-狻基次乙基)苯基]-3-(2,3,4,5-四氫-1H-3 -苯并一氮七圃-7 -基)-四氫咪唑-2-酮-氫氛化物 Rr值:0,64 (逆相矽膠;甲醇/ 5%鹽水液= 6:4) 質譜圖:M + = 377 (22) l-[4-(2-狻基-1-丙基)笨基]-3-(2,3,4,5-四氬-1!1 -3-苯并一氮七園-7-基)-四氬咪唑-2-醑-氫氛化物X H2〇Rf value: 0.6 6 (reverse phase silicone; methanol / 5S; saline solution = 6: 4) theoretical value: C 59.50 Η 7.13 Η 9.91 Cl 8.36 experimental value: 59.26 7.13 9.94 8.44 (21) Bu [4- (Trans-2 -Fluorenylethyl) phenyl] -3- (2,3,4,5-tetrahydro-1H-3 -benzobenzoazine-7-yl) -tetrahydroimidazol-2-one-hydrogen Ambient Rr value: 0,64 (reverse phase silicone; methanol / 5% brine = 6: 4) Mass spectrum: M + = 377 (22) l- [4- (2-fluorenyl-1-propyl) Benzoyl] -3- (2,3,4,5-tetraargine-1! 1-3-benzodiazepine-7-yl) -tetrakimidazol-2-fluorene-hydrogenated compound X H2〇
Rf值:0.34 (逆相矽膠;甲醇/ 5%鹽水液= 6:4) 理論值: C 61.66 Η 6.71 Η 9.38 Cl 7.91 實驗值: 61.5 6 6.75 9.3 0 δ. 14 (2 3 )1-[反-4-(2-羧基乙基)環己基]-3-(2,3,4,5-四氫- -103- 本紙張尺度逍用中國國家標準(CNS)甲4規格(210X 297公釐) ........................................................................................... ........................玎................ {請先閲讀背面之注意事項再填寫本頁 A6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(102) 1H-3-笨并一氮七画-7-基)-3H-二氫咪唑-2-酮-氫氛化物 (2 4)1-[反-4-(2-羧基乙基)環己基]-3-(2,3,4,5-四氫-1H-2-苯并一氮七園-7-基)-四氫眯唑-2-嗣-氫氯化物 (2 5)2-[反-4-(2-羧基乙基)環己基]-4-(2,3,4,5-四氫-1H-3-苯并一氮七圓-7-基)-4Η-1,2,4-三唑-3-酮-氫氛化 物 使用2當虽濃度鹽酸和作為起始物之實施例18(1)之化 合物。 熔酤:> 220 1: 值:0.50 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 理論值: C 59.92 Η 6.94 Ν 13.31 Cl 8.42 實驗值: 60.03 6.99 13.32 8.46 (26)2-[反-4-(2-羧基乙基)環己基]-4-(2,3,4,5-四氫-1H-3-苯并一氮七園-7-基)-5-甲基- 4H-1,2,4-三唑-3-嗣 ••氫氛化物 (2 7)2-[反-4-(2-羧基乙基)環己基]-4-(2 ,3,4,5-四氫-1H-3-苯并一氮七團-7-基)-5-苯基-4H-1,2,4-三唑-3-酮 -氫氯化物 (28) 4-[反-4-(2-羧基乙基)環己基]-2-(2,3,4,5-四氫-1H-3-苯并一氮七團-7-基)-4Η-1,2,4-三唑-3-酮-氫氯化 物 熔點:> 240¾ 值:0·64 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) (29) 4-[反-4-(2-羧基乙基)環己基]-2-(2 ,3,4,5-四氫- (請先閱讀背面之注意事項再填窝本頁} -裝 、p. ‘綉. -104- 本紙張尺度逍用中國國家標準(CNS)甲4规格(210X297公釐) 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(1Q3 ) 1H-3-苯并一氮七園-7-基)-5-甲基-4H-1,2,4-三唑-3- _ -氫氛化物Rf value: 0.34 (reverse phase silicone; methanol / 5% saline solution = 6: 4) Theoretical value: C 61.66 Η 6.71 Η 9.38 Cl 7.91 Experimental value: 61.5 6 6.75 9.3 0 δ. 14 (2 3) 1- [Reverse -4- (2-Carboxyethyl) cyclohexyl] -3- (2,3,4,5-tetrahydro- -103- The standard of this paper is Chinese National Standard (CNS) A4 Specification (210X 297 mm ) ....................................... ................................................ ...... 玎 ................ {Please read the notes on the back before filling this page A6 B6 Central of the Ministry of Economy Printed by the Consumer Cooperatives of the Bureau of Standards V. Description of the invention (102) 1H-3-benzylazine-7-yl) -3H-dihydroimidazol-2-one-hydrogenated compound (2 4) 1- [ Trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3,4,5-tetrahydro-1H-2-benzotriazine-7-yl) -tetrahydrooxazole- 2-fluorene-hydrochloride (2 5) 2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (2,3,4,5-tetrahydro-1H-3-benzo-1 Nitrogen heptadecyl-7-yl) -4H-1,2,4-triazol-3-one-hydrogenated compound was used at a concentration of 2% hydrochloric acid and the compound of Example 18 (1) as a starting material. Melting &:> 220 1: Value: 0.50 (reverse-phase silicone; methanol / 5¾ brine = 6: 4) Theoretical value: C 59.92 Η 6.94 Ν 13.31 Cl 8.42 Experimental value: 60.03 6.99 13.32 8.46 (26) 2- [ Trans-4- (2-carboxyethyl) cyclohexyl] -4- (2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -5-methyl- 4H-1,2,4-triazole-3- 嗣 •• hydrogenated compound (2 7) 2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (2, 3,4, 5-tetrahydro-1H-3-benzodiazepine-7-yl) -5-phenyl-4H-1,2,4-triazol-3-one-hydrochloride (28) 4- [ Trans-4- (2-carboxyethyl) cyclohexyl] -2- (2,3,4,5-tetrahydro-1H-3-benzo-nitroazine-7-yl) -4Η-1,2 , 4-Triazol-3-one-hydrochloride Melting point: > 240¾ Value: 0.64 (reverse phase silicone; methanol / 5¾ brine = 6: 4) (29) 4- [Trans-4- (2 -Carboxyethyl) cyclohexyl] -2- (2,3,4,5-tetrahydro- (Please read the precautions on the back before filling this page} -Packing, p. 'Embroidery. -104- This paper Standards are used in China National Standard (CNS) A4 specifications (210X297mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A6 B6 V. Description of the invention (1Q3) 1H-3-Benzodiazine 7-based ) -5-methyl-4H-1,2,4-tri -3- _ - hydrogen atmosphere thereof
Rf值:0.48 (逆相矽膠;甲酵/5!«鹽水液= 6:4) 理論值: C 60.75 Η 7.18 Η 12.88 Cl 8.15 實驗值: 60.54 7.26 12.68 8.54 (30) 4-[反-4-(2-羧基乙基)環己基]-2-(2,3,4,5-四氫-1H-3-笨并一氮七圈-7-基)-5-苯基- 4H-1,2,4-三唑-3-酮 -氫氛化物 (31) _1-[4-(2-羧基-1-苯基-乙基)苯基]-3-(2,3,4,5-四氫 -1 Η-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氛化物Rf value: 0.48 (reverse phase silicone; formazan / 5! «Brine solution = 6: 4) Theoretical value: C 60.75 Η 7.18 Η 12.88 Cl 8.15 Experimental value: 60.54 7.26 12.68 8.54 (30) 4- [Trans-4- (2-carboxyethyl) cyclohexyl] -2- (2,3,4,5-tetrahydro-1H-3-benzylazine-7-yl) -5-phenyl-4H-1, 2,4-triazol-3-one-hydrogenated compound (31) _1- [4- (2-carboxy-1-phenyl-ethyl) phenyl] -3- (2,3,4,5- Tetrahydro-1 fluorene-3-benzodiazine-7-yl) -tetrahydroimidazol-2-one-hydrogenated compound
Rf值:0.31 (逆相矽膠;甲醇/5¾鹽水液= 6:4) (32) 1-[1-(2-羧基乙基)六氫吡啶-4-基]-3-(2,3,4,5-四 氫-1H-3-苯并一氛七圃-7-基)-四氫咪唑-2-酮-氫氯化物 (33) 1-(反-4-羧基環己基)-3-[2-(2,3,4,5-四氫-1H-3-苯 并一氮七園-7-基)乙基]-四氫咪唑- 2-_-氫氯化物 (34M-[2-(4-羧基笨基)乙基]-3-(2,3,4,5-四氫-111-3-苯 并一氮七團-7-基)-四氫咪唑-2-酮-氫氛化物 X H2〇 值:0.40 (逆相矽膠;甲醇/ 5¾鹽水液=6 :4) 質譜圖:M + = 379 理論值: C 60.89 Η 6.50 Η 9.68 Cl 8.17 實驗值: 60.57 6.62 9.77 8.22 窨倫例1 5 4 -「4 -「2-(用氬某羰某)乙某1¾某1-5 -申某-2-(3-三氩乙 醢某-2.3.4.5-四氩-1只-3-茉#一氪十圈-7-某)-4>1- -105- 本紙張尺度逍用中國國家搮準(CNST^i氣格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁) -裝 訂 經濟部中央標準局員工消费合作社印製 A6 B6 五、發明説明(104) 1 · 2.4- -翻 1.6克7-碘-3-三氟乙醚基- 2,3,4,5-四氫-lH-3-苯并一 氮七園、l.l克4-[4-[2-(甲氧基羧基)-乙基]苯基]-5-甲 基-4H-1,2,4-三唑-3-鬭、0.19毫升三-[2-(2-甲氧基乙 氧基)-乙基]-胺、130毫克氛化亞铜、130毫克碘化亞銅 和1. 1克碳酸鉀於30毫升二甲基甲醢胺內迴流2小時。冷 卻後*混合液經蒸發且殘渣於水和二氛甲烷間區分。固體 經抽氣過濾、有櫬曆分離、以水清洗、脫水、過滅和蒸發 。殘渣K層析法於矽膠管柱中使用環己烷/乙酸乙酯= 1:1純化。 產量:340毫克(理論值之16¾),Rf value: 0.31 (reverse phase silica gel; methanol / 5¾ brine = 6: 4) (32) 1- [1- (2-carboxyethyl) hexahydropyridin-4-yl] -3- (2,3, 4,5-tetrahydro-1H-3-benzo-1a-7-yl) -tetrahydroimidazol-2-one-hydrochloride (33) 1- (trans-4-carboxycyclohexyl) -3 -[2- (2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) ethyl] -tetrahydroimidazole- 2 -_- hydrochloride (34M- [ 2- (4-Carboxybenzyl) ethyl] -3- (2,3,4,5-tetrahydro-111-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one -Hydrogenated atmosphere X H2O value: 0.40 (reverse phase silica gel; methanol / 5¾ brine = 6: 4) Mass spectrum: M + = 379 Theoretical value: C 60.89 Η 6.50 Η 9.68 Cl 8.17 Experimental value: 60.57 6.62 9.77 8.22 Example 1 5 4-"4-" 2- (Using argon, carbonyl), E, 1, 1,2, 1-5,-Shen, -2- (3-Tri-argon, acetyl-, -2.3.4.5-Tetra-argon-1 Only -3- Mo # 一 氪 十 圈 -7-a) -4 > 1- -105- The standard of this paper is Chinese national standard (CNST ^ i gas grid (210X 297mm)) (Please read the back Please fill out this page again)-Binding A6 B6 printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (104) 1 · 2.4--Turn over 1.6 grams of 7-iodine-3-trifluoro Ether group-2,3,4,5-tetrahydro-lH-3-benzodiazepine, 11 g 4- [4- [2- (methoxycarboxy) -ethyl] phenyl] -5 -Methyl-4H-1,2,4-triazole-3-hydrazone, 0.19 ml of tri- [2- (2-methoxyethoxy) -ethyl] -amine, 130 mg of affluent cuprous, 130 mg of cuprous iodide and 1.1 g of potassium carbonate were refluxed in 30 ml of dimethylformamide for 2 hours. After cooling * the mixture was evaporated and the residue was separated between water and dichloromethane. The solid was filtered by suction It is separated by calendar, washed with water, dehydrated, extinguished and evaporated. The residue K chromatography is purified in a silica gel column using cyclohexane / ethyl acetate = 1: 1. Yield: 340 mg (the theoretical value of 16¾ ),
熔點:160-162 °C 值:0.51 (矽膠;環己烷/乙酸乙酯=1 :1) Μ下化合物自類似於實施例15製備: (1) 4-[反-4-[2-(甲氧基羰基)乙基]環己基]-2-(3-三氟 乙醯基-2,3,4,5-四氫-1H-3-笨并一氮七困-7-基)-5-甲基 _4Η~·1,2,4_三睡-3 -嗣 熔點:175-177Ό 值:0.50 (矽膠;二氯甲烷/乙酸乙酯= 90:10) (2) 4-[反-4-[2-(甲氧基羰基)乙基]環己基]-2-(3-三氟 乙醢基-2,3,4,5-四氫-1H-3-苯并一氮t圈-7-基>-Μ- ΐ,2,4-三唑-3-釅Melting point: 160-162 ° C Value: 0.51 (silicone; cyclohexane / ethyl acetate = 1: 1) The compound was prepared from analogous to Example 15 at (1) 4- [trans-4- [2- ( Methoxycarbonyl) ethyl] cyclohexyl] -2- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1H-3-benzyl-7-yl)- 5-methyl_4Η ~ · 1,2,4_trisleep-3-嗣 Melting point: 175-177Ό Value: 0.50 (silicone; dichloromethane / ethyl acetate = 90:10) (2) 4- [Reverse -4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -2- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1H-3-benzo-nitrogen t Circle-7-based > -M-fluorene, 2,4-triazole-3-fluorene
Rf值:0,40 (矽膠·*二氯甲烷/甲醇=100:1)Rf value: 0,40 (silicone · * dichloromethane / methanol = 100: 1)
窖淪俐1 R -106- 本紙張尺度遴用t國國家揉準(CNS)甲4规格(210 X 297公釐) 装.......................訂....................., {請先閲讀背面之注意事項再填窝本頁} 經濟部中央標準局貝工消費合作社印製 A6 ____ B6___ 五、發明説明(105) 1- 「际-4-Γ2-(甲氣某羰某)乙;BM指R某ΜΙ» 某-2.3.4.5-四氣-111-3-苯并一氦十圃-7-某)-廉蠹表 於4.1克(3-三氟乙醣基-2,3,4,5-四氫-1H-3-苯并一氮 七園-7-基)-異氰酸酯和3.7克[[反-4- [2-(甲氧基羰基 )-乙基]環己基]胺基]-醋酸甲酯-氫氛化物於50毫升乙腈 中加入3.2毫升N-乙基-二異丙基胺和混合液在室溫攪拌 2- 1/2日。反應液經蒸發,殘渣K乙酸乙酯溶取且Μ水和 鹽水液清洗。有機曆經脫水和蒸發且殘渣Μ少虽甲醇於冰 浴中再结晶。產物經抽氣遇濾、以冷甲酵清洗和乾埭。 產量:4.1克(理論值之56S!), 熔點:118-120t:Cellar Li 1 R -106- This paper size is selected from the national standard (CNS) A4 size (210 X 297 mm) of the country .............. ..... Order ..........., {Please read the notes on the back before filling in this page} Consumption of shellfish by the Central Standards Bureau of the Ministry of Economic Affairs Printed by the cooperative A6 ____ B6___ V. Description of the invention (105) 1- "ji-4-Γ2- (a gas, a carbonyl, a) B; BM means R, a ΜΙ», a -2.3.4.5-four gas-111-3- Benzo-Helium 10--7) -Linconium is shown in 4.1 g (3-trifluoroethylglycosyl-2,3,4,5-tetrahydro-1H-3-benzo-nitroazine garden-7 -Yl) -isocyanate and 3.7 g of [[trans-4- [2- (methoxycarbonyl) -ethyl] cyclohexyl] amino] -methyl acetate-hydrogenate in 50 ml of acetonitrile and 3.2 ml of N -Ethyl-diisopropylamine and the mixture were stirred at room temperature for 2 1/2 days. After the reaction solution was evaporated, the residue was extracted with ethyl acetate and washed with water and brine. The organics were dehydrated and evaporated and Although the residue M is small, the methanol is recrystallized in an ice bath. The product is filtered through suction, washed with cold formic acid, and dried. Yield: 4.1 g (56S!), Melting point: 118-120t:
Rf值:0.85 (矽膠;乙酸乙酯) g确例1 7 1-「反-4-「2-(星丙氬某镅某某Ί擐R某而甚-2.3.4.5-四氫-:^-3-茏并一氳十圓-7-某)-四氩眯_-9-翮 -fi氣彳h物 230毫克1-[反-4-[2-(異丙氧基羰基)乙基]環己基]-3 -(3-丙烯基-2,3,4,5-四氫-111-3-苯并一氮七圈-7-基)-四 氫眯唑-2-釅-氫氯化物於10毫升異丙醇内在30¾及50 psi氩壓下,在50毫克10J! Pd/C之存在下氫化6小時。觸 媒經抽氣過濾和濾液經蒸發。 產量:240毫克,Rf value: 0.85 (silicone; ethyl acetate) g Example 1 7 1- "trans-4-" 2- (star propyl argon 镅 Ί 擐 Ί 擐 Ί 擐 R 某 even -2.3.4.5-tetrahydro-: ^ -3-pyridine, one round, ten rounds, 7-some) -tetraargon, -9-fluorene-fi gas, 230 mg 1- [trans-4- [2- (isopropoxycarbonyl) ethyl ] Cyclohexyl] -3-(3-propenyl-2,3,4,5-tetrahydro-111-3-benzotriazine-7-yl) -tetrahydrooxazole-2-fluorene-hydrogen Chloride was hydrogenated in 10 ml isopropanol at 30¾ and 50 psi argon in the presence of 50 mg of 10J! Pd / C for 6 hours. The catalyst was filtered by suction and the filtrate was evaporated. Yield: 240 mg,
Rf值:0.55 (矽膠;二氛甲烷/甲醇/濃氨水 =95:5:1) -107- ϋ張尺度4L用中國國家揉準(CNS)甲4规格(210 X 297公釐) (諳先閲讀背面之注意事項再填窝本頁) .0 ·"· .類· 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(106) 奮掄Μ 1 8 2 -「反-4 -「2-(申氬某镅某)7,某1頊R某1-5-0三鐘乙醣 基-2.3.4.5-四氣-1^-荣#一氣十圓-7-某)-3.4-二馥 -211..1^-1.2.5-咯二_-11-二氬化物 於1.25克2-(3-三氟乙醢基-2,3,4,5-四氫-1Η-3-苯并一 氮七画-7-基)-3,4-二氫-2H,5H-1, 2,5-噻二唑-1,1-二氧 化物、0.64克3-(順-4-羥基環己基)丙酸甲酯[Rf值: 0.58克(矽膠;環己烷/乙酸乙酯= 1:1);自順/反混合 物Μ層析法於矽膠管柱中使用環己烷/乙酸乙酯(1:1)分 離〕和0· 90克三苯基膦於2毫升乙賸中,加入0.54毫升偶 氮二甲酸二乙酯。再加入1.5克3-(順-4 -羥基環己基) 丙酸甲酯和0 . 90克三苯基膦和0.5 4毫升偶氮二甲酸二乙酯 於2毫升乙腈之混合液。在室溫播拌30分鐘後,0.90克三 ι 苯基膦和0.54毫升偶氮二甲酸二乙酯之混合液再一次加入 。在室溫攪拌過夜後,混合液經蒸發和殘渣以層析法於矽 膠管柱中使用環己烷/乙酸乙酯/二氯甲烷(1:1:1)純化 〇 產量:700毫克(理論值之3850,Rf value: 0.55 (silicone; methane / methanol / concentrated ammonia = 95: 5: 1) -107- For the 4L scale, use China National Standard (CNS) A4 (210 X 297 mm) (谙 先Read the notes on the back and fill in this page) .0 · " ·· Classes · Printed by A6 B6 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (106) Fen M 1 8 2-"Anti-4 -"2- (Shen arg, y, y, y), 7, y, 1, y, 1-5-0, trisyl glycosyl-2.3.4.5-tetragas-1 ^-荣 # 一气 十 圆 -7-some)- 3.4-Difluorene-211..1 ^ -1.2.5-pyrodi-11-diargonide in 1.25 g of 2- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-1fluoride -3-Benzodiazepine-7-yl) -3,4-dihydro-2H, 5H-1, 2,5-thiadiazole-1,1-dioxide, 0.64 g of 3- (cis -4-Hydroxycyclohexyl) methyl propionate [Rf value: 0.58 g (silica gel; cyclohexane / ethyl acetate = 1: 1); Cyclohexane was used in a silica gel column for cis / trans mixture M chromatography Hexane / ethyl acetate (1: 1)] and 0.990 g of triphenylphosphine in 2 ml of ethyl acetate, 0.54 ml of diethyl azodicarboxylate was added, and 1.5 g of 3- (cis-4- Hydroxycyclohexyl) methyl propionate and 0.90 g of triphenylphosphine and 0.5 4 ml of azo A mixture of diethyl formate in 2 ml of acetonitrile. After stirring at room temperature for 30 minutes, a mixture of 0.90 g of triphenylphosphine and 0.54 ml of diethyl azodicarboxylate was added again. Stir overnight at room temperature. After that, the mixture was evaporated and the residue was chromatographed on a silica gel column using cyclohexane / ethyl acetate / dichloromethane (1: 1: 1). Yield: 700 mg (3850, theoretical value,
熔點:16 9 -17 3 1CMelting point: 16 9 -17 3 1C
Rf值:0.61 (矽膠;環己烷/乙酸乙酯/二氯甲烷 =1:1:1) Μ下化合物自類似於實施例18製備: (1) 2-[反-4-[2-(甲氧基羰基)乙基]環己基]-4-(3-第三 丁氧基羰基-2,3,4,5-四氫-111-3-苯并一氮七園-7-基)- 一 1 0 8 — 本紙張尺度逋用中國國家標準(CNS)甲4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝 訂. 經濟部中央標準局員工消费合作社印製 A6 ____B6_____ 五、發明説明(107) 4H-1,2,4-三唑-3-髑 熔點:162-164ΌRf value: 0.61 (silicone; cyclohexane / ethyl acetate / dichloromethane = 1: 1: 1) The compound was prepared from analogous to Example 18: (1) 2- [trans-4- [2- ( Methoxycarbonyl) ethyl] cyclohexyl] -4- (3-third-butoxycarbonyl-2,3,4,5-tetrahydro-111-3-benzodiazepine-7-yl) -1 0 8 — This paper size uses Chinese National Standard (CNS) A4 specifications (210X297 mm) (Please read the precautions on the back before filling out this page)-Binding. Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation A6 ____B6_____ V. Description of the invention (107) 4H-1,2,4-triazole-3- 髑 Melting point: 162-164Ό
Rr值:0.43 (矽膠;瓌己烷/乙酸乙酯/二氛甲烷 =1:1:1)Rr value: 0.43 (silicone; hexane / ethyl acetate / dichloromethane = 1: 1: 1)
窗淪锎1 Q 1-「反-4-(2-撖某乙某)頊己基1-3-U•田某四Μ -ΙΗ-3-笼# 一葡+圃-7-某1 -四氩脒脞-9-麵-¾短仆物 於5.0克1-[反-4-(2-羧基乙基)環己基]-3-(2,3,4,5-四氫-1H-3-苯并一氮七園-7-基)-四氫咪唑-2-酮-氫氣化 物、4.5毫升甲酸、3.6毫升37X水性甲醛和20毫升之混合 液中,加入2.0克碳酸氫納*然而以冰冷卻,且然後混合 液加熱至65 T。冷卻8小時後,攪拌過夜和混合液經蒸發 。殘渣Κ水播拌和再一次蒸發。然後殘渣Μ水再一次攪拌 和使用鹽酸調整pH至1 。其經蒸發,殘渣以少量水攫拌且 抽氣過滤。濾餅K丙酮攪拌,產物經抽氣過濾、K丙酮清 洗和真空乾燥。 產量:3.7克(理論值之7U), 熔點:292-295t:(分解) 1值:0.38 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4). K下化合物自類似於實施例19製備: (1) 1-[反-4-[(羧基甲基)氧]環己基]-3-(3-甲基-2,3, 4,5-四氫-111-3-苯并一氮七團-7-基)-四氫咪唑-2-酮-氫 氯化物 xNaClx0.5H20Window window 1 Q 1- "trans-4- (2- 撖 a certain Bum) 顼 hexyl 1-3-U • Tianmou four Μ -ΙΗ-3- cage # 一 Portuguese + Pu-7-some 1-4 Argon-9-face-¾ short servant in 5.0 g of 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2,3,4,5-tetrahydro-1H-3 -Benzotriazine-7-yl) -tetrahydroimidazol-2-one-hydrogenate, 4.5 ml of formic acid, 3.6 ml of 37X aqueous formaldehyde, and 20 ml of a mixture were added with 2.0 g of sodium hydrogen carbonate * Ice-cooled, and then the mixture was heated to 65 T. After cooling for 8 hours, stirred overnight and the mixture was evaporated. The residue K water was stirred and evaporated again. Then the residue M water was stirred again and adjusted to pH 1 with hydrochloric acid. After evaporation, the residue was stirred with a small amount of water and filtered with suction. The filter cake was stirred with K acetone, and the product was filtered with suction, washed with K acetone, and dried under vacuum. Yield: 3.7 g (7U of theory), Melting point: 292-295t: (Decomposition) 1 value: 0.38 (reverse phase silicone; methanol / 5¾ brine = 6: 4). The compound under K was prepared similarly to Example 19: (1) 1- [trans-4-[(carboxymethyl) Oxy] cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-111-3-benzo-nitroazine-7-yl) -tetrahydro -2-one - hydrochloride xNaClx0.5H20
Rf值:0.62 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) -109- 本紙張尺度逍用中8國家揉準(CNS)甲4規格(210X297公釐)~~~ (請先閲讀背面之注意事項再填寫本頁} •裝 ..Tr -綉. •-W- A6 _B6 _ 五、發明説明(1〇8 ) ' * l 理論值: C 52.28 Η 6.58 Η 8.31 Cl 13.49 實驗值:、52.28 6.58 8.33 14.03 (2) 1-[4-(2-後基-1-丙..基)苯基]-3-.(3-甲基-2,3,4,5-四 氫-1H-3-苯并一氮七画-7-基)-四氫咪唑-2-酮-氫氛化物 X 0.5 H2〇 ', 1^值:0·29 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 理論值: C 63.63 Η 6.90 Ν 9.28 Cl 7.83 實驗值: 63.32 6.99 9.32 7.81 , (3) 3-[反-4-(2-狻基乙基)環己基]-1-(3-甲基-2,3,4,5 -四氫-1H-3-笨并一氮七團-7-基)-尿囊素-氫氛化物 熔點:〉250Ό 值:0.32 (逆相矽膠;甲醇/ 5¾鹽水液=6:4) 理論值: C 61.39 Η 7.17 Ν 9.34 Cl 7.8 8 實驗值: 61.39 7.25 9.37 7.92 (4) 1-[反-4-(2-羧基乙基)環己基]-3-(3-甲基-2,3,4, 5 -四氫-1H-3-苯并一氮七園-7-基)-尿囊素-氫氯化物Rf value: 0.62 (reverse-phase silicone; methanol / 5¾ brine = 6: 4) -109- This paper size is used in 8 countries (CNS) A4 specification (210X297 mm) ~~~ (Please read first Note on the back, please fill out this page again.} • Equipment: Tr-Embroidery. • -W- A6 _B6 _ V. Description of the invention (108) ′ * l Theoretical value: C 52.28 Η 6.58 Η 8.31 Cl 13.49 Experimental value: 52.28 6.58 8.33 14.03 (2) 1- [4- (2-Postyl-1-propene..yl) phenyl] -3-. (3-methyl-2,3,4,5-tetrahydro- 1H-3-Benzodiazepine-7-yl) -tetrahydroimidazol-2-one-hydrogenated compound X 0.5 H2 0 ', 1 ^ value: 0 · 29 (reverse phase silicone; methanol / 5¾ saline solution = 6: 4) Theoretical value: C 63.63 Η 6.90 Ν 9.28 Cl 7.83 Experimental value: 63.32 6.99 9.32 7.81, (3) 3- [trans-4- (2-fluorenylethyl) cyclohexyl] -1- (3 -Methyl-2,3,4,5 -tetrahydro-1H-3-benzylazine-7-yl) -Allantoin-Hydrogenide Melting point:> 250Ό Value: 0.32 (reverse phase silicone; Methanol / 5¾ brine = 6: 4) Theoretical value: C 61.39 Η 7.17 Ν 9.34 Cl 7.8 8 Experimental value: 61.39 7.25 9.37 7.92 (4) 1- [trans-4- (2-carboxyethyl) cyclohexyl]- 3- (3-methyl-2,3,4,5 -tetrahydro-1H-3-benzo-nitroazine-7- ) - allantoin - hydrochloride
Rf值:0。37 (矽膠;二氛甲烷/甲醇/濃氨水 〆 =80:20:2) 理論值: C 61.39 Η 7.17 Η 9.34 Cl 7.88 實驗值: 61.11 ' 7.26 9.36 7.86 經濟部中央標準局員工消费合作社印製 (請先閲讀背面之注意事項再填寫本頁} (5) 2-[反- 4-(2-羧基乙基)環己基]-4-(3-甲基-2,3,4,5 -四氫-111-3-苯并一氮七_-7-基)-1-甲^-211,411-1,2,4-三唑-3,5-二酮-氫氛化物 (6) 2-[反-4-(2-羧基乙基)環己基]-4-(3-甲基-2,3,4,5 -110- 本紙張尺度適用中國國家標準(CNS)甲4規格(210X297公釐) ___ B6 _ 五、發明説明(109)Rf value: 0.37 (silicone; methane / methanol / concentrated ammonia water = 80: 20: 2) Theoretical value: C 61.39 Η 7.17 Η 9.34 Cl 7.88 Experimental value: 61.11 '7.26 9.36 7.86 Employees of the Central Standards Bureau of the Ministry of Economic Affairs Printed by Consumer Cooperatives (Please read the precautions on the back before filling out this page) (5) 2- [Trans- 4- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2,3, 4,5-tetrahydro-111-3-benzotriazine-7-yl) -1-methyl ^ -211,411-1,2,4-triazole-3,5-dione-hydrogenated compound ( 6) 2- [trans-4- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2,3,4,5 -110- This paper size applies to China National Standard (CNS) A4 Specifications (210X297 mm) ___ B6 _ V. Description of the invention (109)
-四氳-1H-3-苯并一氮t画-7-基>-4Η-1,2,4-三唑-3-酮-氫氛化物 熔點:> 220TC-Tetrapyrene-1H-3-benzo-nitrogen t--7-yl > -4 pyrene-1,2,4-triazol-3-one-hydrogenated compound Melting point: > 220TC
Rr值:0.48 (逆相矽膠;甲酵/5*!鹽水液= 6:4) 理論值: C 58.10 Η 7.36 Η 12.32 Cl 7.80 實驗值: 58.07 7.36 12.28 7.83 (7) 2-[反-4-(2-羧基乙基)環己基]-4-(3-甲基-2,3,4,5 -四氫-1H-3-苯并一氮if圓-7-基)-5-甲基-4H-1,2,4-三唑 -3-酮-氫氛化物 (8) 2-[反M-(2-羧基乙基)環己基]-4-(3-甲基-2,3,4,5 -四氫-1H-3-苯并一氮七團-7-基)-5-苯基- 4H-1,2,4-三唑 -3-酮-氫氛化物 (9) 4-[反- 4-(2-羧基乙基)環己基]-2-(3-甲基-2,3,4,5 -四氫-1H-3-苯并一氮七團-7-基)-4Η-1,2,4-三唑- 3-_-氫氯化物 (10) 4-[反- 4-(2-羧基乙基)環己基]-2-(3-甲基-2,3,4,5 -四氫-1H-3-苯并一氮七画-7-基)-5-甲基- 4H-1,2,4-三唑 -3-酮 X 1.1 HC1 x0.2H20 熔點:238-24〇υRr value: 0.48 (reverse phase silicone; formazan / 5 *! Saline solution = 6: 4) Theoretical value: C 58.10 Η 7.36 Η 12.32 Cl 7.80 Experimental value: 58.07 7.36 12.28 7.83 (7) 2- [Trans-4- (2-Carboxyethyl) cyclohexyl] -4- (3-methyl-2,3,4,5-tetrahydro-1H-3-benzo-nitrogen if-7-yl) -5-methyl -4H-1,2,4-triazol-3-one-hydrogenated compound (8) 2- [transM- (2-carboxyethyl) cyclohexyl] -4- (3-methyl-2,3 , 4,5 -tetrahydro-1H-3-benzodiazepine-7-yl) -5-phenyl-4H-1,2,4-triazol-3-one-hydrogenated compound (9) 4- [trans-4- (2-carboxyethyl) cyclohexyl] -2- (3-methyl-2,3,4,5 -tetrahydro-1H-3-benzomonoazine seven group-7- ) -4Η-1,2,4-triazole- 3 -_- hydrochloride (10) 4- [trans- 4- (2-carboxyethyl) cyclohexyl] -2- (3-methyl- 2,3,4,5 -tetrahydro-1H-3-benzodiazepine-7-yl) -5-methyl-4H-1,2,4-triazol-3-one X 1.1 HC1 x0 .2H20 Melting point: 238-24〇υ
Rf值:0.37 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) 理論值: C 60.55 H7.40 N 12.28 C1 8.5 5 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁). 實驗值: 60.68 7.53 12.31 8.36 (11) 4-[反- 4-(2-羧基乙基)環己基]-2-(3-甲基-2,3 ,4,5 -四氣-1H-3-笨并一氮七画-7-基)-5 -苯基-4H-1,2,4-三唾 -111 - 本紙張尺度逋用t國國家標準(CNS)甲4規格(210x297公釐) 經濟部中央標準局員工消費合作社印製 A6 B6__ 五、發明説明(11(D) -3-酮-氫氛化物 (12) 1-[反-4-(2-羧基乙基)環己基]-3-(3-甲基-2,3,4,5 -四氫-1H-3-笨并一氮七園-7-基)-3,4,5,6-四氬-111-嘧啶 -2-酮 X 1.05 HC1 χθ.3 H2〇 熔點:237-240¾ 。值:0.37 (逆相矽膠;甲醇/ 5X鹽水液= 6:4) 理論值: C 63.04 Η 8.07 Ν 9.18 Cl 8.14 實驗值: 62.97 8.05 9.15 8.16 (13) 卜[4-(2-羧基-;1-苯基-乙基)苯基]-3-(3-甲基-2,3, 4.5- 四氫-11!-3-苯并一氮七園-7-基)-四氫咪唑-2-_-氫 氮化物 (14) 1-[1-(2-羧基乙基)六氫吡啶-4-基]-3-(3-甲基-2, 3.4.5- 四氫-:^-3-苯并一氮七團-7-基)-四氫咪唑-2-酮-氫氯化物 (15) 1-(反-4-羧基環己基)-3-[2-(3-甲基-2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)乙基]-四氫咪唑-2-酮-氫氯化 物 (16) 卜[2-(4-羧基苯基)乙基]-3-(3-甲基-2,3,4,5-四氫 -1H-3-苯并一氮七画-7-基)-四氫眯唑-2-酮-氫氛化物 (17) 1-[反-4-(2-羧基乙基)環己基)-3-(7-甲基-6,7,8,9 -四氫- 5H-嘧啶并[4:5-01] —氮七團-2-基)四氫咪唑-2-酮 -氫氛化物 1^值:0.56 (逆相矽膠;甲醇/ 5¾盥水液= 6:4) 質譜圖:M + = 401 / -112- 本紙張尺度逋用中國國家樣準(CNS)甲4規格(210X297公釐) (請先閲讀背面之注意事項再填窝本頁) -裝 訂: 經濟部中央標準局員工消费合作社印製 A6 B6 五、發明説明(111) (18) 1-[反-4-(2-羧基乙基)環己基)-3-(7-甲基-6,7,8,9 -四氫-5H-吡畊并[2,3-d] —氮七困-2-基)四氫咪唑-2-酮 -氫氛化物 (19) 1-[反-4-(2-羧基乙基)環己基)-3-(7-甲基-6,7,8,9 -四氫- 5H-吡啶并[2,3-d] —氮七團-2-基)四氫眯唑-2- _ 氫氛化物 (20) 1-[反-4-(2-羧基乙基)環己基]-3-(2-甲基-1,2,3,4 -四氫-異喹啉-6-基)-四氫咪唑-2-嗣-氫氛化物 (21) 1-[反-4-(2-羧基乙基)環己基]-3-(2-甲基-2,3,4,5 -四氫-1H-3-苯并一氮七團-7-基)-四氫咪唑-2-酮-氫氛化 物 (22) 1-[反- 4-(2-羧基乙基)環己基]-3-(3-甲基-1,2,3, 4.5 ,6-夂氫-3-苯并一氮八團-8-基)-四氫咪唑-2-酮-氫氯 化物 (23) 2-[反-4-(2-狻基乙基)環己基]-4-(3-甲基-2,3,4,5 -四氫-1H-3-苯并一氮七團-7-基)-2Η,4Η-1,2,4-三唑- 3.5 -二酮-氫氯化物 啻淪例2 0 1-M-7,某…四氩-1H-:¾-笼井一M十W-7-某)Ί 「4-「2-(g氬某镅某)ス某Ί¾某-四氩眯ll¢-2-aa 600毫克1-[ 4-[2-(甲氧基羰基)乙基]苯基]-3 -(2,3, 4,5-四氫-111-3-苯并一氮七圈-7-基)-四氫眯唑-2-酮-氫 氛化物和128毫克氫化納(55¾於石腊油中)於15毫升二 甲基甲醯胺中在超音波浴中處理2.5小時。加入125微升 -113- 本紙張尺度遴用中國國家標準(CNS)甲4规格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) -裝 ,訂. 經濟部中央標準局貝工消費合作社印製 A6 ___ B6_____ 五、發明説明(112) 碘乙烷和混合液再處理2·5小時。反應液與50毫升水姐合 ,沉锻經油氣過«,以水清洗和乾燥。粗產物Μ曆析法於 矽膠管柱中使用二氛甲烷/甲酵/濃氨水(9:1 :0.1)純化 0 產量:260奄克(理論值之44¾)Rf value: 0.37 (reverse phase silicone; methanol / 5¾ brine = 6: 4) Theoretical value: C 60.55 H7.40 N 12.28 C1 8.5 5 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back first) Fill out this page again.) Experimental values: 60.68 7.53 12.31 8.36 (11) 4- [trans- 4- (2-carboxyethyl) cyclohexyl] -2- (3-methyl-2,3,4,5- Siqi-1H-3-benzyl-1N-7-yl) -5 -phenyl-4H-1,2,4-trisialol-111-This paper uses National Standard (CNS) A 4 Specifications (210x297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A6 B6__ V. Description of the Invention (11 (D) -3-keto-hydrogenated compound (12) 1- [trans-4- (2-carboxyl Ethyl) cyclohexyl] -3- (3-methyl-2,3,4,5-tetrahydro-1H-3-benzylazine-7-yl) -3,4,5,6- Tetra-111-pyrimidin-2-one X 1.05 HC1 χθ.3 H2 0 Melting point: 237-240¾. Value: 0.37 (reverse phase silicone; methanol / 5X saline solution = 6: 4) Theoretical value: C 63.04 Η 8.07 Ν 9.18 Cl 8.14 Experimental value: 62.97 8.05 9.15 8.16 (13) [4- (2-carboxy-; 1-phenyl-ethyl) phenyl] -3- (3-methyl-2,3, 4.5- tetra Hydrogen-11! -3-benzo-nitroazine-7-yl) -tetrahydroimidazole-2- _-Hydronitride (14) 1- [1- (2-carboxyethyl) hexahydropyridin-4-yl] -3- (3-methyl-2, 3.4.5- tetrahydro-: ^-3 -Benzobenzoazine-7-yl) -tetrahydroimidazol-2-one-hydrochloride (15) 1- (trans-4-carboxycyclohexyl) -3- [2- (3-methyl- 2,3,4,5-tetrahydro-1H-3-benzodiazine-7-yl) ethyl] -tetrahydroimidazol-2-one-hydrochloride (16) Bu [2- (4 -Carboxyphenyl) ethyl] -3- (3-methyl-2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydrooxazole-2 -Keto-hydrogenated compound (17) 1- [trans-4- (2-carboxyethyl) cyclohexyl) -3- (7-methyl-6,7,8,9 -tetrahydro-5H-pyrimido [4: 5-01] —Nitrazine-2-yl) tetrahydroimidazol-2-one-hydrogenated compound 1 ^ value: 0.56 (reverse phase silicone; methanol / 5¾ toilet solution = 6: 4) Mass spectrum : M + = 401 / -112- This paper size adopts China National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)-Binding: Central Standard of the Ministry of Economic Affairs Printed by the Consumer Cooperative of the Bureau A6 B6 V. Description of the invention (111) (18) 1- [trans-4- (2-carboxyethyl) cyclohexyl) -3- (7-methyl-6,7,8, 9-tetrahydro-5H-pyracino [2,3-d] —nitrosepta-2-yl) tetra Imidazol-2-one-hydrogenated compound (19) 1- [trans-4- (2-carboxyethyl) cyclohexyl) -3- (7-methyl-6,7,8,9 -tetrahydro-5H -Pyrido [2,3-d] —aza-seven-2-yl) tetrahydrooxazole-2- _hydrogenated compound (20) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (2-methyl-1,2,3,4-tetrahydro-isoquinolin-6-yl) -tetrahydroimidazole-2-fluorene-hydrogenated compound (21) 1- [trans-4- (2-Carboxyethyl) cyclohexyl] -3- (2-methyl-2,3,4,5 -tetrahydro-1H-3-benzomonoazine-7-yl) -tetrahydroimidazole- 2-keto-hydrogenated compound (22) 1- [trans-4- (2-carboxyethyl) cyclohexyl] -3- (3-methyl-1,2,3, 4.5,6-fluorenhydro-3 -Benzotriazol-8-yl) -tetrahydroimidazol-2-one-hydrochloride (23) 2- [trans-4- (2-fluorenylethyl) cyclohexyl] -4- (3 -Methyl-2,3,4,5-tetrahydro-1H-3-benzomonoazine-7-yl) -2Η, 4Η-1,2,4-triazole-3.5-dione-hydrogen Example of chloride bleaching 2 0 1-M-7, some ... tetra-argon-1H-: ¾-cage well-one M ten W-7-some) Ί "4-" 2- (g argon some 镅) ¾¾-tetraargon ll ¢ -2-aa 600 mg 1- [4- [2- (methoxycarbonyl) ethyl] phenyl] -3-(2,3, 4,5-tetrahydro-111 -3-Benzotriazine-7-yl) -tetrahydroxazol-2-one-hydrogenated compound and 128 mM Sodium hydride (55¾ in paraffin oil) was treated in 15 ml of dimethylformamide in an ultrasonic bath for 2.5 hours. Add 125 microliters -113- This paper uses Chinese National Standard (CNS) A4 specifications (210X297 mm) (please read the precautions on the back before filling this page)-binding, ordering. Printed by the Industrial and Consumer Cooperatives A6 ___ B6_____ V. Description of the invention (112) Ethyl iodide and the mixed solution are processed for another 2.5 hours. The reaction solution was combined with 50 ml of water, and the forging was passed through oil and gas, washed with water and dried. Crude product M is analyzed by silica gel column using dichloromethane / formaldehyde / concentrated ammonia (9: 1: 0.1). 0 Yield: 260 g (44¾ of theory)
熔點:168-170T R*·值:0.45 (矽膠;二氛甲烷/甲醇/濃氨水 =4:1:0.2) Μ下化合物自類似於實施例20製備: (1) 1-(3-丁基-2, 3,4,5-四氫-1Η-3-苯并一氮七画-7-基 )-3-[4-[2-(甲氧基羰基)乙基]苯基]-四氫咪唑-2-酮 值:0.64(矽膠;二氮甲烷/甲醇/濃氨水 =4:1:0.2) (2) 1-[反-4-[2-(異丙氧基羰基)乙基]環己基]-3-(3-丙 烯基-2,3,4,5-四氫-111-3-苯并一氮七画-7-基)-四氫咪唑 -2-酮-氫氮化物 以溴丙烯/ N-乙基二異丙基胺於乙腈中進行。 1^值:0.63 (矽膠;二氛甲烷/甲酵/濃氨水 =95:5:1) (3) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(3-苄基 -2,3,4,5-四氫-11^3-苯并一.氮七睡-7-基)-四氫眯唑-2-酮-氫氯化物 值:0.30 (矽膠;二氯甲烷/甲醇= 95: 5) (4) 1-[反-4-[2 -(甲氧基羰基)乙基]環己基]-3-[3-(環丙 —114 — :本紙張尺度遑用_國國家揉準(CNS)甲4规格(210X297公釐) {請先閲讀背面之注意事項界填寫本頁) .装· ,訂. 經濟部中央標準局員工消費合作社印製 _B6__ 五、發明説明(113) 基甲基)-2,3,4,5-四氫-1H-3-苯并一氮七画-7-基)-四氫 咪唑-2-酮-氫氛化物 乙睛和環丙基甲基溴在碘化納和N-乙基二異丙基胺之存 在下使用。 熔點:225-230 ¾ (分解)Melting point: 168-170T R *. Value: 0.45 (silicone; methane / methanol / concentrated ammonia = 4: 1: 0.2) The compound was prepared from similar to Example 20: (1) 1- (3-butyl -2,3,4,5-tetrahydro-1fluorene-3-benzodiazepine-7-yl) -3- [4- [2- (methoxycarbonyl) ethyl] phenyl] -tetra Hydroimidazol-2-one value: 0.64 (silicone; diazomethane / methanol / concentrated ammonia = 4: 1: 0.2) (2) 1- [trans-4- [2- (isopropoxycarbonyl) ethyl] Cyclohexyl] -3- (3-propenyl-2,3,4,5-tetrahydro-111-3-benzotriazine-7-yl) -tetrahydroimidazol-2-one-hydronitride Bromopropene / N-ethyldiisopropylamine was performed in acetonitrile. 1 ^ value: 0.63 (silicone; methane / formaldehyde / concentrated ammonia = 95: 5: 1) (3) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl]- 3- (3-benzyl-2,3,4,5-tetrahydro-11 ^ 3-benzo-1.azine-7-yl) -tetrahydrooxazol-2-one-hydrochloride value: 0.30 (silicone; dichloromethane / methanol = 95: 5) (4) 1- [trans-4- [2-(methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (cyclopropyl-114 —: This paper size is used _ China National Standards (CNS) A4 specifications (210X297 mm) {Please read the notes on the back to complete this page). Install, order, and staff consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Printed _B6__ V. Description of the Invention (113) methylmethyl) -2,3,4,5-tetrahydro-1H-3-benzodiazepine-7-yl) -tetrahydroimidazol-2-one -Hydrogenated acetonitrile and cyclopropylmethyl bromide are used in the presence of sodium iodide and N-ethyldiisopropylamine. Melting point: 225-230 ¾ (decomposed)
Rr值:0.72 (矽膠;二氛甲烷/甲醇/濃氨水 =90:10:2) (5) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-[3-(2-羥 基乙基)-2,3,4,5 -四氫-1H-3 -苯并一氮七園-7-基)-四氫 咪唑-2-酮-氫碘化物 乙腈和2-溴乙醇在碘化納和N-乙基二異丙基胺之存在下 使用。 熔點:> 200 t:Rr value: 0.72 (silicone; methane / methanol / concentrated ammonia = 90: 10: 2) (5) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- [3- (2-hydroxyethyl) -2,3,4,5 -tetrahydro-1H-3 -benzobenzoazine-7-yl) -tetrahydroimidazol-2-one-hydroiodide acetonitrile And 2-bromoethanol are used in the presence of sodium iodide and N-ethyldiisopropylamine. Melting point: > 200 t:
Rf值:0.55 (矽膠;二氛甲烷/甲醇/濃氨水 =90:10:2) (6) 卜[反-4-[2 -(甲氧基羰基)乙基]環己基]-3 - [3-(甲氧 基羰基甲基)-2,3,4,5-四氫-1卜3-苯并一氮七圃_7-基)-四氩咪唑-2-酮 乙腈和2-溴乙酸甲酯在碘化納和N -乙基二異丙基胺之存 在下使用,分維出游離碱。 熔點:127-129¾ 值:0.28 (逆相矽膠;甲醇/ 5¾鹽水液= 6:4) n m m 2λ 3 -「反-4 -「2-(甲氬某羰某某1頊R基1-1-(2.3.4.5-四 -115- 本紙張尺度进用t國國家標準(CNS)甲4规格(210 (請先閲讀背面之注意事項再填窝本頁} -裝 訂. A6 B6 五、發明説明U4 ) (請先閲讀背面之注意事項再填窝本頁)Rf value: 0.55 (silicone; methane / methanol / concentrated ammonia = 90: 10: 2) (6) [[trans-4- [2-(methoxycarbonyl) ethyl] cyclohexyl] -3-[ 3- (methoxycarbonylmethyl) -2,3,4,5-tetrahydro-1b 3-benzodiazepine-7-yl) -tetrakimidazol-2-oneacetonitrile and 2-bromo Methyl acetate is used in the presence of sodium iodide and N-ethyldiisopropylamine to fractally extract the free base. Melting point: 127-129¾ Value: 0.28 (reverse phase silica gel; methanol / 5¾ saline solution = 6: 4) nmm 2λ 3-"trans-4-" 2- (methyl argon carbonyl certain 1 某 R group 1-1-1 (2.3.4.5-IV-115- National Standard (CNS) A4 specifications for this paper size (210 (Please read the precautions on the back before filling in this page)-Binding. A6 B6 V. Invention Description U4 ) (Please read the notes on the back before filling this page)
ff-in笼祐一短十圃-7-<n-M蠹素-««伤物I 氯化氨氣通入920奄克3-[反_4-[2-(甲氧基羰基)乙基 ]-環己基]-1-(3-三氟乙醢基- 2,3,4,5-四氫-lH-3-苯并一 氮七園-7-基)-尿囊素於5()奄升甲醇中10分鐘和混合液然 後迴流5小時。其經冷卻,產物經抽氣過滹、以甲酵和乙 醚清洗和在80 t:乾煉。 產量:770毫克(理論值之95¾) 熔點:> 250t: 值:0.23 (逆相矽膠;甲醇/ 53ί鹽水液=6:4) Κ下化合物自類似於實施例21製備: -裝 (1) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(2,3,4, 5-四氫-1H-3-苯并一氮七画-7-基)-尿囊素-氫氛化物 熔點:> 2 5 0 t: 值:0.43 (逆相矽膠;甲酵/ 5¾鹽水液= 6:4) 理論值: C 61.39 Η 7.17 Ν 9.34 Cl 7.88 實驗值: 61.10 7.21 9.29 8.03 (2) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(2,3,4, 5-四氫-111-3-苯并一氮七圈-7-基)-3,4,5,6-四氫-1{1-嘧 啶-2-嗣-氫氯化物ff-in Cangyou a short ten garden-7- < nM 蠹 素-«« Wound I ammonium chloride gas flow 920 g g 3- [trans_4- [2- (methoxycarbonyl) ethyl] -Cyclohexyl] -1- (3-trifluoroethylfluorenyl-2,3,4,5-tetrahydro-lH-3-benzodiazepine-7-yl)-allantoin in 5 () The mixture was decanted for 10 minutes and the mixture was refluxed for 5 hours. After cooling, the product is pumped through 滹, washed with formic acid and ethyl ether and dried at 80 t: dry refining. Yield: 770 mg (95¾ of theory) Melting point: > 250t: Value: 0.23 (reverse-phase silicone; methanol / 53 liters of saline solution = 6: 4) The compound under κ was prepared similarly to Example 21: -pack (1) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (2,3,4, 5-tetrahydro-1H-3-benzomonoazine-7- Base) -Allantoin-Hydrogenate Melting point: > 2 5 0 t: Value: 0.43 (reverse phase silicone; formazan / 5¾ saline solution = 6: 4) Theoretical value: C 61.39 Η 7.17 Ν 9.34 Cl 7.88 Experiment Value: 61.10 7.21 9.29 8.03 (2) 1- [trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (2,3,4, 5-tetrahydro-111-3- Benzoazine-7-yl) -3,4,5,6-tetrahydro-1 {1-pyrimidine-2-hydrazone-hydrochloride
Rf值:0.31 (逆相矽膠;甲醇/5»;鹽水液= 6:4) n m ? ? 3-「反-4-「2-(甲氢某羰某)π甚·|揭P.甚1-1-三 濟 部 中 央 標 準 Μ 貝 工 消 費 合 作 社 印 製 基-2.3.4· 5-四氫-1Η-3-笼并一氬十酾-7-某尿爨袤 40毫克第三丁氧化鉀加入至2.1克Ν-[反-4-[2-(甲氧基 116 本紙張尺度逋用t國國家樣準(CNS)甲4规格(210X297公釐) 經濟部中央標準局貝工消费合作社印製 A6 B6 _ 五、發明説明f15 ) 羰基)乙基]-環己基]-Η’-[(苄氧基羰基)甲基]-Ν’-(3-三 氟乙醢基-2,3,4,5-四氩-1卜3-苯并一氮七睡-7-基)-腺 於25橐升沸鼸甲笨中,和混合液經酒流3 0分鐘。反應液冷 卻後*與數滴冰醣酸攪拌、蒸發和以牖析法於矽膠管柱中 使用環己烷/乙酸乙醮(8:2至7:3)纯化和自甲酵中再结 晶0 產悬·· 0.95克(理論值之55X), 熔點:132-134TC IU值:0.59 (矽謬;環己烷/乙酸乙_ = 1:1) g淪例H 1-Γ反-4-Γ2-【田氬某镛某某1頊R某卜四 瓴-;^-喃啶#「4.5-41—值十圃-2-某)-四《眯邮-?-麵 1.0克1-[反-4-[2-(甲氧基羰基)乙基]-環己基]-3-(7-苄基-6,7,8,9-四氫-5{1-嘧啶[4,5-(1]—氮七圖-2-基 )-3Η-二氫咪唑-2-酮於15毫升甲醇中在500毫克Pd/C ( 10¾鉑)在室溫及50 psi氫壓下氫化17小時。觸媒經濾掉 且濾液經蒸發。殘渣直接用K製備實施例9(16)之化合物 Ο 值:0.44 (逆相矽膠;甲醇/5SK麴水液= 6:4) K下化合物自類似於實施例23製備: (1) 1-[反-4-[2-(甲氧基羰基)乙基]環己基]-3-(6,7,8, 9 -四氫-5H -吡啶[2,3-d] —氮七園-2 -基)-四氫咪唑-2-酮 氫氛化物n m m ?λ {請先閲讀背面之注意事項再填窝本頁) *裝 訂. -117- 本紙張尺度逋用中Η國家標準(CNS)甲4规格(210X_297公釐) A6 B6 五、發明説明f16 ) 1-Γ2-(7,氬某激甚某 1-2-「4-(3-甲某-2.3.4.5-四氣 —思園-7-某)笼甚1-四瓴脒啤-2-酮 3.1克(3-甲基-2,3,4,5-四氫-1H-3-笨并一氮七園-7 基)-砸酸、4.1克卜[2-(乙氧基羰基) 基磺_氧基)苯基]-四氫咪唑-2-醑、 )-鉑和6.5奄升三乙基胺於25毫升二 100 ΐ:下攫拌4小時。反應液冷卻後 殘渣溶於二氛甲烷。混合液於矽酸土 和所得殘渣K層析法於矽膠管柱中使 (100:7)纯化。 產量:2.7克(理論值之63¾), Rr值:0,31 (矽膠;二氛甲烷/甲醇 當倫例2 5 · 含毎毫并2.5畜京抹件物皙夕_水安 乙基]-3-[4-(三氟甲 3.5克四(三苯基膦 甲基甲醢胺在氮氣及 ,真空下蒸發和所得 中濾遇、濾液烴蒸發 用二氛甲烷/甲酵 100:7) M. {請先閲讀背面之注意事項再填寫本頁) •裝 訂. 經 中 央 標 準 局 貝 X. 消 費 合 作 社 印 製 2.5毫克 50.0奄克 1.0毫升 姐成: 活性物質 甘露酵 加_水Μ注射 製備: 活性物質和甘露醇溶於水中。該溶液經轉至安缻中後 其經冷凍乾煉。 在使用之時,該溶液用水調成以注射。 當淪例2 fi 含毎2毫并3 5毫克活桦物皙夕铖太夯瓿 118 本紙張尺度遑用中國國家標準(CNS)甲4规格(.210 X 297公釐) A6 B6 五、發明説明(117) 姐成: 35.0毫克 100.0毫克 2.0毫升 {請先閲讀背面之注意事項再填窝本頁} 活性物質 甘露醇 加_水Μ注射 製備: 活性物質和甘露酵溶於水中。該溶液娌轉至安瓿中後* 其經冷凍乾嫌》 在使用之時•該溶液用水讕成Κ注射。 富淪俐27Rf value: 0.31 (reverse phase silicone; methanol / 5 »; saline solution = 6: 4) nm?? 3-" trans-4- "2- (methyl hydrogen carbonyl) π even -1-The central standard of the Ministry of Health of the PR of China, Beige Consumer Cooperative Co., Ltd.-2.3.4 · 5-tetrahydro-1Η-3-cage and one argon ten 酾 -7-urine 40mg third butoxide Added to 2.1 grams of NR- [trans-4- [2- (methoxyl 116) This paper is in the national standard (CNS) A4 specification (210X297 mm). Printed by the Bayer Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. Preparation of A6 B6 _ 5. Description of the invention f15) carbonyl) ethyl] -cyclohexyl] -fluorene '-[(benzyloxycarbonyl) methyl] -N'-(3-trifluoroethylfluorenyl-2,3, 4,5-tetra-argon-1, 3-benzo-nitroazine, 7-yl) -gland in 25 liters of boiling carbamidine, and the mixed solution was passed through a wine stream for 30 minutes. After the reaction solution was cooled * and A few drops of sorbic acid were stirred, evaporated and decanted in a silica gel column using cyclohexane / ethyl acetate (8: 2 to 7: 3), purified and recrystallized from formazan fermentation. 0.95 g (Theoretical value of 55X), Melting point: 132-134TC IU value: 0.59 (Silicon; cyclohexane / ethyl acetate _ = 1: 1) g Example H 1-Γ trans-4-Γ2- [Tian arg some 镛So so 1 顼 R so Tetrapyrene; ^ -furidine # "4.5-41-value Shipu-2-a)-Tetrapyrene-?-Face 1.0 g 1- [trans-4- [2- (methoxycarbonyl) ethyl Group] -cyclohexyl] -3- (7-benzyl-6,7,8,9-tetrahydro-5 {1-pyrimidine [4,5- (1] -azaheptyl-2-yl) -3Η -Dihydroimidazol-2-one was hydrogenated in 15 ml of methanol at 500 mg Pd / C (10¾ platinum) at room temperature and 50 psi hydrogen pressure for 17 hours. The catalyst was filtered off and the filtrate was evaporated. The residue was directly used K Compound 0 in Preparation Example 9 (16) Value: 0.44 (reverse phase silicone; methanol / 5SK 麴 water = 6: 4) The compound under K was prepared similarly to Example 23: (1) 1- [Trans-4- [2- (methoxycarbonyl) ethyl] cyclohexyl] -3- (6,7,8, 9 -tetrahydro-5H -pyridine [2,3-d] -azaheptad-2-yl)- Tetrahydroimidazol-2-one hydrogen odorant nmm? Λ (Please read the precautions on the back before filling in this page) * Binding. -117- This paper is a standard of China National Standard (CNS) A4 (210X_297) (Mm) A6 B6 V. Description of the invention f16) 1-Γ2- (7, argon excites a certain 1- 2- "4- (3-a certain a-2.3.4.5-four gas-Siyuan-7-a certain) cage Even 1-tetramidine-2-one 3.1 g (3-methyl-2,3,4,5-tetrahydro-1H-3-benzylazine-7-group)-acid, 4.1 g of [2- (ethoxycarbonyl) sulfo_oxy) phenyl] -tetrahydroimidazole-2-fluorene, platinum) and 6.5 liters of triethylamine in 25 ml of two 100 100: lower ΐ Mix for 4 hours. After the reaction solution was cooled, the residue was dissolved in dichloromethane. The mixture was purified by silica gel column chromatography (100: 7) with silica gel and the resulting residue. Yield: 2.7 g (63¾ of theoretical value), Rr value: 0,31 (silicone; dichloromethane / methanol when Denglun example 2 5 · Contains 2.5 millimeters and 2.5 gram Beijing Wishes_Shui'an Ethyl]- 3- [4- (Trifluoromethyl 3.5 g tetrakis (triphenylphosphinemethylformamidine) is evaporated under nitrogen and vacuum, and the resulting solution is filtered, and the filtrate hydrocarbon is evaporated. Dichloromethane / formaldehyde 100: 7) M {Please read the precautions on the back before filling this page) • Binding. Printed by the Central Bureau of Standards X. Consumer Cooperative 2.5 mg 50.0 g 1.0 ml Sister: Active substance Mannase plus _water M Injection Preparation: Active Substances and mannitol are dissolved in water. The solution is transferred to amphibians and freeze-dried. When in use, the solution is prepared with water for injection. When Example 2 fi contains rhenium 2 milligrams and 35 milligrams live物 物 西 夕 铖 Tamped ampoule 118 This paper size uses Chinese National Standard (CNS) A4 specifications (.210 X 297 mm) A6 B6 V. Description of the invention (117) Sister: 35.0 mg 100.0 mg 2.0 ml { Please read the notes on the back before filling this page} Active substance mannitol plus _water M injection preparation: Active substance and After fermentation Lu dissolved in water. The solution was transferred to an ampoule OilPainting which * "• Lan The solution was washed with water in use to the freeze-dried injection Κ suspected. Li-rich perish 27
佥.R0奎克活桦物1笛之SH .裝 姐成: (1) 活性物質 50.0奄克 (2) 乳糖 98.0奄克 (3>玉米澱粉 50.0奄克 (4) 聚乙烯吡咯啶酮 15.0奄克 (5) 硬脂酸鎂 2.0亲克 215.0奄克 製備: 經濟部中央標準局貝工消费合作社印製 (1>、(2)和(3)混合在一起且與(4)之水溶液粒狀化。加 入(5)至乾粒中。自此混合物製成壓縮的藥片,在雙面上 有雙平面、複面,和在單面上刻有凹痕。藥片直徑:9毫 米〇 管倫剜28 含350綦京抹桦物皙夕链Η -119- 本紙張尺度逋用令困國家祺準(CNS)甲4规格(210X297公釐) 350.0毫克 136.0毫克 80.0毫克 30.0毫克 4.0¾¾ 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(118) 姐成: (1) 活性物質 (2) 乳糖 (3) 玉米澱粉 (4) 聚乙烯吡咯啶酮 (5) 硬脂酸鎂 600.0毫克 製備: (1)、(2)和(3)混合在一起且與(4)之水溶液粒狀化。加 入(5)至乾粒中。自此混合物製成壓縮的藥片,在雙面上 有?I平面、複面,和在單面上刻有凹痕。藥片直徑:12毫 米。 當掄例29 含10¾竞活神物皙之孩II 姐成: (1) 活性物質 50.0毫克 (2) 無水玉米澱粉 58.0毫克 (3) 粉末化乳糖 50.0奄克 (4) 硬脂酸鎂 2.0毫克 160.0奄克 製備: (1)與(3) —同搗碎。此搗碎物在镦底混合下加入至(2) 和(4)之混合物中。 此粉末的混合物在膠囊填充櫬器中裝入3號硬明膠櫬圓 120 本紙張尺度遑用中國國家揉準(CNS)肀4规格(210X297公釐}: (請先閲讀背面之注意事項再填窝本頁)佥 .R0 Quaker live birch 1 SH SH. Pretend to be: (1) 50.0 g of active substance (2) 98.0 g of lactose (3 > 50.0 g of corn starch) (4) 15.0 g of polyvinylpyrrolidone Gram (5) Magnesium stearate 2.0 Prog 215.0 g Preparation: Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (1 >, (2) and (3) mixed together and granular with the aqueous solution of (4) Add (5) to dry granules. Since then, the mixture is made into compressed tablets with bi-planar, double-sided, and indentations on one side. Tablet diameter: 9 mm 28 Contains 350 liters of Beijing birch chain -119- This paper is designed to meet national standards (CNS) A4 specifications (210X297 mm) 350.0 mg 136.0 mg 80.0 mg 30.0 mg 4.0 ¾ ¾ Central Standard of the Ministry of Economic Affairs Printed by the Consumer Cooperative of the Bureau A6 B6 V. Description of the invention (118) Sister-in-law: (1) Active substance (2) Lactose (3) Corn starch (4) Polyvinyl pyrrolidone (5) Preparation of magnesium stearate 600.0 mg : (1), (2) and (3) are mixed together and granulated with the aqueous solution of (4). Add (5) to the dry granules. The tablet has two sides? I plane, double side, and indentation on one side. The diameter of the tablet: 12 mm. When the example 29 contains 10 ¾ competing living creatures II: (1 ) Active substance 50.0 mg (2) Anhydrous corn starch 58.0 mg (3) Powdered lactose 50.0 g (4) Magnesium stearate 2.0 mg 160.0 g g Preparation: (1) and (3)-same mashing. This mashing The crushed material is added to the mixture of (2) and (4) with the bottom of the mixture. The powder mixture is filled in a capsule-filled container with No. 3 hard gelatin. Round 120 paper size. ) 肀 4 specifications (210X297mm): (Please read the precautions on the back before filling this page)
350. 0毫克 46.0毫克 30.0毫克 4.0¾¾ 43 0.0毫克 A6 B6 五、發明説明(119 ) 膠囊中。 窗淪例·?Ω 含:畜京活件物皙夕瞭蠹 姐成: (1) 活性物質 (2) 無水玉米澱粉 (3) 粉末化乳糖 (4) 硬脂酸鎂 製備: (1)與(3) —同搗碎。此搗碎物在徹底混合下加入至(2) 和(4)之混合物中。 此粉末的混合物在膠囊填充機器中裝入0號硬明膠橢圓 膠囊中。 {請先閲讀背面之注意事項再填寫本頁) -裝 訂 經濟部中央標準局員工消费合作社印製 -121 - 本紙張尺度逋用中國國家標準(CNS)甲4规格(210X297公釐)35.0 mg 46.0 mg 30.0 mg 4.0¾¾ 43 0.0 mg A6 B6 V. Description of the invention (119) Capsule. Example of window degradation? Ω Contains: Live-birth of the living animal Xi Xi Li Xiu Cheng: (1) Active substance (2) Anhydrous corn starch (3) Powdered lactose (4) Preparation of magnesium stearate: (1) and (3) — Same as mashing. This mash is added to the mixture of (2) and (4) with thorough mixing. This powder mixture was filled in a capsule-filling machine into a # 0 hard gelatin oval capsule. (Please read the notes on the back before filling this page)-Binding Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -121-This paper uses the Chinese National Standard (CNS) A4 specification (210X297 mm)
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4305388A DE4305388A1 (en) | 1993-02-22 | 1993-02-22 | Cyclic derivatives, pharmaceutical compositions containing these compounds and process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW384286B true TW384286B (en) | 2000-03-11 |
Family
ID=6481038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083101259A TW384286B (en) | 1993-02-22 | 1994-02-17 | Novel cyclic urea derivatives and their use in inhibiting cell aggregation and thrombosis |
Country Status (5)
| Country | Link |
|---|---|
| BR (1) | BR1100484A (en) |
| DE (1) | DE4305388A1 (en) |
| RU (1) | RU2126002C1 (en) |
| TW (1) | TW384286B (en) |
| ZA (1) | ZA941159B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120004876B (en) * | 2023-11-16 | 2026-02-06 | 英矽智能科技(上海)有限公司 | Protein tyrosine phosphatase inhibitors and their applications |
| CN117343052B (en) * | 2023-12-04 | 2024-02-06 | 英矽智能科技(上海)有限公司 | Protein tyrosine phosphatase inhibitors and their applications |
-
1993
- 1993-02-22 DE DE4305388A patent/DE4305388A1/en not_active Withdrawn
-
1994
- 1994-02-17 TW TW083101259A patent/TW384286B/en not_active IP Right Cessation
- 1994-02-21 ZA ZA941159A patent/ZA941159B/en unknown
- 1994-02-21 RU RU94006007A patent/RU2126002C1/en active
-
1997
- 1997-05-06 BR BR1100484-3A patent/BR1100484A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2126002C1 (en) | 1999-02-10 |
| BR1100484A (en) | 2000-08-01 |
| ZA941159B (en) | 1995-08-21 |
| DE4305388A1 (en) | 1994-08-25 |
| RU94006007A (en) | 1997-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60002554T2 (en) | PYRAZINO (AZA) indole derivatives | |
| JP3545446B2 (en) | Cyclic derivatives, pharmaceutical compositions containing these compounds and methods for their preparation | |
| AU2009237650B2 (en) | Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 | |
| TW426684B (en) | Tricyclic benzazepine vasopressin antagonists | |
| AU2006232660B2 (en) | 1H-Pyrazole 4-Carboxylamides, their preparation and their use as 11Beta-hydroxysteroid dehydrogenase | |
| TW200305423A (en) | N-carbamoyl nitrogen-containing condensed ring compound and medicament containing same as active ingredient | |
| WO2001056607A1 (en) | Integrin expression inhibitors | |
| TW200916446A (en) | Chiral cis-imidazolines | |
| MX2011005449A (en) | Pyridazinone derivatives. | |
| AU2007284542A1 (en) | Tricyclic compounds and its use as tyrosine kinase modulators | |
| EA019554B1 (en) | Amino pyrazole compound | |
| EP3700911A1 (en) | Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same | |
| CN102066378A (en) | 3-(3-Pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors | |
| EP2265582B1 (en) | Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. | |
| TWI222449B (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
| JPH0565288A (en) | Novel acylamino-substituted hetrazepine derivative, process for producing the same, and pharmaceutical composition containing the same | |
| EP2294068B1 (en) | 1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof | |
| CN101305004A (en) | Novel diazabicyclic aryl derivatives and their medical use | |
| TW200418469A (en) | CCK-1 receptor modulators | |
| TW384286B (en) | Novel cyclic urea derivatives and their use in inhibiting cell aggregation and thrombosis | |
| US20230014137A1 (en) | Compound having lysophosphatidic acid receptor agonist activity and pharmaceutical use thereof | |
| FR2960876A1 (en) | 3,4-DIHYDROPYRROLO [1,2-A] PYRAZINE-2,8 (1H) -DICARBOXAMIDE DERIVATIVES FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE. | |
| JP2005517705A (en) | Benzenesulfonamide derivatives and their use as dopamine D3 and D2 receptor ligands | |
| TW589312B (en) | Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression | |
| CN101341151A (en) | Diazepinones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent | ||
| MM4A | Annulment or lapse of patent due to non-payment of fees |